No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1azcA, 0.7970, 1.90, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
2, 1azbA, 0.7969, 1.90, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
3, 2azaA, 0.7968, 1.97, 0.161, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
4, 1azbB, 0.7967, 1.88, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
5, 1azcB, 0.7966, 1.88, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
6, 1dz0A, 0.7964, 1.76, 0.138, 129, 123, REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
7, 1dyzA, 0.7964, 1.75, 0.138, 129, 123, OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
8, 1aizB, 0.7961, 1.90, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
9, 1aizA, 0.7958, 1.93, 0.161, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
10, 1uriA, 0.7956, 1.78, 0.154, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
11, 1uriB, 0.7952, 1.85, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
12, 1a4aA, 0.7950, 1.99, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
13, 2azaB, 0.7945, 1.97, 0.161, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
14, 1a4aB, 0.7936, 1.92, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
15, 1cuoA, 0.7927, 1.93, 0.177, 129, 124, CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J
16, 1a4bA, 0.7923, 1.95, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
17, 2ccwA, 0.7922, 1.82, 0.138, 129, 123, CRYSTAL STRUCTURE OF AZURIN II AT ATOMIC RESOLUTION (1.13 ANGSTROM)
18, 1rkrA, 0.7921, 2.00, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
19, 1rkrC, 0.7916, 2.02, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
20, 1rkrD, 0.7913, 2.02, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
21, 1uatA, 0.7912, 1.97, 0.177, 129, 124, THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ-ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J
22, 1rkrB, 0.7909, 2.02, 0.161, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
23, 1a4cB, 0.7904, 1.91, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
24, 1a4bB, 0.7897, 1.94, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
25, 2oj1B, 0.7887, 1.92, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
26, 2tsbA, 0.7881, 1.80, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
27, 1a4cD, 0.7880, 2.04, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
28, 4ko5B, 0.7877, 1.89, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
29, 1a4cA, 0.7876, 2.02, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
30, 2oj1A, 0.7872, 1.92, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
31, 1a4cC, 0.7872, 1.91, 0.154, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
32, 6mjtB, 0.7871, 1.99, 0.154, 128, 123, AZURIN 122F/124W/126RE 
33, 2tsaA, 0.7871, 1.81, 0.139, 128, 122, AZURIN MUTANT M121A
34, 1nwpA, 0.7871, 1.87, 0.138, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
35, 1jzjA, 0.7870, 1.94, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
36, 4hz1D, 0.7866, 1.87, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
37, 3iboC, 0.7866, 1.89, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
38, 4ko6C, 0.7863, 1.95, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
39, 3azuA, 0.7863, 1.83, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
40, 2tsbD, 0.7859, 1.83, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
41, 2tsaD, 0.7857, 1.83, 0.131, 128, 122, AZURIN MUTANT M121A
42, 3azuD, 0.7856, 1.82, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
43, 1gr7B, 0.7856, 1.71, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
44, 6gyiB, 0.7851, 1.81, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
45, 4ko6B, 0.7851, 1.96, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
46, 1gr7C, 0.7847, 1.72, 0.157, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
47, 6gyiC, 0.7846, 2.03, 0.146, 128, 123, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
48, 1jziA, 0.7846, 2.00, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
49, 3ugeD, 0.7844, 1.84, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
50, 1e5zD, 0.7844, 1.83, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
51, 4ko5A, 0.7843, 1.97, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
52, 1vlxD, 0.7843, 1.83, 0.139, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
53, 1jzhA, 0.7843, 2.02, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83)
54, 5azuD, 0.7841, 1.83, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
55, 1jzeA, 0.7841, 2.02, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83)
56, 1jvoD, 0.7841, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
57, 1vlxC, 0.7840, 2.03, 0.138, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
58, 1jvoJ, 0.7840, 1.83, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
59, 1jvoG, 0.7839, 1.83, 0.139, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
60, 1jvoB, 0.7839, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
61, 1e5zA, 0.7839, 1.83, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
62, 4qlwA, 0.7838, 1.84, 0.131, 128, 122, AZURIN MUTANT M121E WITH IRON
63, 2h47C, 0.7838, 1.93, 0.106, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 1)
64, 1nwoB, 0.7838, 1.94, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
65, 2azuA, 0.7837, 1.84, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
66, 1jvoE, 0.7837, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
67, 1jvoC, 0.7837, 1.84, 0.139, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
68, 1e5zC, 0.7837, 2.01, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
69, 1xb8A, 0.7836, 1.85, 0.139, 127, 122, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
70, 1nwoA, 0.7836, 1.94, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
71, 1e65A, 0.7835, 1.83, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
72, 1e5yD, 0.7835, 1.83, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
73, 5azuC, 0.7834, 2.02, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
74, 4mfhC, 0.7834, 2.00, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
75, 4ko6A, 0.7834, 1.98, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
76, 2tsaB, 0.7834, 1.85, 0.131, 128, 122, AZURIN MUTANT M121A
77, 1jvoL, 0.7834, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
78, 4kobD, 0.7833, 1.99, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
79, 2azuB, 0.7833, 1.86, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
80, 1nwpB, 0.7833, 1.92, 0.130, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
81, 1jvoI, 0.7833, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
82, 1etjC, 0.7833, 1.83, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
83, 1e65D, 0.7833, 1.83, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
84, 3azuC, 0.7832, 1.85, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
85, 1jvoH, 0.7832, 1.85, 0.139, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
86, 1jvoF, 0.7831, 1.84, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
87, 1gr7D, 0.7831, 1.91, 0.156, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
88, 1gr7A, 0.7831, 1.91, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
89, 1e65C, 0.7831, 2.02, 0.138, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
90, 1e5yA, 0.7831, 1.83, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
91, 5azuA, 0.7830, 1.85, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
92, 4ko9D, 0.7830, 2.00, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
93, 3fswB, 0.7830, 2.05, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
94, 1jvoA, 0.7830, 1.84, 0.139, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
95, 3jtbD, 0.7829, 2.01, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
96, 2i7sD, 0.7829, 1.97, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
97, 1i53A, 0.7829, 2.01, 0.138, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
98, 4ko9C, 0.7828, 1.99, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
99, 4ko7D, 0.7828, 1.96, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
100, 2tsaC, 0.7828, 1.86, 0.139, 128, 122, AZURIN MUTANT M121A
101, 4kobC, 0.7827, 1.97, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
102, 1ilsD, 0.7827, 1.83, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
103, 1e5zB, 0.7827, 1.89, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
104, 2xv3A, 0.7826, 2.05, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
105, 5azuB, 0.7824, 1.89, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
106, 4azuD, 0.7824, 1.84, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
107, 2tsbC, 0.7824, 1.86, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
108, 1jvoK, 0.7824, 1.85, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
109, 1azrD, 0.7824, 1.84, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
110, 4hz1A, 0.7823, 1.87, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
111, 2fnwB, 0.7823, 1.77, 0.139, 128, 122, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
112, 1jzgA, 0.7823, 2.06, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83)
113, 1etjD, 0.7823, 1.84, 0.131, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
114, 3fszA, 0.7822, 2.04, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
115, 2tsbB, 0.7822, 1.86, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
116, 1jziB, 0.7822, 2.03, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
117, 2idfB, 0.7821, 2.03, 0.138, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
118, 2idfA, 0.7821, 2.03, 0.138, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
119, 1azrC, 0.7821, 2.05, 0.138, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
120, 6mjsA, 0.7820, 1.95, 0.154, 128, 123, AZURIN 122W/124W/126RE 
121, 3ugeC, 0.7820, 2.06, 0.138, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
122, 1nzrD, 0.7819, 1.84, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
123, 1jzjB, 0.7819, 2.11, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
124, 1jzfA, 0.7819, 2.06, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83)
125, 1e5yC, 0.7819, 2.06, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
126, 4azuA, 0.7818, 1.85, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
127, 3iboB, 0.7818, 1.99, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
128, 1vlxA, 0.7818, 1.85, 0.139, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
129, 6gyiD, 0.7817, 1.83, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
130, 3azuB, 0.7817, 1.86, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
131, 1ezlA, 0.7817, 1.84, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
132, 1e67C, 0.7817, 2.05, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
133, 1e67A, 0.7817, 1.84, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
134, 6iavA, 0.7816, 1.84, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
135, 4azuC, 0.7816, 2.05, 0.138, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
136, 1nzrC, 0.7816, 2.05, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
137, 1iluK, 0.7816, 1.88, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
138, 2azuD, 0.7815, 1.86, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
139, 1e67D, 0.7815, 1.85, 0.139, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
140, 4jknA, 0.7814, 1.85, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
141, 2i7sB, 0.7813, 1.94, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
142, 6mjrA, 0.7812, 2.04, 0.154, 128, 123, AZURIN 122W/124F/126RE 
143, 4ko7C, 0.7812, 2.03, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
144, 3ft0B, 0.7812, 2.06, 0.145, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
145, 3ugeA, 0.7811, 1.86, 0.139, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
146, 2xv3B, 0.7811, 2.08, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
147, 2azuC, 0.7811, 1.88, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
148, 1r1cA, 0.7811, 1.84, 0.172, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
149, 1ilsA, 0.7811, 1.85, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
150, 4qlwC, 0.7810, 1.84, 0.131, 128, 122, AZURIN MUTANT M121E WITH IRON
151, 1xb3A, 0.7810, 1.96, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
152, 1jvlB, 0.7810, 2.04, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
153, 1jvlA, 0.7810, 2.04, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
154, 3ft0A, 0.7809, 2.07, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
155, 1e67B, 0.7809, 1.89, 0.139, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
156, 4hz1C, 0.7808, 1.88, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
157, 1i53B, 0.7808, 2.00, 0.138, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
158, 6iavB, 0.7807, 1.84, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
159, 4azuB, 0.7807, 1.89, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
160, 1ilsB, 0.7807, 1.88, 0.131, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
161, 1e5yB, 0.7807, 1.90, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
162, 1aznA, 0.7807, 1.88, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
163, 4jknB, 0.7806, 2.06, 0.146, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
164, 1vlxB, 0.7806, 1.90, 0.139, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
165, 1nzrB, 0.7806, 1.89, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
166, 1ezlD, 0.7806, 1.91, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
167, 4mfhB, 0.7805, 2.06, 0.130, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
168, 1xb6A, 0.7805, 2.00, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
169, 1nzrA, 0.7805, 1.86, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
170, 1ilsC, 0.7805, 2.06, 0.130, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
171, 6iavC, 0.7804, 1.87, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
172, 4kobA, 0.7804, 2.01, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
173, 3u25B, 0.7804, 1.89, 0.156, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
174, 1xb8C, 0.7804, 1.76, 0.149, 126, 121, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
175, 1ag0B, 0.7804, 2.02, 0.130, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
176, 1ag0A, 0.7804, 2.02, 0.130, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
177, 4ko7B, 0.7803, 2.05, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
178, 3jt2A, 0.7803, 1.86, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
179, 3fszB, 0.7803, 2.08, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
180, 2i7sC, 0.7803, 2.00, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
181, 3jtbA, 0.7802, 2.06, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
182, 2gi0A, 0.7802, 2.05, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
183, 1etjA, 0.7802, 1.89, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
184, 6mjsB, 0.7801, 1.76, 0.157, 126, 121, AZURIN 122W/124W/126RE 
185, 6mjrC, 0.7801, 1.88, 0.156, 128, 122, AZURIN 122W/124F/126RE 
186, 5i28J, 0.7801, 2.00, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
187, 4ko6D, 0.7801, 2.05, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
188, 1iluI, 0.7801, 1.93, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
189, 1azrA, 0.7801, 1.86, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
190, 2iaaC, 0.7800, 2.00, 0.106, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 2)
191, 5i28G, 0.7799, 1.99, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
192, 4jknC, 0.7799, 2.10, 0.138, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
193, 3jt2B, 0.7799, 1.88, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
194, 2h3xF, 0.7799, 1.96, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
195, 2h3xC, 0.7799, 1.96, 0.114, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
196, 1azrB, 0.7799, 1.89, 0.148, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
197, 5i26A, 0.7798, 1.99, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
198, 1r1cD, 0.7797, 1.96, 0.154, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
199, 1ov8C, 0.7796, 1.94, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
200, 1ov8A, 0.7796, 1.94, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
201, 4ko9A, 0.7795, 2.03, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
202, 3fpyA, 0.7795, 2.05, 0.122, 128, 123, AZURIN C112D/M121L
203, 2ghzA, 0.7795, 2.05, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
204, 1ov8B, 0.7795, 1.94, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
205, 1iluA, 0.7795, 1.88, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
206, 3jtbB, 0.7794, 1.83, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
207, 3u25A, 0.7793, 1.93, 0.148, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
208, 3iboD, 0.7792, 2.00, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
209, 1ov8D, 0.7792, 1.94, 0.179, 139, 123, AURACYANIN B STRUCTURE IN SPACE GROUP P65
210, 1e65B, 0.7792, 1.91, 0.139, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
211, 4ko7A, 0.7791, 2.06, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
212, 4ko9B, 0.7790, 2.03, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
213, 2i7oA, 0.7790, 1.97, 0.138, 128, 123, STRUCTURE OF RE(47-DIMETHYL-PHEN)(THR124HIS)(LYS122TRP)(HIS83GLN) AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
214, 6mjsD, 0.7789, 1.78, 0.157, 126, 121, AZURIN 122W/124W/126RE 
215, 3ugeB, 0.7789, 1.91, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
216, 1qhqA, 0.7789, 1.95, 0.179, 139, 123, AURACYANIN A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS
217, 1iluD, 0.7789, 1.92, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
218, 1aznB, 0.7789, 1.88, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
219, 6gyiA, 0.7788, 1.85, 0.139, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
220, 4kobB, 0.7788, 2.03, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
221, 2gi0B, 0.7787, 2.07, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
222, 4k9jA, 0.7786, 1.88, 0.148, 127, 122, STRUCTURE OF RE(CO)3(47-DIMETHYL-PHEN)(THR126HIS)(LYS122TRP) (HIS83GLU)(TRP48PHE)(TYR72PHE)(TYR108PHE)AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
223, 1bexB, 0.7786, 2.13, 0.138, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
224, 4mfhA, 0.7785, 2.05, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
225, 3jtbC, 0.7785, 2.09, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
226, 2i7sA, 0.7785, 2.00, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
227, 1iluM, 0.7785, 1.89, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
228, 1iluB, 0.7785, 1.94, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
229, 1etjB, 0.7785, 1.88, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
230, 4jknD, 0.7784, 1.88, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
231, 6iavD, 0.7782, 1.83, 0.139, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
232, 1ezlB, 0.7782, 1.93, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
233, 5i28P, 0.7781, 2.03, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
234, 2ghzB, 0.7780, 2.07, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
235, 1bexA, 0.7780, 2.13, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
236, 1iluE, 0.7779, 1.91, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
237, 4qlwB, 0.7776, 2.08, 0.130, 128, 123, AZURIN MUTANT M121E WITH IRON
238, 1joiA, 0.7775, 2.12, 0.130, 128, 123, STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN
239, 1iluH, 0.7775, 1.93, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
240, 4bwwA, 0.7773, 2.05, 0.131, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
241, 1iluF, 0.7772, 1.90, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
242, 5i28A, 0.7771, 2.03, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
243, 1iluL, 0.7771, 1.94, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
244, 1iluC, 0.7771, 1.94, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
245, 6mjsC, 0.7768, 1.73, 0.158, 125, 120, AZURIN 122W/124W/126RE 
246, 5i28H, 0.7767, 2.06, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
247, 4bwwB, 0.7767, 2.06, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
248, 5i26B, 0.7763, 2.02, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
249, 3fq1A, 0.7763, 2.09, 0.130, 128, 123, AZURIN C112D/M121I
250, 5i28N, 0.7762, 2.05, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
251, 1r1cB, 0.7759, 1.92, 0.164, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
252, 5i28D, 0.7758, 2.06, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
253, 3fswD, 0.7758, 1.89, 0.139, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
254, 1aznD, 0.7758, 1.93, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
255, 4bwwC, 0.7757, 2.07, 0.131, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
256, 1iluG, 0.7757, 1.93, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
257, 5i28M, 0.7755, 2.07, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
258, 5i28K, 0.7755, 2.06, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
259, 1aznC, 0.7755, 1.92, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
260, 3iboA, 0.7754, 2.01, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
261, 4kocA, 0.7751, 2.09, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I/Y108F)
262, 6mjtA, 0.7750, 1.92, 0.156, 128, 122, AZURIN 122F/124W/126RE 
263, 5i28O, 0.7749, 2.08, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
264, 5i28E, 0.7748, 2.05, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
265, 5i28C, 0.7748, 2.09, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
266, 3fqyA, 0.7748, 2.11, 0.130, 128, 123, AZURIN C112D
267, 2hxaB, 0.7748, 2.03, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
268, 4hz1B, 0.7747, 2.01, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
269, 2fnwA, 0.7747, 2.01, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
270, 4bwwD, 0.7744, 1.86, 0.140, 127, 121, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
271, 3ay2A, 0.7743, 1.96, 0.107, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
272, 5i28I, 0.7742, 2.10, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
273, 5i28B, 0.7740, 2.09, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
274, 4qlwD, 0.7739, 1.96, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
275, 3ay2B, 0.7739, 1.96, 0.107, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
276, 6mjrD, 0.7738, 1.95, 0.156, 128, 122, AZURIN 122W/124F/126RE 
277, 1xb6B, 0.7737, 2.07, 0.138, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
278, 2iweA, 0.7734, 2.14, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
279, 5i28F, 0.7732, 2.06, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
280, 5i28L, 0.7729, 2.08, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
281, 3in0C, 0.7727, 1.95, 0.131, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
282, 1r1cC, 0.7726, 2.01, 0.156, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
283, 3np3A, 0.7722, 2.12, 0.130, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
284, 3in2A, 0.7720, 1.94, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
285, 1xb3B, 0.7718, 2.09, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
286, 4hhgA, 0.7717, 2.01, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN RUH107NO YOH109
287, 6mjrB, 0.7715, 2.01, 0.156, 128, 122, AZURIN 122W/124F/126RE 
288, 3fswA, 0.7715, 1.96, 0.139, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
289, 1ezlC, 0.7715, 2.23, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
290, 2iweG, 0.7712, 2.18, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
291, 4hhwB, 0.7711, 2.03, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
292, 2iweJ, 0.7707, 2.19, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
293, 2n0mA, 0.7706, 2.08, 0.106, 130, 123, THE SOLUTION STRUCTURE OF THE SOLUBLE FORM OF THE LIPID-MODIFIED AZURIN FROM NEISSERIA GONORRHOEAE
294, 3in0A, 0.7705, 1.98, 0.131, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
295, 3fq2A, 0.7705, 2.12, 0.130, 128, 123, AZURIN C112D/M121F
296, 3np4A, 0.7700, 2.13, 0.122, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
297, 1azuA, 0.7698, 1.86, 0.149, 126, 121, STRUCTURAL FEATURES OF AZURIN AT 2.7 ANGSTROMS RESOLUTION
298, 2iweD, 0.7695, 2.20, 0.130, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
299, 3in0B, 0.7690, 1.97, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
300, 2hx8B, 0.7687, 2.09, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
301, 4hipA, 0.7685, 2.03, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
302, 4hhwA, 0.7685, 2.16, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
303, 4hipB, 0.7682, 2.07, 0.156, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
304, 3in0D, 0.7680, 2.03, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
305, 2hxaA, 0.7679, 1.87, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
306, 4wkxB, 0.7677, 2.14, 0.122, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
307, 5i26D, 0.7675, 2.09, 0.140, 126, 121, AZURIN T30R1 CRYSTAL FORM I
308, 2hx7B, 0.7673, 2.10, 0.148, 127, 122, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
309, 2hx8A, 0.7668, 1.87, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
310, 2hx9A, 0.7667, 1.89, 0.150, 124, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
311, 3n2jE, 0.7664, 2.17, 0.131, 128, 122, AZURIN H117G OXIDIZED FORM
312, 3n2jL, 0.7659, 2.17, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
313, 3n2jK, 0.7655, 2.13, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
314, 3n2jF, 0.7655, 2.14, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
315, 5i26C, 0.7650, 1.82, 0.143, 124, 119, AZURIN T30R1 CRYSTAL FORM I
316, 3n2jD, 0.7645, 2.18, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
317, 3n2jI, 0.7641, 2.34, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
318, 3n2jB, 0.7641, 2.34, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
319, 2hx9B, 0.7638, 2.07, 0.149, 125, 121, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
320, 3n2jA, 0.7637, 2.17, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
321, 2hx7A, 0.7636, 1.91, 0.150, 125, 120, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
322, 3n2jJ, 0.7632, 2.33, 0.138, 128, 123, AZURIN H117G OXIDIZED FORM
323, 3n2jG, 0.7629, 2.19, 0.139, 128, 122, AZURIN H117G OXIDIZED FORM
324, 3n2jH, 0.7621, 2.18, 0.148, 128, 122, AZURIN H117G OXIDIZED FORM
325, 3n2jC, 0.7619, 2.37, 0.146, 128, 123, AZURIN H117G OXIDIZED FORM
326, 4wkxA, 0.7614, 2.21, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
327, 1cc3B, 0.7611, 2.41, 0.136, 130, 125, PURPLE CUA CENTER
328, 4qktB, 0.7610, 2.10, 0.132, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
329, 2aanA, 0.7582, 1.95, 0.192, 123, 120, AURACYANIN A: A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUMCHLOROFLEXUS AURANTIACUS
330, 2ftaC, 0.7571, 1.93, 0.143, 124, 119, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
331, 1cc3A, 0.7569, 2.51, 0.136, 130, 125, PURPLE CUA CENTER
332, 4qktA, 0.7566, 2.16, 0.132, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
333, 3fswC, 0.7549, 1.98, 0.143, 124, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
334, 2ftaD, 0.7529, 1.79, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
335, 2ftaB, 0.7518, 1.91, 0.144, 123, 118, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
336, 2ftaA, 0.7509, 1.80, 0.154, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
337, 3oqrA, 0.7471, 2.13, 0.126, 123, 119, C112D/M121E AZURIN PH 10.0
338, 2ft7A, 0.7448, 1.89, 0.145, 122, 117, STRUCTURE OF CU(I)AZURIN AT PH 6 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
339, 2ft8A, 0.7440, 1.91, 0.145, 122, 117, STRUCTURE OF CU(I)AZURIN PH8 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
340, 2xv0A, 0.7437, 2.21, 0.142, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.8
341, 2ft6A, 0.7437, 1.90, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
342, 2xv2A, 0.7383, 2.28, 0.142, 124, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.2
343, 3fs9A, 0.7371, 2.29, 0.133, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM)
344, 3fsaA, 0.7304, 2.31, 0.134, 122, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM); CHEMICALLY REDUCED.
345, 5yt7C, 0.6905, 2.09, 0.128, 130, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
346, 5yt7B, 0.6887, 2.01, 0.138, 132, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
347, 5yt7D, 0.6870, 2.15, 0.128, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
348, 5yt7A, 0.6870, 2.10, 0.119, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
349, 2yqbA, 0.6575, 1.94, 0.223, 454, 103, STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION
350, 6fjaA, 0.6573, 2.03, 0.214, 455, 103, CRYSTAL STRUCTURE OF T2D THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
351, 3ziyA, 0.6572, 2.02, 0.214, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE  FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION
352, 3fsvA, 0.6572, 2.40, 0.102, 118, 108, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAHAAAM)
353, 5oboA, 0.6570, 2.02, 0.214, 456, 103, CRYSTAL STRUCTURE OF NITRITE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
354, 3zbmA, 0.6570, 1.94, 0.214, 455, 103, STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII
355, 4ax3C, 0.6566, 2.03, 0.214, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
356, 1ndrC, 0.6565, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
357, 1ndrB, 0.6565, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
358, 1ndrA, 0.6565, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
359, 5ocbA, 0.6564, 2.04, 0.214, 453, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
360, 4ax3D, 0.6563, 2.03, 0.214, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
361, 5ocfA, 0.6560, 1.96, 0.214, 455, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND TO THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
362, 1ndsA, 0.6560, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
363, 6f1qA, 0.6559, 1.96, 0.214, 456, 103, CRYSTAL STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII IN I213 SPACE GROUP 
364, 1ndsC, 0.6557, 1.94, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
365, 1ndsB, 0.6557, 1.95, 0.214, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
366, 4ax3A, 0.6555, 2.04, 0.214, 456, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
367, 2avfE, 0.6554, 1.97, 0.233, 315, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
368, 4ax3B, 0.6553, 1.96, 0.214, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
369, 2avfC, 0.6548, 1.96, 0.233, 316, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
370, 1gs6X, 0.6548, 1.97, 0.233, 336, 103, CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
371, 2vm4A, 0.6545, 1.98, 0.243, 334, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE IN SPACE GROUP R3 - 2 OF 2
372, 1gs8A, 0.6545, 1.97, 0.243, 336, 103, CRYSTAL STRUCTURE OF  MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
373, 5onyA, 0.6544, 1.98, 0.243, 335, 103, AS-ISOLATED RESTING STATE COPPER NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
374, 1waeA, 0.6544, 1.98, 0.243, 334, 103, CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
375, 1wa1X, 0.6544, 1.98, 0.243, 335, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
376, 1ndtA, 0.6544, 1.97, 0.243, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
377, 1hauA, 0.6544, 1.98, 0.243, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9 A RESOLUTION
378, 2xxfB, 0.6543, 1.97, 0.243, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
379, 2xxfA, 0.6543, 1.97, 0.243, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
380, 2vw6B, 0.6543, 1.98, 0.243, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
381, 1oe1A, 0.6543, 1.98, 0.243, 335, 103, ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
382, 1gs7A, 0.6543, 1.98, 0.243, 336, 103, CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
383, 5b1kA, 0.6542, 1.98, 0.243, 334, 103, CRYSTAL STRUCTURE OF THE CHLORIDE-BOUND FORM OF BLUE COPPER NITRITE REDUCTASE
384, 4cspF, 0.6542, 1.98, 0.243, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
385, 2vw4B, 0.6542, 1.98, 0.243, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
386, 2jfcA, 0.6542, 1.98, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
387, 1wa0X, 0.6542, 1.98, 0.243, 335, 103, CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
388, 2xwzD, 0.6541, 1.98, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
389, 2xwzA, 0.6541, 1.98, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
390, 2jfcF, 0.6541, 1.98, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
391, 1oe2A, 0.6541, 1.98, 0.243, 334, 103, ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
392, 1nibB, 0.6541, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
393, 1hawA, 0.6541, 1.98, 0.243, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION
394, 4cspA, 0.6540, 1.99, 0.243, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
395, 2vw6A, 0.6540, 1.99, 0.243, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
396, 2nrdA, 0.6540, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
397, 1mzzC, 0.6540, 1.98, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
398, 2xwzF, 0.6539, 1.98, 0.243, 334, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
399, 2vw7A, 0.6539, 1.99, 0.243, 335, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
400, 1kcbA, 0.6539, 1.98, 0.233, 333, 103, CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION
401, 2zonC, 0.6537, 1.99, 0.243, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
402, 2xx0A, 0.6537, 1.97, 0.243, 335, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
403, 2jfcD, 0.6537, 1.99, 0.223, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
404, 1bq5A, 0.6537, 1.98, 0.243, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051
405, 5onxA, 0.6536, 1.99, 0.243, 335, 103, RESTING STATE COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY
406, 5b1jA, 0.6536, 1.99, 0.243, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
407, 2xx0B, 0.6536, 1.98, 0.243, 336, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
408, 2afnC, 0.6536, 1.98, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
409, 1oe3A, 0.6536, 1.98, 0.243, 335, 103, ATOMIC RESOLUTION STRUCTURE OF  HALF APO  NIR
410, 1nieA, 0.6536, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
411, 1nicA, 0.6536, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
412, 4cszA, 0.6535, 1.99, 0.243, 335, 103, STRUCTURE OF F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS WITH NITRITE BOUND
413, 2vw7B, 0.6535, 1.99, 0.243, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
414, 2zonA, 0.6534, 1.99, 0.243, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
415, 5i6pA, 0.6533, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 27.60 MGY
416, 2bp0B, 0.6533, 1.99, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
417, 1wa2X, 0.6533, 1.99, 0.243, 334, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND
418, 1ntdA, 0.6533, 1.98, 0.223, 336, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC
419, 1j9rC, 0.6533, 1.98, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
420, 2zonB, 0.6532, 1.99, 0.243, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
421, 2xxgC, 0.6532, 1.99, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
422, 2xwzE, 0.6532, 1.99, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
423, 2bp8B, 0.6532, 1.99, 0.233, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
424, 2bo0A, 0.6532, 1.99, 0.233, 335, 103, CRYSTAL STRUCTURE OF THE C130A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
425, 1rzqC, 0.6532, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
426, 1niaB, 0.6532, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
427, 5ogfA, 0.6531, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.27MGY 
428, 5ofhA, 0.6531, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
429, 2xx1A, 0.6531, 1.98, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
430, 1rzqB, 0.6531, 1.99, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
431, 1nidA, 0.6531, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
432, 5og6A, 0.6530, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.24MGY 
433, 5og3A, 0.6530, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
434, 5n8hA, 0.6530, 1.99, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 3.
435, 2zooA, 0.6530, 2.07, 0.223, 438, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM PSEUDOALTEROMONAS HALOPLANKTIS TAC125
436, 2xwzB, 0.6530, 1.99, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
437, 1j9rB, 0.6530, 1.98, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
438, 6gb8A, 0.6529, 1.99, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: SMALL CELL POLYMORPH DATASET 1 
439, 5oggA, 0.6529, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.30MGY 
440, 5i6oA, 0.6529, 1.99, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 20.70 MGY
441, 5d4iA, 0.6529, 1.98, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
442, 1rzpC, 0.6529, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
443, 1nibA, 0.6529, 1.98, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
444, 1niaC, 0.6529, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
445, 5og5A, 0.6528, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.21MGY 
446, 5og4A, 0.6528, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.18MGY 
447, 5og2A, 0.6528, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.09MGY 
448, 5ofgA, 0.6528, 1.99, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.06MGY 
449, 5n8gA, 0.6528, 2.00, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 2.
450, 2xx1F, 0.6528, 1.99, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
451, 2jfcB, 0.6528, 2.00, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
452, 6gtiA, 0.6527, 2.00, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.0 
453, 6gcgA, 0.6527, 2.00, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE POLYMORPH DATASET 15 
454, 6gbbA, 0.6527, 1.99, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE CELL POLYMORPH DATASET 1 
455, 5n8fA, 0.6527, 2.00, 0.233, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 1.
456, 5b1jB, 0.6527, 1.98, 0.243, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
457, 2bp8A, 0.6527, 1.99, 0.233, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
458, 1nifA, 0.6527, 2.00, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
459, 1nibC, 0.6527, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
460, 5i6nA, 0.6526, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 11.73 MGY
461, 2jfcE, 0.6526, 2.00, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
462, 2bwdA, 0.6526, 2.00, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO
463, 1j9tC, 0.6526, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
464, 6gtkA, 0.6525, 2.00, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.5 
465, 5offA, 0.6525, 2.00, 0.233, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.03MGY 
466, 2xxgA, 0.6525, 2.00, 0.243, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
467, 2bw5A, 0.6525, 2.00, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
468, 1npnB, 0.6525, 1.99, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
469, 1niaA, 0.6525, 1.99, 0.233, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
470, 6gtjA, 0.6524, 2.00, 0.233, 333, 103, NEUTRON CRYSTAL STRUCTURE FOR COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.8 A RESOLUTION 
471, 5i6lA, 0.6524, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 2.76 MGY
472, 3h56A, 0.6524, 2.00, 0.223, 335, 103, MET150LEU/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
473, 2afnB, 0.6524, 1.99, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
474, 6gtlA, 0.6523, 2.00, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.0 
475, 5i6kA, 0.6523, 2.00, 0.233, 334, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 0.69 MGY
476, 1j9tB, 0.6523, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
477, 6gbyA, 0.6522, 2.00, 0.233, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: NON- POLYMORPH SEPARATED DATASET 1 
478, 5i6mA, 0.6522, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 7.59 MGY
479, 2ppfC, 0.6522, 2.00, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
480, 2ppdC, 0.6522, 1.99, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
481, 2jfcC, 0.6522, 2.00, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
482, 2fjsC, 0.6522, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
483, 2bp0A, 0.6522, 2.00, 0.233, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
484, 1snrC, 0.6522, 1.99, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
485, 1rzpB, 0.6522, 2.00, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
486, 1npnC, 0.6522, 1.99, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
487, 1npjB, 0.6522, 1.99, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
488, 1e30A, 0.6522, 2.30, 0.162, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
489, 6gtnA, 0.6521, 2.01, 0.233, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.5 
490, 5tb7C, 0.6521, 1.99, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
491, 2xwzC, 0.6521, 2.00, 0.243, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
492, 2b08B, 0.6521, 2.00, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
493, 5ue6F, 0.6520, 1.99, 0.223, 307, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
494, 5d4iC, 0.6520, 2.00, 0.233, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
495, 2y1aA, 0.6520, 2.00, 0.233, 332, 103, CRYSTAL STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH BOUND NO
496, 2ppeC, 0.6520, 1.99, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
497, 2ppaC, 0.6520, 2.00, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
498, 2b08C, 0.6520, 2.00, 0.223, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
499, 1rzqA, 0.6520, 2.00, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
500, 5ofdA, 0.6519, 2.00, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
501, 5ofcA, 0.6519, 2.00, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 21.65MGY 
502, 2ppaB, 0.6519, 2.00, 0.233, 337, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
503, 2bwiA, 0.6519, 2.01, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
504, 1mzzA, 0.6519, 2.01, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
505, 1l9pC, 0.6519, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
506, 1l9pB, 0.6519, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
507, 1j9sB, 0.6519, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
508, 1as8B, 0.6519, 2.00, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
509, 6gt0A, 0.6518, 2.01, 0.233, 333, 103, NITRITE-BOUND COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
510, 5f7aB, 0.6518, 1.99, 0.233, 337, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
511, 5d4jB, 0.6518, 2.00, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
512, 2pp9C, 0.6518, 1.99, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
513, 2pp7C, 0.6518, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
514, 1sjmC, 0.6518, 2.00, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
515, 1mzzB, 0.6518, 2.01, 0.214, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
516, 1l9qB, 0.6518, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
517, 1l9oB, 0.6518, 1.99, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
518, 1j9tA, 0.6518, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
519, 6gsqA, 0.6517, 2.01, 0.233, 333, 103, OXIDISED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
520, 5ue6C, 0.6517, 2.00, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
521, 5tb7A, 0.6517, 1.99, 0.223, 312, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
522, 5f7bB, 0.6517, 1.99, 0.233, 337, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
523, 5d4hC, 0.6517, 2.00, 0.233, 339, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
524, 1npjC, 0.6517, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
525, 1l9rC, 0.6517, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
526, 1l9rB, 0.6517, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
527, 1l9qC, 0.6517, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
528, 1as8C, 0.6517, 2.00, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
529, 1as7B, 0.6517, 1.99, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
530, 1aq8B, 0.6517, 2.00, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
531, 2ppfB, 0.6516, 2.00, 0.233, 337, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
532, 2ppdB, 0.6516, 2.00, 0.223, 337, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
533, 2ppcC, 0.6516, 2.00, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
534, 2pp8B, 0.6516, 2.00, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
535, 2bw4A, 0.6516, 2.01, 0.233, 334, 103, ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
536, 1n70A, 0.6516, 2.01, 0.223, 334, 103, THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES
537, 1j9qC, 0.6516, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
538, 1as8A, 0.6516, 2.00, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
539, 5ue6I, 0.6515, 2.00, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
540, 5of8A, 0.6515, 2.01, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
541, 5f7bC, 0.6515, 2.00, 0.233, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
542, 5d4iB, 0.6515, 1.99, 0.233, 341, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
543, 5d4hA, 0.6515, 2.00, 0.233, 337, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
544, 3h4fB, 0.6515, 2.00, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
545, 2pp8C, 0.6515, 2.00, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
546, 2e86C, 0.6515, 2.00, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
547, 1zdsC, 0.6515, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
548, 1j9sC, 0.6515, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
549, 5ofeA, 0.6514, 2.01, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
550, 5of7A, 0.6514, 2.01, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
551, 5f7aC, 0.6514, 2.00, 0.233, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
552, 5d4hB, 0.6514, 2.00, 0.233, 341, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
553, 2ppeB, 0.6514, 2.00, 0.223, 337, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
554, 2pp9B, 0.6514, 2.00, 0.233, 337, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
555, 2pp8A, 0.6514, 2.00, 0.233, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
556, 2fjsB, 0.6514, 2.00, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
557, 1l9tC, 0.6514, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
558, 1l9sC, 0.6514, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
559, 1as7C, 0.6514, 2.00, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
560, 5d4jC, 0.6513, 2.00, 0.233, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
561, 5akrA, 0.6513, 2.01, 0.233, 337, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE BOUND STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE AT 0.87 A RESOLUTION
562, 4yscB, 0.6513, 2.00, 0.233, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
563, 3h4hB, 0.6513, 2.00, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
564, 2p80C, 0.6513, 2.00, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
565, 2fjsA, 0.6513, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
566, 2e86B, 0.6513, 2.00, 0.233, 337, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
567, 1snrB, 0.6513, 2.00, 0.233, 337, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
568, 1sjmB, 0.6513, 2.00, 0.233, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
569, 1l9tB, 0.6513, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
570, 1as6C, 0.6513, 2.00, 0.233, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
571, 1aq8C, 0.6513, 2.00, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
572, 6gt2A, 0.6512, 2.01, 0.233, 333, 103, REDUCED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
573, 3h4fC, 0.6512, 2.00, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
574, 2ppeA, 0.6512, 2.01, 0.223, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
575, 2dv6D, 0.6512, 2.00, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
576, 1kbwC, 0.6512, 2.00, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
577, 1kbvA, 0.6512, 2.00, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
578, 1j9rA, 0.6512, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
579, 5tb7B, 0.6511, 2.00, 0.223, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
580, 2pp7B, 0.6511, 2.00, 0.233, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
581, 1rzpA, 0.6511, 2.01, 0.233, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
582, 1l9sB, 0.6511, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
583, 1kbwF, 0.6511, 2.00, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
584, 1kbwB, 0.6511, 2.00, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
585, 1kbwA, 0.6511, 2.00, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
586, 1j9qB, 0.6511, 2.00, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
587, 3h4fA, 0.6510, 2.00, 0.233, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
588, 2ppfA, 0.6510, 2.01, 0.233, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
589, 2ppdA, 0.6510, 2.01, 0.223, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
590, 2ppcB, 0.6510, 2.00, 0.233, 337, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
591, 2ppaA, 0.6510, 2.00, 0.233, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
592, 2pp9A, 0.6510, 2.00, 0.233, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
593, 1snrA, 0.6510, 2.01, 0.233, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
594, 1npnA, 0.6510, 2.01, 0.223, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
595, 1mzyA, 0.6510, 2.02, 0.223, 331, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE
596, 1kbwE, 0.6510, 2.00, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
597, 1kbvD, 0.6510, 2.00, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
598, 1as6B, 0.6510, 2.00, 0.233, 336, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
599, 5ue6H, 0.6509, 2.00, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
600, 5of6A, 0.6509, 2.01, 0.233, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
601, 3h4hC, 0.6509, 2.00, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
602, 2a3tA, 0.6509, 2.02, 0.223, 328, 103, CU-CONTAINING NITRITE REDUCTASE
603, 1zdsB, 0.6509, 2.01, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
604, 1npjA, 0.6509, 2.00, 0.223, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
605, 1kbwD, 0.6509, 2.00, 0.223, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
606, 1as7A, 0.6509, 2.01, 0.233, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
607, 1as6A, 0.6509, 2.00, 0.233, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
608, 4yseB, 0.6508, 2.01, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
609, 2ppcA, 0.6508, 2.01, 0.233, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
610, 2p80B, 0.6508, 2.01, 0.233, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
611, 2b08A, 0.6508, 2.01, 0.223, 335, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
612, 2pp7A, 0.6507, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
613, 1j9sA, 0.6507, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
614, 1j9qA, 0.6507, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
615, 5ue6E, 0.6506, 2.01, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
616, 5n8iA, 0.6506, 2.02, 0.233, 334, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 100K REFERENCE DATASET.
617, 1sjmA, 0.6506, 2.01, 0.233, 335, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
618, 1l9rA, 0.6506, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
619, 5d4jA, 0.6505, 2.01, 0.233, 335, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
620, 2dwsA, 0.6505, 2.02, 0.223, 328, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 8.4 WITH BOUND NITRITE
621, 1l9pA, 0.6505, 2.01, 0.233, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
622, 5ue6B, 0.6504, 2.01, 0.223, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
623, 2e86A, 0.6504, 2.01, 0.233, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
624, 1zdqC, 0.6504, 2.01, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
625, 1kbvC, 0.6504, 2.01, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
626, 1aq8A, 0.6504, 2.01, 0.233, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
627, 4yseA, 0.6503, 2.01, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
628, 2dv6C, 0.6503, 2.01, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
629, 1l9tA, 0.6503, 2.02, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
630, 1kbvF, 0.6503, 2.01, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
631, 1e30B, 0.6503, 2.34, 0.162, 153, 105, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
632, 2dy2A, 0.6502, 2.02, 0.223, 329, 103, NITRITE REDUCTASE PH 6.0
633, 2dwtA, 0.6502, 2.03, 0.223, 329, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 6.0 WITH BOUND NITRITE
634, 5ue6D, 0.6501, 2.01, 0.223, 309, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
635, 2p80A, 0.6501, 2.02, 0.233, 335, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
636, 1zdqB, 0.6501, 2.02, 0.223, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
637, 1l9sA, 0.6501, 2.02, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
638, 1l9qA, 0.6501, 2.02, 0.233, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
639, 1kbvE, 0.6501, 2.01, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
640, 3h4hA, 0.6499, 2.02, 0.233, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
641, 1a8zA, 0.6499, 2.30, 0.171, 153, 105, STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS
642, 1gy2B, 0.6498, 2.31, 0.162, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
643, 2dv6F, 0.6497, 2.01, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
644, 2dv6B, 0.6497, 2.02, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
645, 2dv6A, 0.6497, 2.02, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
646, 1zv2A, 0.6497, 2.03, 0.223, 328, 103, CU-CONTAINING NITRITE REDUCTASE
647, 1kbvB, 0.6497, 2.01, 0.223, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
648, 1zdsA, 0.6495, 2.02, 0.223, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
649, 2dv6E, 0.6494, 2.02, 0.223, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
650, 5ue6G, 0.6493, 2.02, 0.223, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
651, 1a3zA, 0.6493, 2.33, 0.171, 150, 105, REDUCED RUSTICYANIN AT 1.9 ANGSTROMS
652, 2xx1D, 0.6492, 2.05, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
653, 2cakA, 0.6491, 2.30, 0.171, 154, 105, 1.27ANGSTROM STRUCTURE OF RUSTICYANIN FROM THIOBACILLUS FERROOXIDANS
654, 1zdqA, 0.6489, 2.03, 0.223, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
655, 5ue6A, 0.6487, 2.02, 0.223, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
656, 1gy1B, 0.6485, 2.35, 0.171, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
657, 1gy2A, 0.6484, 2.35, 0.162, 155, 105, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
658, 1gy1A, 0.6484, 2.32, 0.171, 154, 105, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
659, 1rcyA, 0.6483, 2.33, 0.171, 151, 105, RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS
660, 5of5A, 0.6481, 2.05, 0.233, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 
661, 4yseC, 0.6480, 2.04, 0.233, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
662, 2calA, 0.6475, 2.34, 0.162, 153, 105, CRYSTAL STRUCTURE OF HIS143MET RUSTICYANIN
663, 2xx1E, 0.6473, 2.07, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
664, 2xx1B, 0.6470, 2.08, 0.243, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
665, 2xx1C, 0.6469, 2.07, 0.243, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
666, 5zl1D, 0.6460, 1.85, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
667, 5zl1C, 0.6460, 1.85, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
668, 5zl1A, 0.6460, 1.85, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
669, 5zl1B, 0.6458, 1.85, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
670, 4knuD, 0.6405, 1.87, 0.220, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
671, 4knsC, 0.6403, 1.87, 0.210, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
672, 4knsB, 0.6402, 1.87, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
673, 4knsD, 0.6398, 1.87, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
674, 4knuF, 0.6396, 1.87, 0.220, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
675, 4knuC, 0.6396, 1.88, 0.220, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
676, 2avfD, 0.6395, 2.09, 0.238, 320, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
677, 4knsF, 0.6392, 1.89, 0.210, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
678, 4knuB, 0.6391, 1.68, 0.222, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
679, 4knsA, 0.6387, 1.88, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
680, 4knuA, 0.6385, 1.69, 0.232, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
681, 4kntC, 0.6381, 1.69, 0.222, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
682, 4kntA, 0.6381, 1.69, 0.232, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
683, 4knsE, 0.6381, 1.89, 0.220, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
684, 4kntB, 0.6378, 1.69, 0.232, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
685, 4knuE, 0.6375, 1.70, 0.232, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
686, 2avfA, 0.6373, 2.33, 0.228, 314, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
687, 4q89A, 0.6332, 2.47, 0.087, 501, 104, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
688, 1curA, 0.6332, 2.42, 0.162, 155, 105, REDUCED RUSTICYANIN NMR
689, 4q8bA, 0.6321, 2.48, 0.087, 499, 104, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
690, 4q8bB, 0.6303, 2.50, 0.087, 499, 104, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
691, 2bhfA, 0.6303, 2.79, 0.104, 504, 106, 3D STRUCTURE OF THE REDUCED FORM OF COTA
692, 1of0A, 0.6300, 2.49, 0.087, 502, 104, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS
693, 4yvuA, 0.6298, 2.64, 0.086, 506, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME IN THE ACID CONDITION PH5.6
694, 4yvnA, 0.6297, 2.50, 0.087, 505, 104, CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH ABTS AT A NOVEL BINDING SITE
695, 4akqA, 0.6297, 2.64, 0.086, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498D MUTANT
696, 4akpA, 0.6297, 2.64, 0.086, 504, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE:E498T MUTANT
697, 5zlmA, 0.6296, 2.50, 0.087, 502, 104, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H491C MUTANT; PH 8.0 
698, 3zdwA, 0.6296, 2.50, 0.087, 502, 104, SUBSTRATE AND DIOXYGEN BINDING TO THE ENDOSPORE COAT LACCASE COTA FROM BACILLUS SUBTILIS
699, 4akoA, 0.6295, 2.64, 0.086, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498L MUTANT
700, 1w8eA, 0.6294, 2.50, 0.087, 505, 104, 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE
701, 5zllA, 0.6293, 2.50, 0.087, 503, 104, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493C MUTANT; PH 8.0 
702, 4a67A, 0.6293, 2.80, 0.104, 504, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116E MUTANT
703, 4a68A, 0.6292, 2.80, 0.104, 502, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116N MUTANT
704, 4q89B, 0.6291, 2.52, 0.087, 499, 104, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
705, 5zljA, 0.6290, 2.50, 0.087, 503, 104, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME; PH8.0 
706, 5zlkA, 0.6286, 2.51, 0.087, 506, 104, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493A MUTANT; PH 8.0 
707, 4a66A, 0.6286, 2.80, 0.113, 501, 106, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116A MUTANT
708, 4ysaA, 0.6284, 1.73, 0.214, 294, 98, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
709, 2xllA, 0.6284, 2.45, 0.078, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
710, 1w6wA, 0.6284, 2.63, 0.105, 502, 105, 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE
711, 3x1gA, 0.6283, 1.75, 0.214, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS SHOWING TWO COORDINATION GEOMETRIES AT THE T2CU SITE
712, 2xllD, 0.6283, 2.45, 0.078, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
713, 2xllC, 0.6283, 2.46, 0.078, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
714, 2xllB, 0.6283, 2.45, 0.078, 533, 102, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
715, 1gskA, 0.6283, 2.63, 0.105, 502, 105, CRYSTAL STRUCTURE OF COTA AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS
716, 2x88A, 0.6281, 2.63, 0.105, 504, 105, CRYSTAL STRUCTURE OF HOLOCOTA
717, 2x87A, 0.6281, 2.63, 0.105, 504, 105, CRYSTAL STRUCTURE OF THE RECONSTITUTED COTA
718, 3wiaC, 0.6280, 1.98, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
719, 1qniE, 0.6280, 1.89, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
720, 3x1nA, 0.6279, 1.74, 0.204, 298, 98, NITRITE-BOUND THERMOSTABLE COPPER NITRITE REDUCTASE AT 320 K
721, 3x1fA, 0.6279, 1.76, 0.214, 296, 98, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
722, 3wiaG, 0.6279, 1.75, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
723, 3wiaD, 0.6279, 1.76, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
724, 1w6lA, 0.6279, 2.63, 0.105, 503, 105, 3D STRUCTURE OF COTA INCUBATED WITH CUCL2
725, 6iqxA, 0.6277, 2.65, 0.078, 535, 103, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
726, 5ytlA, 0.6277, 1.76, 0.214, 294, 98, CRYSTAL STRUCTURE OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE DETERMINED WITH AN ANAEROBICALLY MANIPULATED CRYSTAL 
727, 2wsdA, 0.6277, 2.64, 0.105, 504, 105, PROXIMAL MUTATIONS AT THE TYPE 1 CU SITE OF COTA-LACCASE: I494A MUTANT
728, 1qniA, 0.6277, 1.90, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
729, 3wiaH, 0.6276, 1.99, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
730, 3wi9A, 0.6276, 1.76, 0.214, 303, 98, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS KAUSTOPHILUS
731, 3gyrJ, 0.6276, 2.77, 0.160, 587, 106, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
732, 6iqxB, 0.6275, 2.46, 0.078, 535, 102, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
733, 3wiaF, 0.6274, 1.99, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
734, 4ysrA, 0.6273, 1.76, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.6 MGY
735, 3wiaB, 0.6273, 1.76, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
736, 4zk8A, 0.6272, 1.76, 0.214, 294, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM THERMOPHILIC BACTERIUM GEOBACILLUS THERMODENITRIFICANS (RE-REFINED)
737, 4yspA, 0.6272, 1.76, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.32 MGY
738, 3wkqA, 0.6272, 1.76, 0.214, 299, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH FORMATE
739, 3wiaE, 0.6272, 1.99, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
740, 5ytnA, 0.6271, 1.76, 0.204, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH PEROXIDE 
741, 4ystA, 0.6271, 1.76, 0.214, 294, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 24.9 MGY
742, 4yssA, 0.6271, 1.77, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.7 MGY
743, 3wiaA, 0.6271, 1.76, 0.204, 273, 98, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
744, 1fwxC, 0.6271, 1.92, 0.186, 590, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
745, 4ysuA, 0.6270, 1.77, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 25.0 MGY
746, 4ysqA, 0.6270, 1.76, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.38 MGY
747, 1fwxA, 0.6269, 1.92, 0.186, 591, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
748, 5ytmA, 0.6268, 1.78, 0.204, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS DETERMINED BY IN-OUSE SOURCE 
749, 3x1eA, 0.6268, 1.77, 0.214, 295, 98, STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS WITHOUT CHLORIDE
750, 1qniD, 0.6268, 1.91, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
751, 4ysoA, 0.6267, 1.77, 0.214, 295, 98, COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 0.064 MGY
752, 3wniA, 0.6267, 1.77, 0.214, 298, 98, 1.50 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
753, 1qniC, 0.6267, 1.91, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
754, 4e9wC, 0.6266, 2.33, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA2)
755, 3wkpA, 0.6266, 1.77, 0.204, 295, 98, C135A MUTANT OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE IN COMPLEX WITH NITRITE
756, 3wnjA, 0.6265, 1.77, 0.214, 298, 98, 1.20 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
757, 4e9xC, 0.6264, 2.34, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA3)
758, 4e9yC, 0.6263, 2.34, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA4)
759, 4e9vC, 0.6263, 2.34, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA1)
760, 4e9vA, 0.6261, 2.36, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA1)
761, 4e9wA, 0.6260, 2.36, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA2)
762, 3gdcB, 0.6260, 1.98, 0.172, 285, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
763, 4e9yA, 0.6259, 2.37, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA4)
764, 4e9xA, 0.6259, 2.36, 0.190, 317, 100, MULTICOPPER OXIDASE MGLAC (DATA3)
765, 1qniF, 0.6259, 1.92, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
766, 1qniB, 0.6259, 1.90, 0.196, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
767, 3gyrE, 0.6257, 1.84, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
768, 3gdcC, 0.6252, 1.98, 0.172, 286, 99, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
769, 3gyrG, 0.6251, 1.85, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
770, 3gyrB, 0.6251, 1.85, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
771, 3gyrL, 0.6249, 1.85, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
772, 3gyrI, 0.6249, 1.85, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
773, 3gyrD, 0.6249, 1.85, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
774, 2zwnC, 0.6249, 2.12, 0.192, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
775, 3gdcA, 0.6248, 1.84, 0.184, 288, 98, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
776, 2zwnA, 0.6248, 2.13, 0.192, 317, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
777, 5n0kA, 0.6247, 2.89, 0.198, 1034, 106, RAT CERULOPLASMIN ORTHORHOMBIC FORM
778, 3gyrF, 0.6247, 1.85, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
779, 3gyrC, 0.6247, 1.86, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
780, 3gyrH, 0.6246, 1.86, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
781, 3gyrA, 0.6246, 1.86, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
782, 3gyrK, 0.6245, 1.86, 0.192, 587, 99, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
783, 5i5mB, 0.6244, 1.90, 0.144, 576, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
784, 5i5mA, 0.6241, 1.89, 0.144, 575, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
785, 1fwxB, 0.6241, 1.87, 0.187, 589, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
786, 2iwkA, 0.6237, 1.89, 0.198, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
787, 2iwfB, 0.6237, 1.87, 0.198, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
788, 1fwxD, 0.6237, 1.88, 0.187, 588, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
789, 2iwfA, 0.6236, 1.88, 0.198, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
790, 2iwkB, 0.6231, 1.90, 0.198, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
791, 6rkzB, 0.6230, 1.98, 0.224, 586, 98, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
792, 4e9xB, 0.6226, 2.41, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA3)
793, 4e9vB, 0.6222, 2.41, 0.190, 316, 100, MULTICOPPER OXIDASE MGLAC (DATA1)
794, 3g5wA, 0.6222, 2.14, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
795, 2zwnB, 0.6221, 2.18, 0.192, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
796, 3wiaI, 0.6219, 1.75, 0.206, 272, 97, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
797, 4e9yB, 0.6214, 2.18, 0.192, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
798, 3g5wE, 0.6212, 2.15, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
799, 4e9wB, 0.6211, 2.19, 0.192, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
800, 6rl0C, 0.6210, 1.96, 0.227, 582, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
801, 3g5wD, 0.6206, 2.16, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
802, 3g5wC, 0.6205, 2.16, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
803, 6rl0D, 0.6204, 1.97, 0.227, 581, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
804, 3g5wF, 0.6203, 2.16, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
805, 5n4lB, 0.6201, 2.48, 0.109, 1034, 101, RAT CERULOPLASMIN TRIGONAL FORM
806, 3g5wB, 0.6201, 2.16, 0.162, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
807, 4bdvA, 0.6200, 2.64, 0.135, 612, 104, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
808, 6rl0A, 0.6198, 1.98, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
809, 4enzA, 0.6198, 2.43, 0.119, 1029, 101, STRUCTURE OF HUMAN CERULOPLASMIN AT 2.6 A RESOLUTION
810, 3sbpF, 0.6196, 1.97, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
811, 1sddA, 0.6196, 3.03, 0.140, 268, 107, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
812, 5n4lA, 0.6194, 2.47, 0.109, 1034, 101, RAT CERULOPLASMIN TRIGONAL FORM
813, 6rl0B, 0.6192, 1.97, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
814, 6hbeA, 0.6191, 2.26, 0.212, 425, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
815, 3sbrF, 0.6190, 1.98, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
816, 6hbeB, 0.6189, 2.26, 0.212, 425, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
817, 3sbrA, 0.6188, 2.03, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
818, 3sbpG, 0.6188, 1.98, 0.227, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
819, 6hbeC, 0.6187, 2.69, 0.218, 427, 101, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
820, 6f5kA, 0.6185, 2.18, 0.153, 557, 98, CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA 
821, 3sbpD, 0.6185, 2.00, 0.216, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
822, 6rkzA, 0.6184, 1.97, 0.227, 586, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
823, 3sbrE, 0.6184, 1.97, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
824, 3sbqB, 0.6183, 1.98, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
825, 3sbqA, 0.6183, 1.99, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
826, 3sbpH, 0.6183, 1.98, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
827, 3sbpE, 0.6182, 1.98, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
828, 1kcwA, 0.6182, 2.42, 0.119, 1017, 101, X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS
829, 5z1xB, 0.6181, 2.57, 0.157, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
830, 5z1xA, 0.6181, 2.57, 0.157, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
831, 5o4iA, 0.6181, 2.44, 0.129, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
832, 3sbpB, 0.6181, 2.02, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
833, 3sbpA, 0.6180, 2.01, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
834, 2uxtA, 0.6180, 2.46, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
835, 5z22A, 0.6179, 2.58, 0.157, 494, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
836, 2fqdA, 0.6179, 2.63, 0.127, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
837, 5o4qD, 0.6178, 2.45, 0.129, 278, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
838, 5ehfA, 0.6178, 2.57, 0.127, 497, 102, LACCASE FROM ANTRODIELLA FAGINEA
839, 3sbrG, 0.6178, 2.00, 0.227, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
840, 6rikA, 0.6177, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRTEENTH STRUCTURE OF THE SERIES WITH 5200 KGY DOSE. 
841, 3sbrD, 0.6177, 1.99, 0.227, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
842, 6rhpA, 0.6175, 2.59, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTY FIRST STRUCTURE OF THE SERIES WITH 4415 KGY DOSE (COLLECTED AFTER REFREEZING). 
843, 6rilA, 0.6174, 2.59, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTEENTH STRUCTURE OF THE SERIES WITH 5600 KGY DOSE (DATA WAS COLLECTED AFTER REFREEZING). 
844, 6ri4A, 0.6174, 2.59, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 13 KGY DOSE. 
845, 6ri2A, 0.6174, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
846, 6riiA, 0.6173, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTH STRUCTURE OF THE SERIES WITH 1200 KGY DOSE. 
847, 6ri8A, 0.6173, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 800 KGY DOSE. 
848, 6ri6A, 0.6173, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 400 KGY DOSE. 
849, 6rhuA, 0.6173, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
850, 6rhrA, 0.6173, 2.59, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
851, 6rhoA, 0.6173, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
852, 6rhhA, 0.6173, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
853, 6rghA, 0.6173, 2.59, 0.147, 499, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
854, 3t6vA, 0.6173, 2.60, 0.137, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
855, 6ri0A, 0.6172, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
856, 6rhxA, 0.6172, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
857, 6rgpA, 0.6172, 2.59, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
858, 5o3kA, 0.6172, 2.44, 0.129, 281, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
859, 6rhiA, 0.6171, 2.60, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
860, 5e9nA, 0.6171, 2.59, 0.147, 495, 102, STECCHERINUM MURASHKINSKYI LACCASE AT 0.95 RESOLUTION
861, 3t6zA, 0.6171, 2.60, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
862, 5migA, 0.6170, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 16-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 453 MIN. THE CRYSTAL WAS QUICK REFREEZING BEFORE THIS DATA COLLECTION.
863, 5micA, 0.6170, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 13-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 363 MIN.
864, 5mhyA, 0.6170, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SEVENTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 183 MIN.
865, 2fqgA, 0.6170, 2.64, 0.127, 464, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
866, 5mieA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 15-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 423 MIN.
867, 5midA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 14-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 393 MIN.
868, 5miaA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 11-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 303 MIN.
869, 5mi2A, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 10-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 273 MIN.
870, 5mi1A, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 9-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 243 MIN.
871, 5mhzA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 8-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 213 MIN.
872, 5mhxA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SIXTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 153 MIN.
873, 5mhwA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FIFTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 123 MIN.
874, 5mhvA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FOURTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 93 MIN.
875, 5mhuA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE THIRD STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 63 MIN.
876, 5mewA, 0.6169, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. SECOND STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 33 MIN.
877, 5mejA, 0.6169, 2.60, 0.147, 499, 102, STRUCTURAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. FIRST STRUCTURE OF THE SERIES WITH 3 MIN TOTAL X-RAY EXPOSITION TIME.
878, 3t6vB, 0.6169, 2.62, 0.147, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
879, 5mibA, 0.6168, 2.60, 0.147, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 12-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 333 MIN.
880, 5b7mB, 0.6168, 2.66, 0.127, 464, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
881, 5b7eA, 0.6168, 2.64, 0.127, 477, 102, STRUCTURE OF PERDEUTERATED CUEO
882, 3t6wB, 0.6168, 2.62, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
883, 3t6vC, 0.6168, 2.60, 0.137, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
884, 3sbrH, 0.6167, 1.99, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
885, 2fqfA, 0.6167, 2.64, 0.127, 465, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
886, 3t6zC, 0.6166, 2.60, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
887, 3sbrC, 0.6165, 2.02, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
888, 3sbpC, 0.6165, 2.00, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
889, 3t6xC, 0.6164, 2.62, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
890, 3t6xA, 0.6164, 2.61, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
891, 3t6wA, 0.6164, 2.61, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
892, 3t6wC, 0.6163, 2.61, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
893, 1n68A, 0.6163, 2.67, 0.127, 464, 102, COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO
894, 4uahB, 0.6162, 2.44, 0.109, 271, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
895, 3t71B, 0.6162, 2.62, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
896, 3t71A, 0.6162, 2.61, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
897, 2j5wA, 0.6162, 2.01, 0.173, 1029, 98, CERULOPLASMIN REVISITED: STRUCTURAL AND FUNCTIONAL ROLES OF VARIOUS METAL CATION BINDING SITES
898, 2fqeA, 0.6162, 2.65, 0.127, 463, 102, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
899, 3t6zB, 0.6161, 2.63, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
900, 5b7mC, 0.6160, 2.67, 0.127, 462, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
901, 3t6xB, 0.6159, 2.63, 0.147, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
902, 3kw7A, 0.6159, 2.58, 0.147, 502, 102, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
903, 3pauA, 0.6158, 2.64, 0.127, 464, 102, CUEO IN THE RESTING OXIDIZED STATE
904, 3t71C, 0.6157, 2.62, 0.137, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
905, 4ejxA, 0.6156, 2.23, 0.190, 1034, 100, STRUCTURE OF CERULOPLASMIN-MYELOPEROXIDASE COMPLEX
906, 3sbrB, 0.6154, 2.01, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
907, 3kw7B, 0.6154, 2.58, 0.147, 502, 102, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
908, 4uanB, 0.6153, 2.22, 0.120, 270, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
909, 1kyaB, 0.6153, 2.58, 0.137, 499, 102, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
910, 1kyaA, 0.6153, 2.58, 0.137, 499, 102, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
911, 3v9cA, 0.6152, 2.58, 0.118, 499, 102, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION
912, 1kyaD, 0.6152, 2.58, 0.137, 499, 102, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
913, 1kyaC, 0.6152, 2.58, 0.137, 499, 102, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
914, 5o3kG, 0.6151, 2.22, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
915, 4w1tB, 0.6149, 2.44, 0.119, 269, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
916, 3pxlA, 0.6149, 2.58, 0.118, 499, 102, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA
917, 6im9A, 0.6148, 2.09, 0.121, 490, 99, MDM2 BOUND CUEO-PM2 SENSOR 
918, 4x4kA, 0.6148, 2.32, 0.143, 525, 98, STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT
919, 3x1bB, 0.6148, 2.61, 0.108, 500, 102, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
920, 3x1bA, 0.6148, 2.61, 0.108, 500, 102, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
921, 2yxwA, 0.6148, 2.67, 0.127, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
922, 2uxtB, 0.6147, 2.63, 0.108, 420, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
923, 1v10A, 0.6147, 2.63, 0.137, 487, 102, STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS
924, 4hakA, 0.6145, 2.67, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506A
925, 3nsfA, 0.6144, 2.66, 0.127, 480, 102, APO FORM OF THE MULTICOPPER OXIDASE CUEO
926, 5b7mA, 0.6143, 2.70, 0.127, 463, 102, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
927, 4uahA, 0.6143, 2.45, 0.109, 272, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
928, 3divA, 0.6143, 2.60, 0.127, 497, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.76A RESOLUTION
929, 3ppsD, 0.6142, 2.44, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
930, 3ppsA, 0.6142, 2.44, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
931, 3pavA, 0.6142, 2.70, 0.127, 466, 102, THE REDUCED FORM OF CUEO
932, 3nscA, 0.6142, 2.69, 0.127, 470, 102, C500S MUTANT OF CUEO BOUND TO CU(II)
933, 1kv7A, 0.6142, 2.68, 0.127, 463, 102, CRYSTAL STRUCTURE OF CUEO A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS
934, 4wtqB, 0.6140, 2.22, 0.120, 269, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
935, 2h5uA, 0.6140, 2.60, 0.137, 497, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION
936, 4w1tA, 0.6139, 2.29, 0.110, 272, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
937, 3fpxA, 0.6139, 2.61, 0.118, 499, 102, NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA
938, 5lwwA, 0.6138, 2.09, 0.155, 550, 97, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC
939, 5o4qA, 0.6137, 2.24, 0.140, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
940, 4uanC, 0.6137, 2.23, 0.130, 272, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
941, 3nsyA, 0.6137, 2.69, 0.127, 465, 102, THE MULTI-COPPER OXIDASE CUEO WITH SIX MET TO SER MUTATIONS (M358S M361SM362SM364SM366SM368S)
942, 5ys5A, 0.6136, 2.57, 0.129, 457, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT WITH SEVEN COPPER IONS 
943, 4wtqA, 0.6136, 2.22, 0.120, 270, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
944, 4halA, 0.6136, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT E506I
945, 2yxwB, 0.6136, 2.66, 0.127, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
946, 6fc7L, 0.6135, 2.12, 0.131, 276, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
947, 5o4iE, 0.6135, 2.24, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
948, 4e9tA, 0.6135, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA6)
949, 1pf3A, 0.6135, 2.69, 0.127, 463, 102, CRYSTAL STRUCTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO
950, 6fdjC, 0.6134, 2.23, 0.130, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
951, 4uahC, 0.6134, 2.47, 0.109, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
952, 4e9sA, 0.6134, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA5)
953, 4e9rA, 0.6134, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA4)
954, 4uanA, 0.6133, 2.47, 0.109, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
955, 4e9qA, 0.6132, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA2)
956, 2yxvB, 0.6132, 2.67, 0.127, 440, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
957, 4nerA, 0.6131, 2.69, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO (DATA1)
958, 3uaeA, 0.6131, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA6)
959, 3od3A, 0.6131, 2.69, 0.127, 488, 102, CUEO AT 1.1 A RESOLUTION INCLUDING RESIDUES IN PREVIOUSLY DISORDERED REGION
960, 3nt0A, 0.6131, 2.69, 0.127, 468, 102, C500S (T1D) MUTANT OF CUEO SOAKED IN AND BOUND TO CU(I)
961, 2yxvA, 0.6131, 2.70, 0.127, 444, 102, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
962, 5o4qJ, 0.6130, 2.25, 0.130, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
963, 5o4iD, 0.6130, 2.25, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
964, 3uadA, 0.6130, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA5)
965, 3uacA, 0.6130, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA4)
966, 6rhqA, 0.6129, 2.25, 0.130, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
967, 6im8A, 0.6129, 2.70, 0.127, 469, 102, CUEO-PM2 MULTICOPPER OXIDASE 
968, 5o4iJ, 0.6129, 2.26, 0.140, 279, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
969, 5lm8A, 0.6129, 2.11, 0.155, 549, 97, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER
970, 3qqxA, 0.6129, 2.70, 0.127, 474, 102, REDUCED NATIVE INTERMEDIATE OF THE MULTICOPPER OXIDASE CUEO
971, 2xybA, 0.6129, 2.62, 0.137, 497, 102, CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS
972, 3uabA, 0.6128, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA2)
973, 3j2qA, 0.6128, 2.81, 0.152, 630, 105, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
974, 3cdzB, 0.6128, 2.28, 0.152, 631, 99, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
975, 3cdzA, 0.6128, 2.81, 0.152, 630, 105, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
976, 2hzhA, 0.6128, 2.62, 0.137, 499, 102, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLUS ZONATUS AT 2.6 A RESOLUTION
977, 5gnoA, 0.6127, 2.72, 0.127, 463, 102, STRUCTURE OF MULTICOPPER OXIDASE CUEO - SIGNAL PEPTIDE-FREE
978, 5b7fA, 0.6127, 2.72, 0.127, 463, 102, STRUCTURE OF CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
979, 3v9eA, 0.6127, 2.15, 0.144, 539, 97, STRUCTURE OF THE L499M MUTANT OF THE LACCASE FROM B.ACLADA
980, 3uaaA, 0.6126, 2.68, 0.127, 476, 102, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA1)
981, 4w1tC, 0.6125, 2.52, 0.119, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
982, 5ys1A, 0.6124, 2.57, 0.129, 461, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT 
983, 5lwxA, 0.6124, 2.11, 0.155, 554, 97, CRYSTAL STRUCTURE OF THE H253D MUTANT OF MCOG FROM ASPERGILLUS NIGER
984, 5lduA, 0.6124, 2.61, 0.118, 499, 102, RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA
985, 4m3hA, 0.6124, 2.25, 0.120, 269, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
986, 3ta4D, 0.6124, 2.48, 0.158, 273, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
987, 5o4qB, 0.6123, 2.26, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
988, 3nsdA, 0.6122, 2.70, 0.127, 462, 102, SILVER BOUND TO THE MULTICOPPER OXIDASE CUEO (UNTAGGED)
989, 5i5iB, 0.6121, 1.59, 0.151, 537, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
990, 4bdvB, 0.6121, 2.30, 0.152, 606, 99, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
991, 3t9wA, 0.6121, 2.24, 0.150, 270, 100, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116
992, 2uxvB, 0.6119, 2.53, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
993, 5o4qK, 0.6117, 2.26, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
994, 4ef3A, 0.6116, 2.75, 0.127, 466, 102, MULTICOPPER OXIDASE CUEO (CITRATE BUFFER)
995, 2qt6A, 0.6116, 2.62, 0.147, 498, 102, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
996, 4m3hB, 0.6114, 2.24, 0.120, 269, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
997, 2qt6B, 0.6112, 2.62, 0.147, 498, 102, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
998, 1gycA, 0.6112, 2.62, 0.137, 499, 102, CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS
999, 5nq9A, 0.6110, 2.64, 0.127, 497, 102, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1000, 6evgA, 0.6106, 2.64, 0.088, 444, 102, STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF A BACTERIAL LACCASE-LIKE MULTI-COPPER OXIDASE CUEO FROM LIGNIN-DEGRADING BACTERIUM OCHROBACTRUM SP. WITH OXIDASE ACTIVITY TOWARDS LIGNIN MODEL COMPOUNDS AND LIGNOSULFONATE 
1001, 5k8dA, 0.6106, 3.10, 0.150, 611, 107, CRYSTAL STRUCTURE OF RFVIIIFC
1002, 5i5iA, 0.6106, 1.55, 0.140, 539, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
1003, 6rh9B, 0.6105, 2.34, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1004, 2r7eB, 0.6102, 2.14, 0.163, 644, 98, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1005, 5nq9C, 0.6098, 2.67, 0.127, 497, 102, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1006, 5nq8A, 0.6097, 2.65, 0.127, 497, 102, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II
1007, 4a2fA, 0.6096, 2.61, 0.139, 495, 101, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 12.65 KEV
1008, 4jhvA, 0.6094, 2.60, 0.139, 496, 101, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA
1009, 2uxvA, 0.6093, 2.66, 0.108, 422, 102, SUFI PROTEIN FROM ESCHERICHIA COLI
1010, 1sddB, 0.6093, 2.32, 0.162, 601, 99, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
1011, 4a2dA, 0.6088, 2.68, 0.137, 495, 102, CORIOLOPSIS GALLICA LACCASE T2 COPPER DEPLETED AT PH  4.5
1012, 2q9oB, 0.6088, 2.27, 0.153, 558, 98, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1013, 4a2hA, 0.6087, 2.67, 0.137, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLOPSIS GALLICA PH 7.0
1014, 3qpkB, 0.6087, 2.27, 0.153, 559, 98, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1015, 3fu7A, 0.6086, 2.50, 0.152, 558, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1016, 3fu9B, 0.6084, 2.28, 0.153, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1017, 2ih8B, 0.6084, 2.27, 0.153, 559, 98, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1018, 2ih8A, 0.6084, 2.27, 0.153, 559, 98, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1019, 3j2qB, 0.6083, 2.38, 0.141, 631, 99, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
1020, 3dkhA, 0.6083, 2.50, 0.152, 558, 99, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1021, 2hrhA, 0.6083, 2.67, 0.147, 496, 102, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII
1022, 2hrgA, 0.6082, 2.68, 0.147, 496, 102, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE
1023, 2ih9B, 0.6081, 2.28, 0.153, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1024, 2ih9A, 0.6081, 2.51, 0.152, 559, 99, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1025, 3dkhB, 0.6080, 2.50, 0.152, 558, 99, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1026, 5anhA, 0.6078, 2.72, 0.147, 496, 102, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1027, 4ysdA, 0.6077, 2.19, 0.184, 299, 98, ROOM TEMPERATURE STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
1028, 3fu8B, 0.6076, 2.50, 0.152, 558, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1029, 5nq7A, 0.6075, 2.69, 0.127, 497, 102, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM I
1030, 4a2gA, 0.6075, 2.69, 0.137, 495, 102, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 8.98 KEV
1031, 1gw0A, 0.6075, 2.52, 0.152, 559, 99, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1032, 4a2eA, 0.6074, 2.69, 0.137, 495, 102, CRYSTAL STRUCTURE OF A CORIOLOPSIS GALLICA LACCASE AT 1.7 A RESOLUTION PH 5.5
1033, 3j2sB, 0.6073, 2.41, 0.141, 631, 99, MEMBRANE-BOUND FACTOR VIII LIGHT CHAIN
1034, 5anhC, 0.6072, 2.72, 0.147, 496, 102, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1035, 3fu9A, 0.6072, 2.50, 0.152, 559, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1036, 4jhuA, 0.6070, 2.70, 0.137, 496, 102, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA SOAKED WITH CUCL
1037, 5anhB, 0.6065, 2.72, 0.147, 496, 102, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1038, 3ta4F, 0.6064, 2.50, 0.218, 282, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1039, 1gw0B, 0.6063, 2.46, 0.162, 559, 99, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1040, 6im7A, 0.6061, 2.33, 0.131, 461, 99, CUEO-12.1 MULTICOPPER OXIDASE 
1041, 5a7eA, 0.6059, 2.96, 0.125, 495, 104, CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION
1042, 6iqyB, 0.6058, 2.90, 0.075, 536, 106, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
1043, 5zd7B, 0.6058, 2.90, 0.075, 536, 106, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
1044, 3abgA, 0.6056, 2.34, 0.100, 508, 100, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1045, 3ta4E, 0.6054, 2.52, 0.218, 267, 101, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1046, 6iqzA, 0.6043, 2.82, 0.076, 535, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
1047, 6iqyA, 0.6043, 2.79, 0.076, 536, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
1048, 5zd7A, 0.6043, 2.79, 0.076, 536, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
1049, 5zd6A, 0.6043, 2.82, 0.076, 535, 105, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
1050, 4bxsV, 0.6029, 2.38, 0.121, 1262, 99, CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS
1051, 3zx1A, 0.6026, 2.58, 0.186, 471, 102, MULTICOPPER OXIDASE FROM CAMPYLOBACTER JEJUNI: A METALLO-OXIDASE
1052, 3abgB, 0.6022, 2.41, 0.100, 518, 100, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1053, 5jrrA, 0.6017, 2.64, 0.186, 439, 102, CRYSTAL STRUCTURE OF NATIVE LACCASE FROM THERMUS THERMOPHILUS HB27
1054, 5afaA, 0.6015, 2.65, 0.176, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH AG CRYSTAL OF THE HOLOENZYME SOAKED FOR 30 M IN 5 MM AGNO3 AT 278 K.
1055, 5k84A, 0.6012, 2.65, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 10 MIN)
1056, 5k5kA, 0.6012, 2.65, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASSE FROM THERMUS THERMOPHILUS HB27 (ASCORBIC ACID 10 MIN)
1057, 5jx9A, 0.6011, 2.65, 0.176, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 5 MIN)
1058, 5o4qF, 0.6009, 2.83, 0.175, 275, 103, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1059, 2yaoA, 0.6008, 2.65, 0.186, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (50.0-62.5 PERCENT DOSE)
1060, 2r7eA, 0.6008, 2.65, 0.099, 693, 101, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1061, 5k15A, 0.6007, 2.66, 0.176, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU2PO 8 MIN)
1062, 2yarA, 0.6007, 2.66, 0.176, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (87.5-100.0 PERCENT DOSE)
1063, 2yafA, 0.6007, 2.66, 0.176, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (12.5-25.0 PERCENT DOSE)
1064, 2yaeA, 0.6007, 2.65, 0.186, 438, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27(0.0-12.5 PERCENT DOSE)
1065, 2xu9A, 0.6007, 2.66, 0.176, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27
1066, 5k7aA, 0.6006, 2.65, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FRON THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 1.5 MIN)
1067, 2yapA, 0.6006, 2.65, 0.186, 437, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (62.5-75.0 PERCENT DOSE)
1068, 2yamA, 0.6006, 2.66, 0.176, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (37.5-50.0 PERCENT DOSE)
1069, 5k0dA, 0.6005, 2.66, 0.176, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 3 MIN)
1070, 1hfuA, 0.6005, 2.64, 0.129, 500, 101, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION
1071, 5g3cA, 0.6004, 2.65, 0.186, 435, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS TERMOPHILUS MULTICOPPER OXIDASE
1072, 2yahA, 0.6004, 2.66, 0.176, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (25.0-37.5 PERCENT DOSE)
1073, 5g3eA, 0.6003, 2.66, 0.186, 437, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1074, 2yaqA, 0.6003, 2.66, 0.176, 436, 102, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (75.0-87.5 PERCENT DOSE)
1075, 6rh9J, 0.6002, 2.72, 0.176, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1076, 5g3hA, 0.6002, 2.66, 0.186, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1077, 5g3dA, 0.6002, 2.66, 0.186, 438, 102, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CCASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1078, 6s0oA, 0.6001, 2.52, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1079, 5k3kA, 0.6001, 2.66, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CUSO4 20 MIN)
1080, 5o4iK, 0.6000, 2.52, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1081, 5o3kI, 0.6000, 2.68, 0.168, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1082, 6rhqF, 0.5996, 2.51, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1083, 6fc7I, 0.5993, 2.51, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1084, 2xuwA, 0.5992, 2.67, 0.176, 437, 102, CRYSTAL STRUCTURE OF APOLACCASE FROM THERMUS THERMOPHILUS HB27
1085, 5o3kB, 0.5991, 2.53, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1086, 6rh9F, 0.5990, 2.51, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1087, 6rh9A, 0.5990, 2.53, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1088, 1a65A, 0.5990, 2.84, 0.127, 504, 102, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS
1089, 6fc7D, 0.5987, 2.53, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1090, 4n8uA, 0.5985, 2.85, 0.175, 275, 103, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1091, 6s0oF, 0.5984, 2.57, 0.178, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1092, 6rh9I, 0.5984, 2.52, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1093, 5o4qC, 0.5984, 2.53, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1094, 5o4iG, 0.5984, 2.53, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1095, 6rhqC, 0.5983, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1096, 6fdjB, 0.5983, 2.54, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1097, 5o4iC, 0.5983, 2.54, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1098, 4n8uB, 0.5982, 2.86, 0.175, 276, 103, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1099, 6fc7C, 0.5981, 2.52, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1100, 5o4qG, 0.5981, 2.53, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1101, 5lhlF, 0.5981, 2.88, 0.175, 275, 103, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1102, 3cg8A, 0.5981, 2.55, 0.170, 270, 100, LACCASE FROM STREPTOMYCES COELICOLOR
1103, 6rh9K, 0.5980, 2.72, 0.176, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1104, 6fc7E, 0.5980, 2.52, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1105, 6rh9H, 0.5979, 2.54, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1106, 6fc7H, 0.5979, 2.53, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1107, 2avfB, 0.5979, 2.54, 0.134, 316, 97, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
1108, 6rh9L, 0.5978, 2.53, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1109, 6rh9D, 0.5978, 2.54, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1110, 5o4qL, 0.5978, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1111, 5o4iI, 0.5978, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1112, 5o3kD, 0.5978, 2.55, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1113, 6rh9G, 0.5977, 2.55, 0.170, 279, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1114, 6fc7J, 0.5977, 2.53, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1115, 6s0oD, 0.5976, 2.54, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1116, 6rhqE, 0.5974, 2.56, 0.170, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1117, 6fdjA, 0.5974, 2.54, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1118, 5o4qE, 0.5974, 2.57, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1119, 5o3kJ, 0.5974, 2.54, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1120, 1l9oC, 0.5974, 2.52, 0.144, 336, 97, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
1121, 6fc7G, 0.5973, 2.53, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1122, 5lhlE, 0.5973, 2.55, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1123, 2avfF, 0.5973, 2.55, 0.134, 323, 97, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
1124, 6fdjL, 0.5972, 2.56, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1125, 5o3kE, 0.5972, 2.54, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1126, 5mkmC, 0.5972, 2.59, 0.178, 275, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1127, 4gybA, 0.5972, 2.60, 0.168, 279, 101, TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AT 2.4 A RESOLUTION AC1709
1128, 6fdjI, 0.5971, 2.54, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1129, 6fdjE, 0.5971, 2.54, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1130, 5o4qI, 0.5971, 2.55, 0.170, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1131, 6rhqD, 0.5970, 2.54, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1132, 6fdjF, 0.5970, 2.54, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1133, 5lhlD, 0.5970, 2.56, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1134, 5lhlC, 0.5969, 2.56, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1135, 6s0oB, 0.5968, 2.55, 0.170, 280, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1136, 5mkmE, 0.5968, 2.54, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1137, 1l9oA, 0.5968, 2.55, 0.144, 336, 97, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
1138, 6s0oE, 0.5967, 2.55, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1139, 6fc7A, 0.5967, 2.55, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1140, 6fc7B, 0.5966, 2.54, 0.170, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1141, 5o4qH, 0.5966, 2.56, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1142, 5o4iB, 0.5966, 2.56, 0.170, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1143, 5mkmA, 0.5966, 2.55, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1144, 6fdjG, 0.5965, 2.55, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1145, 5mkmB, 0.5965, 2.55, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1146, 4najA, 0.5965, 2.60, 0.168, 279, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 90 MIN SOAKING
1147, 6rh9E, 0.5963, 2.56, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1148, 5o3kC, 0.5963, 2.54, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1149, 5mkmF, 0.5963, 2.57, 0.170, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1150, 5lhlB, 0.5963, 2.56, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1151, 5lhlA, 0.5963, 2.56, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1152, 4nb7A, 0.5963, 2.60, 0.168, 280, 101, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 180 MIN SOAKING
1153, 1et5A, 0.5963, 2.56, 0.144, 336, 97, CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6
1154, 5o4iH, 0.5962, 2.56, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1155, 5o4iF, 0.5962, 2.55, 0.170, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1156, 5f7aA, 0.5962, 2.57, 0.144, 336, 97, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
1157, 4n8uC, 0.5962, 2.55, 0.170, 275, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1158, 3cg8B, 0.5962, 2.56, 0.170, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
1159, 1et8A, 0.5962, 2.56, 0.144, 339, 97, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS
1160, 5o3kF, 0.5961, 2.58, 0.170, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1161, 3tbbB, 0.5961, 2.85, 0.175, 278, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1162, 1et7A, 0.5961, 2.56, 0.144, 339, 97, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6
1163, 6fdjD, 0.5960, 2.58, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1164, 6fc7K, 0.5960, 2.55, 0.170, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1165, 5f7bA, 0.5960, 2.57, 0.144, 336, 97, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
1166, 2afnA, 0.5960, 2.57, 0.144, 331, 97, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
1167, 6rhqB, 0.5959, 2.56, 0.170, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1168, 5o3kK, 0.5959, 2.56, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1169, 6fdjH, 0.5958, 2.55, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1170, 6rh9C, 0.5957, 2.56, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1171, 5o3kL, 0.5957, 2.56, 0.170, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1172, 4yscA, 0.5957, 2.55, 0.144, 336, 97, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
1173, 3tasC, 0.5957, 2.88, 0.175, 300, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1174, 5o4iL, 0.5956, 2.56, 0.170, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1175, 6fdjK, 0.5955, 2.55, 0.170, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1176, 5o3kH, 0.5955, 2.56, 0.170, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1177, 3tbcB, 0.5955, 2.87, 0.175, 278, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1178, 3tasB, 0.5955, 2.87, 0.175, 301, 103, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1179, 3tasA, 0.5955, 2.61, 0.178, 300, 101, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1180, 6fc7F, 0.5954, 2.55, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1181, 4gy4B, 0.5952, 2.61, 0.168, 278, 101, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1182, 4gxfB, 0.5951, 2.58, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1183, 2vw4A, 0.5950, 2.85, 0.182, 333, 99, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
1184, 2vmjA, 0.5950, 2.84, 0.182, 326, 99, TYPE 1 COPPER-BINDING LOOP OF NITRITE REDUCTASE MUTANT: 130- CAPEGMVPWHVVSGM-144 TO 130-CTPHPFM-136
1185, 2vm3A, 0.5950, 2.85, 0.182, 333, 99, STRUCTURE OF ALCALIGENES XYLOSOXIDANS IN SPACE GROUP R3 - 1 OF 2
1186, 4gxfC, 0.5949, 2.58, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1187, 4gxfA, 0.5949, 2.58, 0.170, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1188, 2vn3A, 0.5948, 2.84, 0.182, 336, 99, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
1189, 4yscC, 0.5947, 2.57, 0.144, 335, 97, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
1190, 3cg8C, 0.5946, 2.58, 0.170, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
1191, 6fdjJ, 0.5944, 2.57, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1192, 4m3hC, 0.5943, 2.57, 0.170, 270, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
1193, 3tbcC, 0.5941, 2.58, 0.170, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1194, 6s0oC, 0.5940, 2.57, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1195, 4wtqC, 0.5940, 2.56, 0.160, 269, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
1196, 5mkmD, 0.5939, 2.57, 0.170, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1197, 4gy4C, 0.5937, 2.59, 0.170, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1198, 3tbcA, 0.5937, 2.57, 0.170, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1199, 3tbbC, 0.5937, 2.58, 0.170, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1200, 3kw8A, 0.5936, 2.59, 0.170, 273, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR AT 2.3 A RESOLUTION
1201, 5g3fA, 0.5934, 2.67, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1202, 5g3bA, 0.5934, 2.67, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE: THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1203, 4gy4A, 0.5934, 2.60, 0.170, 276, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1204, 4ai7A, 0.5933, 2.73, 0.186, 437, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 2 H IN 5 MM HGCL2 AT 278 K.
1205, 5g3gA, 0.5931, 2.67, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1206, 3tbbA, 0.5926, 2.59, 0.170, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1207, 2xvbA, 0.5923, 2.75, 0.186, 438, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 5 MIN. IN 5 MM HGCL2 AT 278 K.
1208, 3aw5A, 0.5913, 2.71, 0.170, 438, 100, STRUCTURE OF A MULTICOPPER OXIDASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROBACULUM AEROPHILUM
1209, 3sqrA, 0.5908, 2.47, 0.153, 539, 98, CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION
1210, 1aozA, 0.5891, 2.51, 0.173, 552, 98, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
1211, 1aspA, 0.5883, 2.52, 0.163, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1212, 1zpuB, 0.5882, 2.48, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1213, 1asoA, 0.5882, 2.52, 0.173, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1214, 1zpuD, 0.5877, 2.48, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1215, 1zpuC, 0.5877, 2.48, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1216, 1asqB, 0.5877, 2.25, 0.135, 552, 96, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1217, 1zpuF, 0.5876, 2.48, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1218, 1zpuE, 0.5876, 2.48, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1219, 1zpuA, 0.5875, 2.48, 0.152, 529, 99, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1220, 1asqA, 0.5869, 2.54, 0.163, 552, 98, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1221, 1aozB, 0.5853, 2.73, 0.180, 552, 100, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
1222, 1aspB, 0.5842, 2.74, 0.180, 552, 100, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1223, 1asoB, 0.5839, 2.74, 0.180, 552, 100, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1224, 2q9oA, 0.5837, 2.93, 0.172, 558, 99, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1225, 3fu8A, 0.5831, 2.95, 0.172, 558, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1226, 3fu7B, 0.5823, 2.78, 0.173, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1227, 3ppsB, 0.5814, 2.97, 0.162, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1228, 3qpkA, 0.5813, 2.85, 0.173, 559, 98, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1229, 3ppsC, 0.5813, 2.97, 0.162, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1230, 4f7kA, 0.5784, 2.74, 0.122, 377, 98, CRYSTAL STRUCTURE OF LAC15 FROM A MARINE MICROBIAL METAGENOME
1231, 4f7kB, 0.5782, 2.73, 0.122, 373, 98, CRYSTAL STRUCTURE OF LAC15 FROM A MARINE MICROBIAL METAGENOME
1232, 3pnrB, 0.5757, 3.72, 0.035, 129, 115, STRUCTURE OF PBICP-C IN COMPLEX WITH FALCIPAIN-2
1233, 1ibzA, 0.5750, 1.66, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1234, 1ic0E, 0.5746, 1.68, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1235, 1ibzB, 0.5746, 1.95, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1236, 1ibyA, 0.5745, 1.84, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1237, 1ic0C, 0.5741, 1.68, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1238, 1ibyB, 0.5733, 1.92, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1239, 1ibyC, 0.5731, 1.92, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1240, 1ic0D, 0.5727, 1.76, 0.202, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1241, 4m4rF, 0.5722, 3.22, 0.036, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1242, 1ic0B, 0.5721, 1.75, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1243, 1ibzC, 0.5709, 1.62, 0.193, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1244, 4l0pB, 0.5700, 3.26, 0.036, 139, 111, STRUCTURE OF THE HUMAN EPHA3 RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH EPHRIN-A5
1245, 4m4rD, 0.5698, 3.27, 0.036, 140, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1246, 1ic0F, 0.5697, 1.64, 0.193, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1247, 1ibyD, 0.5697, 1.79, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1248, 1ikoP, 0.5692, 3.20, 0.045, 141, 110, CRYSTAL STRUCTURE OF THE MURINE EPHRIN-B2 ECTODOMAIN
1249, 1ibzD, 0.5690, 1.82, 0.202, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1250, 3d12E, 0.5689, 3.05, 0.075, 141, 106, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1251, 5i5jB, 0.5686, 1.30, 0.141, 529, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1252, 5i5jA, 0.5685, 1.30, 0.141, 531, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1253, 2wo3B, 0.5671, 3.38, 0.063, 142, 111, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINA2 COMPLEX
1254, 1ic0A, 0.5661, 1.75, 0.216, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1255, 4m4rB, 0.5660, 3.29, 0.036, 141, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1256, 4m4rH, 0.5647, 3.34, 0.036, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1257, 4bkfD, 0.5645, 3.08, 0.085, 141, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1258, 4bkfC, 0.5645, 3.08, 0.085, 141, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1259, 3d12B, 0.5645, 3.08, 0.085, 141, 106, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1260, 2wo2B, 0.5622, 3.08, 0.037, 136, 108, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINB2 COMPLEX
1261, 4f2fA, 0.5620, 1.79, 0.148, 100, 88, CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)
1262, 3mx0D, 0.5615, 3.21, 0.028, 138, 109, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1263, 3mx0B, 0.5606, 3.36, 0.036, 138, 110, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1264, 4w9zA, 0.5597, 2.46, 0.128, 138, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC DOMAIN OF SUBUNIT II OF CYTOCHROME OXIDASE (COXB) OF BRADYRHIZOBIUM JAPONICUM
1265, 1shxA, 0.5596, 3.33, 0.027, 138, 110, EPHRIN A5 LIGAND STRUCTURE
1266, 1shwA, 0.5590, 3.37, 0.036, 138, 110, EPHB2 / EPHRINA5 COMPLEX STRUCTURE
1267, 5z62B, 0.5584, 2.47, 0.138, 227, 94, STRUCTURE OF HUMAN CYTOCHROME C OXIDASE 
1268, 5x1bO, 0.5580, 2.48, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1269, 3abkO, 0.5576, 2.47, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1270, 5b1bO, 0.5575, 2.48, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1271, 2x11B, 0.5574, 3.37, 0.036, 138, 110, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
1272, 6j8mO, 0.5572, 2.50, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1273, 5b3sO, 0.5571, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1274, 3ag4O, 0.5570, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1275, 5zcqO, 0.5569, 2.51, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1276, 5zcpO, 0.5569, 2.50, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1277, 3ag3O, 0.5569, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1278, 3ag2O, 0.5569, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1279, 5z86O, 0.5567, 2.51, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1280, 5b1aO, 0.5567, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1281, 5zcoO, 0.5566, 2.51, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1282, 3wg7O, 0.5566, 2.51, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1283, 3abmO, 0.5566, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1284, 5z85O, 0.5565, 2.52, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1285, 3heiB, 0.5565, 3.14, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1286, 2y69O, 0.5565, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1287, 3asoO, 0.5564, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1288, 5xdqO, 0.5563, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1289, 5x1fO, 0.5563, 2.50, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1290, 5z84O, 0.5562, 2.52, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1291, 3asnO, 0.5561, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1292, 3x2qO, 0.5560, 2.51, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1293, 6nmfO, 0.5559, 2.53, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1294, 5xdxO, 0.5559, 2.49, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1295, 5x19O, 0.5559, 2.50, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1296, 3ag3B, 0.5559, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1297, 1v55O, 0.5559, 2.50, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1298, 1v54O, 0.5559, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1299, 2eikO, 0.5558, 2.50, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1300, 5waub, 0.5557, 2.50, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1301, 3abkB, 0.5557, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1302, 2zxwO, 0.5557, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1303, 5iy5O, 0.5556, 2.52, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1304, 3ag1O, 0.5556, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1305, 3ablO, 0.5555, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1306, 2eikB, 0.5555, 2.51, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1307, 2dyrO, 0.5555, 2.52, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1308, 1v54B, 0.5555, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1309, 2eijO, 0.5554, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1310, 5wauB, 0.5553, 2.52, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1311, 5w97b, 0.5553, 2.51, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1312, 2einB, 0.5553, 2.53, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1313, 1v55B, 0.5553, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1314, 6nmpO, 0.5551, 2.53, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1315, 5z86B, 0.5551, 2.54, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1316, 3ag1B, 0.5551, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1317, 2eimO, 0.5551, 2.52, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1318, 2dyrB, 0.5551, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1319, 1ocrO, 0.5551, 2.53, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1320, 6j8mB, 0.5550, 2.55, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1321, 3wg7B, 0.5550, 2.55, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1322, 2eimB, 0.5550, 2.52, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1323, 2eilO, 0.5550, 2.53, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1324, 2eijB, 0.5550, 2.51, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1325, 4uf7C, 0.5549, 3.23, 0.055, 138, 109, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1326, 2einO, 0.5549, 2.53, 0.117, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1327, 2eilB, 0.5549, 2.53, 0.117, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1328, 2dysO, 0.5549, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1329, 5zcpB, 0.5548, 2.55, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1330, 5z85B, 0.5548, 2.55, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1331, 5z84B, 0.5548, 2.55, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1332, 5b3sB, 0.5548, 2.55, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1333, 1ocrB, 0.5548, 2.53, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1334, 5x1bB, 0.5547, 2.52, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1335, 3ag4B, 0.5547, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1336, 3abmB, 0.5547, 2.55, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1337, 2dysB, 0.5547, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1338, 6nknO, 0.5546, 2.54, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1339, 5zcqB, 0.5546, 2.55, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1340, 5zcoB, 0.5546, 2.55, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1341, 5iy5B, 0.5546, 2.55, 0.117, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1342, 6nmfB, 0.5545, 2.54, 0.117, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1343, 5x1fB, 0.5545, 2.53, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1344, 3x2qB, 0.5545, 2.55, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1345, 3ag2B, 0.5545, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1346, 5xtiWD, 0.5544, 2.55, 0.117, 227, 94, struct.pdbx_descriptor              
1347, 5xtiUA, 0.5544, 2.55, 0.117, 227, 94, struct.pdbx_descriptor              
1348, 5xthUA, 0.5544, 2.55, 0.117, 227, 94, struct.pdbx_descriptor              
1349, 5lufy, 0.5544, 2.55, 0.117, 227, 94, CRYO-EM OF BOVINE RESPIRASOME
1350, 5gupVB, 0.5544, 2.55, 0.117, 227, 94, 
1351, 5gpnIB, 0.5544, 2.55, 0.117, 227, 94, 
1352, 2ybbM, 0.5544, 2.55, 0.117, 227, 94, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
1353, 1occO, 0.5544, 2.55, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1354, 1occB, 0.5544, 2.55, 0.117, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1355, 5xdqB, 0.5543, 2.55, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1356, 5b1bB, 0.5543, 2.54, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1357, 2y69B, 0.5543, 2.55, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1358, 5b1aB, 0.5542, 2.55, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1359, 2zxwB, 0.5542, 2.55, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1360, 2occO, 0.5542, 2.55, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1361, 3asoB, 0.5540, 2.55, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1362, 2occB, 0.5540, 2.55, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1363, 5xdxB, 0.5539, 2.53, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1364, 5x19B, 0.5539, 2.54, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1365, 4uf7E, 0.5538, 3.25, 0.055, 139, 109, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1366, 3heiJ, 0.5538, 3.17, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1367, 5sydB, 0.5537, 2.15, 0.169, 131, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1368, 3asnB, 0.5537, 2.55, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1369, 1ocoO, 0.5537, 2.55, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1370, 1ocoB, 0.5536, 2.55, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1371, 3ablB, 0.5535, 2.56, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1372, 1oczO, 0.5535, 2.56, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1373, 6nknB, 0.5534, 2.56, 0.117, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1374, 1oczB, 0.5534, 2.56, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1375, 5w97B, 0.5533, 2.55, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1376, 6nmpB, 0.5532, 2.57, 0.117, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1377, 3heiL, 0.5530, 3.20, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1378, 3heiN, 0.5528, 3.20, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1379, 1shxB, 0.5522, 3.38, 0.046, 138, 109, EPHRIN A5 LIGAND STRUCTURE
1380, 3heiP, 0.5515, 3.22, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1381, 3gxuB, 0.5510, 3.37, 0.046, 138, 109, CRYSTAL STRUCTURE OF EPH RECEPTOR AND EPHRIN COMPLEX
1382, 4f2eA, 0.5503, 1.75, 0.163, 98, 86, CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE D39 COPPER CHAPERONE CUPA WITH CU(I)
1383, 3heiH, 0.5496, 3.23, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1384, 1kgyE, 0.5491, 3.09, 0.075, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1385, 2vsmB, 0.5489, 3.10, 0.075, 137, 107, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1386, 4bkaC, 0.5488, 3.44, 0.036, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
1387, 5sydA, 0.5487, 2.35, 0.169, 130, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
1388, 3czuB, 0.5485, 3.25, 0.066, 130, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2- EPHRIN A1 COMPLEX
1389, 4bk5C, 0.5483, 3.45, 0.036, 136, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
1390, 3heiD, 0.5471, 3.28, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1391, 4txvB, 0.5464, 2.69, 0.128, 142, 94, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1392, 2mryA, 0.5463, 1.95, 0.172, 98, 87, NMR SOLUTION STRUCTURE OF COPPER BINDING PROTEIN IN THE APO FORM
1393, 1kgyH, 0.5462, 3.16, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1394, 1kgyG, 0.5460, 3.09, 0.094, 138, 106, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1395, 4txvD, 0.5458, 2.52, 0.129, 133, 93, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1396, 2vskD, 0.5451, 3.13, 0.048, 131, 105, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1397, 3heiF, 0.5445, 3.28, 0.066, 132, 106, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1398, 2vskB, 0.5445, 2.99, 0.038, 131, 104, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1399, 1kgyF, 0.5440, 3.31, 0.075, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1400, 3mbwB, 0.5429, 3.17, 0.058, 127, 104, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1
1401, 2hleB, 0.5427, 3.16, 0.067, 133, 104, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE EPHB4-EPHRINB2 PROTEIN PROTEIN INTERACTION AND RECEPTOR SPECIFICITY.
1402, 1ayrC, 0.5340, 3.50, 0.029, 368, 103, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1403, 1ayrA, 0.5340, 3.55, 0.029, 368, 104, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1404, 4jqiA, 0.5308, 3.58, 0.077, 353, 104, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1405, 3f83A, 0.5294, 3.95, 0.096, 508, 114, STRUCTURE OF FUSION COMPLEX OF THE MINOR PILIN CFAE AND MAJOR PILIN CFAB OF CFA/I PILI FROM ETEC E. COLI
1406, 4mbrA, 0.5284, 3.89, 0.072, 316, 111, 3.65 ANGSTROM CRYSTAL STRUCTURE OF SERINE-RICH REPEAT PROTEIN (SRR2) FROM STREPTOCOCCUS AGALACTIAE
1407, 3p2dB, 0.5283, 3.58, 0.039, 352, 103, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1408, 1zshA, 0.5283, 3.59, 0.058, 354, 104, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1409, 3ugxA, 0.5279, 3.59, 0.029, 369, 103, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1410, 1jsyA, 0.5277, 3.61, 0.058, 358, 104, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1411, 3p2dA, 0.5270, 3.67, 0.038, 354, 104, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1412, 1g4rA, 0.5269, 3.57, 0.049, 353, 103, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1413, 6e47G, 0.5249, 3.71, 0.084, 112, 107, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
1414, 1jxgB, 0.5248, 2.59, 0.133, 100, 90, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1415, 6c6qF, 0.5245, 3.91, 0.082, 113, 110, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
1416, 5j7yZB, 0.5240, 2.73, 0.118, 227, 93, 
1417, 5j4zZB, 0.5240, 2.73, 0.118, 227, 93, 
1418, 1ylbB, 0.5240, 2.50, 0.135, 99, 89, NMR SOLUTION STRUCTURE OF THE REDUCED SPINACH PLASTOCYANIN
1419, 1cf1D, 0.5239, 3.66, 0.029, 368, 103, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1420, 5fc9B, 0.5237, 2.03, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1421, 3vacB, 0.5233, 4.15, 0.095, 356, 116, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1422, 1jerA, 0.5231, 3.06, 0.146, 110, 96, CUCUMBER STELLACYANIN CU2+ PH 7.0
1423, 6e48F, 0.5230, 3.75, 0.064, 113, 109, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
1424, 3vacA, 0.5229, 4.18, 0.103, 356, 117, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1425, 4ydjH, 0.5227, 4.06, 0.071, 238, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1426, 1rmfH, 0.5227, 3.99, 0.071, 216, 113, STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
1427, 3gd1C, 0.5225, 3.72, 0.058, 345, 103, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
1428, 2wtrB, 0.5222, 3.60, 0.050, 367, 101, FULL LENGTH ARRESTIN2
1429, 1g4mB, 0.5222, 3.70, 0.049, 357, 103, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1430, 6c74A, 0.5219, 3.72, 0.065, 111, 107, CRYSTAL STRUCTURE OF MURINE CD300LF IN COMPLEX WITH PHOSPHOCHOLINE 
1431, 2hb0A, 0.5217, 4.20, 0.103, 356, 117, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1432, 1zglP, 0.5215, 3.77, 0.083, 242, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1433, 3ugxC, 0.5214, 3.55, 0.030, 358, 101, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1434, 1g4mA, 0.5214, 3.70, 0.058, 356, 104, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1435, 2wtrA, 0.5212, 3.69, 0.058, 356, 104, FULL LENGTH ARRESTIN2
1436, 1jxgA, 0.5212, 2.65, 0.133, 100, 90, THE 1.6 A RESOLUTION CRYSTAL STRUCTURE OF A MUTANT POPLAR PLASTOCYANIN BEARING A 21-25 ENGENEERED DISULFIDE BRIDGE
1437, 7pcyA, 0.5211, 2.70, 0.165, 98, 91, THE CRYSTAL STRUCTURE OF PLASTOCYANIN FROM A GREEN ALGA ENTEROMORPHA PROLIFERA
1438, 2hb0B, 0.5211, 4.10, 0.103, 355, 116, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1439, 1zglT, 0.5211, 3.76, 0.083, 226, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1440, 4mxqC, 0.5208, 3.79, 0.111, 199, 108, 42F3 TCR PCPC5/H-2LD COMPLEX
1441, 1ayrD, 0.5208, 3.49, 0.030, 363, 100, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1442, 1ayrB, 0.5207, 3.49, 0.030, 363, 100, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1443, 5fc9D, 0.5206, 2.13, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1444, 1kiuO, 0.5201, 2.88, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1445, 1kiuM, 0.5201, 2.88, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1446, 1kiuK, 0.5201, 2.88, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1447, 1kiuI, 0.5201, 2.88, 0.074, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1448, 5fc9A, 0.5200, 2.09, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1449, 4elkA, 0.5199, 3.69, 0.094, 199, 106, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1450, 3tfkC, 0.5198, 3.82, 0.112, 201, 107, 42F3-P4B10/H2-LD
1451, 3m4eC, 0.5193, 4.09, 0.054, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1452, 3to4D, 0.5192, 3.76, 0.065, 243, 107, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
1453, 6dfqB, 0.5190, 3.76, 0.074, 239, 108, MOUSE DIABETOGENIC TCR I.29 
1454, 5tv1A, 0.5190, 3.47, 0.050, 337, 101, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
1455, 3m4eA, 0.5189, 4.10, 0.054, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1456, 6e48G, 0.5188, 3.79, 0.074, 111, 108, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
1457, 5fflA, 0.5187, 3.88, 0.073, 113, 110, CRYSTAL STRUCTURE OF MOUSE CD300LF AT 1.6 ANGSTROMS RESOLUTION.
1458, 4grlD, 0.5187, 3.81, 0.147, 257, 109, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
1459, 3chnS, 0.5186, 3.87, 0.091, 585, 110, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
1460, 2ckbC, 0.5185, 3.76, 0.111, 202, 108, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1461, 1cf1B, 0.5185, 3.57, 0.030, 360, 101, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1462, 4ydjA, 0.5184, 4.00, 0.071, 238, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1463, 3tpuA, 0.5184, 3.78, 0.102, 205, 108, 42F3 P5E8/H2-LD COMPLEX
1464, 2ckbA, 0.5184, 3.76, 0.111, 202, 108, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1465, 3m4eD, 0.5183, 4.11, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1466, 3ugxD, 0.5182, 3.51, 0.030, 348, 100, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1467, 3m4eB, 0.5182, 4.10, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1468, 1kdiA, 0.5181, 2.65, 0.157, 102, 89, REDUCED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1469, 3uguA, 0.5180, 3.67, 0.039, 345, 102, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
1470, 4ei6C, 0.5179, 3.73, 0.094, 189, 106, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
1471, 3m4dB, 0.5179, 4.12, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1472, 1kdjA, 0.5179, 2.83, 0.156, 102, 90, OXIDIZED FORM OF PLASTOCYANIN FROM DRYOPTERIS CRASSIRHIZOMA
1473, 4zrgA, 0.5178, 3.56, 0.030, 343, 101, VISUAL ARRESTIN MUTANT - R175E
1474, 3m4eF, 0.5178, 4.13, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1475, 3m4dD, 0.5178, 4.14, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1476, 5x31A, 0.5177, 2.27, 0.140, 125, 86, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
1477, 2pltA, 0.5177, 2.75, 0.165, 98, 91, STRUCTURE DETERMINATION OF PLASTOCYANIN FROM A CRYSTAL SPECIMEN WITH HEMIHEDRAL TWINNING FRACTION OF ONE-HALF
1478, 5fc9C, 0.5176, 2.14, 0.184, 95, 87, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
1479, 3m4eG, 0.5175, 4.10, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1480, 3m3rG, 0.5173, 4.11, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1481, 1zglR, 0.5173, 3.81, 0.083, 238, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1482, 5or7C, 0.5172, 3.85, 0.073, 111, 109, ATOMIC STRUCTURE OF THE MURINE NOROVIRUS PROTRUDING DOMAIN AND SCD300LF RECEPTOR COMPLEX
1483, 3m4eE, 0.5172, 4.10, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1484, 1cf1C, 0.5172, 3.62, 0.029, 380, 102, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1485, 1cf1A, 0.5172, 3.62, 0.029, 373, 102, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1486, 3pl6D, 0.5171, 3.82, 0.147, 257, 109, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
1487, 3m2lE, 0.5171, 4.13, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1488, 4dp5X, 0.5170, 2.60, 0.135, 99, 89, THE 1.88 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 8.0
1489, 3m4dC, 0.5170, 4.10, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1490, 1ws7A, 0.5170, 3.07, 0.135, 107, 96, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1491, 4rqqH, 0.5169, 3.81, 0.045, 240, 110, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1492, 4mayD, 0.5169, 3.83, 0.147, 255, 109, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
1493, 4dp1X, 0.5169, 2.59, 0.135, 99, 89, THE 1.35 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 4.0
1494, 3m4dG, 0.5169, 4.14, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1495, 3m4dF, 0.5169, 4.12, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1496, 3m2lA, 0.5169, 4.12, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1497, 1iuzA, 0.5169, 2.62, 0.133, 98, 90, PLASTOCYANIN
1498, 6dfqF, 0.5168, 3.72, 0.075, 238, 107, MOUSE DIABETOGENIC TCR I.29 
1499, 5x31B, 0.5168, 2.48, 0.115, 125, 87, PSEUDOAZURIN FROM ALCALIGENES FAECALIS (SPACE GROUP P65)
1500, 4dp8X, 0.5168, 2.61, 0.124, 99, 89, THE 1.07 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 4.0
1501, 3m4dA, 0.5168, 4.13, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1502, 7ahlA, 0.5167, 4.15, 0.071, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1503, 4p24A, 0.5167, 4.06, 0.081, 292, 111, PORE FORMING TOXIN
1504, 3m4dE, 0.5167, 4.12, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1505, 4yhdG, 0.5166, 4.16, 0.071, 281, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1506, 4rqqB, 0.5166, 3.80, 0.045, 239, 110, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1507, 3m3rE, 0.5166, 4.12, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1508, 3m2lD, 0.5166, 4.13, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1509, 7ahlD, 0.5165, 4.12, 0.080, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1510, 4dp6X, 0.5165, 2.62, 0.135, 99, 89, THE 1.67 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 8.0
1511, 3v4pB, 0.5165, 4.16, 0.036, 375, 111, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
1512, 7ahlF, 0.5164, 4.12, 0.071, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1513, 6pcyA, 0.5164, 2.61, 0.135, 99, 89, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1514, 3pcyA, 0.5164, 2.60, 0.135, 99, 89, THE CRYSTAL STRUCTURE OF MERCURY-SUBSTITUTED POPLAR PLASTOCYANIN AT 1.9-ANGSTROMS RESOLUTION
1515, 3m2lG, 0.5164, 4.13, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1516, 4pcyA, 0.5163, 2.61, 0.135, 99, 89, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1517, 4ei5C, 0.5163, 3.72, 0.094, 201, 106, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1518, 4dp2X, 0.5163, 2.60, 0.135, 99, 89, THE 1.8 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 6.0
1519, 3ugxB, 0.5163, 3.53, 0.030, 352, 100, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1520, 3m3rB, 0.5163, 4.06, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1521, 3m2lC, 0.5163, 4.14, 0.080, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1522, 3m2lB, 0.5163, 4.14, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1523, 1zglV, 0.5163, 3.82, 0.083, 242, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1524, 3m3rD, 0.5162, 4.13, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1525, 3m3rC, 0.5162, 4.11, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1526, 3m3rA, 0.5162, 4.13, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1527, 1ag6A, 0.5162, 2.58, 0.135, 99, 89, PLASTOCYANIN FROM SPINACH
1528, 4elkC, 0.5161, 3.71, 0.094, 203, 106, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1529, 3q48A, 0.5161, 3.08, 0.125, 194, 96, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
1530, 1oowA, 0.5161, 2.57, 0.135, 99, 89, THE CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN DOUBLE MUTANT G8D/L12E GIVES INSIGHT INTO ITS LOW REACTIVITY TOWARDS PHOTOSYSTEM 1 AND CYTOCHROME F
1531, 3m3rF, 0.5160, 4.13, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1532, 1ws7D, 0.5160, 2.97, 0.137, 105, 95, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1533, 1sujA, 0.5160, 3.54, 0.030, 363, 101, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1534, 4mvbC, 0.5159, 3.69, 0.112, 199, 107, 42F3 PCPB7/H-2LD COMPLEX
1535, 4dp7X, 0.5159, 2.63, 0.112, 99, 89, THE 1.08 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 4.0
1536, 4p24D, 0.5158, 4.07, 0.081, 292, 111, PORE FORMING TOXIN
1537, 3vxrD, 0.5158, 3.90, 0.083, 194, 108, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
1538, 4dp0X, 0.5157, 2.61, 0.135, 99, 89, THE 1.5 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN B AT PH 4.0
1539, 7ahlB, 0.5156, 4.15, 0.071, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1540, 6bj2E, 0.5156, 3.71, 0.112, 241, 107, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
1541, 5whzH, 0.5155, 3.84, 0.045, 341, 112, PGDM1400-10E8V4 CODV FAB
1542, 5pcyA, 0.5155, 2.62, 0.135, 99, 89, CRYSTAL STRUCTURE ANALYSES OF REDUCED (CUI) POPLAR PLASTOCYANIN AT SIX PH VALUES
1543, 4p24E, 0.5155, 4.13, 0.080, 291, 112, PORE FORMING TOXIN
1544, 1ws8A, 0.5155, 2.90, 0.138, 104, 94, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1545, 4rqqD, 0.5154, 3.83, 0.045, 237, 110, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1546, 4mwfA, 0.5154, 3.79, 0.064, 223, 109, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
1547, 4dpaX, 0.5154, 2.63, 0.124, 99, 89, THE 1.05 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 6.0
1548, 4dp4X, 0.5154, 2.62, 0.135, 99, 89, THE 1.54 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN B AT PH 6.0
1549, 5w0pA, 0.5153, 3.79, 0.029, 847, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1550, 5e8eB, 0.5153, 3.89, 0.054, 228, 111, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
1551, 4ms8C, 0.5153, 3.70, 0.112, 196, 107, 42F3 TCR PCPB9/H-2LD COMPLEX
1552, 4ei5G, 0.5153, 3.77, 0.093, 172, 107, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1553, 2j7lA, 0.5153, 3.33, 0.143, 210, 98, E.COLI P PILUS CHAPERONE PAPD IN COMPLEX WITH A PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1554, 3m2lF, 0.5152, 4.13, 0.071, 293, 112, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1555, 1tkwA, 0.5152, 2.63, 0.135, 99, 89, THE TRANSIENT COMPLEX OF POPLAR PLASTOCYANIN WITH TURNIP CYTOCHROME F DETERMINED WITH PARAMAGNETIC NMR
1556, 6dfqH, 0.5150, 3.73, 0.075, 234, 107, MOUSE DIABETOGENIC TCR I.29 
1557, 4yhdE, 0.5150, 4.16, 0.071, 268, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1558, 4n0cG, 0.5150, 3.85, 0.101, 197, 109, 42F3 TCR PCPE3/H-2LD COMPLEX
1559, 2bz7A, 0.5149, 2.79, 0.156, 102, 90, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1560, 1plcA, 0.5149, 2.63, 0.135, 99, 89, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN AT 1.33 ANGSTROMS RESOLUTION
1561, 7ahlE, 0.5148, 4.15, 0.071, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1562, 5w0pC, 0.5148, 3.82, 0.029, 849, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1563, 3njhD, 0.5148, 3.40, 0.122, 122, 98, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1564, 4ww2A, 0.5147, 3.96, 0.074, 203, 108, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
1565, 4uduB, 0.5146, 3.73, 0.103, 238, 107, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR
1566, 4oiiI, 0.5146, 4.06, 0.089, 217, 112, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1567, 4oiiH, 0.5146, 4.06, 0.089, 217, 112, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1568, 3anzK, 0.5146, 4.18, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1569, 1ypzH, 0.5146, 4.14, 0.064, 230, 110, IMMUNE RECEPTOR
1570, 4dpcX, 0.5145, 2.64, 0.135, 99, 89, THE 1.06 ANGSTROM CRYSTAL STRUCTURE OF REDUCED (CUI) POPLAR PLASTOCYANIN A AT PH 8.0
1571, 4dpbX, 0.5145, 2.64, 0.135, 99, 89, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 8.0
1572, 3anzG, 0.5145, 4.14, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1573, 2bzcA, 0.5145, 2.80, 0.156, 102, 90, OXIDIZED AND REDUCED STRUCTURES OF A MUTANT PLASTOCYANIN OF FERN
1574, 4dp9X, 0.5144, 2.64, 0.135, 99, 89, THE 1.00 ANGSTROM CRYSTAL STRUCTURE OF OXIDIZED (CUII) POPLAR PLASTOCYANIN A AT PH 6.0
1575, 7ahlG, 0.5143, 4.15, 0.071, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1576, 6d49B, 0.5143, 4.08, 0.073, 126, 109, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1577, 1pndA, 0.5143, 2.64, 0.124, 99, 89, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
1578, 1gafH, 0.5143, 3.95, 0.090, 217, 111, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1579, 7ahlC, 0.5142, 4.13, 0.071, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1580, 6e47F, 0.5142, 3.71, 0.086, 109, 105, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
1581, 5w0pB, 0.5142, 3.82, 0.029, 802, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1582, 4onhA, 0.5142, 3.79, 0.102, 201, 108, CRYSTAL STRUCTURE OF DN6 TCR
1583, 3anzY, 0.5142, 4.15, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1584, 2pcyA, 0.5142, 2.64, 0.135, 99, 89, THE CRYSTAL STRUCTURE OF POPLAR APOPLASTOCYANIN AT 1.8- ANGSTROMS RESOLUTION. THE GEOMETRY OF THE COPPER-BINDING SITE IS CREATED BY THE POLYPEPTIDE
1585, 1mwaA, 0.5142, 3.89, 0.110, 202, 109, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1586, 1g6rC, 0.5142, 3.82, 0.111, 202, 108, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1587, 6dzrL, 0.5141, 4.02, 0.092, 218, 109, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
1588, 4p24G, 0.5141, 4.14, 0.080, 292, 112, PORE FORMING TOXIN
1589, 5tilK, 0.5140, 4.03, 0.092, 118, 109, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1590, 4p24F, 0.5140, 4.16, 0.071, 290, 112, PORE FORMING TOXIN
1591, 3anzW, 0.5140, 4.18, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1592, 1pncA, 0.5140, 2.64, 0.135, 99, 89, ACCURACY AND PRECISION IN PROTEIN CRYSTAL STRUCTURE ANALYSIS: TWO INDEPENDENT REFINEMENTS OF THE STRUCTURE OF POPLAR PLASTOCYANIN AT 173K
1593, 1lcsA, 0.5139, 4.67, 0.075, 205, 120, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
1594, 6d49A, 0.5138, 3.98, 0.074, 126, 108, CELL SURFACE RECEPTOR IN COMPLEX WITH LIGAND AT 1.80-A RESOLUTION 
1595, 3anzV, 0.5138, 4.18, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1596, 2pcfA, 0.5138, 2.54, 0.124, 99, 89, THE COMPLEX OF CYTOCHROME F AND PLASTOCYANIN DETERMINED WITH PARAMAGNETIC NMR. BASED ON THE STRUCTURES OF CYTOCHROME F AND PLASTOCYANIN 10 STRUCTURES
1597, 1t4wA, 0.5138, 3.50, 0.067, 196, 104, STRUCTURAL DIFFERENCES IN THE DNA BINDING DOMAINS OF HUMAN P53 AND ITS C. ELEGANS ORTHOLOG CEP-1: STRUCTURE OF C. ELEGANS CEP-1
1598, 1a4kB, 0.5137, 4.06, 0.080, 219, 112, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1599, 6mi2A, 0.5136, 3.98, 0.073, 209, 110, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1600, 6b5pH, 0.5136, 3.96, 0.064, 212, 110, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
1601, 3anzL, 0.5136, 4.19, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1602, 3anzJ, 0.5136, 4.19, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1603, 2zpkI, 0.5136, 3.96, 0.073, 207, 110, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
1604, 2n7bA, 0.5136, 4.04, 0.101, 145, 109, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN IN COMPLEX WITH 6 SULFO SIALYL LEWISX
1605, 5w0pD, 0.5135, 3.83, 0.029, 773, 103, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1606, 3anzO, 0.5135, 4.15, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1607, 3anzM, 0.5134, 4.19, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1608, 3anzC, 0.5134, 4.19, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1609, 2qadD, 0.5134, 3.95, 0.071, 229, 112, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1610, 1ws8D, 0.5134, 2.87, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
1611, 4p24C, 0.5133, 4.16, 0.071, 291, 112, PORE FORMING TOXIN
1612, 3anzZ, 0.5133, 4.15, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1613, 3anzF, 0.5133, 4.15, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1614, 6fr3A, 0.5132, 3.98, 0.074, 202, 108, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
1615, 5j06D, 0.5132, 4.12, 0.083, 212, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1616, 3vxqA, 0.5132, 3.95, 0.101, 204, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1617, 3anzb, 0.5132, 4.15, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1618, 3anzN, 0.5132, 4.15, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1619, 3anzI, 0.5132, 4.18, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1620, 2qadH, 0.5132, 3.95, 0.071, 229, 112, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1621, 6eh5A, 0.5131, 3.97, 0.083, 202, 108, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
1622, 6d48H, 0.5131, 4.02, 0.083, 124, 108, CELL SURFACE RECEPTOR 
1623, 3anzR, 0.5131, 4.16, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1624, 3anzE, 0.5131, 4.19, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1625, 3anzA, 0.5131, 4.15, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1626, 6cqqI, 0.5130, 3.74, 0.085, 200, 106, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1627, 4qokE, 0.5130, 3.83, 0.101, 244, 109, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
1628, 4nhuA, 0.5130, 3.82, 0.102, 197, 108, THE M33 TCR P3M33L/H-2 LD COMPLEX
1629, 3vxqD, 0.5130, 3.94, 0.101, 204, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1630, 6q3sD, 0.5129, 3.97, 0.101, 203, 109, ENGINEERED HUMAN HLA_A2 MHC CLASS I MOLECULE IN COMPLEX WITH TCR AND SV9 PEPTIDE 
1631, 6b5tH, 0.5129, 3.96, 0.055, 211, 110, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
1632, 3qpqJ, 0.5129, 3.93, 0.090, 216, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1633, 3anzQ, 0.5129, 4.16, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1634, 6c6qD, 0.5128, 3.71, 0.066, 109, 106, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
1635, 6avfA, 0.5128, 3.94, 0.131, 202, 107, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1636, 4x6cG, 0.5128, 3.72, 0.085, 201, 106, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
1637, 4n5eC, 0.5128, 3.93, 0.101, 199, 109, 42F3 TCR PCPA12/H-2LD COMPLEX
1638, 3anzX, 0.5128, 4.16, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1639, 3anzS, 0.5128, 4.16, 0.071, 295, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1640, 3anzH, 0.5128, 4.16, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1641, 6dfsB, 0.5127, 3.60, 0.094, 241, 106, MOUSE TCR I.29 IN COMPLEX WITH IAG7-P8E9E6SS 
1642, 5swzE, 0.5127, 3.68, 0.123, 240, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1643, 4j2qB, 0.5127, 3.89, 0.039, 346, 103, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1644, 2oslH, 0.5127, 4.07, 0.089, 224, 112, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1645, 1bypA, 0.5127, 2.63, 0.146, 99, 89, E43KD44K DOUBLE MUTANT PLASTOCYANIN FROM SILENE
1646, 2nmsA, 0.5126, 3.95, 0.093, 112, 107, THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE INHIBITOR RECEPTOR EXPRESSED ON MYELOID CELLS IREM-1
1647, 6cphE, 0.5125, 3.74, 0.084, 244, 107, CRYSTAL STRUCTURE OF A TCR 
1648, 4a6yH, 0.5125, 4.09, 0.088, 215, 113, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1649, 3sjvI, 0.5125, 3.77, 0.085, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1650, 3anzP, 0.5125, 4.16, 0.071, 294, 112, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1651, 6mefH, 0.5124, 3.84, 0.064, 224, 110, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
1652, 5m00G, 0.5124, 3.87, 0.102, 187, 108, CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A MODIFIED GP33 PEPTIDE FROM LCMV
1653, 3arfC, 0.5124, 3.88, 0.148, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
1654, 1g6rA, 0.5124, 3.83, 0.111, 202, 108, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1655, 5swzJ, 0.5123, 3.69, 0.123, 240, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1656, 3ardC, 0.5123, 3.90, 0.157, 202, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1657, 3anzD, 0.5123, 4.05, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1658, 6d4aA, 0.5122, 3.99, 0.074, 123, 108, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1659, 5yxnB, 0.5122, 3.79, 0.083, 241, 108, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
1660, 4a6yB, 0.5122, 3.97, 0.090, 214, 111, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1661, 3anzU, 0.5122, 4.05, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1662, 2bnuA, 0.5122, 3.92, 0.074, 203, 108, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
1663, 6dc9L, 0.5121, 3.97, 0.084, 215, 107, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1664, 4grmD, 0.5121, 3.65, 0.085, 243, 106, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
1665, 3anzT, 0.5121, 4.07, 0.081, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1666, 4yhdD, 0.5120, 4.10, 0.072, 282, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1667, 3jabQ, 0.5120, 4.05, 0.071, 221, 112, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1668, 3jabH, 0.5120, 4.05, 0.071, 221, 112, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1669, 3iyoB, 0.5120, 4.05, 0.056, 468, 108, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1670, 3iyoA, 0.5120, 4.05, 0.056, 468, 108, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1671, 3hg1E, 0.5120, 3.94, 0.109, 244, 110, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
1672, 1hxmF, 0.5120, 4.12, 0.134, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1673, 12e8H, 0.5120, 4.05, 0.071, 221, 112, 2E8 FAB FRAGMENT
1674, 6aniI, 0.5119, 4.05, 0.089, 214, 112, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1675, 5cckH, 0.5119, 3.96, 0.073, 224, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
1676, 4yhdB, 0.5119, 4.20, 0.071, 283, 112, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1677, 4dwhC, 0.5119, 2.96, 0.084, 201, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1678, 3tjhC, 0.5119, 3.94, 0.111, 201, 108, 42F3-P3A1/H2-LD COMPLEX
1679, 3jwnC, 0.5119, 2.98, 0.084, 199, 95, COMPLEX OF FIMC FIMF FIMG AND FIMH
1680, 3anzB, 0.5119, 4.05, 0.072, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1681, 5m01G, 0.5118, 3.89, 0.102, 188, 108, CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA MODIFIED GP33 PEPTIDE FROM LCMV
1682, 5k93A, 0.5118, 3.35, 0.143, 210, 98, PAPD WILD-TYPE CHAPERONE
1683, 4gg8F, 0.5118, 3.74, 0.075, 244, 106, IMMUNE RECEPTOR
1684, 4gg8B, 0.5118, 3.74, 0.075, 244, 106, IMMUNE RECEPTOR
1685, 3jwnI, 0.5118, 2.96, 0.084, 198, 95, COMPLEX OF FIMC FIMF FIMG AND FIMH
1686, 3he6C, 0.5117, 3.91, 0.148, 203, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
1687, 3anza, 0.5117, 4.06, 0.072, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1688, 1byoB, 0.5117, 2.65, 0.135, 99, 89, WILD-TYPE PLASTOCYANIN FROM SILENE
1689, 6b5rH, 0.5116, 3.98, 0.054, 211, 111, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
1690, 4ww1A, 0.5116, 3.70, 0.076, 197, 105, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8
1691, 4n0cC, 0.5116, 3.92, 0.101, 195, 109, 42F3 TCR PCPE3/H-2LD COMPLEX
1692, 6mi2D, 0.5115, 4.08, 0.054, 210, 111, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1693, 4zsoB, 0.5115, 4.11, 0.088, 218, 113, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1694, 4g8eA, 0.5115, 3.89, 0.120, 201, 108, CRYSTAL STRUCTURE OF CLONE18 TCR
1695, 3tn0C, 0.5115, 3.91, 0.148, 203, 108, STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX
1696, 6fxnO, 0.5114, 3.92, 0.065, 215, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1697, 5j06B, 0.5114, 4.11, 0.083, 215, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
1698, 4dwhA, 0.5114, 2.97, 0.084, 197, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
1699, 4b0mM, 0.5114, 3.05, 0.095, 212, 95, COMPLEX OF THE CAF1AN USHER DOMAIN CAF1M CHAPERONE AND CAF1 SUBUNIT FROM YERSINIA PESTIS
1700, 3t2nH, 0.5114, 3.87, 0.056, 203, 108, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
1701, 1zoxA, 0.5114, 3.84, 0.074, 110, 108, CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN
1702, 6fr8A, 0.5113, 3.83, 0.130, 202, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1703, 6cqrJ, 0.5113, 3.72, 0.085, 245, 106, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1704, 5jqdD, 0.5113, 3.93, 0.055, 214, 110, ANTIBODY FAB FRAGMENT
1705, 5ihbB, 0.5113, 4.11, 0.083, 214, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33
1706, 3njhB, 0.5113, 3.37, 0.124, 121, 97, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1707, 2y36H, 0.5113, 4.00, 0.089, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
1708, 6rcuB, 0.5112, 4.05, 0.063, 222, 111, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
1709, 4m43H, 0.5112, 4.19, 0.080, 219, 113, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
1710, 2cdeD, 0.5112, 3.78, 0.065, 244, 108, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1711, 6amuE, 0.5111, 3.70, 0.084, 241, 107, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE MMWDRGLGMM 
1712, 4gg6H, 0.5111, 3.78, 0.065, 243, 107, PROTEIN COMPLEX
1713, 3njmA, 0.5111, 3.32, 0.124, 122, 97, P117A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1714, 6fr7A, 0.5110, 3.82, 0.130, 203, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1715, 6am5E, 0.5110, 3.66, 0.075, 242, 106, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
1716, 5d2lI, 0.5110, 3.89, 0.094, 185, 106, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1717, 3sddC, 0.5110, 3.91, 0.157, 189, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
1718, 3qpqH, 0.5110, 3.99, 0.090, 215, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1719, 1ngqH, 0.5110, 4.11, 0.088, 215, 113, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1720, 1n7mL, 0.5110, 4.10, 0.071, 216, 112, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1721, 5j0bB, 0.5109, 4.12, 0.083, 214, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
1722, 5eu6D, 0.5109, 3.95, 0.102, 204, 108, HLA CLASS I ANTIGEN
1723, 3ulvF, 0.5109, 4.14, 0.089, 217, 112, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1724, 3areC, 0.5109, 3.88, 0.148, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE
1725, 3arbC, 0.5109, 3.89, 0.157, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
1726, 2xzqH, 0.5109, 3.99, 0.089, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF
1727, 6dfqD, 0.5108, 3.57, 0.086, 237, 105, MOUSE DIABETOGENIC TCR I.29 
1728, 6cqrI, 0.5108, 3.74, 0.112, 201, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1729, 5yxuB, 0.5108, 3.73, 0.075, 242, 107, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
1730, 5k93B, 0.5108, 3.36, 0.143, 210, 98, PAPD WILD-TYPE CHAPERONE
1731, 5dgyC, 0.5108, 3.98, 0.029, 789, 104, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1732, 4zwjC, 0.5108, 3.98, 0.029, 789, 104, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1733, 3t2nI, 0.5108, 3.87, 0.056, 205, 108, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
1734, 2jelH, 0.5108, 3.98, 0.080, 218, 112, JEL42 FAB/HPR COMPLEX
1735, 2eysA, 0.5108, 3.95, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
1736, 6cqqD, 0.5107, 3.73, 0.112, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1737, 5yslA, 0.5107, 4.06, 0.071, 211, 112, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1738, 5swzT, 0.5107, 3.77, 0.131, 239, 107, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1739, 5swzO, 0.5107, 3.68, 0.123, 241, 106, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1740, 4yhdC, 0.5107, 4.06, 0.073, 279, 110, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1741, 4mnqE, 0.5107, 3.81, 0.083, 240, 108, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
1742, 4jrxD, 0.5107, 4.01, 0.109, 204, 110, CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX
1743, 3uzqA, 0.5107, 4.10, 0.054, 234, 111, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
1744, 3ffcE, 0.5107, 3.95, 0.101, 247, 109, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1745, 2ntfB, 0.5107, 4.12, 0.071, 222, 113, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1746, 6eqaE, 0.5106, 3.92, 0.100, 244, 110, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
1747, 6avgE, 0.5106, 3.80, 0.093, 245, 107, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1748, 5m02G, 0.5106, 3.85, 0.103, 187, 107, CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF MODIFIED GP33 PEPTIDE FROM LCMV
1749, 5dgyA, 0.5106, 3.64, 0.020, 833, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1750, 4zwjA, 0.5106, 3.64, 0.020, 833, 100, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1751, 3iyoD, 0.5106, 3.96, 0.056, 461, 107, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
1752, 3gsnB, 0.5106, 3.75, 0.085, 243, 106, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
1753, 2cdeB, 0.5106, 3.88, 0.064, 244, 109, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1754, 1al0F, 0.5106, 4.55, 0.053, 418, 113, PROCAPSID OF BACTERIOPHAGE PHIX174
1755, 6erxD, 0.5105, 3.89, 0.065, 215, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1756, 6d4aB, 0.5105, 4.11, 0.073, 124, 109, CELL SURFACE RECEPTOR WITH BOUND LIGAND AT 1.75-A RESOLUTION 
1757, 4nhuC, 0.5105, 3.76, 0.103, 199, 107, THE M33 TCR P3M33L/H-2 LD COMPLEX
1758, 4gg6F, 0.5105, 3.74, 0.075, 243, 107, PROTEIN COMPLEX
1759, 4ei6D, 0.5105, 3.82, 0.103, 241, 107, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
1760, 3qeuB, 0.5105, 3.70, 0.084, 238, 107, THE CRYSTAL STRUCTURE OF TCR DMF5
1761, 3argC, 0.5105, 3.94, 0.157, 202, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
1762, 2d7tL, 0.5105, 4.03, 0.093, 110, 107, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
1763, 2cdfB, 0.5105, 3.71, 0.075, 244, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
1764, 1hxmB, 0.5105, 4.18, 0.134, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1765, 6cqnD, 0.5104, 3.76, 0.085, 200, 106, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1766, 5lvcb, 0.5104, 3.93, 0.057, 289, 105, AICHI VIRUS 1: EMPTY PARTICLE
1767, 5dgyD, 0.5104, 3.79, 0.029, 833, 102, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1768, 5aooB, 0.5104, 3.93, 0.057, 314, 105, X-RAY STRUCTURE OF A HUMAN KOBUVIRUS: AICHI VIRUS A (AIV)
1769, 4zwjD, 0.5104, 3.79, 0.029, 833, 102, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1770, 4elmE, 0.5104, 3.86, 0.093, 179, 107, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1771, 3hujF, 0.5104, 3.86, 0.083, 242, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1772, 3ffcJ, 0.5104, 3.96, 0.101, 247, 109, CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR
1773, 1i7zA, 0.5104, 3.87, 0.094, 219, 106, ANTIBODY GNC92H2 BOUND TO LIGAND
1774, 4jryD, 0.5103, 3.89, 0.103, 201, 107, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
1775, 4guqA, 0.5103, 3.64, 0.107, 200, 103, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
1776, 3dpaA, 0.5103, 3.38, 0.143, 218, 98, CRYSTAL STRUCTURE OF CHAPERONE PROTEIN PAPD REVEALS AN IMMUNOGLOBULIN FOLD
1777, 2xg4A, 0.5103, 3.31, 0.144, 216, 97, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 2C
1778, 2po6C, 0.5103, 3.90, 0.092, 203, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1779, 2op4H, 0.5103, 4.20, 0.079, 217, 114, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
1780, 1ngpH, 0.5103, 4.06, 0.098, 215, 112, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1781, 1l4iA, 0.5103, 3.00, 0.074, 189, 95, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
1782, 5yslC, 0.5102, 4.04, 0.072, 210, 111, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1783, 5jhdI, 0.5102, 3.96, 0.083, 203, 109, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
1784, 3zk4B, 0.5102, 3.70, 0.039, 571, 103, STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS
1785, 3vxsE, 0.5102, 3.79, 0.093, 242, 107, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
1786, 3vwjC, 0.5102, 3.94, 0.102, 193, 108, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
1787, 2ntfH, 0.5102, 4.04, 0.071, 222, 112, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1788, 1py0A, 0.5102, 2.59, 0.115, 122, 87, CRYSTAL STRUCTURE OF E51C/E54C PSAZ FROM A.FAECALIS WITH CLANP PROBE
1789, 1nj9H, 0.5102, 3.97, 0.064, 215, 109, COCAINE HYDROLYTIC ANTIBODY 15A10
1790, 4p4kD, 0.5101, 3.74, 0.094, 241, 106, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
1791, 3qdgE, 0.5101, 3.72, 0.084, 242, 107, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
1792, 1za3A, 0.5101, 3.92, 0.084, 213, 107, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1793, 1tegA, 0.5101, 2.66, 0.135, 99, 89, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
1794, 6cjkA, 0.5100, 3.83, 0.094, 216, 106, ANTI HIV FAB 10A 
1795, 5tilG, 0.5100, 3.75, 0.094, 114, 106, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1796, 5brzD, 0.5100, 3.90, 0.111, 197, 108, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
1797, 4jfhE, 0.5100, 3.93, 0.119, 244, 109, HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
1798, 2y06H, 0.5100, 4.07, 0.080, 215, 113, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
1799, 1z9sA, 0.5100, 3.04, 0.096, 196, 94, CRYSTAL STRUCTURE OF THE NATIVE CHAPERONE:SUBUNIT:SUBUNIT CAF1M:CAF1:CAF1 COMPLEX
1800, 6fxnD, 0.5099, 3.90, 0.065, 215, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1801, 6cqlD, 0.5099, 3.77, 0.085, 200, 106, CRYSTAL STRUCTURE OF A TCR 
1802, 5e6rB, 0.5099, 4.05, 0.093, 454, 107, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
1803, 4dzbB, 0.5099, 3.93, 0.101, 244, 109, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
1804, 3uttI, 0.5099, 3.80, 0.113, 199, 106, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
1805, 3tzvG, 0.5099, 3.87, 0.093, 201, 108, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
1806, 3tzvA, 0.5099, 3.87, 0.093, 196, 108, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
1807, 2uweL, 0.5099, 3.81, 0.104, 194, 106, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
1808, 2eyrA, 0.5099, 3.96, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
1809, 1pdkA, 0.5099, 3.34, 0.153, 215, 98, PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX FROM E.COLI P PILUS
1810, 1byoA, 0.5099, 2.98, 0.132, 99, 91, WILD-TYPE PLASTOCYANIN FROM SILENE
1811, 6dkpE, 0.5098, 3.67, 0.075, 242, 106, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
1812, 5u17E, 0.5098, 3.74, 0.075, 244, 107, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1813, 4grmB, 0.5098, 3.55, 0.087, 240, 104, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
1814, 3to4C, 0.5098, 3.83, 0.150, 190, 107, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
1815, 3gsnA, 0.5098, 3.91, 0.103, 199, 107, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
1816, 2b3iA, 0.5098, 2.98, 0.152, 97, 92, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (19 STRUCTURES)
1817, 1oarJ, 0.5098, 4.04, 0.080, 122, 112, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1818, 1oarH, 0.5098, 4.04, 0.080, 122, 112, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1819, 9pcyA, 0.5097, 2.65, 0.124, 99, 89, HIGH-RESOLUTION SOLUTION STRUCTURE OF REDUCED FRENCH BEAN PLASTOCYANIN AND COMPARISON WITH THE CRYSTAL STRUCTURE OF POPLAR PLASTOCYANIN
1820, 5yxnA, 0.5097, 4.00, 0.109, 192, 110, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
1821, 5xctA, 0.5097, 3.92, 0.046, 167, 109, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
1822, 5t5fH, 0.5097, 4.06, 0.098, 212, 112, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
1823, 5bs0E, 0.5097, 3.79, 0.104, 241, 106, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
1824, 4ki5C, 0.5097, 4.01, 0.063, 218, 111, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
1825, 3qynD, 0.5097, 3.84, 0.086, 190, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
1826, 2bnrD, 0.5097, 3.98, 0.102, 203, 108, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
1827, 6d48E, 0.5096, 3.93, 0.075, 125, 107, CELL SURFACE RECEPTOR 
1828, 5nmeI, 0.5096, 3.92, 0.111, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1829, 4rirH, 0.5096, 4.10, 0.081, 219, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1830, 4elmF, 0.5096, 3.86, 0.103, 224, 107, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1831, 3d34A, 0.5096, 3.53, 0.080, 211, 100, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1832, 2z4qB, 0.5096, 4.27, 0.080, 218, 113, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
1833, 1tcrA, 0.5096, 3.93, 0.120, 202, 108, MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
1834, 1kj2E, 0.5096, 3.57, 0.068, 117, 103, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1835, 6cqrD, 0.5095, 3.74, 0.112, 200, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1836, 6aniH, 0.5095, 4.11, 0.089, 216, 112, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1837, 5u6fA, 0.5095, 3.85, 0.078, 288, 102, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P21) 
1838, 4z7uF, 0.5095, 3.82, 0.075, 244, 106, S13 COMPLEX
1839, 4p1yB, 0.5095, 4.02, 0.073, 264, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
1840, 4ei5H, 0.5095, 4.00, 0.101, 230, 109, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1841, 1afvK, 0.5095, 4.05, 0.080, 220, 112, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1842, 5iblH, 0.5094, 3.90, 0.083, 216, 109, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
1843, 5iblC, 0.5094, 3.82, 0.065, 216, 108, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
1844, 5epmA, 0.5094, 3.98, 0.099, 218, 111, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
1845, 4n20A, 0.5094, 3.69, 0.077, 639, 104, CRYSTAL STRUCTURE OF PROTEIN ARGININE DEIMINASE 2 (0 MM CA2+)
1846, 4elkD, 0.5094, 3.93, 0.102, 242, 108, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
1847, 3sjvS, 0.5094, 3.82, 0.112, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1848, 1fytD, 0.5094, 3.95, 0.119, 198, 109, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
1849, 1a4jH, 0.5094, 4.01, 0.080, 217, 112, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1850, 6dfjL, 0.5093, 3.84, 0.086, 214, 105, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO DENV-1 ENVELOPE PROTEIN DIII 
1851, 6cqrE, 0.5093, 3.76, 0.084, 245, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1852, 4r7nD, 0.5093, 4.02, 0.075, 211, 107, FAB C2E3
1853, 4elmH, 0.5093, 3.84, 0.103, 211, 107, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
1854, 4apqC, 0.5093, 3.92, 0.148, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
1855, 3of6C, 0.5093, 3.91, 0.101, 243, 109, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
1856, 3mv8E, 0.5093, 3.80, 0.094, 242, 106, CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG
1857, 3hujG, 0.5093, 3.98, 0.092, 202, 109, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1858, 3he7C, 0.5093, 3.93, 0.148, 197, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
1859, 3d34B, 0.5093, 3.55, 0.080, 215, 100, STRUCTURE OF THE F-SPONDIN DOMAIN OF MINDIN
1860, 1hxmD, 0.5093, 4.16, 0.134, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1861, 6d48F, 0.5092, 4.12, 0.083, 125, 109, CELL SURFACE RECEPTOR 
1862, 4r7dB, 0.5092, 4.01, 0.084, 211, 107, FAB HU 15C1
1863, 4ei5D, 0.5092, 3.88, 0.102, 242, 108, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
1864, 3vxsD, 0.5092, 3.96, 0.101, 204, 109, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
1865, 3vxqB, 0.5092, 3.83, 0.093, 242, 107, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1866, 3v4vB, 0.5092, 4.30, 0.062, 375, 113, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
1867, 3qi9C, 0.5092, 3.93, 0.148, 196, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
1868, 3qdjE, 0.5092, 3.73, 0.084, 242, 107, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
1869, 3g6jE, 0.5092, 4.01, 0.075, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1870, 3dxaO, 0.5092, 3.73, 0.093, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
1871, 2f53D, 0.5092, 3.99, 0.101, 193, 109, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
1872, 1nezG, 0.5092, 4.18, 0.045, 122, 111, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
1873, 1klfO, 0.5092, 3.08, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1874, 1klfM, 0.5092, 3.08, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1875, 1klfK, 0.5092, 3.08, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1876, 1klfI, 0.5092, 3.08, 0.073, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
1877, 6dg2C, 0.5091, 4.17, 0.097, 211, 113, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
1878, 5xcqA, 0.5091, 4.08, 0.062, 166, 112, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
1879, 5jziI, 0.5091, 3.98, 0.109, 207, 110, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
1880, 4zsoD, 0.5091, 4.35, 0.087, 219, 115, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1881, 4z7uE, 0.5091, 3.90, 0.132, 198, 106, S13 COMPLEX
1882, 4nenB, 0.5091, 4.01, 0.084, 665, 107, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
1883, 3vwjD, 0.5091, 3.76, 0.085, 241, 106, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
1884, 3tpuC, 0.5091, 3.82, 0.101, 204, 109, 42F3 P5E8/H2-LD COMPLEX
1885, 3scmC, 0.5091, 3.93, 0.157, 191, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
1886, 3qjfB, 0.5091, 3.94, 0.073, 240, 109, CRYSTAL STRUCTURE OF THE 2B4 TCR
1887, 3hujH, 0.5091, 3.86, 0.083, 245, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1888, 2qk7A, 0.5091, 4.19, 0.071, 259, 112, A COVALENT S-F HETERODIMER OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN
1889, 2po6D, 0.5091, 3.94, 0.083, 244, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1890, 1tefB, 0.5091, 2.69, 0.124, 99, 89, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
1891, 5u5oA, 0.5090, 3.87, 0.078, 287, 102, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P1) 
1892, 5ks9G, 0.5090, 3.82, 0.066, 192, 106, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
1893, 5eu6E, 0.5090, 3.87, 0.148, 244, 108, HLA CLASS I ANTIGEN
1894, 4l4tE, 0.5090, 3.75, 0.075, 243, 107, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
1895, 3sqbA, 0.5090, 2.94, 0.096, 191, 94, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1896, 2eytA, 0.5090, 3.97, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
1897, 1hxmC, 0.5090, 3.80, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1898, 6avgD, 0.5089, 3.82, 0.093, 245, 107, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
1899, 5u6qG, 0.5089, 3.81, 0.074, 239, 108, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1900, 5u6qE, 0.5089, 3.79, 0.074, 244, 108, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1901, 5kbdB, 0.5089, 3.51, 0.118, 201, 102, STRUCTURAL STUDIES OF TRANSCRIPTION FACTOR P73 DNA BINDING DOMAIN BOUND TO PA26 20-MER RESPONSE ELEMENT
1902, 4z7vF, 0.5089, 3.87, 0.074, 243, 108, L3-12 COMPLEX
1903, 4j3oC, 0.5089, 3.10, 0.083, 199, 96, CRYSTAL STRUCTURE OF THE FIMD USHER TRAVERSED BY THE PILUS TIP COMPLEX ASSEMBLY COMPOSED OF FIMC:FIMF:FIMG:FIMH
1904, 3q5yB, 0.5089, 3.85, 0.112, 238, 107, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
1905, 1kj2B, 0.5089, 3.58, 0.068, 117, 103, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
1906, 1j8hD, 0.5089, 3.92, 0.119, 198, 109, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
1907, 1hxmH, 0.5089, 4.14, 0.116, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1908, 1c1eH, 0.5089, 4.02, 0.072, 219, 111, CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
1909, 6dg2A, 0.5088, 4.14, 0.106, 217, 113, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
1910, 6d48G, 0.5088, 3.90, 0.075, 124, 106, CELL SURFACE RECEPTOR 
1911, 5u72G, 0.5088, 3.71, 0.075, 243, 107, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1912, 5nmdD, 0.5088, 3.89, 0.074, 242, 108, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
1913, 5brzE, 0.5088, 3.78, 0.104, 241, 106, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
1914, 4xzuA, 0.5088, 4.01, 0.063, 213, 111, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
1915, 4qrrE, 0.5088, 3.72, 0.085, 241, 106, CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR CLONE 12 TCR
1916, 4p4kH, 0.5088, 3.74, 0.094, 239, 106, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
1917, 4nqcH, 0.5088, 3.75, 0.075, 243, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
1918, 4en3B, 0.5088, 3.78, 0.084, 240, 107, CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
1919, 4alaH, 0.5088, 4.16, 0.080, 208, 112, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
1920, 3rfzC, 0.5088, 2.99, 0.084, 201, 95, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
1921, 3qh3D, 0.5088, 3.70, 0.085, 241, 106, THE CRYSTAL STRUCTURE OF TCR A6
1922, 3phoA, 0.5088, 3.95, 0.103, 216, 107, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
1923, 3cm9S, 0.5088, 4.02, 0.063, 585, 111, SOLUTION STRUCTURE OF HUMAN SIGA2
1924, 1dbkH, 0.5088, 3.90, 0.073, 219, 110, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1925, 12e8P, 0.5088, 4.05, 0.071, 221, 112, 2E8 FAB FRAGMENT
1926, 6fr5A, 0.5087, 4.00, 0.101, 202, 109, HA1.7 TCR STUDY OF CDR LOOP FLEXIBILITY 
1927, 6cqnE, 0.5087, 3.77, 0.084, 244, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1928, 6cphD, 0.5087, 3.82, 0.085, 200, 106, CRYSTAL STRUCTURE OF A TCR 
1929, 5swsE, 0.5087, 3.88, 0.121, 239, 107, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
1930, 5nmgE, 0.5087, 3.83, 0.075, 242, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
1931, 5nmeE, 0.5087, 3.83, 0.084, 242, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1932, 5nmeD, 0.5087, 3.81, 0.131, 201, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
1933, 4j2qA, 0.5087, 3.66, 0.030, 340, 101, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1934, 4amkH, 0.5087, 3.94, 0.091, 215, 110, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
1935, 3tyfA, 0.5087, 3.93, 0.092, 199, 109, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
1936, 2po6H, 0.5087, 3.87, 0.083, 244, 108, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1937, 5yslG, 0.5086, 3.92, 0.073, 210, 110, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1938, 5tkjJ, 0.5086, 4.01, 0.098, 211, 112, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1939, 5ksaC, 0.5086, 3.93, 0.084, 195, 107, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
1940, 4jzjH, 0.5086, 4.14, 0.062, 215, 113, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1941, 3qynC, 0.5086, 3.72, 0.087, 196, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
1942, 3dxaE, 0.5086, 3.77, 0.093, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
1943, 3bn9E, 0.5086, 3.98, 0.075, 211, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
1944, 2pyfA, 0.5086, 3.90, 0.084, 205, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
1945, 2f54K, 0.5086, 3.71, 0.104, 206, 106, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
1946, 1rjlB, 0.5086, 4.03, 0.081, 221, 111, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
1947, 1i7zC, 0.5086, 3.84, 0.094, 219, 106, ANTIBODY GNC92H2 BOUND TO LIGAND
1948, 1hxmE, 0.5086, 3.92, 0.083, 206, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1949, 6b5sH, 0.5085, 4.06, 0.054, 215, 112, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
1950, 5nmdB, 0.5085, 3.98, 0.073, 242, 109, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
1951, 5lxaH, 0.5085, 4.07, 0.062, 238, 112, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
1952, 5d2lK, 0.5085, 3.78, 0.094, 192, 106, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
1953, 4m62M, 0.5085, 3.99, 0.075, 113, 106, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
1954, 4l8sB, 0.5085, 3.80, 0.093, 242, 108, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
1955, 3vxrE, 0.5085, 3.89, 0.093, 242, 108, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
1956, 3sdxG, 0.5085, 3.97, 0.092, 196, 109, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1957, 3sdxE, 0.5085, 3.96, 0.092, 196, 109, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1958, 3rifG, 0.5085, 4.05, 0.071, 214, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1959, 2jccL, 0.5085, 3.83, 0.094, 194, 106, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
1960, 2cdgB, 0.5085, 3.71, 0.084, 244, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
1961, 1tegB, 0.5085, 2.68, 0.135, 99, 89, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
1962, 1rzgC, 0.5085, 3.93, 0.064, 213, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1963, 5w1vO, 0.5084, 3.90, 0.084, 243, 107, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
1964, 5udcH, 0.5084, 3.99, 0.072, 217, 111, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
1965, 5swzN, 0.5084, 3.88, 0.093, 201, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1966, 5menE, 0.5084, 3.83, 0.074, 240, 108, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
1967, 4x6dG, 0.5084, 3.74, 0.076, 200, 105, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
1968, 4r7nH, 0.5084, 4.03, 0.075, 211, 107, FAB C2E3
1969, 4g8fA, 0.5084, 3.85, 0.132, 184, 106, CRYSTAL STRUCTURE OF CLONE42 TCR
1970, 3us0D, 0.5084, 3.71, 0.087, 192, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
1971, 3sqbC, 0.5084, 3.02, 0.095, 200, 95, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
1972, 3rifJ, 0.5084, 4.05, 0.071, 200, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1973, 3of6A, 0.5084, 3.82, 0.102, 240, 108, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
1974, 1pazA, 0.5084, 2.47, 0.141, 120, 85, REFINEMENT OF THE STRUCTURE OF PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT 1.55 ANGSTROMS RESOLUTION
1975, 1ahwE, 0.5084, 4.12, 0.080, 214, 112, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1976, 5u72E, 0.5083, 3.84, 0.074, 243, 108, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1977, 5u1rE, 0.5083, 3.76, 0.075, 243, 107, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1978, 5lfrB, 0.5083, 4.27, 0.117, 312, 111, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3
1979, 5e6sF, 0.5083, 4.10, 0.083, 455, 108, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
1980, 4z7vH, 0.5083, 3.87, 0.074, 242, 108, L3-12 COMPLEX
1981, 4am0H, 0.5083, 4.11, 0.089, 214, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1982, 3v4vD, 0.5083, 4.32, 0.062, 375, 113, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
1983, 3tpuM, 0.5083, 3.84, 0.101, 204, 109, 42F3 P5E8/H2-LD COMPLEX
1984, 3njhA, 0.5083, 3.40, 0.124, 121, 97, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
1985, 2j2zA, 0.5083, 3.32, 0.144, 216, 97, X-RAY STRUCTURE OF THE CHAPERONE PAPD IN COMPLEX WITH THE PILUS TERMINATOR SUBUNIT PAPH AT 2.3 ANGSTROM RESOLUTION
1986, 1ypzF, 0.5083, 3.92, 0.065, 230, 108, IMMUNE RECEPTOR
1987, 1lcsB, 0.5083, 4.89, 0.066, 205, 122, RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS
1988, 5w5xH, 0.5082, 4.06, 0.081, 211, 111, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY 
1989, 5fk9B, 0.5082, 3.95, 0.083, 241, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN A F47A MUTANT IN COMPLEX WITH A T CELL RECEPTOR
1990, 4r7nT, 0.5082, 4.05, 0.075, 211, 107, FAB C2E3
1991, 4r7nB, 0.5082, 4.04, 0.075, 211, 107, FAB C2E3
1992, 4l4vE, 0.5082, 3.80, 0.074, 243, 108, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
1993, 4iyaA, 0.5082, 4.16, 0.054, 283, 112, STRUCTURE OF THE Y250A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
1994, 3tyfC, 0.5082, 3.93, 0.092, 197, 109, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
1995, 3sdcD, 0.5082, 3.92, 0.065, 239, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
1996, 3scmD, 0.5082, 3.80, 0.065, 239, 107, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
1997, 3rifH, 0.5082, 4.05, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1998, 3bn9C, 0.5082, 3.99, 0.084, 210, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
1999, 2vl5A, 0.5082, 4.14, 0.107, 218, 112, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2000, 1ob1E, 0.5082, 3.99, 0.081, 219, 111, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
2001, 1oaxJ, 0.5082, 4.14, 0.080, 122, 113, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
2002, 1hxmA, 0.5082, 3.88, 0.093, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2003, 5u16H, 0.5081, 3.80, 0.074, 243, 108, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2004, 5tjeG, 0.5081, 3.74, 0.094, 112, 106, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
2005, 5nmfD, 0.5081, 3.94, 0.111, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
2006, 5e6uB, 0.5081, 4.11, 0.093, 453, 107, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
2007, 4r7dN, 0.5081, 4.02, 0.084, 211, 107, FAB HU 15C1
2008, 4m6nH, 0.5081, 4.14, 0.071, 213, 113, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
2009, 3rfzF, 0.5081, 3.00, 0.084, 201, 95, CRYSTAL STRUCTURE OF THE FIMD USHER BOUND TO ITS COGNATE FIMC:FIMH SUBSTRATE
2010, 3q5yC, 0.5081, 3.86, 0.121, 239, 107, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
2011, 3hujE, 0.5081, 3.97, 0.092, 199, 109, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
2012, 3dxaJ, 0.5081, 3.77, 0.093, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
2013, 2uylN, 0.5081, 4.30, 0.070, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2014, 1rzfH, 0.5081, 3.97, 0.083, 218, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
2015, 1fgnH, 0.5081, 4.08, 0.080, 214, 112, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
2016, 6eh4E, 0.5080, 3.80, 0.084, 244, 107, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
2017, 6didH, 0.5080, 3.83, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2018, 6didE, 0.5080, 3.83, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2019, 6didC, 0.5080, 3.83, 0.094, 217, 106, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
2020, 5tkjD, 0.5080, 4.08, 0.097, 211, 113, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2021, 5tkjA, 0.5080, 4.09, 0.106, 211, 113, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2022, 5nyxN, 0.5080, 3.90, 0.075, 210, 106, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2023, 5nmeJ, 0.5080, 3.89, 0.074, 241, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTVATL
2024, 5nmdC, 0.5080, 3.90, 0.103, 200, 107, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
2025, 5fkaB, 0.5080, 3.89, 0.083, 240, 108, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR
2026, 5cbeA, 0.5080, 3.84, 0.066, 125, 106, E10 IN COMPLEX WITH CXCL13
2027, 4zezG, 0.5080, 4.00, 0.109, 207, 110, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
2028, 4u6hC, 0.5080, 3.97, 0.073, 217, 110, VACCINIA L1/M12B9-FAB COMPLEX
2029, 4tnvV, 0.5080, 3.99, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2030, 4nehB, 0.5080, 4.12, 0.065, 668, 108, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
2031, 3vi4D, 0.5080, 4.36, 0.080, 433, 113, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
2032, 3uttJ, 0.5080, 3.85, 0.073, 245, 109, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
2033, 3tpuG, 0.5080, 3.89, 0.101, 202, 109, 42F3 P5E8/H2-LD COMPLEX
2034, 3ri5I, 0.5080, 4.00, 0.072, 199, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2035, 3qpqD, 0.5080, 3.99, 0.099, 218, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2036, 3q5yA, 0.5080, 3.79, 0.113, 240, 106, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
2037, 3dpbA, 0.5080, 3.04, 0.096, 196, 94, CRYSTAL STRUCTURE OF THE COMPLEX OF THE CAF1M CHAPERONE WITH THE MINI-FIBER OF TWO CAF1 SUBUNITS (CAF1:CAF1) CARRYING THE ALA9VAL ALA11VAL AND LEU13VAL MUTATIONS IN THE GD DONOR STRAND
2038, 2po6G, 0.5080, 3.93, 0.092, 204, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2039, 2nx5T, 0.5080, 3.66, 0.143, 188, 105, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2040, 2nx5I, 0.5080, 3.72, 0.132, 188, 106, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2041, 2f54D, 0.5080, 3.70, 0.104, 205, 106, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2042, 1ws7B, 0.5080, 2.94, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2043, 1qppA, 0.5080, 3.43, 0.133, 207, 98, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
2044, 1afvH, 0.5080, 4.01, 0.098, 220, 112, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
2045, 8pazA, 0.5079, 2.64, 0.128, 123, 86, OXIDIZED NATIVE PSEUDOAZURIN FROM A. FAECALIS
2046, 5uddK, 0.5079, 4.11, 0.071, 220, 112, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2047, 5j06A, 0.5079, 4.17, 0.083, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
2048, 5e6sD, 0.5079, 4.14, 0.083, 455, 109, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
2049, 4z7uH, 0.5079, 3.86, 0.075, 244, 107, S13 COMPLEX
2050, 4l3eE, 0.5079, 3.74, 0.084, 242, 107, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
2051, 4i3sH, 0.5079, 4.20, 0.071, 222, 112, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
2052, 4ei6B, 0.5079, 3.92, 0.093, 244, 108, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
2053, 4am0E, 0.5079, 4.13, 0.089, 212, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2054, 3tf7C, 0.5079, 3.74, 0.112, 232, 107, 42F3 QL9/H2-LD COMPLEX
2055, 3qh3B, 0.5079, 3.74, 0.084, 245, 107, THE CRYSTAL STRUCTURE OF TCR A6
2056, 3of6B, 0.5079, 3.82, 0.093, 242, 108, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
2057, 3g6jG, 0.5079, 4.01, 0.065, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
2058, 2zahA, 0.5079, 4.12, 0.038, 296, 104, X-RAY STRUCTURE OF MELON NECROTIC SPOT VIRUS
2059, 2xg5A, 0.5079, 3.41, 0.153, 216, 98, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 5D
2060, 2oslA, 0.5079, 4.10, 0.098, 221, 112, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2061, 2cdeE, 0.5079, 3.85, 0.113, 192, 106, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2062, 1tefA, 0.5079, 2.74, 0.122, 99, 90, CRYSTAL STRUCTURE OF THE SPINACH PLASTOCYANIN MUTANTS G8D/K30C/T69C AND K30C/T69C- A STUDY OF THE EFFECT ON CRYSTAL PACKING AND THERMOSTABILITY FROM THE INTRODUCTION OF A NOVEL DISULFIDE BOND
2063, 1oaxH, 0.5079, 4.14, 0.080, 122, 113, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
2064, 1oauJ, 0.5079, 4.04, 0.080, 122, 112, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
2065, 1oauH, 0.5079, 4.04, 0.080, 122, 112, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
2066, 6mtoH, 0.5078, 4.06, 0.062, 219, 112, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
2067, 6cqqE, 0.5078, 3.77, 0.084, 244, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2068, 5uddM, 0.5078, 4.11, 0.071, 221, 112, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2069, 5nmfJ, 0.5078, 3.93, 0.083, 240, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
2070, 5ivxE, 0.5078, 3.78, 0.094, 194, 106, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
2071, 5ihbA, 0.5078, 4.18, 0.083, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33
2072, 5d6cA, 0.5078, 4.12, 0.093, 219, 108, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
2073, 5d2nC, 0.5078, 3.88, 0.142, 198, 106, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2074, 4x8jB, 0.5078, 3.90, 0.123, 214, 106, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
2075, 4tnvG, 0.5078, 4.00, 0.072, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2076, 4gkzA, 0.5078, 3.88, 0.119, 202, 109, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
2077, 4bz1H, 0.5078, 3.99, 0.081, 212, 111, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
2078, 3rifI, 0.5078, 4.06, 0.071, 192, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2079, 3qynB, 0.5078, 3.71, 0.087, 193, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
2080, 2qk7B, 0.5078, 4.12, 0.090, 287, 111, A COVALENT S-F HETERODIMER OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN
2081, 2nx5N, 0.5078, 3.73, 0.132, 188, 106, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2082, 2cdeF, 0.5078, 3.89, 0.064, 244, 109, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2083, 6frcA, 0.5077, 3.98, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2084, 6eh5B, 0.5077, 3.80, 0.084, 244, 107, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
2085, 5yslE, 0.5077, 3.93, 0.073, 210, 110, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
2086, 5uddN, 0.5077, 4.00, 0.072, 221, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2087, 5otjB, 0.5077, 3.99, 0.064, 222, 110, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2088, 4hjjH, 0.5077, 4.45, 0.078, 341, 116, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
2089, 4am0C, 0.5077, 4.08, 0.080, 211, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2090, 3sdxF, 0.5077, 3.80, 0.084, 242, 107, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2091, 2zg3A, 0.5077, 3.99, 0.084, 210, 107, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5 IN COMPLEX WITH 3 -SIALYLLACTOSE
2092, 2w07A, 0.5077, 3.39, 0.143, 215, 98, STRUCTURAL DETERMINANTS OF POLYMERIZATION REACTIVITY OF THE P PILUS ADAPTOR SUBUNIT PAPF
2093, 1ktkE, 0.5077, 4.06, 0.099, 247, 111, COMPLEX OF STREPTOCOCCAL PYROGENIC ENTEROTOXIN C (SPEC) WITH A HUMAN T CELL RECEPTOR BETA CHAIN (VBETA2.1)
2094, 1hxmG, 0.5077, 3.90, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2095, 1bd2D, 0.5077, 3.92, 0.085, 190, 106, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
2096, 1a5fH, 0.5077, 4.12, 0.098, 212, 112, FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
2097, 6cjkC, 0.5076, 3.84, 0.094, 217, 106, ANTI HIV FAB 10A 
2098, 5w1wE, 0.5076, 3.70, 0.076, 243, 105, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2099, 5vqmD, 0.5076, 4.03, 0.063, 216, 111, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
2100, 5u1rG, 0.5076, 3.78, 0.075, 241, 107, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2101, 5ksbF, 0.5076, 3.76, 0.085, 241, 106, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
2102, 4y19D, 0.5076, 3.80, 0.093, 205, 108, IMMUNE COMPLEX
2103, 4tnvJ, 0.5076, 4.00, 0.072, 223, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2104, 4r7nJ, 0.5076, 4.05, 0.084, 211, 107, FAB C2E3
2105, 4j1uC, 0.5076, 4.00, 0.093, 213, 107, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2106, 3us0B, 0.5076, 3.71, 0.087, 193, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
2107, 3sdaC, 0.5076, 3.90, 0.167, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2108, 3q5yD, 0.5076, 3.86, 0.121, 238, 107, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
2109, 3pqyJ, 0.5076, 3.71, 0.104, 240, 106, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2110, 3nykA, 0.5076, 2.64, 0.128, 120, 86, THE STRUCTURE OF COBALT-SUBSTITUTED PSEUDOAZURIN FROM ALCALIGENES FAECALIS
2111, 3lh9A, 0.5076, 3.68, 0.110, 286, 100, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
2112, 3hagA, 0.5076, 4.02, 0.056, 468, 107, CRYSTAL STRUCTURE OF THE HEPATITIS E VIRUS-LIKE PARTICLE
2113, 2vweE, 0.5076, 4.09, 0.089, 219, 112, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2114, 1hklH, 0.5076, 4.00, 0.090, 217, 111, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
2115, 6pazA, 0.5075, 2.64, 0.116, 123, 86, OXIDIZED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS
2116, 6idgL, 0.5075, 3.96, 0.112, 217, 107, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
2117, 6funA, 0.5075, 3.99, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2118, 6fr5B, 0.5075, 3.80, 0.084, 244, 107, HA1.7 TCR STUDY OF CDR LOOP FLEXIBILITY 
2119, 5yxuA, 0.5075, 4.04, 0.109, 191, 110, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2120, 5tjeE, 0.5075, 3.95, 0.101, 116, 109, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
2121, 5j0bC, 0.5075, 4.17, 0.083, 212, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
2122, 5iszD, 0.5075, 3.77, 0.121, 200, 107, CRYSTAL STRUCTURE OF LS01-TCR/M1-HLA-A*02 COMPLEX
2123, 5ikcB, 0.5075, 3.98, 0.073, 210, 109, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2124, 4z95L, 0.5075, 3.99, 0.084, 214, 107, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
2125, 4z8fL, 0.5075, 4.00, 0.084, 214, 107, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
2126, 3pqyT, 0.5075, 3.82, 0.103, 240, 107, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2127, 3gi8H, 0.5075, 4.29, 0.088, 220, 114, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2128, 2vl5C, 0.5075, 4.08, 0.107, 218, 112, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2129, 2p5wE, 0.5075, 3.71, 0.085, 242, 106, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2130, 1qfuH, 0.5075, 4.08, 0.098, 223, 112, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2131, 1kvpA, 0.5075, 4.62, 0.062, 497, 113, STRUCTURAL ANALYSIS OF THE SPIROPLASMA VIRUS SPV4 IMPLICATIONS FOR EVOLUTIONARY VARIATION TO OBTAIN HOST DIVERSITY AMONG THE MICROVIRIDAE ELECTRON MICROSCOPY ALPHA CARBONS ONLY
2132, 1klfG, 0.5075, 3.09, 0.083, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2133, 1klfE, 0.5075, 3.09, 0.083, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2134, 1klfC, 0.5075, 3.09, 0.083, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2135, 1klfA, 0.5075, 3.09, 0.083, 205, 96, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2136, 6fumA, 0.5074, 3.98, 0.145, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2137, 6c09C, 0.5074, 3.84, 0.093, 192, 107, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
2138, 5npjA, 0.5074, 4.20, 0.062, 232, 113, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2139, 5npiA, 0.5074, 4.19, 0.062, 232, 113, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2140, 5ksbH, 0.5074, 3.76, 0.094, 241, 106, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
2141, 4y1aD, 0.5074, 3.74, 0.093, 205, 107, IMMUNE COMPLEX
2142, 4x6cF, 0.5074, 3.89, 0.073, 243, 109, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2143, 4r7nF, 0.5074, 4.04, 0.075, 211, 107, FAB C2E3
2144, 4od2B, 0.5074, 3.88, 0.083, 214, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-DR5 ANTIBODY BOUND TO DR5
2145, 3ri5G, 0.5074, 4.06, 0.071, 200, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2146, 3qeuA, 0.5074, 3.87, 0.113, 195, 106, THE CRYSTAL STRUCTURE OF TCR DMF5
2147, 2y07H, 0.5074, 4.02, 0.089, 215, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
2148, 2r4sH, 0.5074, 4.28, 0.106, 217, 113, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2149, 2b1aH, 0.5074, 3.94, 0.055, 226, 109, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2150, 1yuhH, 0.5074, 4.26, 0.088, 218, 114, FAB FRAGMENT
2151, 1xcqD, 0.5074, 4.06, 0.089, 218, 112, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2152, 6ey0F, 0.5073, 3.89, 0.073, 131, 109, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
2153, 6cqlE, 0.5073, 3.76, 0.085, 244, 106, CRYSTAL STRUCTURE OF A TCR 
2154, 5u2vH, 0.5073, 3.73, 0.075, 242, 106, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2155, 5tkjG, 0.5073, 4.09, 0.097, 208, 113, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
2156, 5nmgD, 0.5073, 3.95, 0.111, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
2157, 5lxgH, 0.5073, 3.89, 0.056, 119, 108, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 IN AN OPEN CONFORMATION
2158, 5ks9E, 0.5073, 3.85, 0.066, 193, 106, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2159, 5jo4C, 0.5073, 3.87, 0.083, 221, 109, ANTIBODY FAB FRAGMENT COMPLEX
2160, 4priE, 0.5073, 3.84, 0.075, 240, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX
2161, 4pj5E, 0.5073, 3.81, 0.074, 243, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
2162, 4p46A, 0.5073, 3.89, 0.121, 199, 107, J809.B5 Y31A TCR BOUND TO IAB3K
2163, 4nqeE, 0.5073, 3.72, 0.075, 243, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2164, 3uluF, 0.5073, 4.16, 0.098, 217, 112, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2165, 2iamD, 0.5073, 3.75, 0.066, 239, 106, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2166, 2gcyA, 0.5073, 4.09, 0.074, 216, 108, HUMANIZED ANTIBODY C25 FAB FRAGMENT
2167, 1uweU, 0.5073, 3.96, 0.112, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2168, 1qsfD, 0.5073, 3.89, 0.112, 200, 107, STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
2169, 1a4kH, 0.5073, 4.06, 0.080, 217, 112, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
2170, 6eh7A, 0.5072, 4.00, 0.136, 202, 110, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2171, 5yhlH, 0.5072, 3.88, 0.063, 223, 111, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2172, 5u16F, 0.5072, 3.74, 0.075, 240, 106, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2173, 5tezJ, 0.5072, 3.77, 0.075, 240, 107, TCR F50 RECGONIZING M1-HLA-A2
2174, 5pazA, 0.5072, 2.64, 0.116, 123, 86, REDUCED MUTANT P80A PSEUDOAZURIN FROM A. FAECALIS
2175, 5f7nD, 0.5072, 3.94, 0.092, 115, 109, BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH BLOOD GROUP A LEWIS B PENTASACCHARIDE
2176, 4rh4A, 0.5072, 2.27, 0.143, 123, 84, ZINC-SUBSTITUTED PSEUDOAZURIN SOLVED BY S/ZN-SAD PHASING
2177, 4lccB, 0.5072, 3.81, 0.074, 238, 108, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
2178, 3ri5J, 0.5072, 4.06, 0.071, 215, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2179, 2zg1A, 0.5072, 4.02, 0.075, 208, 107, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF SIGLEC-5 IN COMPLEX WITH 6 -SIALYLLACTOSE
2180, 1oazJ, 0.5072, 4.09, 0.080, 122, 112, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
2181, 1i9rX, 0.5072, 3.98, 0.064, 219, 110, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2182, 6dwcA, 0.5071, 4.00, 0.103, 217, 107, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
2183, 5yxuF, 0.5071, 4.01, 0.100, 190, 110, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2184, 5tezI, 0.5071, 3.89, 0.112, 202, 107, TCR F50 RECGONIZING M1-HLA-A2
2185, 5mhrN, 0.5071, 4.22, 0.061, 214, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2186, 5d2nD, 0.5071, 3.91, 0.140, 198, 107, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2187, 5d06B, 0.5071, 3.46, 0.050, 1506, 101, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME
2188, 4x6dF, 0.5071, 3.67, 0.067, 241, 105, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
2189, 4pj8D, 0.5071, 3.93, 0.102, 243, 108, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
2190, 4odtL, 0.5071, 4.00, 0.084, 214, 107, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
2191, 4nqdE, 0.5071, 3.72, 0.075, 243, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2192, 4mxvE, 0.5071, 3.97, 0.093, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2193, 4etqA, 0.5071, 4.02, 0.080, 217, 112, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
2194, 3vxmE, 0.5071, 3.79, 0.075, 243, 107, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
2195, 3utpD, 0.5071, 3.82, 0.084, 199, 107, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
2196, 3ri5H, 0.5071, 4.06, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2197, 3pqyE, 0.5071, 3.70, 0.105, 240, 105, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2198, 3kj6H, 0.5071, 4.14, 0.107, 217, 112, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
2199, 3ixyI, 0.5071, 4.25, 0.080, 221, 113, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
2200, 1xedA, 0.5071, 3.50, 0.087, 111, 103, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2201, 1ws7C, 0.5071, 2.93, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2202, 1f5wA, 0.5071, 3.95, 0.093, 124, 108, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
2203, 5xovH, 0.5070, 3.87, 0.083, 245, 108, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
2204, 5w42H, 0.5070, 3.92, 0.065, 227, 108, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2) 
2205, 5w23J, 0.5070, 4.09, 0.072, 219, 111, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2206, 5nmgJ, 0.5070, 3.91, 0.074, 241, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
2207, 5mhrI, 0.5070, 4.19, 0.061, 213, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2208, 5lfvB, 0.5070, 4.29, 0.117, 311, 111, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3 WITH SOAKED TRISACCHARIDE LIGAND
2209, 5bs0D, 0.5070, 3.93, 0.111, 197, 108, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
2210, 4xr8D, 0.5070, 3.95, 0.038, 199, 105, CRYSTAL STRUCTURE OF THE HPV16 E6/E6AP/P53 TERNARY COMPLEX AT 2.25 A RESOLUTION
2211, 4tnwH, 0.5070, 4.05, 0.071, 223, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2212, 4kroC, 0.5070, 3.88, 0.085, 211, 106, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
2213, 4jo3L, 0.5070, 4.01, 0.065, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
2214, 4guqB, 0.5070, 3.92, 0.095, 198, 105, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
2215, 3us0C, 0.5070, 3.74, 0.087, 196, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
2216, 3rifF, 0.5070, 4.07, 0.071, 171, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2217, 3qeuD, 0.5070, 4.00, 0.120, 202, 108, THE CRYSTAL STRUCTURE OF TCR DMF5
2218, 3pazA, 0.5070, 2.47, 0.118, 123, 85, REDUCED NATIVE PSEUDOAZURIN FROM A. FAECALIS
2219, 3mlwH, 0.5070, 4.03, 0.055, 228, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
2220, 2vweL, 0.5070, 4.04, 0.089, 219, 112, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2221, 2p80D, 0.5070, 2.47, 0.118, 123, 85, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
2222, 1pzbA, 0.5070, 2.48, 0.141, 120, 85, THE CRYSTAL STRUCTURES OF REDUCED PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT TWO PH VALUES
2223, 1pzaA, 0.5070, 2.52, 0.141, 120, 85, THE CRYSTAL STRUCTURES OF REDUCED PSEUDOAZURIN FROM ALCALIGENES FAECALIS S-6 AT TWO PH VALUES
2224, 1oayH, 0.5070, 3.99, 0.081, 121, 111, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
2225, 1i9rH, 0.5070, 3.97, 0.064, 219, 110, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2226, 1eajA, 0.5070, 3.94, 0.093, 124, 108, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
2227, 7pazA, 0.5069, 2.64, 0.116, 123, 86, REDUCED MUTANT P80I PSEUDOAZURIN FROM A. FAECALIS
2228, 6mkrA, 0.5069, 3.97, 0.112, 195, 107, 5287 TCR BOUND TO IAB PADI4 
2229, 6fn1C, 0.5069, 4.12, 0.097, 225, 113, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2230, 6dwaA, 0.5069, 3.98, 0.103, 217, 107, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2231, 5xovJ, 0.5069, 3.88, 0.083, 245, 108, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
2232, 5w0kL, 0.5069, 4.05, 0.112, 210, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2233, 5c08I, 0.5069, 3.79, 0.104, 191, 106, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
2234, 4ztpL, 0.5069, 4.04, 0.103, 216, 107, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2235, 4udtB, 0.5069, 3.96, 0.093, 241, 108, T CELL RECEPTOR (TRAV22TRBV7-9) STRUCTURE
2236, 4r7nN, 0.5069, 4.04, 0.075, 211, 107, FAB C2E3
2237, 4l4tH, 0.5069, 3.74, 0.075, 242, 106, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
2238, 4g9fE, 0.5069, 3.76, 0.075, 250, 107, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
2239, 3v4vM, 0.5069, 4.06, 0.080, 213, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2240, 3qi9D, 0.5069, 3.82, 0.075, 239, 107, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
2241, 3ixxG, 0.5069, 4.24, 0.080, 221, 113, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
2242, 2ypvH, 0.5069, 4.15, 0.088, 215, 113, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
2243, 2w60A, 0.5069, 4.09, 0.071, 217, 112, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
2244, 2bdnH, 0.5069, 4.14, 0.080, 217, 112, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
2245, 1uweL, 0.5069, 3.98, 0.112, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2246, 1qpxA, 0.5069, 3.31, 0.144, 206, 97, CRYSTAL STRUCTURES OF SELF-CAPPING PAPD CHAPERONE HOMODIMERS
2247, 1qblH, 0.5069, 4.12, 0.071, 219, 112, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
2248, 1oazH, 0.5069, 4.14, 0.088, 122, 113, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
2249, 1iqwH, 0.5069, 4.06, 0.089, 221, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
2250, 6ol5B, 0.5068, 3.98, 0.093, 213, 107, STRUCTURE OF IGLB12 FAB IN COMPLEX WITH ANTI-IDIOTYPE IB3 FAB 
2251, 6fuqA, 0.5068, 3.99, 0.145, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2252, 6f2sB, 0.5068, 4.64, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2253, 6eh4D, 0.5068, 4.01, 0.101, 204, 109, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
2254, 6dc9M, 0.5068, 4.03, 0.084, 215, 107, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
2255, 5ywyH, 0.5068, 3.88, 0.063, 223, 111, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2256, 5mhrK, 0.5068, 4.08, 0.062, 122, 112, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2257, 5ks9H, 0.5068, 3.78, 0.085, 240, 106, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2258, 5ikcH, 0.5068, 4.00, 0.073, 214, 110, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2259, 5gzoL, 0.5068, 3.89, 0.094, 213, 106, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2260, 5c08D, 0.5068, 3.74, 0.075, 189, 106, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
2261, 4u6hA, 0.5068, 4.04, 0.072, 217, 111, VACCINIA L1/M12B9-FAB COMPLEX
2262, 4tnvW, 0.5068, 4.06, 0.071, 224, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2263, 4r7dF, 0.5068, 4.06, 0.084, 211, 107, FAB HU 15C1
2264, 4pazA, 0.5068, 2.64, 0.116, 123, 86, OXIDIZED MUTANT P80A PSEUDOAZURIN FROM A. FAECALIS
2265, 4lcwE, 0.5068, 3.72, 0.075, 243, 107, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
2266, 4iiqB, 0.5068, 3.83, 0.074, 243, 108, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
2267, 3sdcC, 0.5068, 3.85, 0.150, 191, 107, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
2268, 3opzH, 0.5068, 4.02, 0.064, 220, 110, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
2269, 3lh9B, 0.5068, 4.08, 0.096, 288, 104, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
2270, 2xwtA, 0.5068, 4.17, 0.071, 215, 113, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
2271, 2eytB, 0.5068, 3.82, 0.084, 243, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2272, 6r2sA, 0.5067, 3.95, 0.084, 213, 107, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
2273, 6frbA, 0.5067, 4.00, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2274, 6c09D, 0.5067, 3.83, 0.102, 244, 108, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
2275, 5wk2H, 0.5067, 4.07, 0.080, 217, 112, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
2276, 5nmfI, 0.5067, 3.98, 0.111, 201, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
2277, 5hyjE, 0.5067, 3.91, 0.073, 246, 109, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
2278, 5d2lE, 0.5067, 3.82, 0.094, 187, 106, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2279, 4tnvI, 0.5067, 4.06, 0.071, 222, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2280, 4p5tA, 0.5067, 3.80, 0.112, 197, 107, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
2281, 4p3dL, 0.5067, 4.01, 0.121, 218, 107, MT1-MMP:FAB COMPLEX (FORM II)
2282, 4jhwH, 0.5067, 4.02, 0.072, 226, 111, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
2283, 4iycC, 0.5067, 4.18, 0.054, 280, 112, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
2284, 4elkB, 0.5067, 3.97, 0.102, 242, 108, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
2285, 3v4vH, 0.5067, 4.06, 0.080, 211, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
2286, 3v4pM, 0.5067, 4.04, 0.080, 211, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2287, 3h9sE, 0.5067, 3.76, 0.084, 245, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE
2288, 2zzqA, 0.5067, 4.05, 0.056, 483, 107, CRYSTAL STRUCTURE ANALYSIS OF THE HEV CAPSID PROTEIN PORF2
2289, 1v7nJ, 0.5067, 4.01, 0.082, 217, 110, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2290, 1tetH, 0.5067, 4.04, 0.071, 209, 112, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
2291, 1t5rD, 0.5067, 4.19, 0.054, 267, 112, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2292, 1ob1B, 0.5067, 4.01, 0.081, 219, 111, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
2293, 1oayJ, 0.5067, 3.99, 0.081, 121, 111, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
2294, 6furA, 0.5066, 3.99, 0.145, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2295, 6fr4A, 0.5066, 4.01, 0.101, 202, 109, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
2296, 5zmjH, 0.5066, 4.01, 0.054, 227, 111, CRYSTAL STRUCTURE OF THE FAB REGION OF A NEUTRALIZING FULLY HUMAN ANTIBODY AGAINST GM-CSF 
2297, 5wk3W, 0.5066, 4.06, 0.081, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2298, 5viyJ, 0.5066, 4.04, 0.089, 223, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2299, 5viyH, 0.5066, 4.04, 0.089, 223, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2300, 5ur8B, 0.5066, 4.00, 0.075, 215, 107, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2301, 5udcE, 0.5066, 4.12, 0.071, 220, 112, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2302, 5swzS, 0.5066, 3.88, 0.093, 203, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2303, 5nmgI, 0.5066, 3.96, 0.111, 200, 108, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
2304, 5lgyB, 0.5066, 3.85, 0.058, 197, 104, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
2305, 5iw1C, 0.5066, 3.84, 0.093, 189, 108, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
2306, 5d8jH, 0.5066, 4.39, 0.096, 216, 115, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
2307, 4tnwY, 0.5066, 4.06, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2308, 4m6mH, 0.5066, 4.14, 0.071, 215, 113, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
2309, 4jo4M, 0.5066, 4.02, 0.075, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
2310, 4j0oB, 0.5066, 4.17, 0.054, 277, 112, STRUCTURE OF THE Y246A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2311, 3sknA, 0.5066, 3.95, 0.093, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
2312, 3jbc7, 0.5066, 3.88, 0.074, 129, 108, COMPLEX OF POLIOVIRUS WITH VHH PVSP29F
2313, 3cviH, 0.5066, 4.21, 0.062, 213, 113, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2314, 2zg2A, 0.5066, 4.16, 0.083, 214, 109, CRYSTAL STRUCTURE OF TWO N-TERMINAL DOMAINS OF NATIVE SIGLEC-5
2315, 2jxmA, 0.5066, 2.71, 0.122, 97, 90, ENSEMBLE OF TWENTY STRUCTURES OF THE PROCHLOROTHRIX HOLLANDICA PLASTOCYANIN- CYTOCHROME F COMPLEX
2316, 2eytD, 0.5066, 3.81, 0.084, 243, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2317, 2eytC, 0.5066, 3.98, 0.092, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2318, 1zeaH, 0.5066, 4.02, 0.080, 209, 112, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
2319, 1pzcA, 0.5066, 2.49, 0.118, 122, 85, APO-PSEUDOAZURIN (METAL FREE PROTEIN)
2320, 1b3iA, 0.5066, 2.71, 0.122, 97, 90, NMR SOLUTION STRUCTURE OF PLASTOCYANIN FROM THE PHOTOSYNTHETIC PROKARYOTE PROCHLOROTHRIX HOLLANDICA (MINIMIZED AVERAGE STRUCTURE)
2321, 5xotE, 0.5065, 3.76, 0.075, 242, 106, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
2322, 5wkhD, 0.5065, 3.72, 0.113, 198, 106, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
2323, 5wk3Q, 0.5065, 4.15, 0.080, 221, 113, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2324, 5sx4L, 0.5065, 3.96, 0.075, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
2325, 4kq4L, 0.5065, 3.94, 0.132, 214, 106, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
2326, 3phqA, 0.5065, 3.99, 0.103, 216, 107, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
2327, 3mv7E, 0.5065, 3.83, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
2328, 3ixxI, 0.5065, 4.24, 0.080, 221, 113, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
2329, 2iooA, 0.5065, 3.85, 0.038, 187, 104, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DOMAIN
2330, 1lmkE, 0.5065, 3.91, 0.056, 238, 108, THE STRUCTURE OF A BIVALENT DIABODY
2331, 6fr9A, 0.5064, 4.00, 0.145, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2332, 6d78E, 0.5064, 3.59, 0.086, 240, 105, THE COMPLEX BETWEEN HIGH-AFFINITY TCR DMF5(ALPHA-D26Y;BETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35)PEPTIDE 
2333, 5yxuG, 0.5064, 3.96, 0.073, 239, 109, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2334, 5x0tD, 0.5064, 3.84, 0.133, 213, 105, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
2335, 5ihbC, 0.5064, 4.12, 0.083, 212, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33
2336, 5d2nF, 0.5064, 3.97, 0.092, 246, 109, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2337, 5d2nE, 0.5064, 3.95, 0.092, 245, 109, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2338, 5d06A, 0.5064, 3.53, 0.049, 1526, 102, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME
2339, 4xzuE, 0.5064, 4.00, 0.063, 208, 111, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2340, 4xr8C, 0.5064, 3.93, 0.038, 199, 105, CRYSTAL STRUCTURE OF THE HPV16 E6/E6AP/P53 TERNARY COMPLEX AT 2.25 A RESOLUTION
2341, 4tnwX, 0.5064, 4.07, 0.071, 224, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2342, 4r97C, 0.5064, 4.02, 0.081, 218, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
2343, 4r7dP, 0.5064, 4.05, 0.084, 211, 107, FAB HU 15C1
2344, 4lciH, 0.5064, 3.96, 0.064, 120, 109, ANTI CANINE CD28 ANTIBODY 1C6
2345, 4apqD, 0.5064, 3.84, 0.065, 240, 107, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
2346, 4alaL, 0.5064, 4.06, 0.112, 212, 107, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2347, 3wihI, 0.5064, 4.07, 0.081, 219, 111, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2348, 3vwkD, 0.5064, 3.85, 0.084, 242, 107, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
2349, 3u9pL, 0.5064, 4.02, 0.093, 212, 107, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2350, 3riaG, 0.5064, 4.07, 0.071, 200, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2351, 3rhwG, 0.5064, 4.07, 0.071, 200, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2352, 2nr6E, 0.5064, 4.00, 0.112, 211, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2353, 2h32H, 0.5064, 4.04, 0.072, 211, 111, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
2354, 1rb8F, 0.5064, 4.60, 0.044, 422, 113, THE PHIX174 DNA BINDING PROTEIN J IN TWO DIFFERENT CAPSID ENVIRONMENTS.
2355, 1pmyA, 0.5064, 2.65, 0.105, 123, 86, REFINED CRYSTAL STRUCTURE OF PSEUDOAZURIN FROM METHYLOBACTERIUM EXTORQUENS AM1 AT 1.5 ANGSTROMS RESOLUTION
2356, 1p2cD, 0.5064, 4.01, 0.112, 211, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
2357, 1dbjH, 0.5064, 3.89, 0.054, 219, 111, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2358, 6r7tA, 0.5063, 4.04, 0.054, 123, 111, CRYSTAL STRUCTURE OF HUMAN MELANOMA-ASSOCIATED ANTIGEN B1 (MAGEB1) IN COMPLEX WITH NANOBODY 
2359, 6fupA, 0.5063, 4.03, 0.145, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2360, 6c08B, 0.5063, 4.01, 0.084, 215, 107, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2361, 6bzuH, 0.5063, 4.07, 0.121, 215, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2362, 5ysgA, 0.5063, 2.84, 0.126, 120, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
2363, 5xotD, 0.5063, 3.93, 0.111, 203, 108, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
2364, 5w1wI, 0.5063, 3.88, 0.133, 202, 105, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2365, 5o14L, 0.5063, 3.98, 0.075, 212, 107, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2366, 5l2kD, 0.5063, 3.77, 0.113, 185, 106, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
2367, 5kw9H, 0.5063, 3.90, 0.075, 215, 107, STRUCTURAL BASIS FOR NOROVIRUS NEUTRALIZATION BY A HBGA BLOCKING HUMAN IGA ANTIBODY
2368, 4x7sL, 0.5063, 3.99, 0.084, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
2369, 4wo4D, 0.5063, 4.04, 0.101, 242, 109, THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.
2370, 4tnvH, 0.5063, 4.07, 0.071, 223, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2371, 4tnvF, 0.5063, 4.06, 0.071, 222, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2372, 4r7dJ, 0.5063, 4.05, 0.075, 212, 107, FAB HU 15C1
2373, 4oduB, 0.5063, 4.01, 0.084, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
2374, 4lofA, 0.5063, 3.76, 0.038, 198, 104, HUMAN P53 CORE DOMAIN MUTANT V157F/N235K/N239Y
2375, 3riaJ, 0.5063, 4.07, 0.071, 215, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2376, 3rhwJ, 0.5063, 4.07, 0.071, 215, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2377, 3pqyO, 0.5063, 3.85, 0.093, 240, 107, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2378, 3gi9H, 0.5063, 4.27, 0.096, 217, 114, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2379, 2uylW, 0.5063, 4.27, 0.088, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2380, 2bnqD, 0.5063, 3.91, 0.102, 203, 108, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2381, 1xedF, 0.5063, 3.90, 0.065, 111, 107, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
2382, 6f2sJ, 0.5062, 4.56, 0.062, 195, 112, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2383, 6f2sI, 0.5062, 4.66, 0.062, 203, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2384, 6erxO, 0.5062, 3.97, 0.055, 215, 110, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2385, 5tq2H, 0.5062, 4.03, 0.080, 205, 112, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT GLUN1 AND GLUN2A
2386, 5j0bA, 0.5062, 4.15, 0.083, 213, 109, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
2387, 5j06C, 0.5062, 4.13, 0.083, 211, 108, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 3 -SIALYLLACTOSE
2388, 4tnwW, 0.5062, 4.07, 0.071, 224, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2389, 4tnwU, 0.5062, 4.07, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2390, 4tnwG, 0.5062, 4.07, 0.071, 222, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2391, 4jhaH, 0.5062, 4.03, 0.072, 226, 111, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
2392, 4jffE, 0.5062, 3.96, 0.119, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2393, 4gq9H, 0.5062, 4.11, 0.089, 218, 112, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
2394, 4a63G, 0.5062, 3.70, 0.097, 205, 103, CRYSTAL STRUCTURE OF THE P73-ASPP2 COMPLEX AT 2.6A RESOLUTION
2395, 3ze1E, 0.5062, 4.08, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2396, 3v4pH, 0.5062, 4.05, 0.080, 211, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2397, 3hi6Y, 0.5062, 3.98, 0.075, 209, 107, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
2398, 2uy7E, 0.5062, 3.44, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2399, 2iomA, 0.5062, 3.72, 0.039, 187, 103, MOUSE P53 CORE DOMAIN SOAKED WITH 2-PROPANOL
2400, 2ataB, 0.5062, 3.73, 0.058, 198, 103, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
2401, 1mjjA, 0.5062, 4.07, 0.084, 218, 107, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2402, 1m06F, 0.5062, 4.60, 0.044, 422, 113, STRUCTURAL STUDIES OF BACTERIOPHAGE ALPHA3 ASSEMBLY X-RAY CRYSTALLOGRAPHY
2403, 1kcsL, 0.5062, 4.03, 0.103, 214, 107, CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
2404, 1ahwB, 0.5062, 4.10, 0.080, 214, 112, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2405, 6nz7L, 0.5061, 3.94, 0.075, 214, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
2406, 6eh6A, 0.5061, 4.01, 0.136, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2407, 5ysgD, 0.5061, 2.84, 0.126, 120, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
2408, 5wkfJ, 0.5061, 3.96, 0.120, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
2409, 5wkfI, 0.5061, 3.73, 0.113, 198, 106, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
2410, 5ks9F, 0.5061, 3.78, 0.085, 240, 106, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2411, 5d7iF, 0.5061, 3.76, 0.075, 243, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2412, 5cmaA, 0.5061, 4.04, 0.084, 213, 107, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
2413, 4x7tB, 0.5061, 3.99, 0.084, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2414, 4tnvU, 0.5061, 4.07, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2415, 4nqcE, 0.5061, 3.78, 0.075, 240, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2416, 4elmG, 0.5061, 3.76, 0.095, 171, 105, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
2417, 3qpqF, 0.5061, 4.06, 0.090, 220, 111, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
2418, 3p0vM, 0.5061, 3.99, 0.075, 212, 107, ANTI-EGFR/HER3 FAB DL11 ALONE
2419, 3j2zH, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2420, 3j2zF, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2421, 3j2zD, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2422, 3j2zB, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2423, 3j2yH, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2424, 3j2yF, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2425, 3j2yD, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2426, 3j2yB, 0.5061, 4.11, 0.089, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2427, 2oslB, 0.5061, 3.84, 0.124, 213, 105, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2428, 1yuhB, 0.5061, 4.23, 0.088, 218, 114, FAB FRAGMENT
2429, 1nfdD, 0.5061, 3.94, 0.110, 239, 109, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2430, 1l7iL, 0.5061, 3.97, 0.084, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
2431, 6c08E, 0.5060, 4.03, 0.093, 215, 107, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2432, 6bfsL, 0.5060, 4.02, 0.093, 212, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2433, 5x0tB, 0.5060, 3.83, 0.133, 213, 105, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
2434, 5u17G, 0.5060, 3.78, 0.075, 241, 107, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2435, 5mvjB, 0.5060, 4.04, 0.131, 218, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2436, 5jhlL, 0.5060, 3.90, 0.123, 211, 106, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
2437, 5epmE, 0.5060, 3.93, 0.100, 218, 110, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
2438, 5c09J, 0.5060, 3.87, 0.083, 246, 108, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
2439, 4p1xH, 0.5060, 4.01, 0.055, 258, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2440, 4l5fL, 0.5060, 4.00, 0.103, 213, 107, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
2441, 4j1uA, 0.5060, 4.01, 0.093, 210, 107, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2442, 4am0A, 0.5060, 4.07, 0.080, 211, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2443, 3riaI, 0.5060, 4.07, 0.071, 199, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2444, 3riaH, 0.5060, 4.07, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2445, 3rhwI, 0.5060, 4.07, 0.071, 199, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2446, 3rhwH, 0.5060, 4.07, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2447, 3q5tA, 0.5060, 3.85, 0.093, 238, 108, V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES
2448, 3p11L, 0.5060, 4.02, 0.065, 211, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION
2449, 3iu4L, 0.5060, 3.99, 0.112, 213, 107, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
2450, 2vl5B, 0.5060, 3.99, 0.103, 217, 107, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2451, 2p52A, 0.5060, 3.63, 0.039, 196, 102, MOUSE P53 DNA-BINDING DOMAIN IN ZINC-FREE OXIDIZED STATE
2452, 1p5uA, 0.5060, 3.00, 0.097, 206, 93, X-RAY STRUCTURE OF THE TERNARY CAF1M:CAF1:CAF1 CHAPERONE:SUBUNIT:SUBUNIT COMPLEX
2453, 1ncbL, 0.5060, 4.03, 0.131, 214, 107, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2454, 1h3pL, 0.5060, 4.02, 0.121, 219, 107, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
2455, 6fr6A, 0.5059, 3.91, 0.128, 202, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2456, 5az2L, 0.5059, 4.00, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
2457, 4yk4Y, 0.5059, 4.02, 0.084, 211, 107, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2458, 4x7tH, 0.5059, 4.06, 0.081, 222, 111, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2459, 4tnvY, 0.5059, 4.07, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2460, 4tnvX, 0.5059, 4.07, 0.071, 224, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2461, 4p1xB, 0.5059, 4.01, 0.055, 257, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2462, 4nobA, 0.5059, 3.83, 0.104, 112, 106, CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
2463, 4l4vH, 0.5059, 3.78, 0.075, 240, 107, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
2464, 4jfeE, 0.5059, 3.89, 0.120, 245, 108, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2465, 3se9H, 0.5059, 4.13, 0.089, 225, 112, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
2466, 3o9wC, 0.5059, 3.93, 0.148, 203, 108, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
2467, 3lhpL, 0.5059, 4.01, 0.056, 111, 107, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
2468, 3fo2A, 0.5059, 3.94, 0.113, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2469, 3fctD, 0.5059, 4.15, 0.071, 216, 112, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
2470, 2uy7A, 0.5059, 3.44, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2471, 2ok0H, 0.5059, 3.99, 0.081, 216, 111, FAB ED10-DNA COMPLEX
2472, 2nw2A, 0.5059, 3.92, 0.150, 196, 107, CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2473, 2ntsP, 0.5059, 3.80, 0.085, 240, 106, CRYSTAL STRUCTURE OF SEK-HVB5.1
2474, 2geqA, 0.5059, 3.72, 0.039, 188, 103, CRYSTAL STRUCTURE OF A P53 CORE DIMER BOUND TO DNA
2475, 1nfdB, 0.5059, 3.94, 0.110, 239, 109, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2476, 1cz8X, 0.5059, 4.00, 0.084, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2477, 6oc3B, 0.5058, 3.91, 0.094, 213, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
2478, 6furC, 0.5058, 4.00, 0.145, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2479, 5ysgB, 0.5058, 2.84, 0.126, 120, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT; REDUCED FORM. 
2480, 5wkhJ, 0.5058, 3.93, 0.111, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
2481, 5udcB, 0.5058, 4.03, 0.072, 218, 111, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2482, 5jhdD, 0.5058, 3.95, 0.101, 201, 109, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
2483, 5hyjD, 0.5058, 3.71, 0.095, 193, 105, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
2484, 5bzwA, 0.5058, 3.92, 0.085, 213, 106, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2485, 4tnwI, 0.5058, 4.07, 0.071, 222, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2486, 4rgoL, 0.5058, 4.01, 0.103, 212, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
2487, 4rgnD, 0.5058, 4.04, 0.090, 210, 111, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2488, 3zdzE, 0.5058, 4.05, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2489, 3utsE, 0.5058, 3.91, 0.073, 246, 109, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2490, 3ra7M, 0.5058, 4.01, 0.084, 211, 107, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
2491, 3qynA, 0.5058, 3.79, 0.096, 195, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
2492, 3qfjE, 0.5058, 3.81, 0.084, 245, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
2493, 3gi8L, 0.5058, 4.02, 0.093, 220, 107, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
2494, 3d3vE, 0.5058, 3.72, 0.085, 245, 106, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(34-DIFLUOROPHENYLALANINE)) PEPTIDE
2495, 1ws8B, 0.5058, 2.96, 0.129, 103, 93, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
2496, 1riuL, 0.5058, 3.90, 0.094, 218, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2497, 6f2sK, 0.5057, 4.66, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2498, 6bj2D, 0.5057, 3.85, 0.084, 202, 107, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
2499, 5w23H, 0.5057, 4.00, 0.073, 219, 110, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2500, 5uweH, 0.5057, 3.78, 0.075, 224, 107, CRYSTAL STRUCTURE OF THE ADCC-POTENT; WEAKLY NEUTRALIZING HIV ENV CO- RECEPTOR BINDING SITE ANTIBODY N12-I2 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1 
2501, 5u2vF, 0.5057, 3.78, 0.075, 242, 107, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2502, 5tljF, 0.5057, 4.08, 0.100, 219, 110, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
2503, 5nyxL, 0.5057, 3.92, 0.075, 211, 106, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2504, 5mvjD, 0.5057, 3.87, 0.123, 218, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2505, 5lz0B, 0.5057, 3.76, 0.075, 124, 106, LLAMA NANOBODY PORM_01
2506, 5lfuA, 0.5057, 4.38, 0.126, 487, 111, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) GLYCOSYLATED AND LYSINE- METHYLATED FULL EXTRACELLULAR DOMAIN
2507, 4z7wE, 0.5057, 3.97, 0.111, 199, 108, T316 COMPLEX
2508, 4ywgM, 0.5057, 3.89, 0.104, 215, 106, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
2509, 4ydlH, 0.5057, 4.14, 0.072, 223, 111, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
2510, 4ydlB, 0.5057, 4.14, 0.072, 223, 111, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
2511, 4qrpL, 0.5057, 3.96, 0.131, 243, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
2512, 4prpE, 0.5057, 3.84, 0.075, 241, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX
2513, 4jfdE, 0.5057, 3.98, 0.119, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2514, 4djmH, 0.5057, 3.12, 0.096, 201, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
2515, 3wihH, 0.5057, 4.03, 0.090, 219, 111, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2516, 3vg9C, 0.5057, 4.23, 0.071, 224, 113, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
2517, 3ujjH, 0.5057, 4.15, 0.071, 230, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
2518, 3sqoL, 0.5057, 3.88, 0.104, 213, 106, PCSK9 J16 FAB COMPLEX
2519, 3p0vL, 0.5057, 4.00, 0.075, 212, 107, ANTI-EGFR/HER3 FAB DL11 ALONE
2520, 3mffD, 0.5057, 3.79, 0.084, 242, 107, 1F1E8HU TCR
2521, 3gnmH, 0.5057, 4.13, 0.080, 218, 112, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
2522, 2q8bH, 0.5057, 4.01, 0.083, 199, 108, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2523, 2p5eD, 0.5057, 4.01, 0.084, 194, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2524, 1t5rA, 0.5057, 4.20, 0.054, 265, 112, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2525, 1qrnD, 0.5057, 3.90, 0.103, 200, 107, CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
2526, 1h5bC, 0.5057, 3.87, 0.114, 113, 105, T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN
2527, 6mkdA, 0.5056, 3.95, 0.120, 193, 108, 4699 TCR BOUND TO I-AB PADI4 
2528, 6f2sE, 0.5056, 4.66, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2529, 6dfiL, 0.5056, 3.90, 0.085, 215, 106, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII 
2530, 6avgC, 0.5056, 3.84, 0.132, 196, 106, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
2531, 5o14D, 0.5056, 4.00, 0.075, 215, 107, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2532, 5ksaD, 0.5056, 3.77, 0.085, 242, 106, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
2533, 5k59F, 0.5056, 4.00, 0.084, 212, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2534, 5do2L, 0.5056, 4.03, 0.084, 214, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
2535, 4r7dD, 0.5056, 4.05, 0.084, 211, 107, FAB HU 15C1
2536, 4pjbH, 0.5056, 3.78, 0.075, 238, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
2537, 4pjaF, 0.5056, 3.78, 0.093, 235, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
2538, 4kxzH, 0.5056, 3.98, 0.064, 223, 110, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
2539, 4g8gE, 0.5056, 3.73, 0.075, 248, 106, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
2540, 4ei6A, 0.5056, 3.77, 0.095, 201, 105, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
2541, 3ze0E, 0.5056, 4.11, 0.063, 216, 111, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2542, 3vxtB, 0.5056, 3.80, 0.084, 241, 107, T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
2543, 3sobL, 0.5056, 4.01, 0.093, 213, 107, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
2544, 3q13A, 0.5056, 3.50, 0.071, 235, 99, THE STRUCTURE OF THE CA2+-BINDING GLYCOSYLATED F-SPONDIN DOMAIN OF F- SPONDIN A C2-DOMAIN VARIANT FROM EXTRACELLULAR MATRIX
2545, 3mv9E, 0.5056, 4.04, 0.074, 241, 108, CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG
2546, 3idyC, 0.5056, 4.05, 0.074, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
2547, 3bwuC, 0.5056, 3.39, 0.103, 200, 97, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N-TERMINAL DOMAIN FIMDN) WITH FIMC AND THE N-TERMINALLY TRUNCATED PILUS SUBUNIT FIMF (FIMFT)
2548, 2xa8L, 0.5056, 4.00, 0.084, 218, 107, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2549, 2vljD, 0.5056, 3.88, 0.113, 199, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2550, 2j21A, 0.5056, 3.72, 0.049, 188, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R282W
2551, 1yntD, 0.5056, 4.10, 0.089, 218, 112, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
2552, 1ngwB, 0.5056, 4.17, 0.062, 216, 112, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2553, 1kelH, 0.5056, 3.99, 0.072, 218, 111, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4 -NITROBENZYL-N-4 -CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
2554, 1cz8L, 0.5056, 4.00, 0.075, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2555, 6nz7I, 0.5055, 3.96, 0.084, 214, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
2556, 6fxnQ, 0.5055, 3.97, 0.056, 215, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2557, 6furB, 0.5055, 3.67, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2558, 5ywpR, 0.5055, 4.12, 0.054, 218, 112, JEV-2H4 FAB COMPLEX 
2559, 5wk3U, 0.5055, 4.14, 0.080, 221, 113, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2560, 5nmfE, 0.5055, 3.86, 0.075, 239, 107, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
2561, 5mp5D, 0.5055, 3.87, 0.123, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2562, 5k59L, 0.5055, 4.00, 0.084, 212, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2563, 5fuzH, 0.5055, 4.03, 0.063, 222, 111, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
2564, 5d7lE, 0.5055, 3.79, 0.065, 241, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
2565, 5c08J, 0.5055, 3.84, 0.084, 245, 107, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
2566, 4yxlH, 0.5055, 4.29, 0.079, 218, 114, CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB
2567, 4yk4B, 0.5055, 4.03, 0.084, 211, 107, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2568, 4r7nL, 0.5055, 4.06, 0.084, 211, 107, FAB C2E3
2569, 4r7dH, 0.5055, 4.06, 0.075, 212, 107, FAB HU 15C1
2570, 4p3dB, 0.5055, 4.02, 0.121, 218, 107, MT1-MMP:FAB COMPLEX (FORM II)
2571, 4nwtH, 0.5055, 3.97, 0.045, 232, 110, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
2572, 4jo4L, 0.5055, 4.05, 0.075, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
2573, 4jm0A, 0.5055, 4.23, 0.115, 175, 113, STRUCTURE OF HUMAN CYTOMEGALOVIRUS IMMUNE MODULATOR UL141
2574, 3qeqE, 0.5055, 3.65, 0.105, 243, 105, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2575, 3idyL, 0.5055, 4.05, 0.074, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
2576, 3fo1A, 0.5055, 3.95, 0.113, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
2577, 3c5zE, 0.5055, 3.83, 0.151, 201, 106, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
2578, 2uylB, 0.5055, 4.28, 0.088, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2579, 2r4rH, 0.5055, 4.20, 0.107, 217, 112, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2580, 2nr6F, 0.5055, 4.12, 0.071, 213, 112, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2581, 2nr6C, 0.5055, 4.01, 0.121, 211, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2582, 2ac0B, 0.5055, 3.84, 0.058, 198, 104, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
2583, 1yntB, 0.5055, 4.10, 0.089, 218, 112, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
2584, 1uweX, 0.5055, 3.99, 0.112, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2585, 1q72L, 0.5055, 3.90, 0.104, 218, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
2586, 1cicB, 0.5055, 4.23, 0.096, 217, 114, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
2587, 6fuoA, 0.5054, 4.00, 0.145, 202, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2588, 6eh7B, 0.5054, 3.70, 0.075, 240, 106, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2589, 6cqqJ, 0.5054, 3.88, 0.084, 244, 107, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2590, 6avuL, 0.5054, 3.82, 0.105, 211, 105, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
2591, 6avrL, 0.5054, 3.82, 0.105, 211, 105, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
2592, 5npjB, 0.5054, 4.24, 0.061, 232, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2593, 5dr5L, 0.5054, 4.00, 0.084, 215, 107, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
2594, 5d2lO, 0.5054, 3.85, 0.121, 187, 107, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2595, 5c0cJ, 0.5054, 3.85, 0.093, 247, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
2596, 4q6iL, 0.5054, 4.03, 0.112, 218, 107, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2597, 4p2rJ, 0.5054, 4.12, 0.054, 245, 111, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
2598, 4ma7H, 0.5054, 4.08, 0.080, 218, 112, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
2599, 4g8eB, 0.5054, 3.67, 0.067, 241, 105, CRYSTAL STRUCTURE OF CLONE18 TCR
2600, 3tu6A, 0.5054, 2.58, 0.116, 127, 86, THE STRUCTURE OF A PSEUDOAZURIN FROM SINORHIZOBIUM MELILTOI
2601, 3sknC, 0.5054, 3.71, 0.105, 197, 105, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
2602, 3qeqD, 0.5054, 3.72, 0.154, 194, 104, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2603, 3p0yL, 0.5054, 4.00, 0.075, 213, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
2604, 3l7fA, 0.5054, 4.07, 0.084, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2605, 3l5wA, 0.5054, 3.96, 0.075, 213, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2606, 2jixL, 0.5054, 3.96, 0.075, 214, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2607, 2eyrB, 0.5054, 3.83, 0.084, 241, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2608, 1rfdL, 0.5054, 3.89, 0.094, 218, 106, ANTI-COCAINE ANTIBODY M82G2
2609, 1p2cA, 0.5054, 4.02, 0.112, 212, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
2610, 1iaiH, 0.5054, 4.07, 0.071, 219, 112, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2611, 1dbbH, 0.5054, 3.97, 0.054, 219, 112, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
2612, 6mnmA, 0.5053, 3.90, 0.121, 196, 107, 6256 TCR BOUND TO I-AB PADI4 
2613, 6higH, 0.5053, 4.11, 0.062, 209, 113, HPD-1/NBO1A FAB COMPLEX 
2614, 6fj5C, 0.5053, 3.63, 0.059, 199, 102, P53-DNA COMPLEX 5 
2615, 6bftB, 0.5053, 4.01, 0.084, 214, 107, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
2616, 6avqL, 0.5053, 3.82, 0.105, 211, 105, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
2617, 5sx5L, 0.5053, 3.97, 0.075, 212, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2618, 5swzI, 0.5053, 3.89, 0.093, 186, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2619, 5npiB, 0.5053, 4.24, 0.061, 233, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2620, 5kzpG, 0.5053, 4.01, 0.081, 226, 111, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
2621, 5bk3F, 0.5053, 4.03, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2622, 5bk3B, 0.5053, 4.05, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
2623, 4z7uG, 0.5053, 3.81, 0.143, 198, 105, S13 COMPLEX
2624, 4rirA, 0.5053, 4.20, 0.080, 219, 113, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2625, 4pjdF, 0.5053, 3.78, 0.084, 233, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
2626, 4pjbF, 0.5053, 3.79, 0.075, 230, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
2627, 4p2cJ, 0.5053, 3.84, 0.075, 127, 106, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
2628, 4aehH, 0.5053, 4.32, 0.096, 219, 114, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
2629, 3v0wL, 0.5053, 4.01, 0.093, 211, 107, CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
2630, 3u9pM, 0.5053, 3.90, 0.094, 211, 106, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2631, 3t77A, 0.5053, 3.99, 0.112, 219, 107, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
2632, 3mmeC, 0.5053, 4.09, 0.071, 222, 112, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
2633, 3l7fL, 0.5053, 3.94, 0.094, 213, 106, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2634, 3fo1L, 0.5053, 3.96, 0.113, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
2635, 3fo0L, 0.5053, 3.95, 0.113, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
2636, 2uylY, 0.5053, 4.28, 0.088, 213, 114, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2637, 2dweA, 0.5053, 4.30, 0.079, 219, 114, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
2638, 1xf5C, 0.5053, 4.05, 0.093, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
2639, 1qppB, 0.5053, 3.35, 0.134, 212, 97, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
2640, 6qexC, 0.5052, 4.29, 0.088, 225, 114, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
2641, 6frbB, 0.5052, 3.69, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2642, 6fj5D, 0.5052, 3.63, 0.059, 199, 102, P53-DNA COMPLEX 5 
2643, 6f2sH, 0.5052, 4.66, 0.062, 218, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2644, 6f2sF, 0.5052, 4.65, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
2645, 6eqbE, 0.5052, 3.95, 0.119, 244, 109, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
2646, 5xj4L, 0.5052, 3.93, 0.085, 113, 106, COMPLEX STRUCTURE OF DURVALUMAB-SCFV/PD-L1 
2647, 5w23I, 0.5052, 4.06, 0.081, 219, 111, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2648, 5w0kF, 0.5052, 4.05, 0.112, 212, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2649, 5sx4I, 0.5052, 3.98, 0.075, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
2650, 5mp5L, 0.5052, 3.87, 0.123, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2651, 5mp5F, 0.5052, 3.88, 0.123, 216, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2652, 5lx9H, 0.5052, 4.19, 0.062, 228, 113, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 2.4 ANGSTROM RESOLUTION
2653, 5jueH, 0.5052, 4.04, 0.089, 225, 112, CRYSTAL STRUCTURE OF UIC2 FAB
2654, 5hyjJ, 0.5052, 3.91, 0.073, 246, 109, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
2655, 5e6iL, 0.5052, 3.74, 0.084, 242, 107, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
2656, 5bzdA, 0.5052, 4.02, 0.075, 213, 107, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2657, 5az2H, 0.5052, 4.05, 0.064, 220, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
2658, 4z7wG, 0.5052, 3.96, 0.120, 191, 108, T316 COMPLEX
2659, 4z7oE, 0.5052, 4.05, 0.063, 216, 111, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2660, 4x6cH, 0.5052, 3.86, 0.065, 243, 108, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2661, 4tnwV, 0.5052, 4.07, 0.071, 224, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2662, 4rgnC, 0.5052, 3.97, 0.112, 213, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2663, 4q6iD, 0.5052, 4.03, 0.112, 218, 107, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2664, 4mwfH, 0.5052, 3.89, 0.063, 228, 111, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
2665, 4lkcA, 0.5052, 4.03, 0.093, 213, 107, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
2666, 3w0wD, 0.5052, 4.03, 0.111, 204, 108, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
2667, 3ri5F, 0.5052, 4.07, 0.071, 188, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2668, 3qeuE, 0.5052, 3.66, 0.094, 243, 106, THE CRYSTAL STRUCTURE OF TCR DMF5
2669, 3o2dL, 0.5052, 4.04, 0.103, 216, 107, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
2670, 3fo2L, 0.5052, 3.96, 0.113, 216, 106, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2671, 2oz4L, 0.5052, 4.01, 0.103, 214, 107, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2672, 2n7aA, 0.5052, 4.01, 0.102, 145, 108, SOLUTION STRUCTURE OF THE HUMAN SIGLEC-8 LECTIN DOMAIN
2673, 2ioiA, 0.5052, 3.61, 0.039, 187, 102, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DOMAIN AT 1.55 A
2674, 2fjfW, 0.5052, 4.02, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
2675, 1ze3C, 0.5052, 2.95, 0.096, 205, 94, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N- TERMINAL DOMAIN) WITH FIMC AND THE PILIN DOMAIN OF FIMH
2676, 1rivL, 0.5052, 3.90, 0.094, 218, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
2677, 1q9oC, 0.5052, 4.00, 0.103, 219, 107, S45-18 FAB UNLIGANDED
2678, 1ncdL, 0.5052, 4.01, 0.131, 214, 107, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2679, 6foeL, 0.5051, 4.04, 0.075, 214, 107, BAXB01 FAB FRAGMENT
2680, 6fj5A, 0.5051, 3.75, 0.058, 199, 103, P53-DNA COMPLEX 5 
2681, 6e4xY, 0.5051, 3.70, 0.096, 208, 104, HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2) 
2682, 5yfiH, 0.5051, 3.92, 0.063, 221, 111, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
2683, 5mhrP, 0.5051, 4.21, 0.061, 213, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2684, 5k9jL, 0.5051, 3.90, 0.094, 212, 106, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
2685, 5iw1E, 0.5051, 3.82, 0.094, 189, 106, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
2686, 5i71C, 0.5051, 4.06, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
2687, 5i1dA, 0.5051, 4.03, 0.093, 218, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
2688, 5hhmD, 0.5051, 3.78, 0.114, 194, 105, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
2689, 4q6iF, 0.5051, 4.03, 0.112, 218, 107, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2690, 4pjiF, 0.5051, 3.78, 0.084, 240, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
2691, 4mxvL, 0.5051, 4.02, 0.103, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2692, 4etqH, 0.5051, 4.05, 0.080, 215, 112, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
2693, 4d3cL, 0.5051, 4.02, 0.075, 209, 107, CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68.
2694, 3u46A, 0.5051, 3.95, 0.091, 225, 110, CH04H/CH02L P212121
2695, 3t0eC, 0.5051, 4.06, 0.131, 193, 107, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
2696, 3sdaD, 0.5051, 3.96, 0.065, 239, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2697, 3rhwF, 0.5051, 4.08, 0.071, 191, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2698, 3opzI, 0.5051, 4.05, 0.064, 220, 110, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
2699, 3d39E, 0.5051, 3.77, 0.084, 245, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
2700, 2ianJ, 0.5051, 3.90, 0.065, 239, 108, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2701, 1xcqA, 0.5051, 4.00, 0.103, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2702, 1t5rB, 0.5051, 4.19, 0.054, 271, 112, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2703, 1rzgA, 0.5051, 4.03, 0.063, 223, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
2704, 1mfdH, 0.5051, 4.09, 0.099, 211, 111, THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
2705, 1kiuE, 0.5051, 3.13, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2706, 1kiuC, 0.5051, 3.13, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2707, 6oc3D, 0.5050, 3.87, 0.094, 213, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
2708, 6jmqD, 0.5050, 3.99, 0.103, 219, 107, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
2709, 6fumB, 0.5050, 3.70, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2710, 6fr9B, 0.5050, 3.79, 0.075, 240, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2711, 6foeB, 0.5050, 4.04, 0.084, 214, 107, BAXB01 FAB FRAGMENT
2712, 6bzuB, 0.5050, 3.99, 0.112, 216, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2713, 5kqvC, 0.5050, 4.23, 0.071, 211, 112, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
2714, 5e6iB, 0.5050, 3.79, 0.084, 241, 107, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
2715, 4tnwF, 0.5050, 4.08, 0.071, 221, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2716, 4rgnL, 0.5050, 3.97, 0.112, 213, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2717, 4pjaH, 0.5050, 3.79, 0.093, 238, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
2718, 4o5iQ, 0.5050, 4.01, 0.055, 226, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
2719, 4i9wG, 0.5050, 4.25, 0.080, 210, 113, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
2720, 3ze1H, 0.5050, 4.13, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2721, 3vfgL, 0.5050, 3.93, 0.104, 211, 106, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
2722, 3ujtH, 0.5050, 4.18, 0.089, 207, 112, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
2723, 3riaF, 0.5050, 4.08, 0.071, 191, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2724, 2ialC, 0.5050, 3.82, 0.123, 195, 106, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2725, 2b4cL, 0.5050, 3.84, 0.094, 215, 106, CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
2726, 2axjA, 0.5050, 3.77, 0.093, 242, 107, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
2727, 2ak4N, 0.5050, 4.14, 0.109, 204, 110, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
2728, 1ogaD, 0.5050, 3.88, 0.113, 199, 106, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
2729, 1kiuG, 0.5050, 3.13, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2730, 1kiuA, 0.5050, 3.13, 0.073, 205, 96, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
2731, 1ct8C, 0.5050, 4.01, 0.093, 214, 107, CATALYTIC ANTIBODY 7C8 COMPLEX
2732, 1beyL, 0.5050, 3.98, 0.084, 214, 107, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
2733, 1ahwD, 0.5050, 3.89, 0.094, 214, 106, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2734, 6mnnA, 0.5049, 3.83, 0.121, 196, 107, 6236 TCR BOUND TO I-AB PADI4 
2735, 6eh6B, 0.5049, 3.70, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2736, 6dw2A, 0.5049, 4.04, 0.084, 213, 107, STRUCTURE OF THE 6078 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2737, 6dcwL, 0.5049, 4.02, 0.093, 219, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
2738, 6cdpA, 0.5049, 4.08, 0.098, 221, 112, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2739, 6bpaC, 0.5049, 4.02, 0.093, 212, 107, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
2740, 6b73C, 0.5049, 3.85, 0.074, 126, 108, CRYSTAL STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE KAPPA- OPIOID RECEPTOR
2741, 5wuxD, 0.5049, 4.01, 0.075, 201, 107, TNFALPHA-CERTOLIZUMAB FAB
2742, 5w1wJ, 0.5049, 3.96, 0.074, 243, 108, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2743, 5vqmH, 0.5049, 4.05, 0.063, 216, 111, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
2744, 5o1rL, 0.5049, 3.91, 0.075, 211, 106, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2745, 5nmdA, 0.5049, 3.93, 0.103, 200, 107, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
2746, 5mp1L, 0.5049, 4.03, 0.121, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2747, 5jziD, 0.5049, 3.98, 0.110, 207, 109, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
2748, 5c0bE, 0.5049, 3.82, 0.084, 247, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
2749, 4zykL, 0.5049, 3.99, 0.075, 213, 107, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
2750, 4z7oH, 0.5049, 4.10, 0.071, 216, 112, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2751, 4y1aE, 0.5049, 3.86, 0.074, 240, 108, IMMUNE COMPLEX
2752, 4pb9L, 0.5049, 3.91, 0.113, 216, 106, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
2753, 4p3cL, 0.5049, 4.03, 0.121, 218, 107, MT1-MMP:FAB COMPLEX (FORM I)
2754, 4p2qJ, 0.5049, 4.00, 0.055, 245, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
2755, 4nqeH, 0.5049, 3.79, 0.075, 231, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2756, 4nqdH, 0.5049, 3.70, 0.075, 242, 106, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2757, 4ma8H, 0.5049, 4.07, 0.080, 218, 112, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
2758, 4edwL, 0.5049, 3.86, 0.085, 214, 106, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
2759, 3tzvH, 0.5049, 3.83, 0.093, 244, 107, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
2760, 3t4yA, 0.5049, 4.00, 0.112, 219, 107, S25-2- KDO MONOSACCHARIDE COMPLEX
2761, 3nifE, 0.5049, 4.15, 0.062, 216, 112, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2762, 3mv7D, 0.5049, 3.92, 0.085, 200, 106, CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
2763, 3igkA, 0.5049, 3.77, 0.039, 197, 103, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 2)
2764, 2p5wD, 0.5049, 4.02, 0.084, 192, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2765, 2ialB, 0.5049, 3.87, 0.065, 239, 108, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2766, 1rz8A, 0.5049, 4.05, 0.084, 214, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
2767, 1qseD, 0.5049, 3.92, 0.103, 200, 107, STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
2768, 1q9wA, 0.5049, 3.97, 0.103, 219, 107, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2769, 1igfL, 0.5049, 4.01, 0.103, 219, 107, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
2770, 1i9eA, 0.5049, 3.80, 0.104, 115, 106, TCR DOMAIN
2771, 1e4xH, 0.5049, 4.08, 0.089, 216, 112, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2772, 1b6dA, 0.5049, 3.96, 0.065, 212, 107, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
2773, 1ap2D, 0.5049, 4.09, 0.064, 123, 109, SINGLE CHAIN FV OF C219
2774, 6ncpD, 0.5048, 3.97, 0.084, 212, 107, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
2775, 6fj5B, 0.5048, 3.75, 0.058, 199, 103, P53-DNA COMPLEX 5 
2776, 6eh9A, 0.5048, 3.90, 0.138, 202, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2777, 6bliB, 0.5048, 4.03, 0.075, 214, 107, RSV G PEPTIDE BOUND TO FAB CB002.5
2778, 6b73D, 0.5048, 3.85, 0.074, 122, 108, CRYSTAL STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE KAPPA- OPIOID RECEPTOR
2779, 6attL, 0.5048, 3.88, 0.094, 220, 106, 39S FAB BOUND TO HER2 ECD 
2780, 5wkzH, 0.5048, 4.06, 0.063, 221, 111, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
2781, 5w1vJ, 0.5048, 3.73, 0.076, 243, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
2782, 5uddL, 0.5048, 4.14, 0.071, 221, 112, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2783, 5mp1G, 0.5048, 4.04, 0.121, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2784, 5mhrR, 0.5048, 4.21, 0.061, 213, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2785, 5mcvA, 0.5048, 3.76, 0.039, 200, 103, P53-DNA COMPLEX 3 
2786, 5j0bD, 0.5048, 4.12, 0.084, 209, 107, STRUCTURE OF THE IMMUNE RECEPTOR CD33 IN COMPLEX WITH 6 -SIALYLLACTOSE
2787, 5i6xC, 0.5048, 4.05, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2788, 5gzoD, 0.5048, 3.90, 0.085, 213, 106, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2789, 4z7nE, 0.5048, 4.06, 0.063, 216, 111, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2790, 4wfhE, 0.5048, 4.24, 0.080, 211, 113, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
2791, 4q6iA, 0.5048, 4.03, 0.112, 218, 107, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
2792, 4p1xD, 0.5048, 4.06, 0.064, 257, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2793, 4k3jL, 0.5048, 4.02, 0.084, 217, 107, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
2794, 4h88H, 0.5048, 4.09, 0.080, 218, 112, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
2795, 3uzeB, 0.5048, 4.07, 0.055, 226, 109, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2796, 3difA, 0.5048, 4.04, 0.131, 213, 107, CRYSTAL STRUCTURE OF FABOX117
2797, 3c60E, 0.5048, 3.65, 0.125, 199, 104, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
2798, 2xraL, 0.5048, 4.01, 0.084, 215, 107, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
2799, 1uwgL, 0.5048, 3.99, 0.112, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2800, 1s5hB, 0.5048, 4.19, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
2801, 1lmkA, 0.5048, 3.96, 0.046, 238, 108, THE STRUCTURE OF A BIVALENT DIABODY
2802, 1gpoM, 0.5048, 4.02, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
2803, 1fl6A, 0.5048, 3.88, 0.113, 217, 106, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2804, 1clzL, 0.5048, 4.00, 0.121, 219, 107, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
2805, 6flbL, 0.5047, 4.02, 0.103, 216, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
2806, 6cdmD, 0.5047, 4.08, 0.107, 218, 112, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2807, 6cd2A, 0.5047, 3.51, 0.162, 215, 99, CRYSTAL STRUCTURE OF THE PAPC USHER BOUND TO THE CHAPERONE-ADHESIN PAPD-PAPG 
2808, 5x2nL, 0.5047, 4.01, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2809, 5x2nK, 0.5047, 4.01, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2810, 5vshF, 0.5047, 4.00, 0.093, 211, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2811, 5mvjL, 0.5047, 3.86, 0.123, 219, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2812, 5mp5B, 0.5047, 3.88, 0.123, 217, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2813, 5mp1K, 0.5047, 3.89, 0.123, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2814, 5mcvB, 0.5047, 3.76, 0.039, 200, 103, P53-DNA COMPLEX 3 
2815, 5i1eL, 0.5047, 4.03, 0.084, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39
2816, 4xhjG, 0.5047, 4.02, 0.065, 196, 107, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
2817, 4x7tL, 0.5047, 4.01, 0.084, 218, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2818, 4rgnF, 0.5047, 4.06, 0.090, 210, 111, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
2819, 4r7nP, 0.5047, 4.07, 0.075, 211, 107, FAB C2E3
2820, 4pj9D, 0.5047, 3.69, 0.085, 230, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR
2821, 4oduL, 0.5047, 4.02, 0.084, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
2822, 4i9wE, 0.5047, 4.26, 0.080, 211, 113, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
2823, 3zknD, 0.5047, 4.03, 0.112, 217, 107, BACE2 FAB INHIBITOR COMPLEX
2824, 3l7fD, 0.5047, 4.09, 0.084, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2825, 3l7eA, 0.5047, 4.00, 0.085, 213, 106, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2826, 3kpsE, 0.5047, 3.85, 0.112, 241, 107, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
2827, 3hmwL, 0.5047, 4.04, 0.093, 214, 107, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
2828, 3fctB, 0.5047, 4.15, 0.071, 216, 112, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
2829, 3dggA, 0.5047, 4.04, 0.084, 217, 107, CRYSTAL STRUCTURE OF FABOX108
2830, 3clfH, 0.5047, 4.11, 0.098, 220, 112, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
2831, 3cleH, 0.5047, 4.11, 0.089, 218, 112, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
2832, 2w65A, 0.5047, 4.07, 0.080, 212, 112, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
2833, 2vxqL, 0.5047, 3.99, 0.075, 213, 107, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2834, 2nljB, 0.5047, 4.32, 0.079, 218, 114, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2835, 2gsiC, 0.5047, 3.86, 0.085, 215, 106, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2836, 2ac0A, 0.5047, 3.82, 0.038, 198, 104, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
2837, 1xcqB, 0.5047, 4.06, 0.090, 218, 111, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2838, 1t5rF, 0.5047, 4.19, 0.054, 269, 112, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2839, 1nmaH, 0.5047, 3.94, 0.092, 122, 109, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
2840, 1gff1, 0.5047, 4.53, 0.054, 417, 112, THE ATOMIC STRUCTURE OF THE DEGRADED PROCAPSID PARTICLE OF THE BACTERIOPHAGE G4: INDUCED STRUCTURAL CHANGES IN THE PRESENCE OF CALCIUM IONS AND FUNCTIONAL IMPLICATIONS
2841, 1fskL, 0.5047, 4.31, 0.105, 220, 114, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2842, 1fskI, 0.5047, 4.31, 0.105, 220, 114, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2843, 1fskF, 0.5047, 4.31, 0.105, 220, 114, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2844, 1fskC, 0.5047, 4.31, 0.105, 220, 114, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2845, 1fl6L, 0.5047, 3.89, 0.113, 217, 106, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2846, 1faiH, 0.5047, 4.14, 0.089, 221, 112, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
2847, 6jjdA, 0.5046, 4.19, 0.065, 193, 108, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) FULL VLP 
2848, 6erxQ, 0.5046, 3.96, 0.056, 215, 108, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2849, 6dfxH, 0.5046, 3.82, 0.075, 237, 106, HUMAN DIABETOGENIC TCR T1D3 IN COMPLEX WITH DQ8-P8E9E PEPTIDE 
2850, 6ddvB, 0.5046, 3.96, 0.072, 222, 111, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2851, 6bjzL, 0.5046, 4.03, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY CONTAINING THE FLUORESCENT NON-CANONICAL AMINO ACID L-(7- HYDROXYCOUMARIN-4-YL)ETHYLGLYCINE AT PH 5.5 
2852, 6at6A, 0.5046, 3.84, 0.131, 190, 107, CRYSTAL STRUCTURE OF THE KFJ5 TCR
2853, 5zv3H, 0.5046, 4.11, 0.089, 219, 112, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
2854, 5w1vN, 0.5046, 3.96, 0.140, 202, 107, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
2855, 5otjH, 0.5046, 4.13, 0.071, 222, 112, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2856, 5mu0J, 0.5046, 4.14, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
2857, 5lf5A, 0.5046, 4.31, 0.117, 484, 111, MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) DEGLYCOSYLATED FULL EXTRACELLULAR DOMAIN WITH CO-PURIFIED LIGAND
2858, 5kvfL, 0.5046, 4.01, 0.121, 220, 107, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
2859, 5c7kE, 0.5046, 3.94, 0.064, 224, 110, CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195
2860, 4yzfL, 0.5046, 4.04, 0.084, 218, 107, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
2861, 4tnwJ, 0.5046, 4.08, 0.071, 222, 112, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2862, 4qrpI, 0.5046, 3.93, 0.140, 243, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
2863, 4pjxH, 0.5046, 3.80, 0.075, 241, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
2864, 4pjiH, 0.5046, 3.79, 0.084, 238, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
2865, 4nnpY, 0.5046, 4.01, 0.084, 213, 107, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
2866, 4nc1E, 0.5046, 3.90, 0.065, 124, 107, CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO A20.1 VHH AND A26.8 VHH
2867, 4krpC, 0.5046, 3.91, 0.085, 211, 106, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
2868, 4djmD, 0.5046, 3.13, 0.096, 204, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
2869, 4dcqB, 0.5046, 4.11, 0.071, 218, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10 AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
2870, 4a63C, 0.5046, 3.70, 0.087, 205, 103, CRYSTAL STRUCTURE OF THE P73-ASPP2 COMPLEX AT 2.6A RESOLUTION
2871, 3zkmL, 0.5046, 4.03, 0.112, 217, 107, BACE2 FAB COMPLEX
2872, 3zkmD, 0.5046, 4.03, 0.112, 217, 107, BACE2 FAB COMPLEX
2873, 3sjvN, 0.5046, 3.86, 0.104, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
2874, 3mbeG, 0.5046, 3.77, 0.142, 192, 106, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
2875, 3mbeC, 0.5046, 3.77, 0.142, 192, 106, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
2876, 3k2uL, 0.5046, 4.03, 0.084, 208, 107, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
2877, 3ixyG, 0.5046, 4.25, 0.080, 221, 113, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
2878, 3dx9D, 0.5046, 3.89, 0.093, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
2879, 2wmpA, 0.5046, 3.43, 0.143, 215, 98, STRUCTURE OF THE E. COLI CHAPERONE PAPD IN COMPLEX WITH THE PILIN DOMAIN OF THE PAPGII ADHESIN
2880, 2r29H, 0.5046, 4.21, 0.062, 216, 113, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
2881, 2g5bC, 0.5046, 3.98, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
2882, 2ahiB, 0.5046, 3.97, 0.038, 198, 105, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
2883, 1x9rA, 0.5046, 3.00, 0.140, 105, 93, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM
2884, 1uwgX, 0.5046, 3.99, 0.121, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2885, 1aj7H, 0.5046, 4.15, 0.088, 217, 113, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
2886, 6mwvC, 0.5045, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2887, 6mehH, 0.5045, 4.26, 0.062, 225, 112, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2888, 6fuqB, 0.5045, 3.70, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2889, 6fraB, 0.5045, 3.69, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2890, 6eyoI, 0.5045, 3.86, 0.064, 208, 110, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
2891, 6dcvA, 0.5045, 4.02, 0.093, 220, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2892, 6btjA, 0.5045, 3.94, 0.074, 216, 108, CRYSTAL STRUCTURE OF PAN-H7; ANTI-HEMAGGLUTININ MONOCLONAL ANTIBODY H7.5 (FAB FRAGMENT) 
2893, 5xrqH, 0.5045, 4.03, 0.065, 220, 108, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
2894, 5wkfD, 0.5045, 3.66, 0.114, 198, 105, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
2895, 5vshL, 0.5045, 4.00, 0.093, 213, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2896, 5tpwH, 0.5045, 4.06, 0.071, 211, 112, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT THE GLUN2A
2897, 5sx5K, 0.5045, 3.98, 0.075, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2898, 5o1rM, 0.5045, 3.91, 0.075, 212, 106, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2899, 5i66B, 0.5045, 4.03, 0.121, 213, 107, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
2900, 5c07E, 0.5045, 3.86, 0.093, 246, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
2901, 4zykB, 0.5045, 3.99, 0.075, 214, 107, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
2902, 4wfgG, 0.5045, 4.25, 0.080, 210, 113, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
2903, 4wffE, 0.5045, 4.24, 0.080, 211, 113, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
2904, 4risH, 0.5045, 4.04, 0.072, 228, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2905, 4k2uM, 0.5045, 4.10, 0.075, 200, 107, CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT
2906, 4hfuH, 0.5045, 4.14, 0.071, 224, 112, CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
2907, 4ftvE, 0.5045, 3.94, 0.083, 245, 108, THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE
2908, 3uzeA, 0.5045, 4.07, 0.055, 229, 109, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2909, 3utsJ, 0.5045, 3.89, 0.092, 246, 109, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2910, 3tf7G, 0.5045, 3.75, 0.075, 224, 106, 42F3 QL9/H2-LD COMPLEX
2911, 3t65A, 0.5045, 3.99, 0.112, 219, 107, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
2912, 3na9H, 0.5045, 4.16, 0.080, 225, 113, CRYSTAL STRUCTURE OF FAB15
2913, 3kmdC, 0.5045, 3.75, 0.058, 200, 103, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
2914, 3i9gH, 0.5045, 4.18, 0.053, 222, 113, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
2915, 2xknC, 0.5045, 3.99, 0.065, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
2916, 2uy6A, 0.5045, 3.46, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2917, 2r6pF, 0.5045, 4.21, 0.062, 216, 113, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
2918, 2r6pD, 0.5045, 4.21, 0.062, 216, 113, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
2919, 2pyeE, 0.5045, 3.76, 0.066, 242, 106, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
2920, 2ianT, 0.5045, 3.73, 0.067, 238, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2921, 2f54E, 0.5045, 3.68, 0.086, 241, 105, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
2922, 1yjdL, 0.5045, 4.06, 0.093, 212, 107, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
2923, 1x9uA, 0.5045, 3.01, 0.151, 105, 93, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE REDUCED FORM
2924, 1i9rK, 0.5045, 4.11, 0.071, 219, 112, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2925, 1e4wH, 0.5045, 4.06, 0.089, 213, 112, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2926, 1dbaH, 0.5045, 3.91, 0.054, 219, 112, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
2927, 6mwxO, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2928, 6mwxK, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2929, 6mwxG, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2930, 6mwxC, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2931, 6mwvO, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2932, 6mwvK, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2933, 6mwvG, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2934, 6mwcO, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2935, 6mwcK, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2936, 6mwcG, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2937, 6mwcC, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2938, 6mw9O, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2939, 6mw9K, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2940, 6mw9G, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2941, 6mw9C, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2942, 6muiO, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2943, 6muiK, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2944, 6muiG, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2945, 6muiC, 0.5044, 4.16, 0.080, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2946, 6jmqC, 0.5044, 4.22, 0.053, 214, 113, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
2947, 6gk7L, 0.5044, 4.06, 0.084, 216, 107, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
2948, 6bzyL, 0.5044, 3.92, 0.094, 215, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
2949, 6amuD, 0.5044, 3.74, 0.124, 195, 105, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE MMWDRGLGMM 
2950, 5yl1A, 0.5044, 4.07, 0.075, 185, 107, T=1 SUBVIRAL PARTICLE OF PENAEUS VANNAMEI NODAVIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-37  and 251-368) 
2951, 5xkuB, 0.5044, 4.04, 0.075, 211, 107, CRYSTAL STRUCTURE OF HEMAGGLUTININ GLOBULAR HEAD FROM AN H7N9 INFLUENZA VIRUS IN COMPLEX WITH A NEUTRALIZING ANTIBODY HNIGGA6
2952, 5xhvQ, 0.5044, 3.95, 0.085, 214, 106, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
2953, 5vshD, 0.5044, 4.01, 0.093, 211, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2954, 5mvjF, 0.5044, 4.02, 0.121, 218, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2955, 5mp1D, 0.5044, 3.89, 0.123, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2956, 5l0qE, 0.5044, 4.02, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
2957, 5k9kB, 0.5044, 3.91, 0.094, 215, 106, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
2958, 5ezoL, 0.5044, 3.99, 0.103, 213, 107, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
2959, 5bo1L, 0.5044, 4.03, 0.093, 214, 107, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
2960, 5anyL, 0.5044, 4.16, 0.080, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2961, 5anyK, 0.5044, 4.16, 0.080, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2962, 5anyJ, 0.5044, 4.16, 0.080, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2963, 5anyI, 0.5044, 4.16, 0.080, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2964, 5ab9A, 0.5044, 3.76, 0.049, 195, 103, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE 7-ETHYL-3-(PIPERIDIN-4-YL)-1H-INDOLE
2965, 4x6dH, 0.5044, 3.84, 0.065, 242, 107, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
2966, 4ww2B, 0.5044, 3.86, 0.103, 243, 107, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
2967, 4qrpE, 0.5044, 3.93, 0.121, 243, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
2968, 4prhE, 0.5044, 3.86, 0.075, 240, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX
2969, 4pjeF, 0.5044, 3.79, 0.093, 240, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
2970, 4dgvH, 0.5044, 4.08, 0.098, 226, 112, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 P2(1) FORM
2971, 4a63K, 0.5044, 3.72, 0.097, 205, 103, CRYSTAL STRUCTURE OF THE P73-ASPP2 COMPLEX AT 2.6A RESOLUTION
2972, 3zdxH, 0.5044, 4.14, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2973, 3w9dA, 0.5044, 3.92, 0.065, 209, 108, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
2974, 3vxuE, 0.5044, 3.75, 0.084, 241, 107, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
2975, 3utpE, 0.5044, 3.91, 0.083, 246, 108, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
2976, 3tyfD, 0.5044, 3.80, 0.093, 242, 107, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
2977, 3t3mH, 0.5044, 4.09, 0.071, 216, 112, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2978, 3sy0A, 0.5044, 4.00, 0.112, 219, 107, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
2979, 3rdtA, 0.5044, 3.80, 0.104, 199, 106, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
2980, 3qumC, 0.5044, 4.04, 0.093, 218, 107, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
2981, 3ogcA, 0.5044, 4.27, 0.089, 219, 112, KCSA E71A VARIANT IN PRESENCE OF NA+
2982, 3mv9D, 0.5044, 3.92, 0.085, 200, 106, CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG
2983, 3eobL, 0.5044, 4.05, 0.084, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
2984, 3dx9B, 0.5044, 3.89, 0.093, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
2985, 2vlmE, 0.5044, 3.80, 0.084, 240, 107, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2986, 2jixA, 0.5044, 3.99, 0.065, 214, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
2987, 2b1hH, 0.5044, 4.00, 0.073, 226, 110, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2988, 1seqL, 0.5044, 3.81, 0.124, 208, 105, FAB MNAC13
2989, 1q9wC, 0.5044, 3.99, 0.103, 219, 107, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2990, 1ncdH, 0.5044, 4.17, 0.080, 221, 113, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2991, 1mhhB, 0.5044, 4.09, 0.089, 215, 112, ANTIBODY-ANTIGEN COMPLEX
2992, 6obzL, 0.5043, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2993, 6ncpB, 0.5043, 3.93, 0.065, 212, 107, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
2994, 6fuoB, 0.5043, 3.72, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2995, 6bckH, 0.5043, 4.04, 0.081, 222, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P7 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE. 
2996, 5ye3A, 0.5043, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 2A7D9 FAB FRAGMENT 
2997, 5x2qK, 0.5043, 4.02, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2998, 5wkhE, 0.5043, 3.97, 0.120, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
2999, 5w1vS, 0.5043, 3.72, 0.106, 201, 104, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
3000, 5w0kE, 0.5043, 4.11, 0.098, 214, 112, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
3001, 5vh4B, 0.5043, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
3002, 5uddJ, 0.5043, 4.13, 0.071, 224, 112, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3003, 5tzuL, 0.5043, 4.00, 0.103, 213, 107, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2
3004, 5mu2N, 0.5043, 4.13, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3005, 5ihbD, 0.5043, 4.13, 0.084, 209, 107, STRUCTURE OF THE IMMUNE RECEPTOR CD33
3006, 5hcgH, 0.5043, 4.01, 0.073, 332, 110, CRYSTAL STRUCTURE OF FREE-CODV.
3007, 5e1aB, 0.5043, 4.05, 0.103, 212, 107, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
3008, 5c07J, 0.5043, 3.88, 0.083, 246, 108, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
3009, 4xhjC, 0.5043, 4.03, 0.065, 207, 107, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
3010, 4wfgE, 0.5043, 4.25, 0.080, 211, 113, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
3011, 4wfeG, 0.5043, 4.25, 0.080, 210, 113, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3012, 4wfeE, 0.5043, 4.26, 0.080, 211, 113, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3013, 4qxtA, 0.5043, 4.01, 0.056, 114, 108, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30
3014, 4pjxF, 0.5043, 3.80, 0.075, 237, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
3015, 4mwfL, 0.5043, 4.09, 0.075, 212, 107, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
3016, 4i2xC, 0.5043, 4.05, 0.131, 214, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3017, 3ze0H, 0.5043, 4.10, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3018, 3fzuL, 0.5043, 3.99, 0.075, 213, 107, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3019, 3difC, 0.5043, 4.04, 0.131, 214, 107, CRYSTAL STRUCTURE OF FABOX117
3020, 3c5zA, 0.5043, 3.84, 0.151, 202, 106, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3021, 2w65C, 0.5043, 4.09, 0.081, 211, 111, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
3022, 2pyeD, 0.5043, 4.04, 0.101, 195, 109, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
3023, 2eysB, 0.5043, 3.92, 0.083, 243, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
3024, 1uwgH, 0.5043, 4.18, 0.062, 208, 112, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
3025, 1s3kL, 0.5043, 4.10, 0.102, 216, 108, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
3026, 6mnoA, 0.5042, 3.85, 0.121, 196, 107, 6235 TCR BOUND TO I-AB PADI4 
3027, 6h3uL, 0.5042, 4.06, 0.075, 113, 107, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
3028, 6funB, 0.5042, 3.71, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3029, 6e3hH, 0.5042, 4.07, 0.071, 226, 112, CRYSTAL STRUCTURE OF S9-3-37 BOUND TO H5 INFLUENZA HEMAGGLUTININ 
3030, 5xovG, 0.5042, 3.87, 0.103, 207, 107, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
3031, 5x2pL, 0.5042, 4.02, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
3032, 5mu2B, 0.5042, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3033, 5mp3B, 0.5042, 3.91, 0.113, 218, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
3034, 5mctA, 0.5042, 3.76, 0.039, 200, 103, P53-DNA COMPLEX 1 
3035, 5ec2A, 0.5042, 4.28, 0.088, 219, 114, KCSA WITH V76ESTER+G77DA MUTATIONS
3036, 5d7kE, 0.5042, 3.80, 0.065, 241, 107, STRUCTURE OF MR1-REACTIVE MAV36 TCR
3037, 5c1mB, 0.5042, 3.92, 0.065, 118, 108, CRYSTAL STRUCTURE OF ACTIVE MU-OPIOID RECEPTOR BOUND TO THE AGONIST BU72
3038, 5bq7A, 0.5042, 4.09, 0.062, 220, 112, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
3039, 4z7nH, 0.5042, 4.11, 0.071, 216, 112, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
3040, 4wfhG, 0.5042, 4.21, 0.080, 210, 113, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
3041, 4priD, 0.5042, 4.02, 0.084, 202, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX
3042, 4ki5D, 0.5042, 3.85, 0.114, 211, 105, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
3043, 4jo3M, 0.5042, 4.06, 0.075, 214, 107, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
3044, 3sjvD, 0.5042, 3.85, 0.085, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
3045, 3mlwI, 0.5042, 4.06, 0.055, 228, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3046, 3mffB, 0.5042, 3.85, 0.084, 242, 107, 1F1E8HU TCR
3047, 3l1oH, 0.5042, 4.05, 0.081, 224, 111, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
3048, 3idxL, 0.5042, 4.08, 0.065, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C222
3049, 3d0aB, 0.5042, 3.73, 0.058, 197, 103, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND SITE SUPPRESSOR MUTATION H168R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3050, 3aazL, 0.5042, 4.01, 0.103, 228, 107, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3051, 2wgxA, 0.5042, 3.86, 0.038, 195, 104, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I- N268D
3052, 2pcpD, 0.5042, 4.05, 0.072, 215, 111, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3053, 2oslL, 0.5042, 3.86, 0.105, 213, 105, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
3054, 2ocwA, 0.5042, 3.73, 0.058, 585, 103, SOLUTION STRUCTURE OF HUMAN SECRETORY COMPONENT
3055, 2fjfC, 0.5042, 4.02, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3056, 2adfH, 0.5042, 4.07, 0.071, 218, 112, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
3057, 1ngxL, 0.5042, 4.02, 0.103, 213, 107, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
3058, 1kzyA, 0.5042, 3.76, 0.039, 195, 103, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
3059, 1ahwA, 0.5042, 3.91, 0.094, 214, 106, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
3060, 6ocbL, 0.5041, 3.88, 0.094, 213, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H3 (A/HONG KONG/1/1968) 
3061, 6dwaL, 0.5041, 4.13, 0.093, 219, 108, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3062, 6dfxJ, 0.5041, 3.83, 0.075, 237, 106, HUMAN DIABETOGENIC TCR T1D3 IN COMPLEX WITH DQ8-P8E9E PEPTIDE 
3063, 6dcaK, 0.5041, 4.25, 0.071, 213, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3064, 6c68D, 0.5041, 3.79, 0.057, 238, 106, MHC-INDEPENDENT T CELL RECEPTOR A11 
3065, 6c61B, 0.5041, 4.01, 0.064, 243, 109, MHC-INDEPENDENT T-CELL RECEPTOR B12A 
3066, 6bftL, 0.5041, 3.90, 0.085, 213, 106, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
3067, 5x4gB, 0.5041, 4.08, 0.121, 213, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD147 MONOCLONAL ANTIBODY 6H8
3068, 5x2pK, 0.5041, 4.01, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
3069, 5w1vI, 0.5041, 3.93, 0.142, 202, 106, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
3070, 5vh4L, 0.5041, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
3071, 5opyL, 0.5041, 3.98, 0.104, 212, 106, CRYSTAL STRUCTURE OF ANTI-ALPHAVBETA3 INTEGRIN FAB LM609
3072, 5nivA, 0.5041, 3.94, 0.113, 212, 106, CRYSTAL STRUCTURE OF 5D3 FAB
3073, 5mcwA, 0.5041, 3.75, 0.039, 199, 103, P53-DNA COMPLEX 4 
3074, 5iw1A, 0.5041, 3.80, 0.094, 189, 106, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
3075, 5bzdC, 0.5041, 4.01, 0.084, 214, 107, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
3076, 5bk3L, 0.5041, 4.05, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3077, 4zypG, 0.5041, 3.99, 0.065, 213, 107, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3078, 4zezI, 0.5041, 3.97, 0.110, 207, 109, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
3079, 4z7qH, 0.5041, 4.11, 0.071, 216, 112, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
3080, 4yxhH, 0.5041, 4.31, 0.079, 218, 114, CRYSTAL STRUCTURE OF DEER PRION PROTEIN COMPLEXED WITH POM1 FAB
3081, 4pjdH, 0.5041, 3.70, 0.085, 239, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
3082, 4p5tE, 0.5041, 3.79, 0.113, 188, 106, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
3083, 4oziH, 0.5041, 4.00, 0.091, 243, 110, S2 PROTEIN COMPLEX
3084, 4lcwH, 0.5041, 3.79, 0.075, 240, 107, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
3085, 4janH, 0.5041, 4.20, 0.072, 218, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
3086, 4i3rH, 0.5041, 3.96, 0.081, 228, 111, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
3087, 4g8gD, 0.5041, 4.05, 0.110, 204, 109, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
3088, 4ffyH, 0.5041, 4.08, 0.072, 119, 111, CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII STRAIN 16007.
3089, 4djmE, 0.5041, 3.15, 0.106, 198, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3090, 3vxuJ, 0.5041, 3.75, 0.084, 241, 107, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
3091, 3okmA, 0.5041, 4.01, 0.112, 215, 107, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
3092, 3o41B, 0.5041, 4.03, 0.103, 217, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
3093, 3nidH, 0.5041, 4.14, 0.062, 216, 112, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3094, 3j6lB, 0.5041, 3.99, 0.093, 121, 108, KINETIC AND STRUCTURAL ANALYSIS OF COXSACKIEVIRUS B3 RECEPTOR INTERACTIONS AND FORMATION OF THE A-PARTICLE
3095, 3igaA, 0.5041, 4.39, 0.070, 219, 115, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
3096, 3bj91, 0.5041, 4.20, 0.155, 116, 110, CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
3097, 2qscL, 0.5041, 4.02, 0.065, 215, 107, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE
3098, 2q8bL, 0.5041, 3.99, 0.121, 213, 107, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3099, 2nr6D, 0.5041, 4.11, 0.071, 213, 112, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
3100, 2g5bA, 0.5041, 3.98, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3101, 2ahiC, 0.5041, 3.65, 0.059, 193, 102, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
3102, 1ncbH, 0.5041, 4.16, 0.080, 221, 113, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
3103, 1lk3H, 0.5041, 4.30, 0.070, 219, 114, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
3104, 1jpsL, 0.5041, 4.02, 0.075, 213, 107, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
3105, 1f5wB, 0.5041, 3.99, 0.093, 121, 108, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
3106, 1f11C, 0.5041, 4.04, 0.103, 216, 107, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
3107, 1e4xI, 0.5041, 4.10, 0.080, 217, 112, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
3108, 1bj1J, 0.5041, 4.02, 0.065, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3109, 6jmrC, 0.5040, 4.03, 0.063, 214, 111, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3110, 6jjcA, 0.5040, 4.21, 0.065, 193, 108, CRYO-EM STRUCTURE OF GIANT FRESHWATER PRAWN MACROBRACHIUM ROSENBERGII NODAVIRUS (MRNV) SEMI-EMPTY VLP 
3111, 6flaB, 0.5040, 4.03, 0.103, 216, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
3112, 6eluC, 0.5040, 4.04, 0.103, 217, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
3113, 6dcvL, 0.5040, 4.03, 0.093, 220, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
3114, 6bfqD, 0.5040, 4.03, 0.075, 213, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3115, 6awnB, 0.5040, 4.17, 0.088, 218, 113, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
3116, 5x2mK, 0.5040, 4.02, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
3117, 5vzxL, 0.5040, 3.89, 0.094, 218, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3118, 5uelH, 0.5040, 4.12, 0.062, 232, 113, CRYSTAL STRUCTURE OF 354NC102 FAB
3119, 5mu0F, 0.5040, 4.15, 0.111, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3120, 5mctB, 0.5040, 3.76, 0.039, 200, 103, P53-DNA COMPLEX 1 
3121, 5kmvL, 0.5040, 3.89, 0.094, 218, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3122, 5j9pA, 0.5040, 4.38, 0.079, 219, 114, KCSA IN VITRO
3123, 5hdbE, 0.5040, 4.15, 0.071, 214, 112, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
3124, 4qo1A, 0.5040, 3.91, 0.082, 127, 110, P53 DNA BINDING DOMAIN IN COMPLEX WITH NB139
3125, 4q0xH, 0.5040, 4.08, 0.071, 216, 112, CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2
3126, 4prhD, 0.5040, 4.02, 0.084, 202, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX
3127, 4pozC, 0.5040, 4.03, 0.075, 211, 107, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
3128, 4nylF, 0.5040, 4.03, 0.085, 124, 106, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3129, 4nylB, 0.5040, 3.88, 0.085, 117, 106, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3130, 4nwvA, 0.5040, 4.15, 0.037, 355, 107, CRYSTAL STRUCTURE OF ORSAY VIRUS-LIKE PARTICLE
3131, 4nrxL, 0.5040, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3132, 4jlrL, 0.5040, 3.83, 0.105, 210, 105, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3133, 4hs8L, 0.5040, 3.91, 0.075, 218, 106, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3
3134, 4ffvH, 0.5040, 4.08, 0.090, 209, 111, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
3135, 3zdzH, 0.5040, 4.11, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3136, 3q3gK, 0.5040, 4.17, 0.062, 224, 112, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3137, 3lkfA, 0.5040, 4.29, 0.116, 292, 112, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS WITH PHOSPHOCHOLINE BOUND
3138, 3eoaL, 0.5040, 4.05, 0.075, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
3139, 3dggD, 0.5040, 4.37, 0.087, 215, 115, CRYSTAL STRUCTURE OF FABOX108
3140, 3d0aA, 0.5040, 3.76, 0.058, 195, 103, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND SITE SUPPRESSOR MUTATION H168R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3141, 3bpcA, 0.5040, 4.01, 0.112, 216, 107, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
3142, 2vl5D, 0.5040, 4.03, 0.112, 216, 107, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
3143, 2uy7G, 0.5040, 3.46, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
3144, 2r1xA, 0.5040, 4.00, 0.112, 219, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3145, 2nx5D, 0.5040, 3.69, 0.143, 188, 105, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3146, 2fjfE, 0.5040, 4.02, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3147, 2adjA, 0.5040, 4.01, 0.112, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
3148, 1x9rB, 0.5040, 2.91, 0.130, 104, 92, UMECYANIN FROM HORSE RADDISH- CRYSTAL STRUCTURE OF THE OXIDISED FORM
3149, 1r24B, 0.5040, 4.05, 0.072, 217, 111, FAB FROM MURINE IGG3 KAPPA
3150, 1ngxA, 0.5040, 4.02, 0.103, 213, 107, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
3151, 1fl5L, 0.5040, 3.91, 0.113, 217, 106, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
3152, 1bj1L, 0.5040, 4.03, 0.075, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3153, 1ae6H, 0.5040, 4.12, 0.071, 218, 112, IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
3154, 6obzB, 0.5039, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF FLUA-20 FAB 
3155, 6iekE, 0.5039, 4.12, 0.063, 223, 111, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
3156, 6i9iB, 0.5039, 3.97, 0.093, 216, 107, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
3157, 6eynL, 0.5039, 3.93, 0.094, 217, 106, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
3158, 6dfvA, 0.5039, 3.97, 0.083, 190, 108, MOUSE DIABETOGENIC TCR 8F10 
3159, 6awqC, 0.5039, 4.05, 0.121, 214, 107, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
3160, 6awoC, 0.5039, 4.05, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
3161, 6a3wA, 0.5039, 4.10, 0.064, 116, 109, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3162, 5yupL, 0.5039, 3.95, 0.113, 215, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF FVIIA ANTIBODY MAB4F5 
3163, 5x2mL, 0.5039, 4.02, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
3164, 5wkhI, 0.5039, 3.71, 0.142, 198, 106, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
3165, 5w1wT, 0.5039, 3.72, 0.075, 243, 106, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
3166, 5mu2J, 0.5039, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3167, 5i75C, 0.5039, 4.07, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
3168, 5i1aA, 0.5039, 4.05, 0.075, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3169, 5hj3F, 0.5039, 4.06, 0.084, 189, 107, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
3170, 5ggqL, 0.5039, 4.02, 0.075, 211, 107, CRYSTAL STRUCTURE OF NIVOLUMAB FAB FRAGMENT
3171, 4x7tA, 0.5039, 4.06, 0.072, 222, 111, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
3172, 4wffG, 0.5039, 4.30, 0.079, 210, 114, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
3173, 4mjiJ, 0.5039, 3.81, 0.131, 241, 107, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
3174, 4lmqL, 0.5039, 4.03, 0.093, 214, 107, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
3175, 4ibuB, 0.5039, 3.76, 0.058, 198, 103, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3176, 4dkfM, 0.5039, 4.03, 0.075, 207, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
3177, 3t3pE, 0.5039, 4.15, 0.071, 214, 112, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3178, 3or7A, 0.5039, 4.37, 0.087, 219, 115, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
3179, 3njiA, 0.5039, 3.37, 0.115, 119, 96, S114A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
3180, 3nigH, 0.5039, 4.13, 0.062, 216, 112, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3181, 3naaH, 0.5039, 4.16, 0.088, 225, 113, CRYSTAL STRUCTURE OF FAB15 MUT5
3182, 3mv8D, 0.5039, 3.92, 0.085, 200, 106, CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG
3183, 3hg1D, 0.5039, 3.76, 0.123, 194, 106, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
3184, 3d85A, 0.5039, 4.04, 0.093, 213, 107, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3185, 2zpkH, 0.5039, 4.11, 0.080, 207, 112, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
3186, 2r0kL, 0.5039, 4.02, 0.084, 214, 107, PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
3187, 2gkiB, 0.5039, 4.03, 0.103, 238, 107, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
3188, 2g5bE, 0.5039, 4.00, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3189, 2f53E, 0.5039, 3.71, 0.085, 243, 106, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
3190, 2e7lA, 0.5039, 3.80, 0.111, 112, 108, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3191, 2dblH, 0.5039, 3.95, 0.054, 219, 111, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
3192, 1z3gI, 0.5039, 4.04, 0.073, 214, 110, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
3193, 1c5dA, 0.5039, 4.03, 0.093, 213, 107, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
3194, 6dznH, 0.5038, 3.94, 0.073, 226, 110, PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB 
3195, 6cugE, 0.5038, 3.71, 0.066, 244, 106, CRYSTAL STRUCTURE OF BC8B TCR-CD1B-PC COMPLEX 
3196, 6cnvH, 0.5038, 4.06, 0.064, 214, 110, INFLUENZA B/BRISBANE HEMAGGLUTININ FAB CR9115 SD84H COMPLEX 
3197, 6bliK, 0.5038, 4.04, 0.065, 214, 107, RSV G PEPTIDE BOUND TO FAB CB002.5
3198, 6bfqL, 0.5038, 4.03, 0.075, 212, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3199, 5wjoB, 0.5038, 3.94, 0.102, 248, 108, CRYSTAL STRUCTURE OF THE UNLIGANDED PG90 TCR
3200, 5wdfH, 0.5038, 3.96, 0.100, 209, 110, CRYSTAL STRUCTURE OF 10E8V4-5R+100CF FAB IN COMPLEX WITH HIV-1 GP41 PEPTIDE
3201, 5vshB, 0.5038, 4.03, 0.093, 213, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
3202, 5v7rL, 0.5038, 4.00, 0.084, 215, 107, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-7.1 FAB
3203, 5swsD, 0.5038, 3.95, 0.102, 198, 108, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
3204, 5mu2L, 0.5038, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3205, 5mu2D, 0.5038, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3206, 5mu0N, 0.5038, 4.14, 0.111, 215, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3207, 5mu0L, 0.5038, 4.14, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3208, 5e6iH, 0.5038, 3.72, 0.085, 239, 106, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
3209, 5buaA, 0.5038, 3.65, 0.039, 199, 102, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH DNA.
3210, 5bmfL, 0.5038, 4.13, 0.102, 216, 108, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
3211, 4y4kC, 0.5038, 3.96, 0.148, 202, 108, CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX
3212, 4xccH, 0.5038, 4.10, 0.063, 226, 111, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP
3213, 4pjgH, 0.5038, 3.80, 0.075, 240, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3214, 4pj7G, 0.5038, 3.90, 0.121, 199, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
3215, 4p1xF, 0.5038, 4.19, 0.054, 255, 111, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
3216, 4oqtL, 0.5038, 4.06, 0.084, 214, 107, LINGO-1/LI81 FAB COMPLEX
3217, 4nryL, 0.5038, 4.05, 0.084, 207, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3218, 4nrxB, 0.5038, 4.04, 0.084, 207, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3219, 4jzjA, 0.5038, 4.10, 0.062, 214, 112, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
3220, 4jryE, 0.5038, 3.91, 0.084, 242, 107, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
3221, 4irsC, 0.5038, 3.96, 0.148, 202, 108, STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
3222, 4hs6L, 0.5038, 4.04, 0.084, 218, 107, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
3223, 3ze2H, 0.5038, 4.11, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3224, 3vxqE, 0.5038, 3.96, 0.093, 242, 108, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
3225, 3tjhD, 0.5038, 3.67, 0.057, 239, 105, 42F3-P3A1/H2-LD COMPLEX
3226, 3qjfD, 0.5038, 3.95, 0.074, 239, 108, CRYSTAL STRUCTURE OF THE 2B4 TCR
3227, 3oklA, 0.5038, 4.00, 0.112, 219, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
3228, 3o8xC, 0.5038, 3.96, 0.148, 203, 108, RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3229, 3nigE, 0.5038, 4.15, 0.071, 214, 112, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3230, 3gkwL, 0.5038, 4.14, 0.111, 199, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3231, 2uy7C, 0.5038, 3.46, 0.143, 216, 98, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
3232, 2r2bA, 0.5038, 4.00, 0.112, 217, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3233, 2dwdB, 0.5038, 4.07, 0.103, 212, 107, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
3234, 2arjL, 0.5038, 4.03, 0.093, 211, 107, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
3235, 1xctB, 0.5038, 4.17, 0.089, 218, 112, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
3236, 1ncaL, 0.5038, 4.02, 0.131, 214, 107, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
3237, 1mwaC, 0.5038, 3.89, 0.111, 202, 108, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
3238, 1mhhD, 0.5038, 4.10, 0.080, 214, 113, ANTIBODY-ANTIGEN COMPLEX
3239, 1bqhH, 0.5038, 4.28, 0.045, 125, 112, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
3240, 6jmrE, 0.5037, 4.42, 0.070, 215, 114, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3241, 6fupB, 0.5037, 3.72, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3242, 6f2sG, 0.5037, 4.59, 0.062, 195, 112, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
3243, 6f2sD, 0.5037, 4.78, 0.070, 195, 114, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
3244, 6e0pM, 0.5037, 4.01, 0.082, 229, 110, CRYO-EM STRUCTURE OF THE CENTROMERIC NUCLEOSOME (NATIVE ALPHA SATELLITE DNA) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
3245, 6cdoB, 0.5037, 4.19, 0.111, 219, 108, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3246, 6bfqF, 0.5037, 4.03, 0.075, 213, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3247, 5w0kH, 0.5037, 4.43, 0.078, 213, 115, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
3248, 5trpL, 0.5037, 4.02, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
3249, 5tq0H, 0.5037, 4.13, 0.080, 212, 113, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN THE PRESENCE OF EDTA
3250, 5nb5M, 0.5037, 4.05, 0.103, 218, 107, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
3251, 5mv4B, 0.5037, 4.13, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3252, 5mv3B, 0.5037, 4.08, 0.112, 218, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3253, 5mu0P, 0.5037, 4.14, 0.111, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3254, 5i1dL, 0.5037, 4.05, 0.084, 220, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
3255, 5ezjB, 0.5037, 3.99, 0.112, 213, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
3256, 5c08E, 0.5037, 3.84, 0.093, 244, 107, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
3257, 4zs6D, 0.5037, 4.02, 0.075, 210, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
3258, 4xzuB, 0.5037, 3.84, 0.114, 213, 105, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
3259, 4r7dL, 0.5037, 4.07, 0.084, 211, 107, FAB HU 15C1
3260, 4np4I, 0.5037, 4.22, 0.071, 221, 113, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
3261, 4jm0B, 0.5037, 4.16, 0.116, 183, 112, STRUCTURE OF HUMAN CYTOMEGALOVIRUS IMMUNE MODULATOR UL141
3262, 4jlrB, 0.5037, 3.83, 0.095, 210, 105, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3263, 4gg6E, 0.5037, 3.96, 0.142, 187, 106, PROTEIN COMPLEX
3264, 4d9rL, 0.5037, 3.90, 0.075, 214, 106, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3265, 4am0D, 0.5037, 4.04, 0.112, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3266, 3vxtD, 0.5037, 3.77, 0.084, 241, 107, T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3267, 3stlA, 0.5037, 4.38, 0.087, 219, 115, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
3268, 3sjvT, 0.5037, 3.79, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
3269, 3qdmE, 0.5037, 3.79, 0.103, 242, 107, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3270, 3lhaA, 0.5037, 3.72, 0.110, 283, 100, CRYSTAL STRUCTURE OF MOUSE VPS26B(R240S/G241A/E242S) IN SPACEGROUP P41 21 2
3271, 3i02C, 0.5037, 3.99, 0.112, 196, 107, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3272, 3c60A, 0.5037, 3.66, 0.125, 199, 104, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
3273, 2y5tA, 0.5037, 4.22, 0.107, 222, 112, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
3274, 2xqyJ, 0.5037, 4.36, 0.096, 216, 114, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3275, 2nyyC, 0.5037, 4.10, 0.074, 216, 108, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
3276, 2axjB, 0.5037, 3.71, 0.094, 242, 106, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
3277, 2adyB, 0.5037, 3.66, 0.059, 198, 102, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX IV)
3278, 1il1B, 0.5037, 3.99, 0.112, 219, 107, CRYSTAL STRUCTURE OF G3-519 AN ANTI-HIV MONOCLONAL ANTIBODY
3279, 1ct8A, 0.5037, 4.02, 0.093, 214, 107, CATALYTIC ANTIBODY 7C8 COMPLEX
3280, 6okqB, 0.5036, 3.84, 0.095, 210, 105, CRYSTAL STRUCTURE OF THE SF12 FAB 
3281, 6c9uH, 0.5036, 4.02, 0.054, 205, 111, CRYSTAL STRUCTURE OF [KS3][AT3] DIDOMAIN FROM MODULE 3 OF 6- DEOXYERTHRONOLIDE B SYNTHASE IN COMPLEX WITH ANTIBODY FRAGMENT (FAB) 
3282, 5wk3S, 0.5036, 4.12, 0.080, 221, 112, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
3283, 5uddT, 0.5036, 4.04, 0.084, 211, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3284, 5mu0H, 0.5036, 4.14, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3285, 5ivxF, 0.5036, 3.95, 0.083, 234, 108, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
3286, 5hhmI, 0.5036, 3.79, 0.114, 196, 105, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
3287, 5eukA, 0.5036, 4.03, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
3288, 5ebmB, 0.5036, 4.07, 0.103, 212, 107, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
3289, 5e2vL, 0.5036, 3.92, 0.094, 216, 106, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
3290, 5d96B, 0.5036, 4.07, 0.103, 214, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
3291, 4yzfH, 0.5036, 4.05, 0.084, 218, 107, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
3292, 4y2dG, 0.5036, 3.97, 0.148, 202, 108, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
3293, 4y2dC, 0.5036, 3.97, 0.148, 202, 108, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
3294, 4uihF, 0.5036, 3.95, 0.055, 120, 109, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.
3295, 4uifI, 0.5036, 3.95, 0.055, 120, 109, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
3296, 4rgnG, 0.5036, 4.05, 0.103, 220, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3297, 4rgnE, 0.5036, 4.05, 0.103, 220, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3298, 4r97B, 0.5036, 4.04, 0.121, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
3299, 4pjgG, 0.5036, 3.81, 0.123, 188, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3300, 4otxM, 0.5036, 4.01, 0.103, 213, 107, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
3301, 4m61A, 0.5036, 3.99, 0.112, 219, 107, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3302, 4lbeB, 0.5036, 4.08, 0.103, 212, 107, STRUCTURE OF KCSA WITH R122A MUTATION
3303, 4kxzN, 0.5036, 4.02, 0.064, 223, 110, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3304, 4kaqH, 0.5036, 4.16, 0.089, 220, 112, STRUCTURE OF RITUXIMAB FAB
3305, 4irjC, 0.5036, 3.96, 0.148, 202, 108, STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
3306, 4hgwA, 0.5036, 4.01, 0.112, 217, 107, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
3307, 4gg6G, 0.5036, 3.96, 0.142, 177, 106, PROTEIN COMPLEX
3308, 4d9qL, 0.5036, 4.00, 0.075, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3309, 4am0F, 0.5036, 4.04, 0.112, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3310, 4a63I, 0.5036, 3.66, 0.107, 205, 103, CRYSTAL STRUCTURE OF THE P73-ASPP2 COMPLEX AT 2.6A RESOLUTION
3311, 3wiiH, 0.5036, 4.13, 0.080, 220, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
3312, 3uypA, 0.5036, 4.00, 0.056, 226, 108, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3313, 3ubxH, 0.5036, 4.11, 0.071, 221, 112, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3314, 3rzcC, 0.5036, 3.80, 0.151, 202, 106, STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
3315, 3qwoL, 0.5036, 3.85, 0.105, 210, 105, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3316, 3o2wH, 0.5036, 4.15, 0.062, 214, 112, CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
3317, 3jbf7, 0.5036, 3.96, 0.082, 123, 110, COMPLEX OF POLIOVIRUS WITH VHH PVSP19B
3318, 3hmxH, 0.5036, 4.06, 0.071, 217, 112, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
3319, 3fzuD, 0.5036, 4.02, 0.075, 213, 107, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3320, 3aazB, 0.5036, 4.03, 0.103, 229, 107, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3321, 2y5tB, 0.5036, 4.03, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
3322, 2r2hA, 0.5036, 4.01, 0.112, 219, 107, STRUCTURE OF S25-2 IN COMPLEX WITH KO
3323, 2ialA, 0.5036, 3.82, 0.123, 196, 106, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3324, 2hvjB, 0.5036, 4.06, 0.103, 212, 107, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
3325, 1ymhA, 0.5036, 4.06, 0.093, 220, 107, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
3326, 1qunM, 0.5036, 3.14, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3327, 1qunI, 0.5036, 3.14, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3328, 1nccL, 0.5036, 4.03, 0.121, 214, 107, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
3329, 1i8mB, 0.5036, 4.14, 0.080, 213, 112, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
3330, 1fj1A, 0.5036, 4.00, 0.075, 213, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3331, 1f11A, 0.5036, 4.04, 0.103, 216, 107, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
3332, 1eajB, 0.5036, 3.98, 0.093, 120, 108, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
3333, 6njmI, 0.5035, 3.98, 0.000, 218, 110, STRUCTURE OF A COMPLEX 
3334, 6fg1L, 0.5035, 4.01, 0.065, 211, 107, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA32. 
3335, 6eynC, 0.5035, 3.93, 0.094, 207, 106, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
3336, 6dwiP, 0.5035, 3.87, 0.075, 204, 107, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3337, 6cx9C, 0.5035, 3.86, 0.150, 201, 107, STRUCTURE OF ALPHA-GSA[16;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3338, 6bzuF, 0.5035, 4.02, 0.112, 214, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3339, 6bj8D, 0.5035, 3.96, 0.102, 201, 108, TCR55 IN COMPLEX WITH PEP20/HLA-B35 
3340, 5ywoR, 0.5035, 4.04, 0.062, 218, 112, STRUCTURE OF JEV-2F2 FAB COMPLEX
3341, 5ywoN, 0.5035, 4.04, 0.062, 218, 112, STRUCTURE OF JEV-2F2 FAB COMPLEX
3342, 5x2qL, 0.5035, 4.02, 0.103, 217, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
3343, 5wkiE, 0.5035, 3.91, 0.093, 248, 108, CRYSTAL STRUCTURE OF PG90 TCR-CD1B-PG COMPLEX
3344, 5w23L, 0.5035, 4.02, 0.103, 216, 107, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3345, 5w1vD, 0.5035, 3.80, 0.135, 201, 104, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
3346, 5mvzH, 0.5035, 4.28, 0.079, 221, 114, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
3347, 5mv4V, 0.5035, 4.14, 0.102, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3348, 5mv4D, 0.5035, 4.13, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3349, 5mu0D, 0.5035, 4.14, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3350, 5k9kL, 0.5035, 3.93, 0.085, 215, 106, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
3351, 5i73C, 0.5035, 4.06, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
3352, 5hdbH, 0.5035, 4.11, 0.071, 216, 112, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
3353, 5e2tL, 0.5035, 4.08, 0.093, 216, 107, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB
3354, 5d96I, 0.5035, 4.07, 0.103, 214, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
3355, 4y19E, 0.5035, 3.88, 0.074, 241, 108, IMMUNE COMPLEX
3356, 4p2qO, 0.5035, 4.04, 0.055, 242, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
3357, 4nnpL, 0.5035, 3.99, 0.084, 213, 107, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
3358, 4m61C, 0.5035, 4.00, 0.112, 219, 107, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3359, 4lbeA, 0.5035, 4.34, 0.079, 219, 114, STRUCTURE OF KCSA WITH R122A MUTATION
3360, 4k7pX, 0.5035, 3.73, 0.087, 213, 103, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3361, 4j1uE, 0.5035, 3.95, 0.094, 214, 106, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
3362, 3vwkC, 0.5035, 3.97, 0.093, 194, 108, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
3363, 3ubxG, 0.5035, 4.11, 0.071, 221, 112, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
3364, 3t3mE, 0.5035, 4.12, 0.071, 214, 112, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3365, 3oknA, 0.5035, 4.01, 0.112, 218, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
3366, 3mugB, 0.5035, 3.94, 0.045, 237, 110, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3367, 3mltH, 0.5035, 4.13, 0.053, 215, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3368, 3l7eL, 0.5035, 4.11, 0.084, 213, 107, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
3369, 3j7eC, 0.5035, 3.84, 0.105, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3370, 3eobA, 0.5035, 4.08, 0.084, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
3371, 3cvhH, 0.5035, 4.04, 0.081, 213, 111, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3372, 2nz9E, 0.5035, 4.03, 0.084, 216, 107, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
3373, 2nljA, 0.5035, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
3374, 2itdB, 0.5035, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
3375, 2itcB, 0.5035, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
3376, 2ih1A, 0.5035, 4.47, 0.086, 219, 116, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
3377, 2g60H, 0.5035, 4.20, 0.080, 208, 113, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
3378, 2ap2B, 0.5035, 4.06, 0.054, 122, 111, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
3379, 2adiA, 0.5035, 3.98, 0.103, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
3380, 1xcqF, 0.5035, 4.08, 0.089, 218, 112, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3381, 1r3lA, 0.5035, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
3382, 1qunO, 0.5035, 3.14, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3383, 1qunK, 0.5035, 3.14, 0.094, 198, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
3384, 1ngwH, 0.5035, 4.32, 0.070, 216, 114, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
3385, 1k4dB, 0.5035, 4.09, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
3386, 6okqE, 0.5034, 4.09, 0.075, 210, 107, CRYSTAL STRUCTURE OF THE SF12 FAB 
3387, 6miyC, 0.5034, 3.97, 0.148, 200, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
3388, 6faxH, 0.5034, 4.18, 0.080, 216, 113, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
3389, 6cx7C, 0.5034, 3.87, 0.150, 202, 107, STRUCTURE OF ALPHA-GSA[12;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3390, 6cw6C, 0.5034, 3.97, 0.148, 202, 108, STRUCTURE OF ALPHA-GC[8;18] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3391, 6by2B, 0.5034, 4.07, 0.103, 212, 107, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
3392, 6bj3D, 0.5034, 3.95, 0.111, 202, 108, TCR55 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
3393, 6bfqB, 0.5034, 4.03, 0.075, 212, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3394, 6aq7L, 0.5034, 4.03, 0.093, 216, 107, STRUCTURE OF POM6 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC
3395, 5xrqB, 0.5034, 3.92, 0.094, 212, 106, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
3396, 5wdfA, 0.5034, 3.91, 0.101, 202, 109, CRYSTAL STRUCTURE OF 10E8V4-5R+100CF FAB IN COMPLEX WITH HIV-1 GP41 PEPTIDE
3397, 5w24H, 0.5034, 4.17, 0.071, 216, 112, CRYSTAL STRUCTURE OF 5C4 FAB
3398, 5w0dB, 0.5034, 4.07, 0.054, 235, 111, INFERRED PRECURSOR (UCA) OF THE HUMAN ANTIBODY LINEAGE K03.12 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
3399, 5tl5L, 0.5034, 4.04, 0.093, 217, 107, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
3400, 5o6vH, 0.5034, 3.94, 0.073, 212, 109, THE CRYO-EM STRUCTURE OF TICK-BORNE ENCEPHALITIS VIRUS COMPLEXED WITH FAB FRAGMENT OF NEUTRALIZING ANTIBODY 19/1786
3401, 5mv4J, 0.5034, 4.14, 0.102, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3402, 5mcwB, 0.5034, 3.74, 0.039, 199, 103, P53-DNA COMPLEX 4 
3403, 5icxA, 0.5034, 4.04, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
3404, 5hhmE, 0.5034, 3.94, 0.083, 240, 108, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
3405, 5gjtL, 0.5034, 4.04, 0.065, 211, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
3406, 5fuoH, 0.5034, 4.06, 0.063, 216, 111, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
3407, 5ff6A, 0.5034, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
3408, 5ec1A, 0.5034, 4.33, 0.088, 219, 114, KCSA WITH V76ESTER MUTATION
3409, 5e94C, 0.5034, 4.02, 0.075, 214, 107, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
3410, 5dmiL, 0.5034, 4.01, 0.103, 213, 107, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
3411, 5d4kB, 0.5034, 3.98, 0.102, 536, 108, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
3412, 5d0fA, 0.5034, 3.55, 0.039, 1526, 102, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME (E564Q) IN COMPLEX WITH MALTOPENTAOSE
3413, 5bo1M, 0.5034, 3.89, 0.094, 214, 106, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
3414, 5aomA, 0.5034, 3.98, 0.029, 195, 105, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE PHIKAN883
3415, 5a3iC, 0.5034, 4.20, 0.071, 226, 113, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
3416, 4zs6C, 0.5034, 4.04, 0.082, 221, 110, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
3417, 4y4fG, 0.5034, 3.97, 0.148, 202, 108, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
3418, 4ww1B, 0.5034, 4.07, 0.092, 241, 109, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8
3419, 4wk0B, 0.5034, 4.38, 0.070, 427, 115, METAL ION AND LIGAND BINDING OF INTEGRIN
3420, 4webL, 0.5034, 4.00, 0.112, 217, 107, STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2
3421, 4prpD, 0.5034, 3.94, 0.085, 200, 106, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX
3422, 4pjgF, 0.5034, 3.80, 0.075, 241, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3423, 4pjcE, 0.5034, 3.91, 0.132, 188, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
3424, 4p23A, 0.5034, 3.83, 0.121, 199, 107, J809.B5 TCR BOUND TO IAB/3K
3425, 4p1xG, 0.5034, 4.30, 0.107, 266, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
3426, 4njaL, 0.5034, 4.02, 0.103, 217, 107, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
3427, 4n8cH, 0.5034, 4.17, 0.080, 220, 112, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
3428, 4mjiE, 0.5034, 3.88, 0.130, 240, 108, T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01
3429, 4mhhL, 0.5034, 4.02, 0.121, 217, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
3430, 4gajL, 0.5034, 4.06, 0.103, 215, 107, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 411-424)
3431, 4fz8H, 0.5034, 4.02, 0.063, 222, 111, CRYSTAL STRUCTURE OF C11 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
3432, 4dn3L, 0.5034, 4.01, 0.093, 214, 107, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
3433, 4djmG, 0.5034, 3.16, 0.096, 199, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3434, 4djmB, 0.5034, 3.15, 0.096, 202, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3435, 3v6oE, 0.5034, 3.95, 0.132, 213, 106, LEPTIN RECEPTOR-ANTIBODY COMPLEX
3436, 3uzvB, 0.5034, 4.21, 0.054, 229, 111, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
3437, 3utsI, 0.5034, 3.98, 0.083, 201, 108, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
3438, 3t3pH, 0.5034, 4.10, 0.071, 216, 112, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
3439, 3s62H, 0.5034, 4.00, 0.081, 215, 111, STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN
3440, 3rtqC, 0.5034, 3.96, 0.148, 203, 108, STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
3441, 3qfjD, 0.5034, 3.92, 0.112, 200, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3442, 3ncjH, 0.5034, 4.17, 0.088, 225, 113, CRYSTAL STRUCTURE OF FAB15 MUT8
3443, 3j7eL, 0.5034, 3.85, 0.105, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3444, 3j7eE, 0.5034, 3.85, 0.105, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3445, 3j7eA, 0.5034, 3.85, 0.105, 115, 105, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
3446, 3i75A, 0.5034, 4.05, 0.084, 212, 107, ANTIBODY STRUCTURE
3447, 3hzyA, 0.5034, 4.00, 0.103, 215, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3448, 3gb7B, 0.5034, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
3449, 3cfdA, 0.5034, 4.09, 0.075, 213, 107, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3450, 3c5zF, 0.5034, 3.80, 0.057, 240, 106, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3451, 3c5zB, 0.5034, 3.80, 0.057, 240, 106, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3452, 2wucL, 0.5034, 3.94, 0.094, 214, 106, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON- INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
3453, 2r1wA, 0.5034, 4.01, 0.112, 216, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3454, 2q86A, 0.5034, 3.92, 0.139, 189, 108, STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14
3455, 2nx5P, 0.5034, 3.91, 0.111, 243, 108, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3456, 2itcA, 0.5034, 4.28, 0.088, 219, 114, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
3457, 2esvE, 0.5034, 3.76, 0.093, 240, 107, STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX
3458, 1v7nI, 0.5034, 3.98, 0.064, 217, 110, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3459, 1nccH, 0.5034, 4.10, 0.054, 221, 112, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
3460, 6ogxD, 0.5033, 4.03, 0.075, 213, 107, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
3461, 6mxsL, 0.5033, 4.00, 0.074, 218, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
3462, 6fraA, 0.5033, 4.03, 0.136, 201, 110, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3463, 6cxeC, 0.5033, 3.96, 0.148, 202, 108, STRUCTURE OF ALPHA-GSA[26;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3464, 6aynA, 0.5033, 4.03, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3465, 5xrqA, 0.5033, 3.96, 0.055, 219, 109, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
3466, 5w42L, 0.5033, 3.91, 0.085, 212, 106, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2) 
3467, 5w23M, 0.5033, 4.14, 0.102, 215, 108, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3468, 5vkhA, 0.5033, 4.28, 0.088, 219, 113, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
3469, 5mthB, 0.5033, 4.06, 0.112, 218, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
3470, 5mp3L, 0.5033, 4.05, 0.112, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
3471, 5icyA, 0.5033, 4.05, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
3472, 5hj3N, 0.5033, 4.08, 0.084, 203, 107, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
3473, 5hhoE, 0.5033, 3.95, 0.083, 240, 108, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E
3474, 5hhmJ, 0.5033, 3.95, 0.083, 240, 108, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
3475, 5f3bB, 0.5033, 4.08, 0.103, 213, 107, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
3476, 5epmF, 0.5033, 4.04, 0.112, 218, 107, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
3477, 5eocL, 0.5033, 4.06, 0.093, 216, 107, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3478, 5dtfL, 0.5033, 3.95, 0.075, 211, 106, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
3479, 5drzA, 0.5033, 3.99, 0.104, 218, 106, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
3480, 5c0aE, 0.5033, 3.94, 0.073, 246, 109, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
3481, 4zakC, 0.5033, 3.79, 0.151, 203, 106, CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX
3482, 4y16C, 0.5033, 3.96, 0.148, 202, 108, CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX
3483, 4s1rH, 0.5033, 4.10, 0.063, 235, 111, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H08.F-117225 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
3484, 4qyoA, 0.5033, 3.99, 0.056, 114, 108, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22
3485, 4mxwV, 0.5033, 4.04, 0.103, 211, 107, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
3486, 4ma3A, 0.5033, 4.01, 0.084, 218, 107, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
3487, 4m6oL, 0.5033, 4.04, 0.093, 214, 107, CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
3488, 4jffD, 0.5033, 3.99, 0.111, 197, 108, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
3489, 4jamH, 0.5033, 4.09, 0.063, 223, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
3490, 4d9qD, 0.5033, 4.05, 0.065, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3491, 4am0B, 0.5033, 4.06, 0.112, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3492, 3zknL, 0.5033, 4.00, 0.112, 217, 107, BACE2 FAB INHIBITOR COMPLEX
3493, 3w0wE, 0.5033, 3.78, 0.084, 241, 107, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
3494, 3s96C, 0.5033, 4.08, 0.071, 218, 112, CRYSTAL STRUCTURE OF 3B5H10
3495, 3nidE, 0.5033, 4.15, 0.071, 214, 112, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3496, 3nacH, 0.5033, 4.16, 0.088, 225, 113, CRYSTAL STRUCTURE OF FAB15 MUT7
3497, 3l95L, 0.5033, 4.06, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
3498, 3kmdD, 0.5033, 3.75, 0.058, 200, 103, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
3499, 3hzmA, 0.5033, 4.01, 0.103, 218, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3500, 3hzkA, 0.5033, 4.01, 0.103, 218, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3501, 3haeH, 0.5033, 3.96, 0.083, 220, 109, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3502, 3gb7A, 0.5033, 4.38, 0.087, 219, 115, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
3503, 3b2vL, 0.5033, 3.98, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3504, 2yplE, 0.5033, 3.79, 0.085, 238, 106, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
3505, 2ygtA, 0.5033, 4.34, 0.100, 282, 110, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
3506, 2r0lL, 0.5033, 4.04, 0.093, 214, 107, SHORT FORM HGFA WITH INHIBITORY FAB75
3507, 2hvkA, 0.5033, 4.39, 0.078, 219, 115, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
3508, 2hfgL, 0.5033, 4.03, 0.093, 213, 107, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
3509, 2ak4D, 0.5033, 4.14, 0.109, 204, 110, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
3510, 1xgyH, 0.5033, 4.16, 0.062, 216, 112, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
3511, 1v7nN, 0.5033, 3.91, 0.114, 212, 105, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3512, 1uywN, 0.5033, 4.04, 0.103, 211, 107, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3513, 1mh5B, 0.5033, 4.25, 0.088, 172, 113, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
3514, 1fj1C, 0.5033, 4.01, 0.075, 213, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3515, 6mftB, 0.5032, 3.88, 0.086, 209, 105, CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN 
3516, 6frcB, 0.5032, 3.73, 0.075, 240, 106, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3517, 6fn4C, 0.5032, 4.14, 0.089, 225, 112, APO FORM OF UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
3518, 6fg2M, 0.5032, 4.04, 0.075, 211, 107, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3519, 6dfqG, 0.5032, 3.96, 0.065, 167, 108, MOUSE DIABETOGENIC TCR I.29 
3520, 6cxaC, 0.5032, 3.96, 0.148, 202, 108, STRUCTURE OF ALPHA-GSA[20;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3521, 6c08D, 0.5032, 3.97, 0.054, 214, 111, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
3522, 6b5mL, 0.5032, 4.03, 0.093, 217, 107, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3523, 6avgB, 0.5032, 3.87, 0.132, 196, 106, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
3524, 6am5D, 0.5032, 3.88, 0.103, 189, 107, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
3525, 5wuvL, 0.5032, 4.03, 0.075, 213, 107, CRYSTAL STRUCTURE OF CERTOLIZUMAB FAB
3526, 5wkfE, 0.5032, 3.97, 0.102, 244, 108, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
3527, 5mv4S, 0.5032, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3528, 5mv3G, 0.5032, 4.06, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3529, 5mv3D, 0.5032, 4.06, 0.112, 217, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3530, 5mf7A, 0.5032, 3.65, 0.039, 188, 102, P53-DNA COMPLEX 6 
3531, 5kqvP, 0.5032, 4.29, 0.080, 220, 113, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
3532, 5hpmA, 0.5032, 4.03, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
3533, 4ztoL, 0.5032, 3.96, 0.104, 216, 106, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
3534, 4zdhB, 0.5032, 3.67, 0.057, 241, 105, CRYSTAL STRUCTURE OF JKA6 TCR
3535, 4z7qE, 0.5032, 4.15, 0.071, 214, 112, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
3536, 4yxkH, 0.5032, 4.10, 0.080, 218, 112, CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB
3537, 4wuuE, 0.5032, 4.20, 0.071, 223, 113, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
3538, 4lu5L, 0.5032, 4.04, 0.103, 219, 107, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
3539, 4kuzL, 0.5032, 4.01, 0.093, 216, 107, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
3540, 4izlD, 0.5032, 4.22, 0.054, 277, 112, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
3541, 4ibwA, 0.5032, 3.77, 0.039, 197, 103, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3542, 4e41E, 0.5032, 3.77, 0.086, 236, 105, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
3543, 4dkeM, 0.5032, 4.03, 0.084, 212, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
3544, 3zdyH, 0.5032, 4.16, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3545, 3tvmC, 0.5032, 4.00, 0.148, 200, 108, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3546, 3sjvO, 0.5032, 3.81, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
3547, 3quzC, 0.5032, 3.97, 0.148, 203, 108, STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3548, 3q3gB, 0.5032, 4.18, 0.062, 224, 112, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3549, 3pwpE, 0.5032, 3.74, 0.085, 245, 106, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3550, 3ikcB, 0.5032, 4.07, 0.089, 221, 112, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3551, 3fctC, 0.5032, 4.05, 0.075, 213, 107, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3552, 2z4qA, 0.5032, 4.03, 0.121, 219, 107, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
3553, 2gj6D, 0.5032, 3.96, 0.103, 200, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
3554, 2ataD, 0.5032, 3.95, 0.038, 197, 105, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
3555, 2arjA, 0.5032, 4.04, 0.093, 211, 107, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
3556, 1za6G, 0.5032, 4.08, 0.093, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3557, 1wcbH, 0.5032, 4.08, 0.080, 222, 112, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
3558, 1rhhC, 0.5032, 4.01, 0.084, 215, 107, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
3559, 1qygL, 0.5032, 4.01, 0.112, 218, 107, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
3560, 1mjjL, 0.5032, 4.08, 0.084, 216, 107, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
3561, 1figL, 0.5032, 4.03, 0.112, 215, 107, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
3562, 6qeeC, 0.5031, 4.22, 0.088, 225, 113, NANODISC RECONSTITUTED HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)-EQ MUTANT IN COMPLEX WITH UIC2 FAB AND ZOSUQUIDAR. 
3563, 6oe5C, 0.5031, 3.82, 0.095, 211, 105, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
3564, 6njnL, 0.5031, 3.97, 0.000, 218, 110, STRUCTURE OF A COMPLEX 
3565, 6mjaC, 0.5031, 3.97, 0.148, 200, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXO (JJ294) /INKTCR TERNARY COMPLEX 
3566, 6ellB, 0.5031, 4.03, 0.084, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3567, 6dcaI, 0.5031, 4.25, 0.071, 213, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3568, 6anaL, 0.5031, 4.01, 0.103, 217, 107, LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
3569, 5w1vE, 0.5031, 3.79, 0.076, 243, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
3570, 5vzxI, 0.5031, 3.91, 0.094, 219, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3571, 5vcoC, 0.5031, 4.07, 0.075, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3572, 5u17B, 0.5031, 3.88, 0.123, 195, 106, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
3573, 5mv4G, 0.5031, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3574, 5mu2P, 0.5031, 4.14, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3575, 5mu2H, 0.5031, 4.14, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3576, 5mu2F, 0.5031, 4.15, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3577, 5l0qB, 0.5031, 4.03, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
3578, 5kmvI, 0.5031, 3.91, 0.094, 219, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3579, 5gjsL, 0.5031, 4.05, 0.065, 207, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
3580, 5g64M, 0.5031, 4.02, 0.084, 214, 107, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
3581, 5fuzL, 0.5031, 3.89, 0.085, 216, 106, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
3582, 5ecgA, 0.5031, 3.75, 0.059, 192, 102, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF 53BP1 IN COMPLEX WITH P53 AND H2AX-PSER139 (GAMMAH2AX)
3583, 5ec1B, 0.5031, 4.06, 0.103, 209, 107, KCSA WITH V76ESTER MUTATION
3584, 5dtfB, 0.5031, 3.96, 0.075, 214, 106, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
3585, 5dfvF, 0.5031, 4.10, 0.103, 217, 107, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
3586, 5c0cI, 0.5031, 3.88, 0.093, 199, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
3587, 5c0aJ, 0.5031, 3.89, 0.103, 244, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
3588, 5c09E, 0.5031, 3.85, 0.084, 244, 107, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
3589, 5a1zI, 0.5031, 3.83, 0.065, 120, 108, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
3590, 4r9yN, 0.5031, 3.91, 0.064, 218, 109, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
3591, 4pp2C, 0.5031, 4.07, 0.075, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3592, 4plkL, 0.5031, 4.09, 0.093, 208, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3593, 4onhB, 0.5031, 3.64, 0.076, 233, 105, CRYSTAL STRUCTURE OF DN6 TCR
3594, 4ijtA, 0.5031, 3.84, 0.039, 198, 103, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM II)
3595, 4ibvA, 0.5031, 3.66, 0.059, 197, 102, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION S240R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3596, 4ffzL, 0.5031, 4.06, 0.103, 216, 107, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
3597, 4c2iH, 0.5031, 4.15, 0.080, 228, 112, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH FAB FRAGMENTS OF HUMAN ANTIBODY 1F4
3598, 3vd0K, 0.5031, 3.59, 0.088, 206, 102, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
3599, 3sknF, 0.5031, 3.80, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3600, 3mugL, 0.5031, 3.90, 0.055, 236, 109, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3601, 3kz8B, 0.5031, 3.67, 0.059, 195, 102, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 3)
3602, 3hmwH, 0.5031, 4.10, 0.071, 218, 112, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3603, 3exjA, 0.5031, 3.64, 0.039, 194, 102, CRYSTAL STRUCTURE OF A P53 CORE TETRAMER BOUND TO DNA
3604, 3cmoH, 0.5031, 4.16, 0.080, 222, 112, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3605, 2r51A, 0.5031, 3.86, 0.120, 283, 100, CRYSTAL STRUCTURE OF MOUSE VPS26B
3606, 2p5eE, 0.5031, 3.85, 0.084, 241, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
3607, 2jk5B, 0.5031, 4.08, 0.103, 212, 107, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
3608, 2jccE, 0.5031, 3.85, 0.104, 194, 106, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
3609, 2hjfA, 0.5031, 4.30, 0.088, 219, 114, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
3610, 2ac0D, 0.5031, 3.98, 0.038, 198, 105, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
3611, 1uwxM, 0.5031, 4.15, 0.071, 218, 112, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
3612, 1rhhA, 0.5031, 4.00, 0.084, 215, 107, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
3613, 1ogaE, 0.5031, 3.74, 0.086, 240, 105, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
3614, 1egjL, 0.5031, 3.92, 0.085, 215, 106, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
3615, 1a4jB, 0.5031, 4.00, 0.054, 217, 111, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
3616, 6mjjC, 0.5030, 3.96, 0.148, 201, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXM (JJ290) /INKTCR TERNARY COMPLEX 
3617, 6mjiC, 0.5030, 3.96, 0.148, 203, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXS (JJ304) /INKTCR TERNARY COMPLEX 
3618, 6cwbC, 0.5030, 3.98, 0.148, 201, 108, STRUCTURE OF ALPHA-GSA[8;4P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3619, 6cuhB, 0.5030, 3.85, 0.065, 240, 107, CRYSTAL STRUCTURE OF THE UNLIGANDED BC8B TCR 
3620, 5x2oL, 0.5030, 4.01, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
3621, 5x2oK, 0.5030, 4.02, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
3622, 5x2nH, 0.5030, 4.29, 0.061, 223, 114, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
3623, 5vxrL, 0.5030, 4.03, 0.103, 217, 107, THE ANTIGEN-BINDING FRAGMENT OF MAB24 IN COMPLEX WITH A PEPTIDE FROM HEPATITIS C VIRUS E2 EPITOPE I (412-423)
3624, 5vkeB, 0.5030, 4.07, 0.103, 212, 107, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
3625, 5u16E, 0.5030, 3.88, 0.123, 185, 106, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
3626, 5tz2H, 0.5030, 4.19, 0.080, 213, 113, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
3627, 5t0yI, 0.5030, 4.08, 0.062, 217, 112, 2A10 ANTIBODY FAB FRAGMENT
3628, 5mvzA, 0.5030, 4.22, 0.080, 221, 113, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
3629, 5mv3V, 0.5030, 4.15, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3630, 5mu0B, 0.5030, 4.15, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3631, 5mo3L, 0.5030, 4.06, 0.112, 218, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
3632, 5kzpE, 0.5030, 4.06, 0.081, 226, 111, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
3633, 5kanL, 0.5030, 4.06, 0.065, 214, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3634, 5d7sH, 0.5030, 4.08, 0.072, 218, 111, CRYSTAL STRUCTURE OF MOR04357 A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT
3635, 5c0bD, 0.5030, 3.85, 0.104, 197, 106, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
3636, 5bk5G, 0.5030, 3.90, 0.104, 217, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
3637, 5bk5A, 0.5030, 3.89, 0.104, 219, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
3638, 5bk3D, 0.5030, 4.05, 0.093, 217, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3639, 5anmB, 0.5030, 4.15, 0.054, 220, 111, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3640, 4wnqA, 0.5030, 4.02, 0.111, 200, 108, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
3641, 4wcyL, 0.5030, 4.14, 0.093, 217, 108, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
3642, 4p2rE, 0.5030, 4.12, 0.055, 245, 110, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
3643, 4i2xA, 0.5030, 4.04, 0.121, 214, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3644, 4hxaL, 0.5030, 3.85, 0.124, 213, 105, CRYSTAL STRUCTURE OF 13D9 FAB
3645, 4g3yL, 0.5030, 4.06, 0.084, 214, 107, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
3646, 4al8H, 0.5030, 4.00, 0.072, 212, 111, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
3647, 3tt1M, 0.5030, 4.05, 0.103, 215, 107, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3648, 3stlB, 0.5030, 4.07, 0.103, 212, 107, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
3649, 3s96A, 0.5030, 4.12, 0.071, 218, 112, CRYSTAL STRUCTURE OF 3B5H10
3650, 3qq9L, 0.5030, 4.07, 0.093, 217, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3651, 3okoA, 0.5030, 4.03, 0.112, 217, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
3652, 3okkA, 0.5030, 4.01, 0.112, 220, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3653, 3okdA, 0.5030, 4.01, 0.112, 219, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3654, 3mmeH, 0.5030, 4.10, 0.071, 235, 112, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3655, 3kprE, 0.5030, 3.84, 0.103, 241, 107, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
3656, 3kj4B, 0.5030, 4.09, 0.112, 219, 107, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3657, 3igaB, 0.5030, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
3658, 3bkyH, 0.5030, 4.11, 0.089, 226, 112, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
3659, 2vdmH, 0.5030, 4.16, 0.071, 219, 112, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
3660, 2q8aH, 0.5030, 4.00, 0.083, 199, 109, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3661, 2or9M, 0.5030, 3.95, 0.094, 218, 106, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
3662, 2ialD, 0.5030, 3.89, 0.065, 239, 108, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3663, 2gsiA, 0.5030, 3.90, 0.094, 215, 106, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3664, 2f19H, 0.5030, 4.10, 0.081, 221, 111, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
3665, 1ymhD, 0.5030, 4.15, 0.080, 218, 113, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
3666, 1t4kC, 0.5030, 4.03, 0.093, 217, 107, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3667, 1ncaH, 0.5030, 4.16, 0.062, 221, 113, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
3668, 1a6tB, 0.5030, 4.14, 0.089, 217, 112, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
3669, 6mlkL, 0.5029, 3.91, 0.094, 217, 106, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
3670, 6ml8H, 0.5029, 3.94, 0.100, 227, 110, CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM H1N1 INFLUENZA A VIRUS A/DENVER/57 BOUND TO THE C05 ANTIBODY 
3671, 6mjqG, 0.5029, 3.97, 0.148, 201, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX 
3672, 6k7oC, 0.5029, 4.04, 0.075, 218, 107, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3673, 6f2sA, 0.5029, 4.77, 0.070, 195, 114, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
3674, 6eynA, 0.5029, 3.94, 0.094, 214, 106, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
3675, 6by3A, 0.5029, 4.29, 0.088, 219, 113, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
3676, 6azkA, 0.5029, 4.04, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3677, 5yw3C, 0.5029, 2.86, 0.138, 124, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN THR36LYS VARIANT 
3678, 5vplC, 0.5029, 4.03, 0.103, 211, 107, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
3679, 5vkhB, 0.5029, 4.07, 0.103, 212, 107, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
3680, 5th2C, 0.5029, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
3681, 5mx3L, 0.5029, 4.16, 0.111, 218, 108, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3682, 5mv4M, 0.5029, 4.13, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3683, 5mf7B, 0.5029, 3.65, 0.039, 188, 102, P53-DNA COMPLEX 6 
3684, 5lqbH, 0.5029, 4.07, 0.081, 219, 111, COMPLEX STRUCTURE OF HUMAN IL2 MUTANT PROLEUKIN WITH FAB FRAGMENT OF NARA1 ANTIBODY
3685, 5jhlH, 0.5029, 4.14, 0.071, 216, 112, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
3686, 5j9pB, 0.5029, 4.08, 0.103, 212, 107, KCSA IN VITRO
3687, 5ifhH, 0.5029, 3.98, 0.064, 178, 110, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  2 CASE P11475
3688, 5i8oL, 0.5029, 3.98, 0.084, 217, 107, HMM5 FAB IN COMPLEX WITH DISACCHARIDE
3689, 5i1gL, 0.5029, 4.07, 0.075, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11
3690, 5hyqA, 0.5029, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
3691, 5b4mD, 0.5029, 4.16, 0.102, 218, 108, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
3692, 4wjkB, 0.5029, 4.44, 0.079, 424, 114, METAL ION AND LIGAND BINDING OF INTEGRIN
3693, 4oz4L, 0.5029, 4.16, 0.111, 218, 108, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3694, 4nylD, 0.5029, 4.05, 0.075, 211, 107, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3695, 4mzrC, 0.5029, 3.85, 0.058, 234, 104, CRYSTAL STRUCTURE OF A POLYPEPTIDE P53 MUTANT BOUND TO DNA
3696, 4jo2L, 0.5029, 4.12, 0.083, 216, 108, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
3697, 4iycA, 0.5029, 4.22, 0.054, 277, 112, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
3698, 4g83B, 0.5029, 3.75, 0.117, 198, 103, CRYSTAL STRUCTURE OF P73 DNA-BINDING DOMAIN TETRAMER BOUND TO A FULL RESPONSE-ELEMENT
3699, 4g6jL, 0.5029, 4.09, 0.093, 212, 107, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
3700, 4fqrc, 0.5029, 3.98, 0.091, 238, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3701, 4fnlH, 0.5029, 3.96, 0.091, 232, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
3702, 4e41J, 0.5029, 3.87, 0.084, 238, 107, STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
3703, 4cmhB, 0.5029, 4.01, 0.073, 216, 110, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
3704, 4bz1L, 0.5029, 4.04, 0.112, 218, 107, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
3705, 4am0L, 0.5029, 4.06, 0.112, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3706, 3ze2E, 0.5029, 4.15, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3707, 3wfbH, 0.5029, 4.04, 0.073, 225, 110, REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
3708, 3vi3F, 0.5029, 4.05, 0.064, 218, 110, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
3709, 3tt1L, 0.5029, 4.05, 0.103, 215, 107, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3710, 3sknG, 0.5029, 3.88, 0.113, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3711, 3rvtC, 0.5029, 4.04, 0.103, 213, 107, STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
3712, 3qymD, 0.5029, 3.83, 0.096, 196, 104, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 10 BASE PAIR A/T RICH RESPONSE ELEMENT HALF SITE
3713, 3mnvB, 0.5029, 4.07, 0.099, 208, 111, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
3714, 3kpsD, 0.5029, 3.79, 0.155, 201, 103, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLQAFTY A SELF PEPTIDE FROM THE ABCD3 PROTEIN
3715, 3exlA, 0.5029, 3.62, 0.039, 194, 102, CRYSTAL STRUCTURE OF A P53 CORE TETRAMER BOUND TO DNA
3716, 3cfdL, 0.5029, 4.09, 0.075, 213, 107, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
3717, 2vc2H, 0.5029, 4.13, 0.071, 219, 112, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
3718, 2lkfA, 0.5029, 4.21, 0.108, 296, 111, LEUKOCIDIN F (HLGB) FROM STAPHYLOCOCCUS AUREUS
3719, 2ih1B, 0.5029, 4.08, 0.103, 212, 107, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
3720, 2ianO, 0.5029, 3.86, 0.065, 238, 107, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3721, 2ianE, 0.5029, 3.75, 0.067, 238, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3722, 2atkA, 0.5029, 4.36, 0.088, 219, 113, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
3723, 2adgA, 0.5029, 4.05, 0.112, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
3724, 1uywL, 0.5029, 4.03, 0.112, 212, 107, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3725, 1tsrA, 0.5029, 3.81, 0.049, 196, 103, P53 CORE DOMAIN IN COMPLEX WITH DNA
3726, 1q0xH, 0.5029, 4.11, 0.071, 215, 112, ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
3727, 1nsnL, 0.5029, 4.06, 0.103, 217, 107, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
3728, 1lo4L, 0.5029, 4.01, 0.112, 217, 107, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
3729, 6mjqC, 0.5028, 3.97, 0.148, 201, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX 
3730, 6mj4C, 0.5028, 3.97, 0.148, 201, 108, CRYSTAL STRUCTURE OF MCD1D/INKTCR TERNARY COMPLEX BOUND TO GLYCOLIPID (XXW) 
3731, 6dwiF, 0.5028, 3.88, 0.075, 200, 107, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
3732, 6d0uH, 0.5028, 3.94, 0.100, 238, 110, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3733, 6c68A, 0.5028, 3.77, 0.105, 205, 105, MHC-INDEPENDENT T CELL RECEPTOR A11 
3734, 5y11A, 0.5028, 4.22, 0.071, 219, 113, SFTSV GN WITH NEUTRALIZING ANTIBODY MAB4-5
3735, 5w1wO, 0.5028, 3.84, 0.075, 243, 107, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
3736, 5w1wD, 0.5028, 3.81, 0.135, 201, 104, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
3737, 5vnwC, 0.5028, 3.83, 0.084, 120, 107, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
3738, 5vcjC, 0.5028, 3.98, 0.148, 201, 108, STRUCTURE OF ALPHA-GALACTOSYLPHYTOSPHINGOSINE BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR
3739, 5ucbH, 0.5028, 4.07, 0.054, 217, 111, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH ENGINEERED SWITCH RESIDUE REGION.
3740, 5t1mA, 0.5028, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
3741, 5szfH, 0.5028, 4.10, 0.062, 217, 112, 2A10 FAB FRAGMENT 2.54 ANGSTOMS
3742, 5nphH, 0.5028, 4.28, 0.070, 214, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
3743, 5mv4P, 0.5028, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3744, 5mhsG, 0.5028, 4.02, 0.075, 205, 107, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3745, 5ksbG, 0.5028, 4.05, 0.084, 200, 107, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
3746, 5iq7H, 0.5028, 3.90, 0.119, 233, 109, CRYSTAL STRUCTURE OF 10E8-S74W FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
3747, 5i1lH, 0.5028, 4.21, 0.080, 225, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
3748, 5i1hL, 0.5028, 3.95, 0.085, 214, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20
3749, 5gz0C, 0.5028, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
3750, 5eziL, 0.5028, 4.00, 0.103, 214, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
3751, 5etuA, 0.5028, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
3752, 5eblB, 0.5028, 4.08, 0.103, 212, 107, KCSA T75G IN THE CONDUCTIVE STATE
3753, 5eblA, 0.5028, 4.28, 0.088, 219, 113, KCSA T75G IN THE CONDUCTIVE STATE
3754, 5do2D, 0.5028, 4.07, 0.084, 214, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
3755, 5c0bI, 0.5028, 3.78, 0.085, 199, 106, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
3756, 5c09I, 0.5028, 3.76, 0.085, 200, 106, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
3757, 4zs6H, 0.5028, 3.95, 0.083, 221, 109, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
3758, 4y4hC, 0.5028, 3.98, 0.148, 202, 108, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
3759, 4x6bA, 0.5028, 3.83, 0.085, 196, 106, BK6 TCR APO STRUCTURE
3760, 4wnqC, 0.5028, 4.02, 0.111, 200, 108, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
3761, 4oz4B, 0.5028, 4.05, 0.112, 218, 107, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3762, 4nwwA, 0.5028, 4.13, 0.028, 341, 106, CRYSTAL STRUCTURE OF AN N-TERMINALLY TRUNCATED CAPSID PROTEIN MUTANT OF ORSAY VIRUS
3763, 4jreL, 0.5028, 4.05, 0.093, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
3764, 4jr9H, 0.5028, 4.02, 0.054, 213, 112, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
3765, 4izlA, 0.5028, 4.23, 0.054, 280, 112, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
3766, 4fqrg, 0.5028, 3.98, 0.091, 238, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3767, 4c56B, 0.5028, 3.97, 0.083, 240, 108, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
3768, 3ulvL, 0.5028, 4.00, 0.075, 214, 107, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
3769, 3or6B, 0.5028, 4.06, 0.103, 212, 107, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
3770, 3o41L, 0.5028, 4.07, 0.103, 218, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
3771, 3i02A, 0.5028, 4.00, 0.112, 219, 107, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3772, 3f7vA, 0.5028, 4.21, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
3773, 2v7hA, 0.5028, 4.04, 0.084, 214, 107, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
3774, 2r1yA, 0.5028, 4.01, 0.112, 217, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3775, 2pcxA, 0.5028, 3.67, 0.059, 205, 102, CRYSTAL STRUCTURE OF P53DBD(R282Q) AT 1.54-ANGSTROM RESOLUTION
3776, 2j1xB, 0.5028, 3.79, 0.049, 195, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y220C-N239Y-N268D
3777, 2hjfB, 0.5028, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
3778, 2dweB, 0.5028, 4.09, 0.103, 212, 107, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
3779, 2bnrE, 0.5028, 3.67, 0.086, 241, 105, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
3780, 2atkB, 0.5028, 4.08, 0.103, 212, 107, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
3781, 1s5hA, 0.5028, 4.08, 0.103, 211, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
3782, 1r3iL, 0.5028, 4.08, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
3783, 1k6qH, 0.5028, 4.32, 0.079, 213, 114, CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
3784, 1hu8A, 0.5028, 3.63, 0.039, 186, 102, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DNA-BINDING DOMAIN AT 2.7A RESOLUTION
3785, 1fl5A, 0.5028, 3.95, 0.104, 217, 106, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
3786, 1acyL, 0.5028, 3.91, 0.094, 215, 106, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
3787, 6okqC, 0.5027, 3.98, 0.085, 210, 106, CRYSTAL STRUCTURE OF THE SF12 FAB 
3788, 6o3aA, 0.5027, 4.02, 0.093, 212, 107, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F7.B FAB 
3789, 6nb8L, 0.5027, 4.14, 0.083, 219, 108, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
3790, 6meiH, 0.5027, 3.97, 0.055, 228, 110, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3791, 6flaL, 0.5027, 4.06, 0.103, 216, 107, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
3792, 6fg2H, 0.5027, 4.11, 0.054, 212, 111, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3793, 6dlbH, 0.5027, 4.09, 0.071, 227, 112, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:1203D4 CHIMERA 
3794, 6dc8L, 0.5027, 4.03, 0.112, 218, 107, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3795, 6d9gC, 0.5027, 4.15, 0.089, 221, 112, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
3796, 6cxfC, 0.5027, 3.96, 0.148, 201, 108, STRUCTURE OF ALPHA-GSA[26;P5P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3797, 6azlA, 0.5027, 4.03, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3798, 5vk6B, 0.5027, 4.08, 0.103, 212, 107, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
3799, 5udcL, 0.5027, 4.04, 0.084, 211, 107, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3800, 5nb5L, 0.5027, 4.07, 0.112, 218, 107, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
3801, 5mx3H, 0.5027, 4.00, 0.072, 219, 111, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3802, 5jsaE, 0.5027, 3.93, 0.064, 224, 110, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
3803, 5ebmA, 0.5027, 4.38, 0.087, 218, 115, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
3804, 5drzL, 0.5027, 3.99, 0.104, 216, 106, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
3805, 5d7lD, 0.5027, 3.89, 0.093, 187, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
3806, 5c0aI, 0.5027, 3.76, 0.075, 197, 106, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
3807, 5c09D, 0.5027, 3.75, 0.094, 197, 106, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN
3808, 4z5rT, 0.5027, 4.06, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3809, 4z5rA, 0.5027, 4.06, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3810, 4yx2H, 0.5027, 4.15, 0.080, 214, 113, CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB
3811, 4qxgH, 0.5027, 4.13, 0.080, 218, 112, ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY
3812, 4qokD, 0.5027, 3.87, 0.103, 194, 107, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
3813, 4oziF, 0.5027, 4.09, 0.081, 243, 111, S2 PROTEIN COMPLEX
3814, 4mwfB, 0.5027, 3.99, 0.075, 211, 106, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
3815, 4g7yL, 0.5027, 4.03, 0.084, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
3816, 4fqrd, 0.5027, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3817, 4dgiH, 0.5027, 4.30, 0.079, 218, 114, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230
3818, 3zdxE, 0.5027, 4.13, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3819, 3vi4B, 0.5027, 4.48, 0.096, 431, 115, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
3820, 3uttE, 0.5027, 3.87, 0.093, 244, 107, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
3821, 3stzB, 0.5027, 4.07, 0.103, 212, 107, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
3822, 3revA, 0.5027, 3.94, 0.092, 201, 109, CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3823, 3quyC, 0.5027, 3.96, 0.148, 202, 108, STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1 -INKT TCR COMPLEX
3824, 3oz9L, 0.5027, 3.89, 0.124, 211, 105, CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
3825, 3or6A, 0.5027, 4.39, 0.087, 219, 115, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
3826, 3ojdB, 0.5027, 4.09, 0.071, 224, 112, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3827, 3mmeA, 0.5027, 4.10, 0.071, 235, 112, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3828, 3lhaB, 0.5027, 4.03, 0.108, 282, 102, CRYSTAL STRUCTURE OF MOUSE VPS26B(R240S/G241A/E242S) IN SPACEGROUP P41 21 2
3829, 3kxfN, 0.5027, 4.20, 0.108, 204, 111, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
3830, 3fb8B, 0.5027, 4.09, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
3831, 3fb6B, 0.5027, 4.09, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
3832, 3f7yB, 0.5027, 4.09, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
3833, 3f5wB, 0.5027, 4.09, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
3834, 2xnaB, 0.5027, 3.85, 0.084, 241, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
3835, 2vdoH, 0.5027, 4.15, 0.071, 219, 112, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
3836, 2q86C, 0.5027, 3.96, 0.139, 190, 108, STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14
3837, 2nx5U, 0.5027, 4.09, 0.101, 243, 109, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3838, 2hvkB, 0.5027, 4.08, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
3839, 1xgyI, 0.5027, 4.16, 0.062, 215, 112, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
3840, 1v7mH, 0.5027, 4.09, 0.071, 217, 112, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
3841, 1mamL, 0.5027, 3.95, 0.085, 214, 106, CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
3842, 1k4cB, 0.5027, 4.09, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
3843, 1jnnL, 0.5027, 4.05, 0.121, 211, 107, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3844, 1jnlL, 0.5027, 4.06, 0.112, 211, 107, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3845, 1iaiL, 0.5027, 4.07, 0.112, 214, 107, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
3846, 1i9jL, 0.5027, 3.95, 0.123, 219, 106, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3847, 6mivC, 0.5026, 3.88, 0.150, 201, 107, CRYSTAL STRUCTURE OF THE MCD1D/XXQ (JJ300)/INKTCR TERNARY COMPLEX 
3848, 6medD, 0.5026, 4.07, 0.075, 212, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3849, 6k7oL, 0.5026, 4.04, 0.075, 218, 107, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3850, 6i8sH, 0.5026, 4.16, 0.072, 214, 111, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
3851, 6emjL, 0.5026, 4.03, 0.084, 211, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3852, 6dkpD, 0.5026, 3.93, 0.112, 192, 107, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
3853, 6a3wG, 0.5026, 4.11, 0.064, 116, 109, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3854, 5wv4B, 0.5026, 2.61, 0.116, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16GLY VARIANT
3855, 5wuxH, 0.5026, 3.95, 0.064, 212, 109, TNFALPHA-CERTOLIZUMAB FAB
3856, 5w23N, 0.5026, 4.05, 0.093, 215, 107, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3857, 5w08O, 0.5026, 3.99, 0.055, 235, 110, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
3858, 5vnwD, 0.5026, 3.81, 0.056, 120, 107, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
3859, 5umnC, 0.5026, 3.97, 0.100, 238, 110, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3860, 5u2vG, 0.5026, 3.88, 0.123, 193, 106, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
3861, 5tlkA, 0.5026, 4.07, 0.093, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3862, 5tbdA, 0.5026, 3.95, 0.065, 114, 107, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB4D11) IN COMPLEX WITH 3D7-MSP2 215-222
3863, 5t1mC, 0.5026, 4.03, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
3864, 5mthL, 0.5026, 4.04, 0.112, 219, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
3865, 5lwyH, 0.5026, 4.03, 0.055, 119, 110, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID
3866, 5lspH, 0.5026, 4.18, 0.080, 216, 113, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
3867, 5k8aL, 0.5026, 3.85, 0.095, 213, 105, NIST FAB
3868, 5i18H, 0.5026, 3.97, 0.082, 211, 110, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1
3869, 5fhbH, 0.5026, 4.05, 0.063, 228, 111, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100
3870, 5d0fB, 0.5026, 3.55, 0.039, 1526, 102, CRYSTAL STRUCTURE OF THE CANDIDA GLABRATA GLYCOGEN DEBRANCHING ENZYME (E564Q) IN COMPLEX WITH MALTOPENTAOSE
3871, 4ztoM, 0.5026, 3.96, 0.104, 216, 106, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
3872, 4z5rR, 0.5026, 4.06, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3873, 4pljC, 0.5026, 4.07, 0.103, 201, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3874, 4p2rO, 0.5026, 4.01, 0.055, 242, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
3875, 4p1yE, 0.5026, 4.29, 0.107, 265, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
3876, 4jhaL, 0.5026, 4.03, 0.075, 211, 107, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
3877, 4g9fD, 0.5026, 4.08, 0.110, 204, 109, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
3878, 4ffzY, 0.5026, 4.06, 0.103, 216, 107, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
3879, 4djmF, 0.5026, 3.17, 0.096, 202, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
3880, 4d9rD, 0.5026, 4.00, 0.075, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3881, 4bxvB, 0.5026, 2.64, 0.140, 123, 86, THREE-DIMENSIONAL STRUCTURE OF THE MUTANT K109A OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN AT PH 7.0
3882, 3wiiI, 0.5026, 4.11, 0.089, 220, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
3883, 3vd2J, 0.5026, 3.79, 0.115, 202, 104, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
3884, 3ujtI, 0.5026, 4.32, 0.088, 207, 113, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
3885, 3rvvC, 0.5026, 4.02, 0.103, 211, 107, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
3886, 3q3gH, 0.5026, 4.14, 0.062, 224, 112, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3887, 3q3gD, 0.5026, 4.19, 0.062, 224, 112, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3888, 3njhC, 0.5026, 3.41, 0.125, 120, 96, D37A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.
3889, 3macH, 0.5026, 4.00, 0.064, 218, 110, CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
3890, 3lrsA, 0.5026, 4.09, 0.071, 221, 112, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3891, 3kykL, 0.5026, 4.07, 0.075, 211, 107, CRYSTAL STRUCTURE OF LI33 IGG1 FAB
3892, 3kxfD, 0.5026, 4.04, 0.119, 204, 109, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
3893, 3e8uL, 0.5026, 4.06, 0.103, 216, 107, CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
3894, 2z35A, 0.5026, 3.79, 0.144, 112, 104, CRYSTAL STRUCTURE OF IMMUNE RECEPTOR
3895, 2vxvH, 0.5026, 4.30, 0.079, 222, 114, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
3896, 2vdpH, 0.5026, 4.13, 0.071, 219, 112, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
3897, 2vdlH, 0.5026, 4.13, 0.071, 219, 112, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3898, 2vdkH, 0.5026, 4.12, 0.071, 219, 112, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3899, 2i9lE, 0.5026, 4.02, 0.112, 219, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3900, 2fjhL, 0.5026, 4.03, 0.084, 214, 107, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3901, 2fjfA, 0.5026, 4.04, 0.093, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3902, 2f58L, 0.5026, 4.06, 0.093, 216, 107, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
3903, 2ak4I, 0.5026, 4.15, 0.109, 204, 110, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
3904, 1zwiB, 0.5026, 4.06, 0.103, 212, 107, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
3905, 1ymhB, 0.5026, 3.89, 0.063, 218, 111, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
3906, 1uwxH, 0.5026, 4.17, 0.071, 218, 112, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
3907, 1uwgY, 0.5026, 4.17, 0.062, 208, 112, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
3908, 1n64L, 0.5026, 4.05, 0.093, 220, 107, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
3909, 1gpoL, 0.5026, 4.04, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
3910, 1afvL, 0.5026, 4.05, 0.084, 217, 107, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
3911, 6rcoA, 0.5025, 4.06, 0.063, 221, 111, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
3912, 6mqrL, 0.5025, 3.91, 0.094, 213, 106, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-A.01 IN COMPLEX WITH FP (RESIDUE 512-519) 
3913, 6k7oE, 0.5025, 3.96, 0.075, 218, 106, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3914, 6furD, 0.5025, 3.83, 0.075, 240, 107, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3915, 6eluI, 0.5025, 4.06, 0.103, 217, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
3916, 6dcaJ, 0.5025, 4.29, 0.071, 213, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3917, 6awnC, 0.5025, 4.08, 0.121, 214, 107, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
3918, 6at6B, 0.5025, 3.67, 0.067, 240, 105, CRYSTAL STRUCTURE OF THE KFJ5 TCR
3919, 5yw3A, 0.5025, 2.96, 0.161, 124, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN THR36LYS VARIANT 
3920, 5yfiL, 0.5025, 4.02, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
3921, 5y9kH, 0.5025, 4.05, 0.064, 216, 109, STRUCTURE OF THE BELIMUMAB FAB FRAGMENT
3922, 5xzcE, 0.5025, 3.75, 0.039, 232, 103, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3923, 5wuxL, 0.5025, 4.04, 0.084, 213, 107, TNFALPHA-CERTOLIZUMAB FAB
3924, 5w08M, 0.5025, 3.99, 0.055, 235, 110, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
3925, 5vjqF, 0.5025, 4.00, 0.112, 212, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3926, 5o14H, 0.5025, 4.20, 0.071, 221, 113, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
3927, 5mx3B, 0.5025, 4.05, 0.112, 218, 107, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3928, 5mubM, 0.5025, 4.16, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3929, 5mthA, 0.5025, 4.01, 0.072, 220, 111, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
3930, 5jziJ, 0.5025, 3.90, 0.093, 241, 107, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
3931, 5j3dL, 0.5025, 4.06, 0.084, 215, 107, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
3932, 5i1aL, 0.5025, 4.04, 0.075, 212, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3933, 5fb8A, 0.5025, 4.06, 0.093, 218, 107, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3934, 5ec2B, 0.5025, 4.08, 0.103, 212, 107, KCSA WITH V76ESTER+G77DA MUTATIONS
3935, 5dqdL, 0.5025, 4.07, 0.112, 217, 107, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3936, 4uujA, 0.5025, 4.23, 0.089, 219, 112, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
3937, 4nrxD, 0.5025, 4.23, 0.088, 228, 113, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3938, 4np4H, 0.5025, 4.23, 0.080, 215, 113, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
3939, 4mswB, 0.5025, 4.08, 0.103, 212, 107, Y78 ESTER MUTANT OF KCSA IN HIGH K+
3940, 4ma3L, 0.5025, 4.04, 0.093, 218, 107, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
3941, 4m7lL, 0.5025, 4.04, 0.093, 220, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
3942, 4lcuA, 0.5025, 4.26, 0.089, 219, 112, STRUCTURE OF KCSA WITH E118A MUTATION
3943, 4jhwL, 0.5025, 3.94, 0.085, 211, 106, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
3944, 4i2xD, 0.5025, 4.18, 0.080, 219, 112, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3945, 4i2xB, 0.5025, 4.18, 0.080, 229, 112, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3946, 4g6mL, 0.5025, 4.10, 0.075, 213, 107, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
3947, 4fnlM, 0.5025, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
3948, 4a63A, 0.5025, 3.93, 0.105, 205, 105, CRYSTAL STRUCTURE OF THE P73-ASPP2 COMPLEX AT 2.6A RESOLUTION
3949, 3ra7L, 0.5025, 4.09, 0.084, 211, 107, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3950, 3ojdA, 0.5025, 4.05, 0.112, 214, 107, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3951, 3o6fD, 0.5025, 3.85, 0.093, 245, 107, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3952, 3nifH, 0.5025, 4.12, 0.071, 219, 112, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
3953, 3mxvL, 0.5025, 4.06, 0.084, 212, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
3954, 3lrsE, 0.5025, 4.14, 0.071, 221, 112, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3955, 3ivkH, 0.5025, 4.06, 0.072, 224, 111, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
3956, 3ivkA, 0.5025, 4.06, 0.072, 224, 111, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
3957, 3cfeL, 0.5025, 4.09, 0.075, 213, 107, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
3958, 3cfeA, 0.5025, 4.09, 0.075, 213, 107, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
3959, 3au0A, 0.5025, 4.24, 0.072, 339, 111, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS
3960, 2vdrH, 0.5025, 4.15, 0.071, 219, 112, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
3961, 2p7tB, 0.5025, 4.09, 0.103, 212, 107, CRYSTAL STRUCTURE OF KCSA MUTANT
3962, 2nx5J, 0.5025, 3.84, 0.103, 243, 107, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3963, 2g5bG, 0.5025, 4.00, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3964, 2co7B, 0.5025, 3.23, 0.147, 197, 95, SALMONELLA ENTERICA SAFA PILIN IN COMPLEX WITH THE SAFB CHAPERONE (TYPE II)
3965, 1xf4H, 0.5025, 4.11, 0.080, 213, 112, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
3966, 1r3jA, 0.5025, 4.09, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
3967, 1q9lC, 0.5025, 4.03, 0.112, 219, 107, S25-2 FAB UNLIGANDED 2
3968, 1mlbA, 0.5025, 4.02, 0.103, 214, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
3969, 1mjuL, 0.5025, 4.09, 0.084, 219, 107, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
3970, 1mfbH, 0.5025, 4.03, 0.090, 211, 111, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
3971, 1k4dA, 0.5025, 4.14, 0.090, 219, 111, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
3972, 1igtC, 0.5025, 4.05, 0.084, 214, 107, STRUCTURE OF IMMUNOGLOBULIN
3973, 1ejoL, 0.5025, 4.04, 0.093, 216, 107, FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
3974, 1a6wH, 0.5025, 4.00, 0.082, 120, 110, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND
3975, 1a3rL, 0.5025, 4.04, 0.112, 220, 107, FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
3976, 6rcoC, 0.5024, 4.05, 0.063, 222, 111, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
3977, 6n81D, 0.5024, 4.05, 0.065, 211, 107, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
3978, 6mj6C, 0.5024, 3.97, 0.148, 200, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXX (JJ166) /INKTCR TERNARY COMPLEX 
3979, 6iuvL, 0.5024, 3.99, 0.103, 215, 107, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3980, 6iekB, 0.5024, 4.13, 0.072, 223, 111, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
3981, 6fg2I, 0.5024, 4.09, 0.054, 218, 111, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3982, 6e15C, 0.5024, 3.07, 0.084, 199, 95, HANDOVER MECHANISM OF THE GROWING PILUS BY THE BACTERIAL OUTER MEMBRANE USHER FIMD 
3983, 6dc3H, 0.5024, 4.13, 0.098, 229, 112, RSV PREFUSION F BOUND TO RSD5 FAB 
3984, 5xzcC, 0.5024, 3.76, 0.039, 232, 103, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3985, 5xajF, 0.5024, 4.09, 0.063, 213, 111, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
3986, 5vk6A, 0.5024, 4.30, 0.088, 219, 113, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
3987, 5vjqD, 0.5024, 4.03, 0.112, 213, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3988, 5tkkL, 0.5024, 3.95, 0.094, 213, 106, STRUCTURE OF MOUSE VACCINATION-ELICITED HIV NEUTRALIZING ANTIBODY VFP5.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
3989, 5t1kA, 0.5024, 4.02, 0.112, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
3990, 5mv3S, 0.5024, 4.14, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3991, 5mubV, 0.5024, 4.16, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3992, 5mubD, 0.5024, 4.17, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3993, 5fhcA, 0.5024, 3.96, 0.064, 221, 110, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
3994, 5fb8B, 0.5024, 4.15, 0.071, 223, 112, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3995, 4x6bC, 0.5024, 3.92, 0.084, 186, 107, BK6 TCR APO STRUCTURE
3996, 4webH, 0.5024, 4.15, 0.071, 216, 112, STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2
3997, 4uujB, 0.5024, 4.07, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
3998, 4uifG, 0.5024, 3.85, 0.056, 120, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
3999, 4r7nR, 0.5024, 3.95, 0.075, 213, 106, FAB C2E3
4000, 4p2qE, 0.5024, 4.09, 0.055, 245, 110, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK
4001, 4odwA, 0.5024, 4.00, 0.082, 208, 110, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6
4002, 4o5iO, 0.5024, 4.05, 0.055, 226, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4003, 4nryB, 0.5024, 4.01, 0.084, 205, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
4004, 4nrxA, 0.5024, 4.13, 0.089, 229, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
4005, 4nbzB, 0.5024, 4.04, 0.073, 132, 109, CRYSTAL STRUCTURE OF TCDA-A1 BOUND TO A26.8 VHH
4006, 4mswA, 0.5024, 4.30, 0.088, 219, 113, Y78 ESTER MUTANT OF KCSA IN HIGH K+
4007, 4lu5M, 0.5024, 4.03, 0.103, 219, 107, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
4008, 4lcuB, 0.5024, 4.09, 0.103, 212, 107, STRUCTURE OF KCSA WITH E118A MUTATION
4009, 4jr9L, 0.5024, 4.06, 0.093, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
4010, 4fqrj, 0.5024, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4011, 4eupH, 0.5024, 3.77, 0.057, 241, 106, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
4012, 4dkeL, 0.5024, 4.04, 0.084, 214, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
4013, 3w11D, 0.5024, 4.02, 0.104, 114, 106, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
4014, 3tvmG, 0.5024, 3.87, 0.150, 203, 107, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
4015, 3qumK, 0.5024, 4.13, 0.089, 219, 112, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4016, 3qa3K, 0.5024, 4.13, 0.062, 224, 112, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4017, 3okeA, 0.5024, 4.02, 0.112, 217, 107, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
4018, 3o45B, 0.5024, 4.02, 0.103, 217, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
4019, 3mo1A, 0.5024, 4.02, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4020, 3kprJ, 0.5024, 3.78, 0.104, 241, 106, CRYSTAL STRUCTURE OF THE LC13 TCR IN COMPLEX WITH HLA B*4405 BOUND TO EEYLKAWTF A MIMOTOPE
4021, 3ijyC, 0.5024, 4.01, 0.112, 217, 107, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
4022, 3hr5Q, 0.5024, 3.90, 0.085, 219, 106, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4023, 3f7vB, 0.5024, 4.06, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
4024, 3d39D, 0.5024, 3.80, 0.105, 200, 105, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
4025, 2ztnA, 0.5024, 3.99, 0.057, 472, 106, HEPATITIS E VIRUS ORF2 (GENOTYPE 3)
4026, 2vdqH, 0.5024, 4.12, 0.071, 219, 112, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
4027, 2r2eA, 0.5024, 4.04, 0.112, 219, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4028, 2ih3B, 0.5024, 4.09, 0.103, 212, 107, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
4029, 2i9lC, 0.5024, 4.02, 0.112, 219, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
4030, 2hfeA, 0.5024, 4.28, 0.088, 219, 114, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
4031, 2h8pA, 0.5024, 4.22, 0.088, 219, 113, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
4032, 2g60L, 0.5024, 4.13, 0.120, 213, 108, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
4033, 2axhB, 0.5024, 3.85, 0.094, 240, 106, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
4034, 1qunE, 0.5024, 3.14, 0.083, 200, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4035, 1qunC, 0.5024, 3.14, 0.083, 200, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4036, 1n64H, 0.5024, 4.20, 0.088, 218, 113, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
4037, 1kcvL, 0.5024, 4.03, 0.112, 214, 107, CRYSTAL STRUCTURE OF ANTIBODY PC282
4038, 1ai1L, 0.5024, 3.92, 0.094, 215, 106, HIV-1 V3 LOOP MIMIC
4039, 1afvM, 0.5024, 4.05, 0.084, 217, 107, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
4040, 1a6uH, 0.5024, 3.95, 0.064, 120, 109, B1-8 FV FRAGMENT
4041, 6eluF, 0.5023, 4.06, 0.103, 217, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4042, 6dc7L, 0.5023, 4.13, 0.120, 218, 108, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
4043, 6cx5C, 0.5023, 3.88, 0.150, 200, 107, STRUCTURE OF ALPHA-GSA[8;8P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4044, 6b5lL, 0.5023, 4.05, 0.093, 218, 107, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4045, 6a3wD, 0.5023, 3.97, 0.065, 116, 108, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
4046, 5wuxB, 0.5023, 4.04, 0.084, 212, 107, TNFALPHA-CERTOLIZUMAB FAB
4047, 5w24L, 0.5023, 4.05, 0.103, 215, 107, CRYSTAL STRUCTURE OF 5C4 FAB
4048, 5vkkB, 0.5023, 4.01, 0.084, 219, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
4049, 5vjoD, 0.5023, 4.05, 0.103, 211, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4050, 5vebL, 0.5023, 3.92, 0.085, 215, 106, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
4051, 5vebB, 0.5023, 3.91, 0.085, 215, 106, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
4052, 5mv3M, 0.5023, 4.17, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4053, 5mubJ, 0.5023, 4.16, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4054, 5id0A, 0.5023, 4.05, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
4055, 5i66A, 0.5023, 4.18, 0.088, 218, 113, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
4056, 5i2iA, 0.5023, 4.04, 0.084, 213, 107, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4057, 5i19L, 0.5023, 4.06, 0.075, 213, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39
4058, 5f3bF, 0.5023, 4.05, 0.112, 213, 107, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
4059, 5ebwA, 0.5023, 4.32, 0.088, 218, 113, KCSA WITH G77ESTER MUTATION
4060, 5d7jH, 0.5023, 3.81, 0.075, 242, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
4061, 5cp3A, 0.5023, 4.01, 0.140, 218, 107, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
4062, 4z5rV, 0.5023, 4.06, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4063, 4z5rJ, 0.5023, 4.07, 0.084, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4064, 4x6cE, 0.5023, 3.63, 0.096, 198, 104, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
4065, 4pjgE, 0.5023, 3.79, 0.124, 198, 105, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
4066, 4ozgH, 0.5023, 3.78, 0.113, 240, 106, D2 PROTEIN COMPLEX
4067, 4oz4H, 0.5023, 4.01, 0.072, 219, 111, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4068, 4otxL, 0.5023, 4.03, 0.103, 211, 107, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
4069, 4o5iM, 0.5023, 4.08, 0.055, 226, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4070, 4l9lA, 0.5023, 3.87, 0.143, 196, 105, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.2 MAIT TCR IN COMPLEX WITH BOVINE MR1
4071, 4kphL, 0.5023, 3.81, 0.133, 209, 105, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
4072, 4k7pL, 0.5023, 3.96, 0.104, 214, 106, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4073, 4ibqC, 0.5023, 3.63, 0.059, 192, 101, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C
4074, 4guoL, 0.5023, 3.62, 0.088, 201, 102, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4075, 4eupI, 0.5023, 4.06, 0.093, 201, 107, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
4076, 4dkfL, 0.5023, 4.05, 0.075, 212, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
4077, 3u46H, 0.5023, 4.04, 0.090, 228, 111, CH04H/CH02L P212121
4078, 3qh3C, 0.5023, 3.97, 0.112, 194, 107, THE CRYSTAL STRUCTURE OF TCR A6
4079, 3kxfM, 0.5023, 4.04, 0.119, 204, 109, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
4080, 3ikcC, 0.5023, 4.01, 0.112, 217, 107, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
4081, 3hr5L, 0.5023, 3.92, 0.085, 219, 106, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4082, 3gnmL, 0.5023, 4.15, 0.111, 217, 108, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
4083, 3ck0L, 0.5023, 4.02, 0.121, 216, 107, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH HUMAN ANGIOTENSIN II
4084, 3c2aH, 0.5023, 4.00, 0.073, 231, 110, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
4085, 2rcsH, 0.5023, 4.19, 0.080, 217, 112, IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
4086, 2r23A, 0.5023, 4.02, 0.112, 217, 107, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4087, 2qqkL, 0.5023, 3.95, 0.094, 211, 106, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
4088, 2pcpB, 0.5023, 4.26, 0.071, 215, 113, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4089, 2pcpA, 0.5023, 4.03, 0.131, 216, 107, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4090, 2p7tA, 0.5023, 4.30, 0.088, 219, 113, CRYSTAL STRUCTURE OF KCSA MUTANT
4091, 2o5yL, 0.5023, 4.05, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
4092, 2nz9C, 0.5023, 4.10, 0.074, 216, 108, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
4093, 2ianS, 0.5023, 3.86, 0.123, 198, 106, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4094, 2i9lA, 0.5023, 4.02, 0.112, 219, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
4095, 2ak4T, 0.5023, 4.01, 0.110, 204, 109, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
4096, 1za6D, 0.5023, 4.28, 0.089, 324, 112, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4097, 1za6A, 0.5023, 4.08, 0.093, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4098, 1xcqG, 0.5023, 4.04, 0.084, 219, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4099, 1sbsL, 0.5023, 3.91, 0.113, 220, 106, CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
4100, 1qunG, 0.5023, 3.15, 0.083, 200, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4101, 1qunA, 0.5023, 3.15, 0.083, 200, 96, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4102, 1nlbL, 0.5023, 4.08, 0.093, 220, 107, CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
4103, 1mi5E, 0.5023, 3.82, 0.113, 241, 106, THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBV PEPTIDE COMPLEX
4104, 1kemH, 0.5023, 4.01, 0.071, 218, 112, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
4105, 1kcrL, 0.5023, 3.88, 0.123, 213, 106, CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
4106, 6fxnH, 0.5022, 4.14, 0.063, 216, 111, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
4107, 6fr7B, 0.5022, 3.82, 0.057, 241, 106, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4108, 6eleL, 0.5022, 4.03, 0.084, 211, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4109, 6cweC, 0.5022, 3.89, 0.150, 199, 107, STRUCTURE OF ALPHA-GSA[8;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4110, 6bnlC, 0.5022, 3.98, 0.148, 202, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
4111, 6b5oL, 0.5022, 4.06, 0.093, 219, 107, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4112, 5ywyL, 0.5022, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
4113, 5xzcB, 0.5022, 3.76, 0.039, 232, 103, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
4114, 5x2oH, 0.5022, 4.30, 0.061, 219, 114, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
4115, 5w1vT, 0.5022, 3.82, 0.094, 243, 106, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
4116, 5um8D, 0.5022, 4.03, 0.098, 240, 112, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
4117, 5uixL, 0.5022, 4.03, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE DH576 CD4BS FAB (UNLIGANDED) FROM THE RV305 HIV VACCINE TRIAL
4118, 5u6qB, 0.5022, 3.75, 0.133, 195, 105, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
4119, 5tljG, 0.5022, 4.03, 0.094, 215, 106, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4120, 5iwlA, 0.5022, 4.01, 0.055, 232, 110, CD47-DIABODY COMPLEX
4121, 5id1A, 0.5022, 4.04, 0.084, 212, 107, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4122, 5f88A, 0.5022, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
4123, 5ewiL, 0.5022, 4.01, 0.112, 217, 107, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90
4124, 5b4mL, 0.5022, 4.17, 0.102, 218, 108, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
4125, 4u6gH, 0.5022, 3.89, 0.119, 232, 109, CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH A HYDROCARBON-STAPLED HIV-1 GP41 MPER PEPTIDE
4126, 4r0lB, 0.5022, 3.93, 0.095, 114, 105, ANTI-CANINE CD28 ANTIBODY 1C6 BOUND CANINE CD28
4127, 4pj8C, 0.5022, 3.86, 0.123, 197, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
4128, 4nrzH, 0.5022, 4.14, 0.089, 226, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
4129, 4mnhB, 0.5022, 3.99, 0.093, 197, 108, STRUCTURE OF THE DP10.7 TCR
4130, 4lexL, 0.5022, 3.90, 0.104, 217, 106, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
4131, 4jj5B, 0.5022, 4.14, 0.080, 217, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
4132, 4f33B, 0.5022, 4.27, 0.062, 219, 113, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4133, 4djmA, 0.5022, 3.19, 0.106, 196, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4134, 3zdyE, 0.5022, 4.19, 0.071, 216, 112, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4135, 3vd1D, 0.5022, 3.73, 0.087, 199, 103, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4136, 3tt1H, 0.5022, 4.13, 0.071, 212, 112, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4137, 3r1gL, 0.5022, 3.90, 0.086, 214, 105, STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY
4138, 3or7B, 0.5022, 4.08, 0.103, 212, 107, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
4139, 3mugJ, 0.5022, 4.02, 0.063, 237, 111, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4140, 3lizL, 0.5022, 4.04, 0.112, 211, 107, CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
4141, 3lh8A, 0.5022, 3.84, 0.099, 283, 101, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
4142, 3lh2H, 0.5022, 4.01, 0.064, 127, 110, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
4143, 3fb5B, 0.5022, 4.07, 0.103, 212, 107, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
4144, 2xn9A, 0.5022, 3.93, 0.113, 199, 106, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
4145, 2wgxB, 0.5022, 4.00, 0.038, 194, 105, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I- N268D
4146, 2vlrJ, 0.5022, 3.74, 0.086, 240, 105, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4147, 2vlrD, 0.5022, 3.81, 0.114, 199, 105, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4148, 2r2eB, 0.5022, 3.97, 0.072, 221, 111, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4149, 2q8aL, 0.5022, 4.02, 0.121, 214, 107, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
4150, 2ih3A, 0.5022, 4.22, 0.089, 219, 112, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
4151, 1yedA, 0.5022, 3.92, 0.132, 219, 106, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
4152, 1xf5B, 0.5022, 4.15, 0.080, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
4153, 1q9wD, 0.5022, 4.04, 0.071, 226, 112, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
4154, 1jptL, 0.5022, 4.05, 0.075, 213, 107, CRYSTAL STRUCTURE OF FAB D3H44
4155, 6qnkD, 0.5021, 3.98, 0.073, 221, 110, ANTIBODY FAB FRAGMENT TARGETING GI PROTEIN HETEROTRIMER 
4156, 6ogxH, 0.5021, 4.09, 0.072, 206, 111, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
4157, 6mqmE, 0.5021, 4.01, 0.093, 217, 107, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY DF1W-A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
4158, 6miyG, 0.5021, 3.97, 0.148, 199, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
4159, 6h3hC, 0.5021, 4.09, 0.071, 214, 112, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
4160, 6eljB, 0.5021, 4.02, 0.084, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4161, 6cmiD, 0.5021, 4.04, 0.072, 228, 111, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
4162, 6cdoA, 0.5021, 4.21, 0.115, 230, 113, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4163, 6bnlG, 0.5021, 3.98, 0.148, 203, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
4164, 6awpB, 0.5021, 4.11, 0.089, 218, 112, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
4165, 5yhlL, 0.5021, 4.02, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
4166, 5x8lO, 0.5021, 4.04, 0.093, 213, 107, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
4167, 5vk2D, 0.5021, 4.15, 0.071, 218, 112, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
4168, 5uddR, 0.5021, 3.91, 0.094, 211, 106, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4169, 5tlkE, 0.5021, 4.07, 0.093, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4170, 5f97F, 0.5021, 3.86, 0.084, 115, 107, BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN A730 IN COMPLEX WITH BLOOD GROUP A TYPE 1 HEXASACCHARIDE
4171, 5ebwB, 0.5021, 4.09, 0.103, 210, 107, KCSA WITH G77ESTER MUTATION
4172, 5cusJ, 0.5021, 3.94, 0.073, 175, 109, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
4173, 5bk5C, 0.5021, 3.91, 0.104, 217, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
4174, 5a16F, 0.5021, 4.07, 0.084, 218, 107, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
4175, 4z5rL, 0.5021, 4.07, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4176, 4xmlL, 0.5021, 3.89, 0.094, 215, 106, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424
4177, 4x6dE, 0.5021, 3.72, 0.086, 189, 105, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
4178, 4plkK, 0.5021, 4.09, 0.093, 208, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4179, 4pj7E, 0.5021, 3.86, 0.123, 199, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
4180, 4p1yC, 0.5021, 4.31, 0.107, 266, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
4181, 4mauL, 0.5021, 4.04, 0.093, 216, 107, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
4182, 4m7kL, 0.5021, 4.06, 0.093, 220, 107, CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
4183, 4lriB, 0.5021, 3.91, 0.094, 217, 106, ANTI CMV FAB FRAGMENT
4184, 4jfdD, 0.5021, 4.02, 0.102, 196, 108, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
4185, 4guoK, 0.5021, 3.67, 0.108, 201, 102, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4186, 4fnlL, 0.5021, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4187, 3wfcH, 0.5021, 4.05, 0.091, 225, 110, REDUCED AND CARBONMONOXIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
4188, 3qa3B, 0.5021, 4.21, 0.062, 224, 113, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4189, 3mffA, 0.5021, 3.85, 0.121, 193, 107, 1F1E8HU TCR
4190, 3ijhC, 0.5021, 4.01, 0.112, 217, 107, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4191, 3ijhB, 0.5021, 4.04, 0.090, 221, 111, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4192, 3exjB, 0.5021, 3.58, 0.039, 194, 102, CRYSTAL STRUCTURE OF A P53 CORE TETRAMER BOUND TO DNA
4193, 3d09A, 0.5021, 3.68, 0.059, 188, 102, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATIONS H168R AND T123A
4194, 3d08A, 0.5021, 3.85, 0.048, 182, 104, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATION H168R
4195, 3bszL, 0.5021, 4.17, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
4196, 2xknA, 0.5021, 4.03, 0.065, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7
4197, 2i9lG, 0.5021, 4.02, 0.112, 219, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
4198, 2bobB, 0.5021, 4.09, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
4199, 2ahiD, 0.5021, 3.79, 0.049, 196, 103, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
4200, 1tupA, 0.5021, 3.77, 0.049, 196, 103, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
4201, 1q9oA, 0.5021, 4.02, 0.103, 219, 107, S45-18 FAB UNLIGANDED
4202, 1p7kH, 0.5021, 4.28, 0.079, 220, 114, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
4203, 1nqbC, 0.5021, 3.98, 0.055, 232, 110, TRIVALENT ANTIBODY FRAGMENT
4204, 1ngyA, 0.5021, 4.05, 0.084, 213, 107, CHIMERIC MATURE FAB 7G12-APO
4205, 1mj8L, 0.5021, 3.99, 0.085, 214, 106, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
4206, 1kgcE, 0.5021, 3.87, 0.093, 241, 107, IMMUNE RECEPTOR
4207, 1igjD, 0.5021, 3.88, 0.064, 217, 109, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
4208, 1hu8B, 0.5021, 3.81, 0.019, 186, 104, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DNA-BINDING DOMAIN AT 2.7A RESOLUTION
4209, 6ea7Q, 0.5020, 4.07, 0.080, 222, 112, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
4210, 6awqB, 0.5020, 4.19, 0.088, 218, 113, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
4211, 6awoB, 0.5020, 4.19, 0.088, 218, 113, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
4212, 5y9cL, 0.5020, 4.03, 0.093, 203, 107, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
4213, 5w08G, 0.5020, 4.00, 0.055, 236, 110, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4214, 5vphC, 0.5020, 4.04, 0.103, 211, 107, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
4215, 5muqA, 0.5020, 4.03, 0.072, 219, 111, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
4216, 5mubB, 0.5020, 4.17, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4217, 5js9E, 0.5020, 3.97, 0.064, 224, 110, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
4218, 5gisH, 0.5020, 4.32, 0.115, 210, 113, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4219, 5ecgB, 0.5020, 3.79, 0.039, 183, 103, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF 53BP1 IN COMPLEX WITH P53 AND H2AX-PSER139 (GAMMAH2AX)
4220, 5e1aA, 0.5020, 4.32, 0.080, 219, 112, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
4221, 5dubB, 0.5020, 4.10, 0.075, 214, 107, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
4222, 5d1zC, 0.5020, 3.91, 0.094, 208, 106, ISDB NEAT1 BOUND BY CLONE D4-10
4223, 5c0bJ, 0.5020, 3.87, 0.084, 244, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI
4224, 5bjzD, 0.5020, 4.07, 0.063, 231, 111, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
4225, 5a16D, 0.5020, 4.08, 0.084, 218, 107, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
4226, 4zs6L, 0.5020, 4.03, 0.084, 210, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
4227, 4z5rP, 0.5020, 4.07, 0.075, 217, 107, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4228, 4y4fC, 0.5020, 3.89, 0.150, 202, 107, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
4229, 4x6bB, 0.5020, 3.96, 0.065, 244, 108, BK6 TCR APO STRUCTURE
4230, 4wnqD, 0.5020, 4.18, 0.091, 242, 110, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
4231, 4pjhF, 0.5020, 3.82, 0.075, 239, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
4232, 4pjcH, 0.5020, 3.79, 0.075, 240, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
4233, 4nj9H, 0.5020, 4.21, 0.080, 217, 112, CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS
4234, 4m7lH, 0.5020, 4.14, 0.063, 222, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
4235, 4m1dH, 0.5020, 4.02, 0.062, 231, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
4236, 4f3fB, 0.5020, 4.00, 0.073, 219, 110, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
4237, 4cadB, 0.5020, 4.11, 0.054, 221, 112, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4238, 4agoB, 0.5020, 3.75, 0.049, 196, 102, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5174
4239, 3uttD, 0.5020, 3.75, 0.086, 199, 105, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
4240, 3rvxC, 0.5020, 4.04, 0.103, 211, 107, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
4241, 3quxC, 0.5020, 3.88, 0.150, 203, 107, STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
4242, 3qa3H, 0.5020, 4.21, 0.071, 224, 113, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4243, 3qa3D, 0.5020, 4.18, 0.062, 224, 112, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4244, 3opzJ, 0.5020, 4.05, 0.054, 221, 111, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4245, 3o45L, 0.5020, 4.07, 0.103, 218, 107, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
4246, 3mbxL, 0.5020, 4.03, 0.112, 220, 107, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
4247, 3jbaL, 0.5020, 3.84, 0.106, 115, 104, THE U4 ANTIBODY EPITOPE ON HUMAN PAPILLOMAVIRUS 16 IDENTIFIED BY CRYO- EM
4248, 3ijsB, 0.5020, 4.08, 0.089, 221, 112, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
4249, 3i50H, 0.5020, 4.07, 0.071, 212, 112, CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
4250, 3hplA, 0.5020, 4.26, 0.088, 219, 113, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
4251, 3fb7B, 0.5020, 4.07, 0.103, 212, 107, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
4252, 3cxdL, 0.5020, 3.94, 0.094, 213, 106, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
4253, 3bgfB, 0.5020, 4.24, 0.089, 216, 112, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
4254, 2uylA, 0.5020, 4.17, 0.111, 218, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4255, 2nx5E, 0.5020, 3.86, 0.112, 243, 107, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4256, 2jkwB, 0.5020, 2.86, 0.149, 124, 87, PSEUDOAZURIN M16F
4257, 2j5lB, 0.5020, 3.93, 0.114, 212, 105, STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
4258, 2hg5B, 0.5020, 4.07, 0.103, 212, 107, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
4259, 2hg5A, 0.5020, 4.23, 0.088, 219, 113, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
4260, 2gsiG, 0.5020, 3.88, 0.094, 215, 106, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4261, 2dtmL, 0.5020, 3.97, 0.123, 218, 106, THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES
4262, 1za6C, 0.5020, 4.08, 0.093, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4263, 1z3gH, 0.5020, 4.12, 0.072, 214, 111, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
4264, 1yedL, 0.5020, 3.92, 0.132, 219, 106, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
4265, 1wc7H, 0.5020, 4.12, 0.080, 223, 112, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
4266, 1q9lA, 0.5020, 4.02, 0.112, 219, 107, S25-2 FAB UNLIGANDED 2
4267, 1kzyB, 0.5020, 3.77, 0.039, 195, 103, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
4268, 1jckC, 0.5020, 3.70, 0.086, 238, 105, T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN
4269, 1jckA, 0.5020, 3.70, 0.086, 238, 105, T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN
4270, 6meeC, 0.5019, 4.01, 0.045, 229, 112, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4271, 6fg2L, 0.5019, 4.05, 0.075, 211, 107, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
4272, 6eljL, 0.5019, 3.91, 0.085, 212, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4273, 6dlaH, 0.5019, 4.13, 0.071, 226, 112, CRYSTAL STRUCTURES OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:7969D2 
4274, 6cw9C, 0.5019, 3.97, 0.148, 203, 108, STRUCTURE OF ALPHA-GC[8;16P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4275, 6c08A, 0.5019, 3.93, 0.027, 214, 111, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
4276, 6bzwB, 0.5019, 4.08, 0.103, 217, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
4277, 6by3B, 0.5019, 4.10, 0.103, 212, 107, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
4278, 6bnkG, 0.5019, 3.96, 0.148, 203, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
4279, 6au5A, 0.5019, 4.05, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
4280, 5ztdA, 0.5019, 2.73, 0.128, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16VAL VARIANT 
4281, 5x2qH, 0.5019, 4.31, 0.061, 219, 114, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
4282, 5w06H, 0.5019, 4.32, 0.070, 216, 114, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
4283, 5vjqH, 0.5019, 4.03, 0.112, 212, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4284, 5u72D, 0.5019, 3.97, 0.121, 198, 107, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
4285, 5u3nH, 0.5019, 4.00, 0.081, 234, 111, CRYSTAL STRUCTURE OF DH511.12P FAB IN COMPLEX WITH HIV-1 GP41 MPER PEPTIDE
4286, 5mv3J, 0.5019, 4.15, 0.111, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4287, 5mubS, 0.5019, 4.16, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4288, 5mubP, 0.5019, 4.17, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4289, 5lspT, 0.5019, 4.08, 0.084, 212, 107, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
4290, 5l2kE, 0.5019, 3.80, 0.075, 242, 106, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
4291, 5i76C, 0.5019, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
4292, 5i74C, 0.5019, 4.10, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
4293, 5girH, 0.5019, 4.30, 0.115, 208, 113, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
4294, 5ezlL, 0.5019, 4.01, 0.103, 213, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
4295, 5d2lF, 0.5019, 3.96, 0.119, 238, 109, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
4296, 5c0aD, 0.5019, 3.90, 0.084, 197, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
4297, 5aumH, 0.5019, 4.03, 0.055, 208, 110, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
4298, 4zptL, 0.5019, 4.04, 0.084, 212, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
4299, 4zfgL, 0.5019, 4.06, 0.075, 213, 107, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
4300, 4zezJ, 0.5019, 3.95, 0.083, 240, 108, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
4301, 4y4hG, 0.5019, 3.91, 0.150, 202, 107, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
4302, 4p9hH, 0.5019, 3.95, 0.064, 215, 110, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2
4303, 4lccA, 0.5019, 3.75, 0.133, 157, 105, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
4304, 4g6aL, 0.5019, 4.07, 0.103, 218, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
4305, 3qnxA, 0.5019, 3.92, 0.113, 219, 106, ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
4306, 3okoB, 0.5019, 3.96, 0.081, 219, 111, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
4307, 3o2vH, 0.5019, 4.17, 0.062, 219, 112, CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
4308, 3nzhL, 0.5019, 4.07, 0.084, 214, 107, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
4309, 3if1D, 0.5019, 3.97, 0.055, 210, 110, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
4310, 3i02B, 0.5019, 3.97, 0.090, 220, 111, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4311, 3hzvA, 0.5019, 4.03, 0.103, 218, 107, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
4312, 3h3pI, 0.5019, 3.91, 0.075, 126, 107, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
4313, 3cmoY, 0.5019, 4.18, 0.080, 222, 112, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
4314, 2w0fB, 0.5019, 4.09, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
4315, 2v17H, 0.5019, 4.08, 0.089, 222, 112, STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
4316, 2uylM, 0.5019, 4.17, 0.111, 216, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4317, 2qqlL, 0.5019, 3.94, 0.085, 214, 106, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
4318, 2ojzI, 0.5019, 4.19, 0.089, 216, 112, ANTI-DNA ANTIBODY ED10
4319, 2ojzH, 0.5019, 4.19, 0.089, 216, 112, ANTI-DNA ANTIBODY ED10
4320, 1za6H, 0.5019, 4.27, 0.089, 324, 112, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4321, 1ynkH, 0.5019, 4.11, 0.054, 219, 112, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
4322, 1xctC, 0.5019, 4.05, 0.103, 220, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
4323, 1r3lB, 0.5019, 4.23, 0.089, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
4324, 1j8hE, 0.5019, 3.88, 0.056, 241, 107, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
4325, 1igyA, 0.5019, 4.10, 0.112, 213, 107, STRUCTURE OF IMMUNOGLOBULIN
4326, 1fl6B, 0.5019, 4.04, 0.062, 219, 112, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
4327, 1bf8A, 0.5019, 3.13, 0.116, 205, 95, PERIPLASMIC CHAPERONE FIMC NMR 20 STRUCTURES
4328, 6medI, 0.5018, 4.08, 0.075, 213, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4329, 6k2iA, 0.5018, 4.12, 0.081, 131, 111, SOLUTION STRUCTURE OF CAMELID NANOBODY NB11 AGAINST AFLATOXIN B1 
4330, 6faxL, 0.5018, 3.93, 0.075, 211, 106, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
4331, 6erxH, 0.5018, 4.15, 0.063, 216, 111, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
4332, 6eh8B, 0.5018, 3.81, 0.057, 241, 106, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4333, 6bnkC, 0.5018, 3.96, 0.148, 203, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
4334, 5w6dD, 0.5018, 4.02, 0.098, 223, 112, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
4335, 5vigL, 0.5018, 4.05, 0.065, 212, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
4336, 5umnE, 0.5018, 3.97, 0.100, 238, 110, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4337, 5tudB, 0.5018, 3.93, 0.105, 211, 105, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
4338, 5t1lA, 0.5018, 4.05, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4339, 5t0yH, 0.5018, 4.09, 0.071, 217, 112, 2A10 ANTIBODY FAB FRAGMENT
4340, 5o6vI, 0.5018, 3.93, 0.074, 212, 108, THE CRYO-EM STRUCTURE OF TICK-BORNE ENCEPHALITIS VIRUS COMPLEXED WITH FAB FRAGMENT OF NEUTRALIZING ANTIBODY 19/1786
4341, 5mubG, 0.5018, 4.16, 0.111, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4342, 5ir1A, 0.5018, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4343, 5i75B, 0.5018, 4.18, 0.088, 218, 113, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
4344, 5i73B, 0.5018, 4.11, 0.089, 218, 112, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
4345, 5hysB, 0.5018, 4.01, 0.075, 217, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4346, 5hyjI, 0.5018, 3.64, 0.086, 193, 105, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
4347, 5fhxH, 0.5018, 4.00, 0.091, 340, 110, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
4348, 5d7iH, 0.5018, 3.77, 0.075, 241, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
4349, 4zxbB, 0.5018, 4.01, 0.112, 218, 107, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
4350, 4xvsH, 0.5018, 4.15, 0.054, 228, 111, CRYSTAL STRUCTURE OF HIV-1 DONOR 45 D45-01DG5 COREE GP120 WITH ANTIBODY 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
4351, 4uimF, 0.5018, 4.06, 0.084, 214, 107, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
4352, 4mayC, 0.5018, 3.96, 0.111, 191, 108, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
4353, 4jreC, 0.5018, 4.07, 0.093, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
4354, 4jm2D, 0.5018, 4.03, 0.063, 220, 111, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4355, 4i9wF, 0.5018, 3.88, 0.105, 211, 105, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4356, 4hbcL, 0.5018, 4.12, 0.075, 213, 107, CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS
4357, 4gw5C, 0.5018, 4.04, 0.084, 213, 107, CQYN MEDITOPE - CETUXIMAB FAB
4358, 4guoB, 0.5018, 3.67, 0.097, 198, 103, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4359, 4ftvD, 0.5018, 3.95, 0.112, 200, 107, THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE
4360, 4fqrl, 0.5018, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4361, 4dvbL, 0.5018, 4.06, 0.123, 215, 106, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4362, 3vxmD, 0.5018, 3.95, 0.128, 198, 109, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
4363, 3v6zD, 0.5018, 4.03, 0.112, 219, 107, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
4364, 3qymB, 0.5018, 3.71, 0.097, 191, 103, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 10 BASE PAIR A/T RICH RESPONSE ELEMENT HALF SITE
4365, 3qwoB, 0.5018, 3.86, 0.095, 210, 105, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
4366, 3mxwH, 0.5018, 4.20, 0.080, 220, 113, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
4367, 3mugF, 0.5018, 3.98, 0.064, 236, 110, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4368, 3erxA, 0.5018, 2.54, 0.163, 123, 86, HIGH-RESOLUTION STRUCTURE OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN
4369, 3eoaA, 0.5018, 4.07, 0.075, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
4370, 3bszM, 0.5018, 4.17, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
4371, 2xwrA, 0.5018, 3.69, 0.059, 199, 102, CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF HUMAN P53 WITH EXTENDED N TERMINUS
4372, 2oz4H, 0.5018, 4.28, 0.061, 208, 114, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
4373, 2i5yR, 0.5018, 4.06, 0.071, 223, 112, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4374, 2h8pB, 0.5018, 4.09, 0.103, 212, 107, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
4375, 2fjgL, 0.5018, 4.06, 0.084, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4376, 2fjgA, 0.5018, 4.06, 0.084, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4377, 2b0sH, 0.5018, 4.07, 0.064, 226, 110, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
4378, 2axhA, 0.5018, 3.80, 0.104, 240, 106, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
4379, 1zwiA, 0.5018, 4.25, 0.071, 219, 113, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
4380, 1t4kA, 0.5018, 4.03, 0.093, 217, 107, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
4381, 1mfcH, 0.5018, 4.12, 0.099, 211, 111, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
4382, 6mxrB, 0.5017, 4.03, 0.074, 217, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
4383, 6marM, 0.5017, 3.86, 0.074, 135, 108, HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151 
4384, 6iuvD, 0.5017, 4.01, 0.093, 215, 107, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
4385, 6fy0I, 0.5017, 4.17, 0.080, 216, 113, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4386, 6fr6B, 0.5017, 3.89, 0.056, 241, 107, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4387, 6e0cM, 0.5017, 4.02, 0.091, 229, 110, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4388, 6azkC, 0.5017, 4.04, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
4389, 6aynC, 0.5017, 4.03, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
4390, 5yw3B, 0.5017, 2.69, 0.128, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN THR36LYS VARIANT 
4391, 5w4lB, 0.5017, 4.05, 0.064, 211, 110, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT C11-LIKE ANTIBODY N12-I3 IN COMPLEX WITH HIV-1 CLADE A/E GP120 THE CD4 MIMETIC M48U1 AND THE ANTIBODY N5-I5.
4392, 5vcoA, 0.5017, 4.08, 0.084, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4393, 5utyD, 0.5017, 3.93, 0.073, 242, 110, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M N300M N302M T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM
4394, 5usiA, 0.5017, 3.98, 0.055, 211, 110, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
4395, 5mhrG, 0.5017, 3.92, 0.123, 211, 106, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4396, 5k8aA, 0.5017, 3.85, 0.095, 213, 105, NIST FAB
4397, 5i6xB, 0.5017, 4.12, 0.089, 218, 112, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
4398, 5i4fA, 0.5017, 4.30, 0.079, 237, 114, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE
4399, 5ea0L, 0.5017, 3.90, 0.085, 219, 106, STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE
4400, 5e6iQ, 0.5017, 3.78, 0.075, 238, 107, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
4401, 5d7lG, 0.5017, 3.90, 0.093, 189, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
4402, 5cgyH, 0.5017, 4.07, 0.063, 222, 111, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
4403, 4z7wF, 0.5017, 3.73, 0.085, 241, 106, T316 COMPLEX
4404, 4wfeF, 0.5017, 3.88, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
4405, 4qthA, 0.5017, 4.13, 0.063, 215, 111, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
4406, 4pp2A, 0.5017, 4.08, 0.084, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4407, 4p4kC, 0.5017, 3.91, 0.112, 204, 107, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
4408, 4p2rT, 0.5017, 4.05, 0.055, 242, 109, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
4409, 4p1yG, 0.5017, 4.29, 0.107, 266, 112, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN PREPORE
4410, 4nryH, 0.5017, 4.14, 0.089, 214, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
4411, 4nc0B, 0.5017, 3.93, 0.065, 124, 107, CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO A26.8 VHH
4412, 4l4tG, 0.5017, 3.89, 0.123, 193, 106, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
4413, 4iiqA, 0.5017, 3.79, 0.133, 197, 105, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
4414, 4gw1A, 0.5017, 4.04, 0.084, 212, 107, CQFD MEDITOPE
4415, 4g6aD, 0.5017, 4.08, 0.103, 218, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
4416, 4fqra, 0.5017, 3.97, 0.100, 238, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4417, 4f33D, 0.5017, 4.27, 0.062, 219, 113, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4418, 4eupG, 0.5017, 4.05, 0.102, 201, 108, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
4419, 4etqB, 0.5017, 3.87, 0.114, 212, 105, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4420, 4dgyH, 0.5017, 4.03, 0.081, 226, 111, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 C2 FORM
4421, 3v6zB, 0.5017, 4.03, 0.112, 219, 107, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
4422, 3utpL, 0.5017, 3.91, 0.083, 246, 108, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
4423, 3ta3C, 0.5017, 3.98, 0.148, 202, 108, STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
4424, 3ogcB, 0.5017, 4.10, 0.103, 212, 107, KCSA E71A VARIANT IN PRESENCE OF NA+
4425, 3mxwL, 0.5017, 4.04, 0.093, 212, 107, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
4426, 3i02D, 0.5017, 3.97, 0.090, 212, 111, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4427, 3fctA, 0.5017, 4.09, 0.084, 213, 107, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
4428, 2xqyG, 0.5017, 4.39, 0.096, 216, 114, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
4429, 2uweE, 0.5017, 3.88, 0.104, 194, 106, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
4430, 2pyfB, 0.5017, 3.81, 0.085, 241, 106, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
4431, 2o5yH, 0.5017, 4.18, 0.062, 219, 112, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
4432, 2jkwA, 0.5017, 2.82, 0.126, 124, 87, PSEUDOAZURIN M16F
4433, 2jixG, 0.5017, 3.99, 0.075, 214, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
4434, 2hffL, 0.5017, 4.04, 0.103, 211, 107, CRYSTAL STRUCTURE OF CB2 FAB
4435, 2e7lB, 0.5017, 3.76, 0.105, 110, 105, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
4436, 1xcqE, 0.5017, 3.93, 0.094, 220, 106, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4437, 1w72I, 0.5017, 4.01, 0.082, 223, 110, CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB- HYB3
4438, 1nakL, 0.5017, 3.93, 0.123, 217, 106, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4439, 1mh5H, 0.5017, 4.26, 0.088, 190, 113, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
4440, 1iqwL, 0.5017, 4.09, 0.103, 215, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
4441, 6qnoH, 0.5016, 4.06, 0.081, 221, 111, RHODOPSIN-GI PROTEIN COMPLEX 
4442, 6mxrL, 0.5016, 4.01, 0.074, 218, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
4443, 6mekF, 0.5016, 4.08, 0.054, 210, 112, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4444, 6medB, 0.5016, 4.07, 0.075, 213, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4445, 6gfeL, 0.5016, 3.94, 0.085, 215, 106, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
4446, 6f2sC, 0.5016, 4.71, 0.062, 195, 113, CRYOEM STRUCTURE OF AGERATUM YELLOW VEIN VIRUS (AYVV) 
4447, 6d9gB, 0.5016, 3.97, 0.085, 216, 106, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
4448, 6bzwF, 0.5016, 4.08, 0.103, 217, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
4449, 6by2A, 0.5016, 4.31, 0.088, 219, 113, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
4450, 6apdN, 0.5016, 4.07, 0.062, 223, 112, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4451, 5x2pH, 0.5016, 4.29, 0.061, 219, 114, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4452, 5x2nJ, 0.5016, 4.30, 0.061, 219, 114, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
4453, 5udcG, 0.5016, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4454, 5tudE, 0.5016, 3.94, 0.105, 211, 105, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
4455, 5tl5H, 0.5016, 4.09, 0.091, 221, 110, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
4456, 5o14C, 0.5016, 4.21, 0.071, 223, 113, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
4457, 5muqH, 0.5016, 4.03, 0.072, 219, 111, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
4458, 5iv2A, 0.5016, 4.05, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4459, 5itfA, 0.5016, 3.94, 0.085, 213, 106, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
4460, 5iopA, 0.5016, 4.05, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4461, 5ik3D, 0.5016, 4.03, 0.103, 218, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
4462, 5i30H, 0.5016, 4.01, 0.072, 212, 111, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
4463, 5i1kH, 0.5016, 4.22, 0.080, 211, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
4464, 5hysF, 0.5016, 3.99, 0.066, 215, 106, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4465, 4zpvL, 0.5016, 4.04, 0.075, 212, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
4466, 4xnyH, 0.5016, 4.24, 0.071, 234, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
4467, 4x7sH, 0.5016, 4.08, 0.072, 222, 111, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
4468, 4uokL, 0.5016, 4.09, 0.112, 215, 107, ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4
4469, 4um8D, 0.5016, 4.22, 0.100, 414, 110, CRYSTAL STRUCTURE OF ALPHA V BETA 6
4470, 4ojfL, 0.5016, 3.91, 0.104, 219, 106, HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8
4471, 4mziA, 0.5016, 3.66, 0.059, 193, 102, CRYSTAL STRUCTURE OF A HUMAN MUTANT P53
4472, 4mxqD, 0.5016, 3.67, 0.076, 239, 105, 42F3 TCR PCPC5/H-2LD COMPLEX
4473, 4kvpC, 0.5016, 3.82, 0.049, 195, 103, HUMAN P53 CORE DOMAIN MUTANT V157F
4474, 4hweH, 0.5016, 4.22, 0.071, 213, 113, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4475, 4gw5A, 0.5016, 4.05, 0.084, 212, 107, CQYN MEDITOPE - CETUXIMAB FAB
4476, 4guoD, 0.5016, 3.69, 0.097, 198, 103, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4477, 4g80F, 0.5016, 4.03, 0.075, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4478, 4g80B, 0.5016, 4.03, 0.075, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4479, 4fqrf, 0.5016, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4480, 4fp8H, 0.5016, 3.95, 0.100, 238, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4481, 4ag4H, 0.5016, 4.35, 0.105, 209, 114, CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
4482, 3vi3D, 0.5016, 4.32, 0.088, 432, 113, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
4483, 3vd2B, 0.5016, 3.69, 0.078, 200, 102, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4484, 3tzvB, 0.5016, 3.87, 0.093, 236, 107, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
4485, 3tpuH, 0.5016, 3.69, 0.067, 240, 105, 42F3 P5E8/H2-LD COMPLEX
4486, 3qpqE, 0.5016, 4.09, 0.084, 215, 107, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
4487, 3pwpD, 0.5016, 3.90, 0.103, 200, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
4488, 3mlrH, 0.5016, 4.17, 0.053, 226, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
4489, 3lrsH, 0.5016, 4.12, 0.062, 220, 112, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4490, 3lrsC, 0.5016, 4.17, 0.080, 228, 112, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4491, 3iywH, 0.5016, 4.01, 0.045, 229, 110, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
4492, 3ixtL, 0.5016, 3.89, 0.095, 211, 105, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
4493, 3ixtB, 0.5016, 3.89, 0.095, 210, 105, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
4494, 3iu3C, 0.5016, 3.94, 0.092, 215, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4495, 3hplB, 0.5016, 4.09, 0.103, 212, 107, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
4496, 3chnO, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4497, 3chnN, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4498, 3chnM, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4499, 3chnL, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4500, 2zjsH, 0.5016, 4.34, 0.061, 220, 114, CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
4501, 2vdnH, 0.5016, 4.14, 0.071, 219, 112, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
4502, 2uylX, 0.5016, 4.17, 0.111, 216, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4503, 2r56L, 0.5016, 4.09, 0.093, 211, 107, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
4504, 2qtjO, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4505, 2qtjN, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4506, 2qtjM, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4507, 2qtjL, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4508, 2mcpH, 0.5016, 4.07, 0.063, 222, 111, REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
4509, 2h1lV, 0.5016, 3.92, 0.058, 199, 104, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4510, 2gk0L, 0.5016, 4.05, 0.123, 217, 106, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
4511, 2esgM, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4512, 2esgL, 0.5016, 4.07, 0.084, 214, 107, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4513, 2bmkH, 0.5016, 4.10, 0.080, 221, 112, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
4514, 2bipA, 0.5016, 3.79, 0.029, 185, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-R249S- N268D
4515, 2aepL, 0.5016, 4.09, 0.093, 129, 107, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
4516, 1xf3H, 0.5016, 4.00, 0.073, 216, 109, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4517, 1vgeL, 0.5016, 4.07, 0.084, 214, 107, TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
4518, 1uweH, 0.5016, 4.29, 0.071, 218, 112, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
4519, 1r3kA, 0.5016, 4.08, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
4520, 1q1jI, 0.5016, 4.06, 0.063, 231, 111, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
4521, 1ngwA, 0.5016, 4.06, 0.084, 213, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
4522, 1nbvH, 0.5016, 3.88, 0.073, 219, 109, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
4523, 1mjjH, 0.5016, 4.18, 0.089, 209, 112, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
4524, 1mimH, 0.5016, 3.94, 0.092, 215, 109, IGG FAB FRAGMENT (CD25-BINDING)
4525, 1lp9L, 0.5016, 3.75, 0.123, 194, 106, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
4526, 1igaD, 0.5016, 4.07, 0.084, 214, 107, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4527, 1igaC, 0.5016, 4.07, 0.084, 214, 107, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4528, 1bbdL, 0.5016, 4.02, 0.112, 219, 107, THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
4529, 6o39A, 0.5015, 3.87, 0.085, 212, 106, CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH F2.I FAB 
4530, 6idhL, 0.5015, 4.15, 0.111, 217, 108, ANTIBODY 64M-5 FAB IN LIGAND-FREE FORM 
4531, 6flcB, 0.5015, 4.07, 0.081, 216, 111, 2C8 FAB BOUND TO EDIII OF DENV 2 
4532, 6ff9C, 0.5015, 3.77, 0.069, 193, 102, MUTANT R280K OF HUMAN P53 
4533, 6b5nL, 0.5015, 4.05, 0.093, 219, 107, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4534, 5wjoD, 0.5015, 3.92, 0.103, 237, 107, CRYSTAL STRUCTURE OF THE UNLIGANDED PG90 TCR
4535, 5u72B, 0.5015, 3.90, 0.123, 200, 106, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
4536, 5mp1C, 0.5015, 4.08, 0.072, 214, 111, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
4537, 5mjvC, 0.5015, 3.92, 0.049, 257, 103, REBUILD AND RE-REFINED MODEL FOR HUMAN PARECHOVIRUS 1
4538, 5iczA, 0.5015, 4.06, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
4539, 5i71B, 0.5015, 4.21, 0.088, 218, 113, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
4540, 5a3iG, 0.5015, 4.21, 0.071, 226, 113, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
4541, 4zffB, 0.5015, 4.07, 0.075, 210, 107, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
4542, 4zezH, 0.5015, 3.92, 0.093, 241, 107, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
4543, 4wffF, 0.5015, 3.88, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
4544, 4s1sH, 0.5015, 4.21, 0.071, 228, 113, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H5.F-185917 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
4545, 4pjcF, 0.5015, 3.76, 0.075, 239, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
4546, 4nrxE, 0.5015, 3.94, 0.104, 211, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
4547, 4nhuB, 0.5015, 3.76, 0.075, 238, 106, THE M33 TCR P3M33L/H-2 LD COMPLEX
4548, 4mhhI, 0.5015, 4.05, 0.121, 217, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4549, 4kxzL, 0.5015, 4.11, 0.084, 213, 107, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4550, 4g6kL, 0.5015, 4.07, 0.075, 212, 107, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
4551, 3v6fB, 0.5015, 4.05, 0.112, 219, 107, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4552, 3qumH, 0.5015, 4.15, 0.089, 217, 112, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4553, 3o6fH, 0.5015, 3.86, 0.093, 243, 107, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
4554, 3fb8A, 0.5015, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
4555, 3fb6A, 0.5015, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
4556, 3fb5A, 0.5015, 4.16, 0.089, 219, 112, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
4557, 3f7yA, 0.5015, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
4558, 3f5wA, 0.5015, 4.29, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
4559, 2xtlB, 0.5015, 3.86, 0.096, 452, 104, STRUCTURE OF THE MAJOR PILUS BACKBONE PROTEIN FROM STREPTOCOCCUS AGALACTIAE
4560, 2q76A, 0.5015, 4.04, 0.112, 212, 107, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
4561, 2nw2B, 0.5015, 3.84, 0.112, 243, 107, CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
4562, 2iamC, 0.5015, 3.82, 0.123, 198, 106, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4563, 2hfeB, 0.5015, 4.09, 0.103, 211, 107, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
4564, 2fl5H, 0.5015, 4.10, 0.063, 220, 111, COFACTOR-CONTAINING ANTIBODIES: CRYSTAL STRUCTURE OF THE ORIGINAL YELLOW ANTIBODY
4565, 2fatL, 0.5015, 3.82, 0.114, 212, 105, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
4566, 2bocA, 0.5015, 4.23, 0.089, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
4567, 2biqA, 0.5015, 3.79, 0.029, 185, 103, HUMAN P53 CORE DOMAIN MUTANT T123A-M133L-H168R-V203A-N239Y- R249S-N268D
4568, 1za6E, 0.5015, 4.08, 0.093, 220, 107, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4569, 1xf5D, 0.5015, 4.19, 0.089, 218, 112, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
4570, 1uweV, 0.5015, 4.29, 0.071, 218, 112, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
4571, 1otuF, 0.5015, 3.95, 0.133, 211, 105, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
4572, 1ngwL, 0.5015, 4.06, 0.093, 213, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
4573, 1nakM, 0.5015, 3.93, 0.123, 217, 106, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4574, 1mieL, 0.5015, 4.08, 0.084, 218, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
4575, 1mexL, 0.5015, 4.10, 0.112, 213, 107, ANTIBODY CATALYSIS OF A BIMOLECULAR CYCLOADDITION REACTION
4576, 1kegH, 0.5015, 4.13, 0.071, 216, 112, ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
4577, 1k4cA, 0.5015, 4.29, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
4578, 6mxsB, 0.5014, 4.03, 0.074, 217, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
4579, 6fy3X, 0.5014, 4.11, 0.062, 178, 112, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4580, 6fy0H, 0.5014, 4.10, 0.080, 226, 112, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4581, 6fr3B, 0.5014, 3.82, 0.094, 243, 106, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
4582, 6eh8A, 0.5014, 3.90, 0.119, 201, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4583, 6au5C, 0.5014, 4.04, 0.084, 213, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
4584, 6al5H, 0.5014, 4.22, 0.071, 221, 112, COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
4585, 5wuxA, 0.5014, 4.19, 0.062, 210, 113, TNFALPHA-CERTOLIZUMAB FAB
4586, 5vjoB, 0.5014, 4.06, 0.112, 211, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4587, 5hysD, 0.5014, 4.02, 0.075, 217, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4588, 5gz0A, 0.5014, 4.07, 0.084, 213, 107, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
4589, 5eszA, 0.5014, 4.07, 0.099, 212, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
4590, 5d7jG, 0.5014, 3.86, 0.132, 196, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
4591, 5d6cL, 0.5014, 4.17, 0.093, 219, 108, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
4592, 4p5sA, 0.5014, 2.95, 0.159, 105, 88, STRUCTURE OF REDUCED W45Y MUTANT OF AMICYANIN
4593, 4n8cI, 0.5014, 4.31, 0.079, 221, 114, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
4594, 4fqrp, 0.5014, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4595, 4djmC, 0.5014, 3.16, 0.096, 199, 94, CRYSTAL STRUCTURE OF THE E. COLI CHAPERONE DRAB
4596, 3tt1I, 0.5014, 4.13, 0.071, 212, 112, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4597, 3tfkD, 0.5014, 3.67, 0.076, 239, 105, 42F3-P4B10/H2-LD
4598, 3sjvE, 0.5014, 3.86, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
4599, 3qdmD, 0.5014, 3.90, 0.152, 195, 105, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
4600, 3pl6C, 0.5014, 3.97, 0.111, 191, 108, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
4601, 3nz8B, 0.5014, 4.04, 0.121, 217, 107, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4602, 3mlsJ, 0.5014, 4.09, 0.054, 226, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4603, 3lqaH, 0.5014, 3.98, 0.063, 225, 111, CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB
4604, 3hfmL, 0.5014, 4.02, 0.112, 214, 107, STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
4605, 3fb7A, 0.5014, 4.16, 0.089, 219, 112, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
4606, 2xqyK, 0.5014, 4.07, 0.103, 218, 107, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
4607, 2w0fA, 0.5014, 4.24, 0.089, 218, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
4608, 2qr0S, 0.5014, 4.04, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4609, 2o5zL, 0.5014, 4.06, 0.112, 218, 107, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
4610, 2i60R, 0.5014, 4.04, 0.071, 222, 112, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4611, 1v7nL, 0.5014, 3.89, 0.114, 213, 105, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4612, 1uweY, 0.5014, 4.29, 0.071, 218, 112, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
4613, 1mlcA, 0.5014, 4.05, 0.103, 214, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
4614, 1g6rB, 0.5014, 3.77, 0.075, 237, 106, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
4615, 1fptL, 0.5014, 4.05, 0.121, 219, 107, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
4616, 1fl6H, 0.5014, 4.08, 0.071, 219, 112, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
4617, 1ck0L, 0.5014, 4.03, 0.121, 216, 107, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II UNLIGANDED FORM
4618, 1bd2E, 0.5014, 3.75, 0.085, 242, 106, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
4619, 6mejH, 0.5013, 3.99, 0.055, 225, 110, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4620, 6hf1C, 0.5013, 4.20, 0.054, 209, 112, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
4621, 6fy2X, 0.5013, 4.16, 0.080, 219, 113, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
4622, 6fy1H, 0.5013, 4.07, 0.080, 226, 112, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
4623, 6ff9B, 0.5013, 3.81, 0.039, 193, 103, MUTANT R280K OF HUMAN P53 
4624, 6ff9A, 0.5013, 3.71, 0.069, 193, 102, MUTANT R280K OF HUMAN P53 
4625, 6eleB, 0.5013, 4.04, 0.084, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4626, 6cmgC, 0.5013, 4.05, 0.063, 226, 111, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
4627, 6axpA, 0.5013, 4.05, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
4628, 6a0xE, 0.5013, 4.10, 0.054, 223, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
4629, 5yd5C, 0.5013, 4.17, 0.062, 240, 112, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
4630, 5xajE, 0.5013, 4.16, 0.054, 215, 112, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
4631, 5uddS, 0.5013, 4.05, 0.084, 211, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4632, 5kzpH, 0.5013, 4.06, 0.081, 226, 111, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
4633, 5ibuH, 0.5013, 4.14, 0.054, 219, 111, FAB (UNBOUND)
4634, 5i1jH, 0.5013, 4.23, 0.080, 213, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
4635, 5hysL, 0.5013, 4.02, 0.075, 217, 107, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4636, 5esqA, 0.5013, 4.05, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
4637, 5e2wL, 0.5013, 4.05, 0.093, 216, 107, ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE
4638, 5drnB, 0.5013, 4.13, 0.074, 215, 108, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
4639, 5dmgD, 0.5013, 4.01, 0.075, 217, 107, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
4640, 5a1zG, 0.5013, 3.85, 0.056, 120, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
4641, 5a16H, 0.5013, 4.08, 0.084, 218, 107, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
4642, 4wfhF, 0.5013, 3.89, 0.105, 211, 105, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4643, 4pjxE, 0.5013, 3.74, 0.133, 187, 105, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
4644, 4laqL, 0.5013, 4.04, 0.132, 118, 106, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4645, 4ibzD, 0.5013, 3.71, 0.059, 192, 102, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R
4646, 4g7vL, 0.5013, 4.04, 0.084, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
4647, 4fqrv, 0.5013, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4648, 4fp8L, 0.5013, 4.06, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4649, 4fp8I, 0.5013, 3.97, 0.100, 238, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4650, 4f33H, 0.5013, 4.30, 0.062, 219, 113, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4651, 4f33F, 0.5013, 4.30, 0.062, 219, 113, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
4652, 4bwuA, 0.5013, 2.63, 0.140, 123, 86, THREE-DIMENSIONAL STRUCTURE OF THE K109A MUTANT OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN AT PH 5.5
4653, 3u4eA, 0.5013, 3.90, 0.074, 227, 108, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
4654, 3tt3L, 0.5013, 4.03, 0.093, 216, 107, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4655, 3o4lE, 0.5013, 4.03, 0.083, 245, 109, GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
4656, 3njkA, 0.5013, 2.93, 0.054, 122, 93, D116A MUTANT OF SO1698 PROTEIN AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS AT PH5.5
4657, 3mj8H, 0.5013, 3.95, 0.073, 211, 110, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
4658, 3j6mB, 0.5013, 4.11, 0.083, 124, 109, KINETIC AND STRUCTURAL ANALYSIS OF COXSACKIEVIRUS B3 RECEPTOR INTERACTIONS AND FORMATION OF THE A-PARTICLE
4659, 3ijhA, 0.5013, 4.04, 0.103, 217, 107, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4660, 3gi9L, 0.5013, 4.05, 0.093, 219, 107, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
4661, 2vlrE, 0.5013, 3.91, 0.084, 240, 107, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4662, 2vljE, 0.5013, 3.88, 0.084, 240, 107, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4663, 2o5xL, 0.5013, 4.07, 0.112, 218, 107, CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
4664, 2jk5A, 0.5013, 4.32, 0.088, 219, 113, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
4665, 2ianD, 0.5013, 3.78, 0.124, 198, 105, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4666, 2brrY, 0.5013, 4.16, 0.071, 225, 113, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
4667, 2bnuB, 0.5013, 3.75, 0.085, 241, 106, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
4668, 1p69B, 0.5013, 4.11, 0.083, 124, 109, STRUCTURAL BASIS FOR VARIATION IN ADENOVIRUS AFFINITY FOR THE CELLULAR RECEPTOR CAR (P417S MUTANT)
4669, 1nmbH, 0.5013, 3.97, 0.093, 122, 108, THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
4670, 1lk3I, 0.5013, 4.31, 0.070, 219, 114, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
4671, 1kacB, 0.5013, 4.11, 0.083, 124, 109, KNOB DOMAIN FROM ADENOVIRUS SEROTYPE 12 IN COMPLEX WITH DOMAIN 1 OF ITS CELLULAR RECEPTOR CAR
4672, 1igyC, 0.5013, 4.10, 0.112, 213, 107, STRUCTURE OF IMMUNOGLOBULIN
4673, 1hu8C, 0.5013, 3.71, 0.039, 186, 103, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DNA-BINDING DOMAIN AT 2.7A RESOLUTION
4674, 1fgnL, 0.5013, 3.95, 0.094, 214, 106, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
4675, 1cf8L, 0.5013, 4.02, 0.113, 215, 106, CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
4676, 1c5dL, 0.5013, 3.96, 0.104, 213, 106, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
4677, 1bqrA, 0.5013, 2.68, 0.128, 124, 86, REDUCED PSEUDOAZURIN
4678, 1bbjL, 0.5013, 3.94, 0.113, 211, 106, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4679, 1bbjA, 0.5013, 3.94, 0.113, 211, 106, CRYSTAL STRUCTURE OF A CHIMERIC FAB  FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS
4680, 6jmrD, 0.5012, 4.02, 0.103, 219, 107, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
4681, 6eqbD, 0.5012, 3.87, 0.112, 196, 107, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
4682, 6ea7H, 0.5012, 3.98, 0.081, 213, 111, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
4683, 6ea5Q, 0.5012, 4.12, 0.080, 222, 112, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
4684, 6dwiB, 0.5012, 3.95, 0.065, 202, 108, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4685, 6dcvB, 0.5012, 4.29, 0.088, 226, 114, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
4686, 6dcaH, 0.5012, 4.25, 0.071, 213, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
4687, 6d0uD, 0.5012, 4.08, 0.075, 213, 107, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
4688, 6cxyL, 0.5012, 3.92, 0.113, 217, 106, CRYSTAL STRUCTURE OF HUMAN E-CADHERIN BOUND BY MOUSE MONOCLONAL ANTIBODY FAB MAB-1_19A11 
4689, 6cbvL, 0.5012, 4.03, 0.075, 213, 107, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
4690, 5whzL, 0.5012, 4.09, 0.112, 336, 107, PGDM1400-10E8V4 CODV FAB
4691, 5umnD, 0.5012, 4.09, 0.084, 213, 107, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4692, 5mx3A, 0.5012, 4.05, 0.072, 219, 111, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4693, 5hdqH, 0.5012, 4.21, 0.071, 213, 113, MNTC CO-STRUCTURE WITH MAB 305-78-7
4694, 5aumB, 0.5012, 4.08, 0.093, 216, 107, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
4695, 5aolB, 0.5012, 3.79, 0.029, 197, 103, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND 3-BROMO-5- (TRIFLUOROMETHYL)BENZENE-12-DIAMINE
4696, 4yo0A, 0.5012, 4.05, 0.081, 209, 111, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
4697, 4w2pB, 0.5012, 4.01, 0.072, 122, 111, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
4698, 4rgmC, 0.5012, 4.06, 0.089, 217, 112, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
4699, 4pj7H, 0.5012, 3.81, 0.093, 238, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
4700, 4odsL, 0.5012, 4.06, 0.103, 218, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3
4701, 4o5iW, 0.5012, 4.07, 0.055, 226, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4702, 4nqcD, 0.5012, 3.76, 0.133, 185, 105, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
4703, 4khtH, 0.5012, 4.01, 0.055, 214, 110, TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066
4704, 4k7pH, 0.5012, 4.08, 0.080, 213, 112, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4705, 4h0gA, 0.5012, 4.19, 0.088, 242, 113, CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV
4706, 3u2sH, 0.5012, 3.92, 0.083, 227, 108, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4707, 3sdxH, 0.5012, 3.82, 0.094, 240, 106, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
4708, 3revB, 0.5012, 3.77, 0.094, 240, 106, CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
4709, 3iywK, 0.5012, 4.02, 0.045, 229, 110, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
4710, 3ijsC, 0.5012, 4.02, 0.112, 216, 107, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
4711, 3hr5P, 0.5012, 4.01, 0.093, 219, 107, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4712, 3hi1L, 0.5012, 4.03, 0.093, 215, 107, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
4713, 3cm9O, 0.5012, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
4714, 3cm9N, 0.5012, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
4715, 3cm9M, 0.5012, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
4716, 3cm9L, 0.5012, 4.06, 0.075, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
4717, 2vlkE, 0.5012, 3.89, 0.084, 240, 107, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4718, 2pcpC, 0.5012, 4.19, 0.120, 216, 108, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4719, 2j1wB, 0.5012, 3.78, 0.029, 195, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-V143A-V203A-N239Y-N268D
4720, 2itdA, 0.5012, 4.26, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
4721, 2ig2H, 0.5012, 4.08, 0.054, 238, 111, DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE LAMBDA-TYP SUBGRUPPE I (GERMAN)
4722, 2hffA, 0.5012, 4.05, 0.093, 213, 107, CRYSTAL STRUCTURE OF CB2 FAB
4723, 2g5bB, 0.5012, 4.12, 0.062, 216, 112, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4724, 2fd6H, 0.5012, 4.14, 0.072, 212, 111, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
4725, 1q1jH, 0.5012, 4.14, 0.071, 231, 112, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
4726, 1mj7L, 0.5012, 4.08, 0.093, 218, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
4727, 1mhhC, 0.5012, 4.09, 0.093, 219, 107, ANTIBODY-ANTIGEN COMPLEX
4728, 1g6rD, 0.5012, 3.77, 0.075, 237, 106, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
4729, 1fl5H, 0.5012, 4.05, 0.072, 219, 111, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
4730, 6qnkB, 0.5011, 4.07, 0.081, 221, 111, ANTIBODY FAB FRAGMENT TARGETING GI PROTEIN HETEROTRIMER 
4731, 6my4B, 0.5011, 4.04, 0.093, 217, 108, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
4732, 6gk8H, 0.5011, 4.15, 0.089, 222, 112, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-28.1; DOUBLE MUTANT (S32R; E35K) OF CBTAU-28.1; IN COMPLEX WITH TAU PEPTIDE A7731 (RESIDUES 52-71) 
4733, 6fr4B, 0.5011, 3.82, 0.085, 243, 106, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
4734, 6emjB, 0.5011, 4.04, 0.084, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4735, 6cdmA, 0.5011, 4.19, 0.097, 218, 113, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4736, 6bzwD, 0.5011, 4.09, 0.103, 216, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
4737, 6apdL, 0.5011, 3.85, 0.086, 213, 105, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4738, 5xzcD, 0.5011, 3.76, 0.039, 232, 103, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
4739, 5vr9L, 0.5011, 3.93, 0.075, 212, 106, CH1/CKAPPA FAB BASED ON MATUZUMAB
4740, 5uemH, 0.5011, 4.16, 0.071, 230, 113, CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
4741, 5u17D, 0.5011, 3.89, 0.123, 200, 106, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
4742, 5th9L, 0.5011, 3.94, 0.094, 214, 106, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
4743, 5t33H, 0.5011, 3.93, 0.073, 223, 109, CRYSTAL STRUCTURE OF STRAIN-SPECIFIC GLYCAN-DEPENDENT CD4 BINDING SITE-DIRECTED NEUTRALIZING ANTIBODY CAP257-RH1 IN COMPLEX WITH HIV-1 STRAIN RHPA GP120 CORE WITH AN OLIGOMANNOSE N276 GLYCAN.
4744, 5k8aE, 0.5011, 3.86, 0.095, 213, 105, NIST FAB
4745, 5ivzA, 0.5011, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
4746, 5it2H, 0.5011, 4.24, 0.080, 218, 113, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
4747, 5i15L, 0.5011, 4.08, 0.084, 214, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
4748, 5hd8F, 0.5011, 3.88, 0.144, 211, 104, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
4749, 5guxH, 0.5011, 4.03, 0.090, 225, 111, CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH XENON
4750, 5eocH, 0.5011, 4.35, 0.105, 212, 114, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
4751, 4xvuC, 0.5011, 4.07, 0.073, 222, 110, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
4752, 4pljL, 0.5011, 4.09, 0.093, 212, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4753, 4ozhG, 0.5011, 3.82, 0.124, 195, 105, S16 PROTEIN COMPLEX
4754, 4ozfG, 0.5011, 3.92, 0.142, 193, 106, JR5.1 PROTEIN COMPLEX
4755, 4okvA, 0.5011, 4.35, 0.106, 214, 113, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4756, 4ofyA, 0.5011, 3.98, 0.077, 230, 104, CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4
4757, 4guoJ, 0.5011, 3.75, 0.097, 199, 103, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4758, 4fqrx, 0.5011, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4759, 4fqrh, 0.5011, 4.05, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4760, 4dzbA, 0.5011, 3.85, 0.123, 196, 106, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
4761, 3vgaC, 0.5011, 4.31, 0.079, 220, 114, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
4762, 3uluH, 0.5011, 4.19, 0.080, 225, 113, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
4763, 3u36E, 0.5011, 3.92, 0.083, 215, 108, CRYSTAL STRUCTURE OF PG9 FAB
4764, 3u36A, 0.5011, 3.92, 0.083, 216, 108, CRYSTAL STRUCTURE OF PG9 FAB
4765, 3okeB, 0.5011, 4.05, 0.089, 217, 112, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
4766, 3ietA, 0.5011, 4.04, 0.121, 215, 107, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
4767, 3i9gL, 0.5011, 4.06, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
4768, 3bgfH, 0.5011, 4.33, 0.088, 216, 113, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
4769, 2xnaA, 0.5011, 4.04, 0.103, 199, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
4770, 2uylV, 0.5011, 4.17, 0.111, 216, 108, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4771, 2qr0Q, 0.5011, 4.04, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4772, 2qr0M, 0.5011, 4.04, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4773, 2qr0K, 0.5011, 4.03, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4774, 2j20B, 0.5011, 3.79, 0.029, 194, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273C
4775, 2i60H, 0.5011, 4.03, 0.063, 221, 111, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4776, 2bukA, 0.5011, 4.97, 0.052, 184, 116, SATELLITE TOBACCO NECROSIS VIRUS
4777, 1xf4B, 0.5011, 4.12, 0.080, 213, 112, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4778, 1ws8C, 0.5011, 2.86, 0.141, 103, 92, CRYSTAL STRUCTURE OF MAVICYANIN FROM CUCURBITA PEPO MEDULLOSA (ZUCCHINI)
4779, 1mf2M, 0.5011, 3.95, 0.094, 215, 106, ANTI HIV1 PROTEASE FAB COMPLEX
4780, 1fe8M, 0.5011, 4.06, 0.075, 211, 107, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
4781, 1emtL, 0.5011, 4.09, 0.084, 214, 107, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
4782, 1cicA, 0.5011, 4.03, 0.131, 214, 107, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
4783, 1ce1L, 0.5011, 4.08, 0.084, 211, 107, 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
4784, 1ao7D, 0.5011, 3.87, 0.104, 115, 106, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR VIRAL PEPTIDE (TAX) AND HLA-A 0201
4785, 6n81L, 0.5010, 4.07, 0.075, 211, 107, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
4786, 6i04D, 0.5010, 4.06, 0.065, 212, 107, CRYSTAL STRUCTURE OF SEMA DOMAIN OF THE MET RECEPTOR IN COMPLEX WITH FAB 
4787, 6ehwB, 0.5010, 4.11, 0.093, 237, 107, SCFV ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN DRUG DISCOVERY
4788, 6dfqA, 0.5010, 3.96, 0.065, 195, 108, MOUSE DIABETOGENIC TCR I.29 
4789, 6bb4I, 0.5010, 4.14, 0.098, 216, 112, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
4790, 6bb4H, 0.5010, 4.10, 0.098, 216, 112, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
4791, 6azlC, 0.5010, 4.04, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
4792, 6axpC, 0.5010, 4.05, 0.084, 212, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
4793, 5yw3D, 0.5010, 2.69, 0.128, 124, 86, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN THR36LYS VARIANT 
4794, 5tljC, 0.5010, 4.06, 0.093, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4795, 5tjeH, 0.5010, 3.94, 0.065, 232, 107, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
4796, 5t1kC, 0.5010, 4.04, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4797, 5mo9H, 0.5010, 4.14, 0.080, 212, 112, STRUCTURE OF HUMAN TRKB RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE FAB FRGMENT OF ANTIBODY AB20
4798, 5mi0B, 0.5010, 3.98, 0.073, 221, 110, A THERMALLY STABILISED VERSION OF PLASMODIUM FALCIPARUM RH5
4799, 5iq9A, 0.5010, 4.00, 0.109, 227, 110, CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.
4800, 5ibtH, 0.5010, 4.22, 0.080, 218, 113, UCA FAB (UNBOUND) FROM 6515 LINEAGE
4801, 5h2bA, 0.5010, 4.28, 0.079, 216, 114, STRUCTURE OF A NOVEL ANTIBODY G196
4802, 5g4nB, 0.5010, 3.87, 0.029, 197, 104, CRYSTAL STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH A DIFLUORINATED DERIVATIVE OF THE SMALL MOLECULE STABILIZER PHIKAN083
4803, 5f88C, 0.5010, 4.05, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
4804, 5dqjL, 0.5010, 4.06, 0.112, 217, 107, STRUCTURE OF UNLIGANDED S55-5 FAB
4805, 5dk3A, 0.5010, 4.05, 0.075, 218, 107, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
4806, 5d2lP, 0.5010, 3.98, 0.110, 235, 109, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
4807, 5c0nD, 0.5010, 4.12, 0.065, 216, 107, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
4808, 5anmH, 0.5010, 4.22, 0.054, 208, 112, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4809, 5a8hJ, 0.5010, 4.04, 0.063, 229, 111, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4810, 5a7xL, 0.5010, 4.04, 0.063, 229, 111, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4811, 5a7bB, 0.5010, 3.78, 0.029, 197, 103, STRUCTURE OF THE P53 CANCER Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5211
4812, 4zpvB, 0.5010, 4.05, 0.084, 212, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
4813, 4x6bD, 0.5010, 3.90, 0.065, 240, 107, BK6 TCR APO STRUCTURE
4814, 4qexM, 0.5010, 4.06, 0.093, 213, 107, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
4815, 4qexL, 0.5010, 4.06, 0.093, 212, 107, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
4816, 4pj7F, 0.5010, 3.73, 0.094, 238, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
4817, 4pj5G, 0.5010, 3.98, 0.121, 190, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
4818, 4oz4A, 0.5010, 4.03, 0.072, 219, 111, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4819, 4ms8D, 0.5010, 3.67, 0.076, 239, 105, 42F3 TCR PCPB9/H-2LD COMPLEX
4820, 4jo1M, 0.5010, 4.13, 0.083, 216, 108, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
4821, 4jo1L, 0.5010, 4.13, 0.083, 216, 108, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
4822, 4gkzB, 0.5010, 3.81, 0.057, 241, 106, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4823, 4gayB, 0.5010, 4.06, 0.103, 216, 107, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4824, 4fqrn, 0.5010, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4825, 4f2mA, 0.5010, 4.14, 0.089, 214, 112, CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
4826, 4dvbB, 0.5010, 4.02, 0.123, 215, 106, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4827, 4bxvA, 0.5010, 2.42, 0.153, 123, 85, THREE-DIMENSIONAL STRUCTURE OF THE MUTANT K109A OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN AT PH 7.0
4828, 3w13D, 0.5010, 3.81, 0.106, 114, 104, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHACT PEPTIDE(693-719) AND FAB 83-7
4829, 3utpK, 0.5010, 3.90, 0.075, 201, 106, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
4830, 3u36C, 0.5010, 3.92, 0.083, 216, 108, CRYSTAL STRUCTURE OF PG9 FAB
4831, 3t0eD, 0.5010, 3.96, 0.083, 245, 109, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
4832, 3nn8C, 0.5010, 3.88, 0.075, 122, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4833, 3mlvN, 0.5010, 4.17, 0.053, 221, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
4834, 3hi1A, 0.5010, 4.03, 0.093, 215, 107, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
4835, 3ef4B, 0.5010, 2.79, 0.138, 124, 87, CRYSTAL STRUCTURE OF NATIVE PSEUDOAZURIN FROM HYPHOMICROBIUM DENITRIFICANS
4836, 2cdeC, 0.5010, 3.97, 0.112, 192, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
4837, 2ap2D, 0.5010, 4.07, 0.064, 122, 109, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
4838, 1zibA, 0.5010, 2.49, 0.129, 124, 85, REDUCED PSEUDOAZURIN
4839, 1z3gL, 0.5010, 3.96, 0.114, 213, 105, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
4840, 1xf2B, 0.5010, 4.17, 0.080, 213, 112, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
4841, 1uywH, 0.5010, 4.15, 0.071, 218, 112, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
4842, 1kb5L, 0.5010, 4.10, 0.140, 214, 107, MURINE T-CELL RECEPTOR VARIABLE DOMAIN/FAB COMPLEX
4843, 1ibgL, 0.5010, 4.03, 0.093, 217, 107, STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
4844, 1fl5B, 0.5010, 4.06, 0.072, 219, 111, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
4845, 1fbiH, 0.5010, 4.08, 0.090, 221, 111, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
4846, 1ehlH, 0.5010, 4.17, 0.071, 217, 112, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
4847, 6oknD, 0.5009, 4.08, 0.065, 213, 107, OX40R (TNFRSF4) BOUND TO FAB 1A7 
4848, 6flcH, 0.5009, 4.08, 0.081, 216, 111, 2C8 FAB BOUND TO EDIII OF DENV 2 
4849, 6a3wJ, 0.5009, 4.06, 0.064, 116, 109, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
4850, 5ztdB, 0.5009, 2.83, 0.138, 124, 87, X-RAY CRYSTAL STRUCTURE OF PSEUDOAZURIN MET16VAL VARIANT 
4851, 5w08K, 0.5009, 4.14, 0.062, 235, 112, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4852, 5vigB, 0.5009, 4.06, 0.065, 212, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
4853, 5vicL, 0.5009, 4.06, 0.075, 211, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z004 BOUND TO DENV-1 ENVELOPE PROTEIN DIII
4854, 5u3kA, 0.5009, 3.86, 0.064, 218, 109, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 662- 683 PEPTIDE
4855, 5tztL, 0.5009, 3.97, 0.104, 219, 106, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4856, 5tztB, 0.5009, 4.11, 0.093, 218, 107, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4857, 5th2A, 0.5009, 4.05, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
4858, 5o1iB, 0.5009, 3.68, 0.049, 197, 102, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB710 
4859, 5i6zC, 0.5009, 4.10, 0.121, 214, 107, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
4860, 5cusK, 0.5009, 4.02, 0.073, 180, 110, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
4861, 5c0nL, 0.5009, 4.13, 0.065, 216, 107, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
4862, 5b1jC, 0.5009, 2.58, 0.128, 124, 86, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
4863, 5aojB, 0.5009, 3.98, 0.029, 197, 105, STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH 2- HYDROXY-35-DIIODO-4-(1H-PYRROL-1-YL)BENZOIC ACID
4864, 4wk2B, 0.5009, 4.56, 0.085, 427, 117, METAL ION AND LIGAND BINDING OF INTEGRIN
4865, 4pjdE, 0.5009, 3.75, 0.133, 188, 105, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
4866, 4pj5D, 0.5009, 3.92, 0.123, 200, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
4867, 4nkoA, 0.5009, 4.11, 0.093, 115, 107, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4868, 4jm4L, 0.5009, 4.00, 0.085, 214, 106, CRYSTAL STRUCTURE OF PGT 135 FAB
4869, 4hwbH, 0.5009, 4.13, 0.071, 216, 112, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4870, 4hs6A, 0.5009, 4.08, 0.093, 218, 107, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
4871, 4ebqL, 0.5009, 3.82, 0.114, 211, 105, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
4872, 4dktA, 0.5009, 3.84, 0.087, 636, 103, CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE 4 IN COMPLEX WITH N-ACETYL-L-THREONYL-L-ALPHA-ASPARTYL-N5-[(1E)-2- FLUOROETHANIMIDOYL]-L-ORNITHINAMIDE
4873, 3zk4A, 0.5009, 3.75, 0.039, 569, 102, STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS
4874, 3wd5L, 0.5009, 4.04, 0.084, 213, 107, CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
4875, 3vd0C, 0.5009, 3.61, 0.088, 202, 102, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4876, 3u36H, 0.5009, 3.92, 0.083, 216, 108, CRYSTAL STRUCTURE OF PG9 FAB
4877, 3sknB, 0.5009, 3.80, 0.075, 241, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
4878, 3sgeI, 0.5009, 3.92, 0.105, 219, 105, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
4879, 3ntcL, 0.5009, 4.18, 0.102, 219, 108, CRYSTAL STRUCTURE OF KD-247 FAB AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
4880, 3mbeD, 0.5009, 3.86, 0.065, 236, 107, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
4881, 3lmjH, 0.5009, 4.21, 0.062, 225, 112, STRUCTURE OF HUMAN ANTI HIV 21C FAB
4882, 3erxB, 0.5009, 2.60, 0.140, 123, 86, HIGH-RESOLUTION STRUCTURE OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN
4883, 3chnD, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4884, 3chnC, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4885, 3chnB, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4886, 3chnA, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4887, 2zkhH, 0.5009, 4.00, 0.073, 209, 110, HUMAN THROMBOPOIETIN NEUTRALIZING ANTIBODY TN1 FAB
4888, 2w9eL, 0.5009, 3.94, 0.114, 212, 105, STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
4889, 2qtjD, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4890, 2qtjC, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4891, 2qtjB, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4892, 2qtjA, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4893, 2j1yB, 0.5009, 3.72, 0.039, 193, 102, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-G245S-N268D
4894, 2exyF, 0.5009, 3.96, 0.133, 211, 105, CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC FAB COMPLEXED IN ABSENCE OF BOUND IONS
4895, 2esgB, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4896, 2esgA, 0.5009, 4.12, 0.062, 475, 112, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4897, 2cdfA, 0.5009, 4.01, 0.104, 191, 106, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
4898, 2cdeA, 0.5009, 4.00, 0.111, 192, 108, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
4899, 1xf4A, 0.5009, 4.09, 0.103, 213, 107, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4900, 1nd0C, 0.5009, 4.07, 0.131, 219, 107, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4901, 1igaB, 0.5009, 4.12, 0.062, 475, 112, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4902, 1igaA, 0.5009, 4.12, 0.062, 475, 112, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4903, 1i9iL, 0.5009, 4.07, 0.121, 219, 107, NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
4904, 1e6jL, 0.5009, 3.81, 0.105, 210, 105, CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
4905, 6ggeB, 0.5008, 3.88, 0.029, 198, 104, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9327 
4906, 6eyoM, 0.5008, 4.10, 0.093, 201, 107, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
4907, 6ea7M, 0.5008, 4.02, 0.081, 217, 111, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
4908, 5w08Q, 0.5008, 4.05, 0.063, 235, 111, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4909, 5w08I, 0.5008, 4.05, 0.063, 238, 111, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4910, 5vvfH, 0.5008, 4.13, 0.089, 223, 112, CRYSTAL STRUCTURE OF 354BG1 FAB
4911, 5vf2A, 0.5008, 4.33, 0.079, 237, 114, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE RE-REFINEMENT
4912, 5ur8A, 0.5008, 4.24, 0.071, 229, 113, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
4913, 5uddO, 0.5008, 4.13, 0.063, 216, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4914, 5udcC, 0.5008, 3.94, 0.085, 211, 106, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4915, 5u6qD, 0.5008, 3.89, 0.123, 200, 106, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
4916, 5mp3H, 0.5008, 4.05, 0.072, 219, 111, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
4917, 5mo3H, 0.5008, 4.15, 0.071, 219, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
4918, 5kbkA, 0.5008, 4.69, 0.086, 157, 116, CANDIDA ALBICANS SUPEROXIDE DISMUTASE 5 (SOD5) E110A MUTANT
4919, 5jhdE, 0.5008, 3.88, 0.084, 239, 107, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
4920, 5i74B, 0.5008, 4.29, 0.079, 218, 114, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
4921, 5i6zB, 0.5008, 3.98, 0.045, 218, 111, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
4922, 5a16B, 0.5008, 4.04, 0.084, 218, 107, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
4923, 4uv4L, 0.5008, 3.92, 0.094, 217, 106, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
4924, 4rgmH, 0.5008, 4.07, 0.089, 216, 112, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
4925, 4ozgF, 0.5008, 3.83, 0.123, 240, 106, D2 PROTEIN COMPLEX
4926, 4of3B, 0.5008, 3.70, 0.069, 233, 102, CRYSTAL STRUCTURE OF SYG-1 D1-D2 GLYCOSYLATED
4927, 4o4yL, 0.5008, 3.92, 0.094, 218, 106, CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
4928, 4nqeD, 0.5008, 3.91, 0.123, 200, 106, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
4929, 4mhhK, 0.5008, 4.06, 0.121, 217, 107, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4930, 4m1dI, 0.5008, 4.07, 0.062, 231, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
4931, 4jo2M, 0.5008, 4.02, 0.084, 216, 107, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
4932, 4irzL, 0.5008, 3.96, 0.066, 208, 106, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
4933, 4ibqB, 0.5008, 3.71, 0.059, 193, 102, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C
4934, 4hkbC, 0.5008, 4.11, 0.062, 218, 112, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4935, 4g8fB, 0.5008, 3.91, 0.074, 243, 108, CRYSTAL STRUCTURE OF CLONE42 TCR
4936, 4fqrt, 0.5008, 4.05, 0.075, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4937, 4fqrr, 0.5008, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4938, 4fqrb, 0.5008, 4.06, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4939, 4agnB, 0.5008, 3.79, 0.029, 197, 103, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5116
4940, 3zhdA, 0.5008, 4.02, 0.082, 119, 110, THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-4 SCAFFOLD.
4941, 3vi4F, 0.5008, 4.18, 0.062, 218, 112, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
4942, 3utsD, 0.5008, 3.86, 0.104, 200, 106, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
4943, 3mugH, 0.5008, 4.19, 0.089, 237, 112, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4944, 3mnwB, 0.5008, 4.02, 0.092, 204, 109, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE IN A HELICAL CONFORMATION
4945, 3mbeH, 0.5008, 3.86, 0.065, 236, 107, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
4946, 3iu3A, 0.5008, 4.03, 0.100, 215, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4947, 3ietC, 0.5008, 4.02, 0.121, 217, 107, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
4948, 3eo1K, 0.5008, 4.11, 0.063, 216, 111, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4949, 3eo1E, 0.5008, 4.11, 0.063, 216, 111, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4950, 2z91D, 0.5008, 3.88, 0.105, 208, 105, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
4951, 2z91B, 0.5008, 3.88, 0.105, 211, 105, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
4952, 2qr0W, 0.5008, 4.04, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4953, 2qr0G, 0.5008, 4.04, 0.084, 213, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4954, 2j21B, 0.5008, 3.77, 0.029, 188, 103, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R282W
4955, 2f54L, 0.5008, 3.84, 0.084, 241, 107, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
4956, 2brrH, 0.5008, 4.03, 0.063, 224, 111, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
4957, 2bocB, 0.5008, 4.12, 0.103, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
4958, 1xedE, 0.5008, 3.72, 0.076, 111, 105, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
4959, 1xedB, 0.5008, 3.45, 0.088, 109, 102, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
4960, 1t3fB, 0.5008, 4.05, 0.081, 219, 111, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
4961, 1r3kB, 0.5008, 4.23, 0.089, 219, 112, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
4962, 1q0yH, 0.5008, 4.06, 0.073, 215, 109, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
4963, 1mvuB, 0.5008, 4.03, 0.056, 121, 108, SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
4964, 1mhhA, 0.5008, 4.08, 0.093, 219, 107, ANTIBODY-ANTIGEN COMPLEX
4965, 1m71A, 0.5008, 3.98, 0.123, 215, 106, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE
4966, 1lo4H, 0.5008, 3.99, 0.064, 220, 109, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
4967, 1id2B, 0.5008, 2.87, 0.115, 106, 87, CRYSTAL STRUCTURE OF AMICYANIN FROM PARACOCCUS VERSUTUS (THIOBACILLUS VERSUTUS)
4968, 6my5L, 0.5007, 4.17, 0.101, 218, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
4969, 6gfeM, 0.5007, 3.95, 0.085, 215, 106, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
4970, 6ff9D, 0.5007, 3.68, 0.050, 193, 101, MUTANT R280K OF HUMAN P53 
4971, 5ywfD, 0.5007, 4.15, 0.062, 218, 113, CRYSTAL STRUCTURE OF 2H4 FAB
4972, 5y9jH, 0.5007, 3.97, 0.056, 218, 108, BAFF IN COMPLEX WITH BELIMUMAB
4973, 5xxyL, 0.5007, 4.07, 0.084, 211, 107, COMPLEX STRUCTURE OF PD-L1 WITH ATEZOLIZUMAB FAB
4974, 5xbmB, 0.5007, 4.29, 0.079, 221, 114, STRUCTURE OF SCARB2-JL2 COMPLEX 
4975, 5x2mH, 0.5007, 4.30, 0.061, 219, 114, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
4976, 5vjqB, 0.5007, 4.05, 0.112, 212, 107, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4977, 5u4lB, 0.5007, 4.06, 0.045, 131, 110, RTA-V1C7_G29R-HIGH-SALT
4978, 5tlkG, 0.5007, 4.02, 0.075, 215, 107, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4979, 5tljE, 0.5007, 4.18, 0.093, 215, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4980, 5t78A, 0.5007, 3.97, 0.123, 216, 106, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
4981, 5k59A, 0.5007, 4.40, 0.044, 292, 114, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
4982, 5e8dH, 0.5007, 4.22, 0.080, 216, 112, CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5
4983, 5dqjB, 0.5007, 4.06, 0.112, 217, 107, STRUCTURE OF UNLIGANDED S55-5 FAB
4984, 5d5mE, 0.5007, 3.88, 0.123, 200, 106, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
4985, 5d4kA, 0.5007, 4.00, 0.102, 539, 108, CRYSTAL STRUCTURE OF THE HUMAN POLYMERIC IG RECEPTOR (PIGR) ECTODOMAIN
4986, 5b3jF, 0.5007, 4.05, 0.084, 211, 107, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
4987, 4xbgA, 0.5007, 4.13, 0.080, 227, 112, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4988, 4v4mRA, 0.5007, 4.88, 0.026, 184, 115, 
4989, 4pjiG, 0.5007, 3.81, 0.132, 189, 106, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
4990, 4p5rA, 0.5007, 2.66, 0.151, 105, 86, STRUCTURE OF OXIDIZED W45Y MUTANT OF AMICYANIN
4991, 4lcwG, 0.5007, 3.90, 0.123, 188, 106, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4992, 4l4vG, 0.5007, 3.88, 0.123, 188, 106, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
4993, 4l3eD, 0.5007, 3.95, 0.103, 199, 107, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
4994, 4fp8N, 0.5007, 4.10, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4995, 4bwuB, 0.5007, 2.57, 0.163, 123, 86, THREE-DIMENSIONAL STRUCTURE OF THE K109A MUTANT OF PARACOCCUS PANTOTROPHUS PSEUDOAZURIN AT PH 5.5
4996, 3tpuN, 0.5007, 3.71, 0.067, 240, 105, 42F3 P5E8/H2-LD COMPLEX
4997, 3nabH, 0.5007, 4.20, 0.080, 217, 113, CRYSTAL STRUCTURE OF FAB15 MUT6
4998, 3mlsI, 0.5007, 4.18, 0.053, 226, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4999, 3ijyB, 0.5007, 4.06, 0.090, 221, 111, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
5000, 2vlrI, 0.5007, 3.83, 0.114, 199, 105, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
5001, 2r8sL, 0.5007, 3.94, 0.085, 214, 106, HIGH RESOLUTION STRUCTURE OF A SPECIFIC SYNTHETIC FAB BOUND TO P4-P6 RNA RIBOZYME DOMAIN
